<html lang="en"><head><!-- Shady DOM styles for custom-style --><!-- Shady DOM styles for dom-template --><!-- Shady DOM styles for dom-repeat --><!-- Shady DOM styles for array-selector --><!-- Shady DOM styles for dom-if --><!-- Shady DOM styles for state-modifier --><style scope="state-modifier">a[inherit].state-modifier {
  color: inherit;
}</style><!-- Shady DOM styles for browser-ui --><!-- Shady DOM styles for outlined-text-field --><style scope="outlined-text-field">outlined-text-field {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: column;
}

outlined-text-field span.outlined-text-field {
  display: flex;
  flex-direction: row;
  align-items: center;
}

outlined-text-field input.outlined-text-field {
  height: 40px;
  padding: 0 33px 0 16px;
  
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  flex-grow: 1;
}

outlined-text-field[orig] input.outlined-text-field {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-text-field[dense] input.outlined-text-field {
  height: 32px;
}

outlined-text-field[uppercase] input.outlined-text-field {
  text-transform: uppercase;
}

outlined-text-field:not([wizard-focused]):hover input.outlined-text-field {
  border-color: #737375;
  color: #414447;
}

outlined-text-field:not([wizard-focused]):focus-within input.outlined-text-field,outlined-text-field[wizard-focused] input.outlined-text-field {
  border-color: #3574e0;
  caret-color: #80a5f1;
}

outlined-text-field[wizard-focused] input.outlined-text-field {
  border-width: 2px;
}

outlined-text-field input.outlined-text-field::placeholder {
  color: #65686c;
}

outlined-text-field[uppercase] input.outlined-text-field::placeholder {
  text-transform: none;
}</style><!-- Shady DOM styles for mat-keyword-editor --><!-- Shady DOM styles for mat-chips-input --><!-- Shady DOM styles for mat-input-chip --><!-- Shady DOM styles for pat-dialog --><style scope="pat-dialog">pat-dialog {
  background: white;
  position: absolute;
  border-radius: 8px;
  
  box-shadow: 0 24px 38px 3px rgb(0 0 0 / 14%),
              0 9px 46px 8px rgb(0 0 0 / 12%),
              0 11px 15px -7px rgb(0 0 0 / 20%);
  z-index: 1;
  display: flex;
  flex-direction: column;
}

pat-dialog:not([open]) {
  display: none;
}</style><!-- Shady DOM styles for mat-tabs --><!-- Shady DOM styles for filter-chip --><style scope="filter-chip">filter-chip {
  align-items: center;
  background-color: #fff;
  border-color: #dadce0;
  border-radius: 8px;
  border-style: solid;
  border-width: 1px;
  color: #606368;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 32px;
  letter-spacing: 0.2px;
  padding: 0 16px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

filter-chip[disabled] {
  background-color: #e8e8e8;
  border-color: #e8e8e8;
  color: #a9abad;
  cursor: auto;
}

filter-chip svg.filter-chip {
  visibility: collapse;
  font-size: 18px;
  width: 0;
  height: 18px;
}

filter-chip[selected] svg.filter-chip {
  visibility: visible;
  margin: 0 8px;
  width: 18px;
}

filter-chip[selected] svg.filter-chip path.filter-chip {
  fill: #4577d1;
}

filter-chip:not([disabled]):hover {
  background-color: #f7f8f8;
  border-color: #d7d9dc;
  color: #454649;
}

filter-chip:not([disabled]):hover:active {
  background-color: #eff0f0;
  border-color: #d2d5d8;
  color: #222326;
}

filter-chip:not([disabled]):focus {
  background-color: #e7e8e8;
  border-color: #232528;
  color: #202124;
}

filter-chip:not([disabled])[selected] {
  background-color: #e9f0fd;
  border-color: #e9f0fd;
  color: #4577d1;
  padding-left: 0;
}

filter-chip:not([disabled]):focus[selected] {
  background-color: #d5e1fb;
  border-color: #d5e1fb;
  color: #2550a0;
}

filter-chip:not([disabled]):hover[selected] {
  box-shadow: rgba(0, 0, 0, 0.2) 0px 3px 1px -2px,
    rgba(0, 0, 0, 0.14) 0px 2px 2px 0px, rgba(0, 0, 0, 0.12) 0px 1px 5px 0px;
}

filter-chip:not([disabled]):hover:active[selected] {
  background-color: #abc8f2;
  border-color: #abc8f2;
  color: #2a54a3;
}</style><!-- Shady DOM styles for figure-callout --><!-- Shady DOM styles for mat-button --><style scope="mat-button-0">.mat-button-0 {
  ;
  align-items: center;
  border-radius: 4px;
  color: hsl(217 4% 39%); 
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: 0.2px;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

.mat-button-0[filled] {
  background-color: hsl(217 73% 54%); 
  color: white;
}

.mat-button-0[filled]:hover {
  background-color: hsl(217 60% 47%);
}

.mat-button-0[filled]:focus {
  background-color: hsl(217 59% 44%);
}

.mat-button-0[filled]:active {
  background-color: hsl(217 59% 45%);
}

.mat-button-0[filled][disabled] {
  background-color: hsl(217 2% 90%); 
  color: hsl(217 1% 65%);
}</style><!-- Shady DOM styles for search-term-wizard --><style scope="search-term-wizard">search-term-wizard:not([open]) {
  display: none;
}

search-term-wizard .header.search-term-wizard {
  border-bottom: 1px solid #e5e5e5;
  padding: 24px;
  padding-bottom: 0;
}

search-term-wizard .title.search-term-wizard {
  color: #3c4043;
  font-family: Google Sans,Roboto,Arial,sans-serif;
  font-size: 22px;
  user-select: none;
  margin: 0 48px;
}

search-term-wizard #panels.search-term-wizard > *.search-term-wizard:not([selected]) {
  display: none;
}</style><!-- Shady DOM styles for outlined-textarea --><style scope="outlined-textarea">outlined-textarea {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: row;
  
  position: relative;
}

outlined-textarea span.outlined-textarea {
  display: flex;
  flex-direction: column;
  flex-grow: 1;
  justify-content: center;
}

outlined-textarea span.right-button-container.outlined-textarea {
  position: absolute;
  right: 0;
  height: 100%;
}

outlined-textarea textarea.outlined-textarea {
  padding: 16px 16px 0 16px;
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  resize: none;
}

outlined-textarea[dense] textarea.outlined-textarea {
  padding: 8px;
}

outlined-textarea[has-icon] textarea.outlined-textarea {
  padding-right: 38px;
}

outlined-textarea[orig] textarea.outlined-textarea {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-textarea:not([rows]) textarea.outlined-textarea {
  height: 40px;
}

outlined-textarea textarea.resizable.outlined-textarea {
  resize: vertical;
}

outlined-textarea textarea.outlined-textarea:focus,outlined-textarea[wizard-focused] textarea.outlined-textarea,outlined-textarea textarea.outlined-textarea:focus:hover {
  border-color: #3574e0 !important;
  
  outline: none !important;
}

outlined-textarea textarea.outlined-textarea:hover {
  border-color: #202124;
  color: #414447;
}

outlined-textarea.hasValue textarea.outlined-textarea {
  border-color: #888d91;
  color: #45474a;
}

outlined-textarea #helperText.outlined-textarea {
  color: #6a6c71;
  font-size: 12px;
  letter-spacing: 0.3px;
  margin-left: 17px;
  margin-top: 6px;
  user-select: none;
}

outlined-textarea:not([helper-text]) #helperText.outlined-textarea {
  display: none;
}

outlined-textarea[error] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
  color: #3d4043;
}

outlined-textarea textarea.outlined-textarea::placeholder {
  font-size: 14px;
  font-weight: 400;
}

outlined-textarea:not([error]):not([disabled]) textarea.outlined-textarea::placeholder {
  color: #6a6c71;
}

outlined-textarea[error] textarea.outlined-textarea::placeholder {
  color: #c84132;
}

outlined-textarea[error] #helperText.outlined-textarea {
  color: #cd5648;
}

outlined-textarea[error] textarea.outlined-textarea:focus {
  border-color: #c84031;
  border-width: 2px;
  outline: none !important;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover {
  border-color: #97231b;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover::placeholder,outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover + #helperText.outlined-textarea {
  color: #a94945;
}

outlined-textarea[disabled] textarea.outlined-textarea {
  border-color: #e9e9e9;
  color: #b5b6b8;
}

outlined-textarea[disabled] #helperText.outlined-textarea {
  color: #c4c6c7;
}

outlined-textarea[error][disabled] {
  opacity: 50%;
}

outlined-textarea[error][disabled] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
}

outlined-textarea[error][disabled] #helperText.outlined-textarea,outlined-textarea[error][disabled] textarea.outlined-textarea {
  color: #a94945;
}

outlined-textarea[error][disabled] textarea.outlined-textarea::placeholder {
  color: #c84132;
}</style><!-- Shady DOM styles for chemistry-search-term-wizard --><style scope="chemistry-search-term-wizard">chemistry-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

chemistry-search-term-wizard .suggestions.chemistry-search-term-wizard {
  margin-top: 4px;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard svg.chemistry-search-term-wizard {
  margin-right: 24px;
}

chemistry-search-term-wizard path.chemistry-search-term-wizard {
  fill: #5f6368;
}

chemistry-search-term-wizard .help.chemistry-search-term-wizard {
  margin-left: 12px;
  margin-right: 0;
  cursor: pointer;
}

chemistry-search-term-wizard outlined-text-field.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard mat-button.chemistry-search-term-wizard {
  margin-left: 48px;
}

chemistry-search-term-wizard filter-chip.chemistry-search-term-wizard {
  margin-right: 4px;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard outlined-text-field[batchMode].chemistry-search-term-wizard {
  display: none;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard:not([batchMode]) {
  display: none;
}</style><!-- Shady DOM styles for text-search-term-wizard --><style scope="text-search-term-wizard">text-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

text-search-term-wizard > span.text-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

text-search-term-wizard > span.text-search-term-wizard svg.text-search-term-wizard {
  margin-right: 24px;
}

text-search-term-wizard path.text-search-term-wizard {
  fill: #5f6368;
}

text-search-term-wizard outlined-text-field.text-search-term-wizard {
  flex-grow: 1;
}

text-search-term-wizard mat-button.text-search-term-wizard {
  margin-left: 48px;
}

text-search-term-wizard filter-chip.text-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for classification-wizard --><style scope="classification-wizard">classification-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

classification-wizard > span.classification-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

classification-wizard .suggestions.classification-wizard {
  margin-top: 4px;
}

classification-wizard > span.classification-wizard svg.classification-wizard {
  margin-right: 24px;
}

classification-wizard path.classification-wizard {
  fill: #5f6368;
}

classification-wizard outlined-text-field.classification-wizard {
  flex-grow: 1;
}

classification-wizard mat-button.classification-wizard {
  margin-left: 48px;
}

classification-wizard filter-chip.classification-wizard {
  margin-right: 4px;
}

classification-wizard .no-matches.classification-wizard {
  margin-left: 64px;
}

classification-wizard .table-container.classification-wizard {
  max-height: 300px;
  overflow: scroll;
  margin-top: 8px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar {
  -webkit-appearance: none;
  width: 10px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar-thumb {
  border-radius: 5px;
  background-color: #5f636880;
  -webkit-box-shadow: 0 0 1px rgba(255,255,255,.5);
}

classification-wizard table.classification-wizard {
  margin-left: 51px;
  max-width: 575px;
}

classification-wizard tr.classification-wizard {
  margin-top: 4px;
}

classification-wizard tr.classification-wizard suggestive-chip.classification-wizard {
  margin-right: 8px;
}

classification-wizard #spinner.classification-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}</style><!-- Shady DOM styles for suggestive-chip --><!-- Shady DOM styles for mat-checkbox --><!-- Shady DOM styles for measure-search-term-wizard --><style scope="measure-search-term-wizard">measure-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

measure-search-term-wizard > span.measure-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

measure-search-term-wizard .suggestions.measure-search-term-wizard {
  margin-top: 4px;
}

measure-search-term-wizard > span.measure-search-term-wizard svg.measure-search-term-wizard {
  margin-right: 24px;
}

measure-search-term-wizard path.measure-search-term-wizard {
  fill: #5f6368;
}

measure-search-term-wizard outlined-text-field.measure-search-term-wizard {
  flex-grow: 1;
}

measure-search-term-wizard mat-button.measure-search-term-wizard {
  margin-left: 48px;
}

measure-search-term-wizard filter-chip.measure-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for numerical-search-term-wizard --><style scope="numerical-search-term-wizard">numerical-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

numerical-search-term-wizard .suggestions.numerical-search-term-wizard {
  margin-top: 4px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard svg.numerical-search-term-wizard {
  margin-right: 24px;
}

numerical-search-term-wizard path.numerical-search-term-wizard {
  fill: #5f6368;
}

numerical-search-term-wizard outlined-text-field.numerical-search-term-wizard,numerical-search-term-wizard outlined-textarea.numerical-search-term-wizard {
  flex-grow: 1;
}

numerical-search-term-wizard mat-button.numerical-search-term-wizard {
  margin-left: 48px;
}

numerical-search-term-wizard filter-chip.numerical-search-term-wizard {
  margin-right: 4px;
}

numerical-search-term-wizard #spinner.numerical-search-term-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}

numerical-search-term-wizard #suggestions.numerical-search-term-wizard {
  margin-left: 58px;
  display: flex;
  flex-direction: column;
  align-items: flex-start;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard mat-checkbox.numerical-search-term-wizard {
  margin-right: 8px;
}</style><!-- Shady DOM styles for text-button --><style scope="text-button">text-button {
  align-items: center;
  border-radius: 4px;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: .25px;
  margin: 6px 0;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
  line-height: 36px;
  text-decoration: none;
  text-transform: none;
  color: #5f6368;
}

text-button:hover {
  background-color: #f8f9fa;
}

text-button:active {
  background-color: #d5e2fa;
}

text-button[selected] {
  background-color: #e8f0fe;
  color: #1967d2;
}

text-button[selected]:active {
  background-color: #d2e3fc;
}</style><!-- Shady DOM styles for mat-spinner --><!-- Shady DOM styles for requery-tile --><style scope="requery-tile">requery-tile {
  display: flex;
  justify-content: space-between;
  align-items: center;
  box-sizing: border-box;
  min-height: 40px;
  padding: 8px 12px 8px 8px;
  gap: 8px;

  border-radius: 16px;
  background: #f7f8f9;
  color: #1f1f1f;
}

requery-tile:hover {
  background: #d7d8d9;
}

requery-tile > [slot="image"] {
  flex-shrink: 0;

  border-radius: 8px;

  background: #fff;
}

.label.requery-tile {
  flex-grow: 999;

  font: 16px/20px "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
}

.search-icon.requery-tile {
  flex-shrink: 0;

  width: 24px;
  height: 24px;
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/search/default/24px.svg');
}</style><!-- Shady DOM styles for s-more-inline --><style scope="s-more-inline">s-more-inline {
  display: block;
  margin-top: 24px;
  padding: 16px;
  padding-top: 0;
  position: relative;

  line-height: 18px;
  text-overflow: ellipsis;
  white-space: nowrap;
  cursor: pointer;
}

hr.s-more-inline {
  background-color: #dadce0;
  margin-top: 18px;
  position: absolute;
  border: 0;
  height: 1px;
  left: 0;
  width: 100%;
}

.button.s-more-inline {
  display: flex;
  align-items: center;
  justify-content: center;

  position: relative; 
  margin: 0 auto;

  font: 400 14px Roboto, arial, sans-serif;
  height: 36px;
  width: 300px;
  border-radius: 18px;
  background-color: #f1f3f4;
}

.button.s-more-inline:hover {
  background-color: #d8d7dc;
}

.button.s-more-inline > [slot] {
  padding-right: 8px;
}

.expand.s-more-inline {
  display: inline-block;
  width: 20px;
  height: 20px;
}

.expand.less.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_less/default/20px.svg');
}

.expand.more.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_more/default/20px.svg');
}</style><!-- Shady DOM styles for workspace-ui-search --><!-- Shady DOM styles for keyword-wizard --><style scope="keyword-wizard">keyword-wizard {
  display: inline-block;
}

iron-icon.keyword-wizard {
  height: 20px;
    width: 20px;
    color: #999;
    cursor: pointer;
}

iron-icon[active].keyword-wizard {
  color: #4285f4 !important;
}

iron-icon.keyword-wizard:hover {
  color: #ccc;
}

#wizardIcon.keyword-wizard {
  padding-left: 1px;
    height: 16px;
    width: 16px;
    margin: 4px 1px 1px 1px;
}

#wizard.keyword-wizard {
  padding: 0;
    left: 0;
    top: 37px;
    position: absolute;
    background-color: white;
    z-index: 2;
    overflow: hidden;
}

.wizard-header.keyword-wizard {
  display: block;
    width: 100%;
    color: #737373;
    text-transform: uppercase;
    font-size: 13px;
    margin: 16px 0 6px 12px;
}

.filter-chips.keyword-wizard {
  margin-left: 20px;
}

.chip.keyword-wizard {
  background-color: #ebebeb;
    color: #6a6a6a;
    display: inline-block;
    font-size: 13px;
    font-family: inherit;
    border-radius: 12px;
    padding: 6px 12px;
}

.chip.keyword-wizard:hover {
  cursor: pointer;
}

.chip[selected].keyword-wizard {
  background-color: #4285f4;
    color: white;
}

.input-label.keyword-wizard {
  display: inline-block;
    font-size: 13px;
    font-family: inherit;
}

.keyword-input.keyword-wizard {
  display: inline-block;
    border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    padding: 3px;
}

.keyword-input.keyword-wizard::placeholder {
  font-style: italic;
}

.keyword-input.keyword-wizard:hover,.keyword-input.keyword-wizard:focus {
  border-color: #4284f4;
    border-width: 1px;
    outline: none;
}

.cpc-field.keyword-wizard {
  display: inline-block;
    margin: 6px 0 0 24px;
}

#checkboxCPC.keyword-wizard:hover {
  cursor: pointer;
}

.checkbox-label.keyword-wizard {
  font-size: 13px;
    font-style: italic;
    color: #737373;
}

.chemistry-field.keyword-wizard {
  display: block;
}

#inputChem.input-batch.keyword-wizard {
  height: 150px;
    border: 1px solid #dfe1e5;
    padding: 6px;
}

#inputChem.keyword-wizard {
  resize: none;
    height: 15px;
    vertical-align: text-top;
    font-size: 13px;
    font-family: inherit;
    padding: 2px;
}

.chem-type-label.keyword-wizard {
  display: inline;
    font-size: 13px;
    margin-left: 12px;
    margin-right: 4px;
}

#chemType.keyword-wizard {
  border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    margin: 6px;
    padding: 2px;
    outline: none;
    font-family: inherit;
    font-size: 13px;
}

.import.keyword-wizard {
  font-size: 13px;
    font-family: inherit;
}

.import-text.keyword-wizard {
  vertical-align: middle;
    display: inline-block;
}

.import-button.keyword-wizard {
  margin: 6px 0 0 24px;
}

.import-button.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.import-button.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard {
  float: right;
    padding: 12px;
}

.wizard-buttons.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    margin: 2px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
}

@media screen and (max-width: 700px) {
#wizard.keyword-wizard {
  width: 275px;
}

.chip.keyword-wizard {
  margin: 4px 2px;
}

.keyword-input.keyword-wizard {
  width: 82%;
      margin: 4px 12px 12px 24px;
}

.search-within.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 225px;
      margin: 12px 0 6px 0;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  margin-top: 6px;
}

#inputChem.keyword-wizard {
  width: 82%;
      padding: 2px;
      margin: 8px 12px 12px 24px;
}

#inputChem.input-batch.keyword-wizard {
  width: 220px;
      padding: 4px;
}

#chemType.keyword-wizard {
  width: 150px;
}

.import-text.keyword-wizard {
  margin: 6px 12px 6px 24px;
      width: 220px;
}

iron-icon.help-header.keyword-wizard {
  display: none;
}

}

@media screen and (min-width: 700px) {
#wizard.keyword-wizard {
  width: 540px;
}

.chip.keyword-wizard {
  margin: 0 2px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 240px;
      margin: 12px 16px 6px 6px;
}

.cpc-inputs.keyword-wizard {
  display: inline;
}

.find-patents.keyword-wizard .keyword-input.keyword-wizard {
  width: 53%;
      margin: 4px 10px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard::placeholder,#inputAnd.keyword-wizard::placeholder,#inputExact.keyword-wizard::placeholder,#inputOr.keyword-wizard::placeholder,#inputMinus.keyword-wizard::placeholder {
  color: white;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  width: 35%;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  width: 42%;
      margin: 6px 4px;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

#inputChem.keyword-wizard {
  width: 290px;
      margin: 2px 12px 2px 6px;
}

#inputChem.input-batch.keyword-wizard {
  width: 280px;
      padding: 6px;
}

.import-text.keyword-wizard {
  margin: 6px 12px;
      width: 415px;
}

#chemType.keyword-wizard {
  width: 105px;
}

iron-icon.keyword-wizard:hover.help-header {
  cursor: default;
}

iron-icon.help-header.keyword-wizard {
  height: 16px;
      padding: 0 2px 2px 2px;
      color: #a3a3a3;
}

.help.keyword-wizard p.keyword-wizard {
  margin: 0 0 8px 0
}

.help.keyword-wizard .q.keyword-wizard {
  font-family: monospace;
      color: #0b8043;
      white-space: nowrap;
}

.help.keyword-wizard {
  z-index: 4;
      position: absolute;
      right: 10px;
      padding: 12px;
      border-radius: 2px;
      border: 1px solid #e0e0e0;
      box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.2), 0 6px 10px 0 rgba(0, 0, 0, 0.3);
      background: white;
      font-size: 13px;
      line-height: 20px;
      width: 450px;
      max-height: 400px;
      overflow: auto;
}

#withinHelp.keyword-wizard {
  top: 75px;
}

#chemHelp.keyword-wizard {
  top: 0;
}

#searchBooleanHelp.keyword-wizard {
  top: 140px;
}

}</style><!-- Shady DOM styles for bottom-bar --><style scope="bottom-bar">.fixed.bottom-bar {
  display: block;
  position: fixed;
  height: 46px;
  bottom: 0;
}

.fixed[medium].bottom-bar {
  height: 280px;
}

.fixed[large].bottom-bar {
  height: 480px;
}

.shadow.bottom-bar {
  background: white;
  padding: 16px;
  border-radius: 8px 8px 0px 0px;
  box-shadow: 0px 8px 10px 1px rgba(0,0,0,.14), 0px 3px 14px 2px rgba(0,0,0,.12), 0px 5px 5px -3px rgba(0,0,0,.2);
}

.oneline.bottom-bar {
  white-space: nowrap;
  overflow: hidden;
  text-overflow: ellipsis;
  cursor: pointer;
}

.button.bottom-bar {
  cursor: pointer;
}

.buttonAlign.bottom-bar {
  margin-top: -4px;
}

.header.bottom-bar {
  height: 30px;
  font-family: 'Google Sans';
  font-size: 18px;
  padding-bottom: 8px;
}

.list.bottom-bar {
  overflow-y: auto;
  line-height: 20px;
}

.definition.bottom-bar {
  padding: 0px 0px 4px 0px;
  cursor: pointer;
}

[medium].bottom-bar .content.bottom-bar {
  height: 230px;
}

[large].bottom-bar .content.bottom-bar {
  height: 430px;
}

[medium].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 200px;
}

[large].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 400px;
}

[hidden].bottom-bar {
  display: none;
}

.label.bottom-bar {
  font-family: 'Google Sans';
  font-size: 12px;
  line-height: 16px;
  font-weight: 400;
  padding: 6px 0px 4px 0px;
  color: #1f1f1f;
}

[pad].bottom-bar {
  margin-left: 16px;
}

.layout.vertical.bottom-bar {
  display: flex;
  flex-direction: column;
}

.layout.horizontal.bottom-bar {
  display: flex;
  flex-direction: row;
}

.flex.bottom-bar {
  flex: 1;
  flex-basis: 0.000000001px;
}

.layout.start.bottom-bar {
  align-items: flex-start;
}

.layout.center.bottom-bar {
  align-items: center;
}

.layout.end.bottom-bar {
  align-items: flex-end;
}

.flex-2.bottom-bar {
  flex: 2;
}

.flex-3.bottom-bar {
  flex: 3;
}

.flex-4.bottom-bar {
  flex: 4;
}

.flex-5.bottom-bar {
  flex: 5;
}

.flex-6.bottom-bar {
  flex: 6;
}

.flex-7.bottom-bar {
  flex: 7;
}

.flex-8.bottom-bar {
  flex: 8;
}

.flex-9.bottom-bar {
  flex: 9;
}

.flex-10.bottom-bar {
  flex: 10;
}

.flex-11.bottom-bar {
  flex: 11;
}

.flex-12.bottom-bar {
  flex: 12;
}</style><!-- Shady DOM styles for landscape-link --><!-- Shady DOM styles for landscape-summary-box --><!-- Shady DOM styles for search-state --><!-- Shady DOM styles for iron-overlay-backdrop --><!-- Shady DOM styles for opaque-animation --><!-- Shady DOM styles for iron-dropdown --><!-- Shady DOM styles for iron-meta --><!-- Shady DOM styles for iron-icon --><style scope="iron-icon-0">.iron-icon-0 {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;-ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;-ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
        position: relative;

        vertical-align: middle;

        fill: currentcolor;
        stroke: none;

        width: 24px;
        height: 24px;;
}

.iron-icon-0[hidden] {
  display: none;
}</style><!-- Shady DOM styles for iron-iconset-svg --><!-- Shady DOM styles for iron-list --><!-- Shady DOM styles for paper-icon-item --><!-- Shady DOM styles for paper-item-body --><!-- Shady DOM styles for paper-item --><!-- Shady DOM styles for dropdown-menu --><!-- Shady DOM styles for chips-input --><!-- Shady DOM styles for input-chip --><!-- Shady DOM styles for keyword-editor --><!-- Shady DOM styles for paper-ripple --><!-- Shady DOM styles for paper-button --><!-- Shady DOM styles for date-editor --><!-- Shady DOM styles for metadata-editor --><!-- Shady DOM styles for restrict-editor --><!-- Shady DOM styles for overlay-tooltip --><style scope="overlay-tooltip">overlay-tooltip {
  display: none;
        color: #fff;
        background-color: #000;
        padding: 10px 12px;
        border-radius: 3px;
        font-size: 13px;
        font-weight: normal;
        line-height: normal;
        position: fixed;
        z-index: 100;
}

#arrow.overlay-tooltip {
  width: 0;
        height: 0;
        border-style: solid;
        border-width: 0 6px 8px 6px;
        border-color: transparent transparent #000 transparent;
        position: absolute;
        top: -8px;
        left: calc(50% - 6px);
}</style><!-- Shady DOM styles for query-renderer --><!-- Shady DOM styles for result-nav --><style scope="result-nav">result-nav {
  display: block;
        white-space: nowrap;
        padding: 0 30px;
        line-height: 30px;
        height: 30px;
        margin-top: 17px;
        font-weight: 500;
        font-size: 15px;
}

state-modifier.result-nav {
  color: #333;
}

state-modifier[disabled].result-nav {
  pointer-events: none;
        color: #ccc;
}</style><!-- Shady DOM styles for raw-html --><!-- Shady DOM styles for paper-material --><style scope="paper-material-0">.paper-material-0 {
  display: block;
        position: relative;
}

.paper-material-0[elevation="1"] {
  box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.14),
                    0 1px 5px 0 rgba(0, 0, 0, 0.12),
                    0 3px 1px -2px rgba(0, 0, 0, 0.2);
}

.paper-material-0[elevation="2"] {
  box-shadow: 0 4px 5px 0 rgba(0, 0, 0, 0.14),
                    0 1px 10px 0 rgba(0, 0, 0, 0.12),
                    0 2px 4px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="3"] {
  box-shadow: 0 6px 10px 0 rgba(0, 0, 0, 0.14),
                    0 1px 18px 0 rgba(0, 0, 0, 0.12),
                    0 3px 5px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="4"] {
  box-shadow: 0 8px 10px 1px rgba(0, 0, 0, 0.14),
                    0 3px 14px 2px rgba(0, 0, 0, 0.12),
                    0 5px 5px -3px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="5"] {
  box-shadow: 0 16px 24px 2px rgba(0, 0, 0, 0.14),
                    0  6px 30px 5px rgba(0, 0, 0, 0.12),
                    0  8px 10px -5px rgba(0, 0, 0, 0.4);
}

.paper-material-0[animated] {
  transition: box-shadow 0.28s cubic-bezier(0.4, 0, 0.2, 1);
}

.paper-material-0 {
  ;
}</style><!-- Shady DOM styles for search-box --><style scope="search-box">.layout.horizontal.search-box,.layout.vertical.search-box {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-box {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-box {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-box {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-box {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-box {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-box,.layout.center-center.search-box {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-box,.layout.center-center.search-box {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-box {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-box {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-box {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.inputbox.search-box {
  border: 1px solid #ccc;
        padding: 0 12px;
        background: white;
}

.inputbox[focused].search-box {
  border: 1px solid #4285f4 !important;
}

.inputbox.search-box:hover {
  border: 1px solid #999;
}

#searchInput.search-box {
  font-family: inherit;
        font-size: 16px;
        padding: 8px 0;
        outline: none;
        border-right: none;
        width: 100%;
        margin-right: 0;
        border: 0;
}

#searchButton.search-box {
  cursor: pointer;
        background-color: #4285f4;
        border: none;
        color: #fff;
        vertical-align: top;
        width: 70px;
        height: 37px;
        outline: none;
}

.suggest-bg.search-box {
  display: inline-block;
        min-width: 0;
        white-space: nowrap;
}

#suggestMenu.search-box {
  position: absolute;
        margin-top: 38px;
        width: 100%;
        background: white;
        z-index: 1;
}

#suggestMenu.search-box .row.search-box {
  font-size: 13px;
        line-height: 28px;
        white-space: nowrap;
        overflow: hidden;
        text-overflow: ellipsis;
        padding: 4px 2px;
        cursor: pointer;
}

.row[selected].search-box {
  background: rgba(0, 0, 0, 0.05);
}

.suggest-icon.search-box {
  height: 20px;
        width: 20px;
        padding: 0 12px 0 6px;
        transition: transform .15s linear;
        transform: scale(1);
}

.suggest-icon[hide].search-box {
  transform: scale(0);
}

#corpora.search-box {
  padding: 6px 0;
        user-select: none;
}

#corpora.search-box iron-icon.search-box {
  height: 20px;
        width: 20px;
        color: #ccc;
        cursor: pointer;
}

#corpora.search-box iron-icon[active].search-box {
  color: #4285f4 !important;
}

#corpora.search-box iron-icon.search-box:hover {
  color: #999;
}</style><!-- Shady DOM styles for iron-media-query --><!-- Shady DOM styles for paper-header-panel --><!-- Shady DOM styles for iron-a11y-announcer --><style scope="iron-a11y-announcer">iron-a11y-announcer {
  display: inline-block;
        position: fixed;
        clip: rect(0px,0px,0px,0px);
}</style><!-- Shady DOM styles for iron-autogrow-textarea --><!-- Shady DOM styles for iron-input --><!-- Shady DOM styles for paper-input-char-counter --><!-- Shady DOM styles for paper-input-container --><!-- Shady DOM styles for paper-input-error --><!-- Shady DOM styles for paper-input --><!-- Shady DOM styles for paper-textarea --><!-- Shady DOM styles for paper-toast --><style scope="paper-toast-0">.paper-toast-0 {
  display: block;
        position: fixed;
        background-color: #323232;
        color: #f1f1f1;
        min-height: 48px;
        min-width: 288px;
        padding: 16px 24px;
        box-sizing: border-box;
        box-shadow: 0 2px 5px 0 rgba(0, 0, 0, 0.26);
        border-radius: 2px;
        margin: 12px;
        font-size: 14px;
        cursor: default;
        -webkit-transition: -webkit-transform 0.3s, opacity 0.3s;
        transition: transform 0.3s, opacity 0.3s;
        opacity: 0;
        -webkit-transform: translateY(100px);
        transform: translateY(100px);font-family: 'Roboto', 'Noto', sans-serif;
        -webkit-font-smoothing: antialiased;
}

.paper-toast-0.capsule {
  border-radius: 24px;
}

.paper-toast-0.fit-bottom {
  width: 100%;
        min-width: 0;
        border-radius: 0;
        margin: 0;
}

.paper-toast-0.paper-toast-open {
  opacity: 1;
        -webkit-transform: translateY(0px);
        transform: translateY(0px);
}</style><!-- Shady DOM styles for paper-toolbar --><!-- Shady DOM styles for search-footer --><style scope="search-footer">#footer.search-footer {
  font-size: 13px;
        margin-top: 10px;
        background: #fafafa;
        padding: 20px 10px;
        align-items: center;
        border-top: 1px solid #ebebeb;
}

#footer.search-footer .links.search-footer > *.search-footer {
  display: inline-block;
        margin: 0 12px;
}

.layout.horizontal.search-footer,.layout.vertical.search-footer {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-footer {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-footer {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-footer {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-footer {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-footer {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-footer {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-footer {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-footer {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-footer {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-footer {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-footer {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-footer {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-footer {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-footer {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-footer {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-footer {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-footer {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-footer {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-footer {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-footer {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-footer {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-footer {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-footer {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-footer {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-footer {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-header --><style scope="search-header">search-header {
  display: block;
}

.lockup-logo.search-header,.lockup-text.search-header {
  display: inline-block;
}

.lockup-logo.search-header {
  width: 74px;
        height: 24px;
        background-image: url('https://www.gstatic.com/images/branding/googlelogo/1x/googlelogo_color_74x24dp.png');
        background-size: 74px 24px;
}

.lockup-text.search-header {
  font-family: "Product Sans", Arial, Helvetica, sans-serif;

        
        font-size: 22.1px;

        
        text-rendering: optimizeLegibility;

        
        position: relative;
        top: -6px;
        left: -5px;

        
        -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
}

.lockup-brand.search-header {
  opacity: 0.54;
}

@media (-webkit-min-device-pixel-ratio: 1.5), (min-resolution: 144dpi) {
.lockup-logo.search-header {
  background-image: url('https://www.gstatic.com/images/branding/googlelogo/2x/googlelogo_color_74x24dp.png');
}

.lockup-text.search-header {
  font-size: 21.3px;
          left: -7px;
}

}

header.search-header {
  background-color: #fafafa;
        border-bottom: 1px solid #ebebeb;
        color: #333;
        height: 60px;
        width: 100%;
        z-index: 1;
        display: block;
}

[latestStyle].search-header header.search-header {
  background-color: transparent;
}

.headerpad.search-header {
  margin-left: 16px;
}

[wide].search-header .headerpad.search-header {
  margin-left: 32px;
}

.leftheader.search-header {
  width: 322px;
}

header.search-header h1.search-header {
  display: none;
}

header.search-header h1.search-header state-modifier.search-header {
  color: #777;
        text-decoration: none;
        display: inline-block;
}

[wide].search-header header.search-header h1.search-header {
  box-sizing: border-box;
        margin: 0;
        padding: 20px 0 10px;
        font-size: 20px;
        font-weight: 400;
        white-space: nowrap;
        display: block;
}

search-box.search-header {
  height: 37px;
        padding: 0 16px;
        width: 900px;
        align-self: center;
}

.layout.horizontal.search-header,.layout.vertical.search-header {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-header {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-header {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-header {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-header {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-header {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-header {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-header {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-header {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-header {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-header {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-header {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-header {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-header {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-header {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-header {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-header {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-header {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-header {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-header {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-header {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-header {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-header {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-header {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-header {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-header {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-ui --><style scope="search-ui-0">.search-ui-0 paper-button.search-ui {
  display: inline-block;
        text-align: center;
        font-family: inherit;
}

.search-ui-0 .layout.horizontal.search-ui,.search-ui-0 .layout.vertical.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.search-ui-0 .layout.inline.search-ui {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.search-ui-0 .layout.horizontal.search-ui {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.search-ui-0 .layout.vertical.search-ui {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.search-ui-0 .layout.wrap.search-ui {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.search-ui-0 .layout.no-wrap.search-ui {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .flex.search-ui {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.search-ui-0 .flex-auto.search-ui {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.search-ui-0 .flex-none.search-ui {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.search-ui-0 .layout.start.search-ui {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.end.search-ui {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.search-ui-0 .layout.baseline.search-ui {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.search-ui-0 .layout.start-justified.search-ui {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .layout.end-justified.search-ui {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.search-ui-0 .layout.around-justified.search-ui {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.search-ui-0 .layout.justified.search-ui {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.search-ui-0 .self-start.search-ui {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.search-ui-0 .self-center.search-ui {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.search-ui-0 .self-end.search-ui {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.search-ui-0 .self-stretch.search-ui {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.search-ui-0 .self-baseline.search-ui {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.search-ui-0 .layout.start-aligned.search-ui {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.search-ui-0 .layout.end-aligned.search-ui {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.search-ui-0 .layout.center-aligned.search-ui {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.search-ui-0 .layout.between-aligned.search-ui {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.search-ui-0 .layout.around-aligned.search-ui {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.search-ui-0 {
  display: block;
        min-width: 350px;
        height: 100%;
}

.search-ui-0 #content.search-ui {
  height: 100%;
}

.search-ui-0 #leftBarOverflow.search-ui {
  padding-right: 16px;
}

.search-ui-0 [wide].search-ui #leftBarOverflow.search-ui {
  overflow: auto;
}

.search-ui-0 #leftBar.search-ui {
  box-sizing: border-box;
        color: #666;
        font-size: 13px;
        padding: 16px 0 16px 16px;
        border-bottom: 1px solid #e5e5e5;
}

.search-ui-0 [wide].search-ui #leftBar.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;

        -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
        position: relative;
        width: 350px;
        margin-bottom: 0;
        padding-bottom: 0;
        border-bottom: none;
}

@media print {
.search-ui-0 #leftBar.search-ui {
  display: none !important;
}

}

.search-ui-0 #leftBar.search-ui h3.search-ui {
  text-transform: uppercase;
        font-size: 13px;
        font-weight: normal;
        margin-top: 6px;
        margin-bottom: 6px;
        cursor: default;
        display: inline-block;
        color: #a3a3a3;
}

.search-ui-0 #closeButton.search-ui {
  position: absolute;
        right: 0;
}

.search-ui-0 #searchTermsHeader.search-ui {
  position: relative;
}

.search-ui-0 #searchTermsQ.search-ui iron-icon.search-ui {
  height: 16px;
        padding: 0 2px 2px 2px;
        color: #a3a3a3;
}

.search-ui-0 #searchTermsHeader.search-ui:hover iron-icon.search-ui {
  color: #4285f4;
}

.search-ui-0 #closeLeftBar.search-ui {
  height: 16px;
        width: 16px;
        padding: 0 0 8px 0;
        cursor: pointer;
}

.search-ui-0 #compactQuery.search-ui iron-icon.search-ui {
  height: 20px;
}

.search-ui-0 #backToResultsButton.search-ui {
  color: #fff;
        background: #4285f4;
        margin-top: 20px;
        text-align: center;
}

.search-ui-0 #main.search-ui {
  display: block;
        min-height: calc(100vh - 127px);
}

@media print {
.search-ui-0 [wide].search-ui main.search-ui {
  margin-left: 0;
}

}</style><!-- Shady DOM styles for import-list --><!-- Shady DOM styles for iron-request --><!-- Shady DOM styles for iron-ajax --><!-- Shady DOM styles for paper-dialog --><!-- Shady DOM styles for coverage-stats --><!-- Shady DOM styles for iron-image --><!-- Shady DOM styles for iron-selector --><!-- Shady DOM styles for paper-card --><!-- Shady DOM styles for paper-checkbox --><!-- Shady DOM styles for landing-page --><!-- Shady DOM styles for remote-fetch --><!-- Shady DOM styles for paper-spinner --><style scope="paper-spinner-0">.paper-spinner-0 {
  display: inline-block;
        position: relative;
        width: 28px;
        height: 28px;
}

.paper-spinner-0 #spinnerContainer.paper-spinner {
  width: 100%;
        height: 100%;

        
        direction: ltr;
}

.paper-spinner-0 #spinnerContainer.active.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite;
        animation: container-rotate-paper-spinner-0 1568ms linear infinite;
}

@-webkit-keyframes container-rotate-paper-spinner-0 {
to {
  -webkit-transform: rotate(360deg)
}

}

@keyframes container-rotate-paper-spinner-0 {
to {
  transform: rotate(360deg)
}

}

.paper-spinner-0 .spinner-layer.paper-spinner {
  position: absolute;
        width: 100%;
        height: 100%;
        opacity: 0;
        white-space: nowrap;
        color: #4285f4;
}

.paper-spinner-0 .layer-1.paper-spinner {
  color: #4285f4;
}

.paper-spinner-0 .layer-2.paper-spinner {
  color: #db4437;
}

.paper-spinner-0 .layer-3.paper-spinner {
  color: #f4b400;
}

.paper-spinner-0 .layer-4.paper-spinner {
  color: #0f9d58;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0;
        -webkit-animation-duration: 5332ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-name: fill-unfill-rotate-paper-spinner-0;
        animation-duration: 5332ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
        opacity: 1;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-1.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-2.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-3.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-4.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
}

@-webkit-keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  -webkit-transform: rotate(135deg)
}

25% {
  -webkit-transform: rotate(270deg)
}

37.5% {
  -webkit-transform: rotate(405deg)
}

50% {
  -webkit-transform: rotate(540deg)
}

62.5% {
  -webkit-transform: rotate(675deg)
}

75% {
  -webkit-transform: rotate(810deg)
}

87.5% {
  -webkit-transform: rotate(945deg)
}

to {
  -webkit-transform: rotate(1080deg)
}

}

@keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  transform: rotate(135deg)
}

25% {
  transform: rotate(270deg)
}

37.5% {
  transform: rotate(405deg)
}

50% {
  transform: rotate(540deg)
}

62.5% {
  transform: rotate(675deg)
}

75% {
  transform: rotate(810deg)
}

87.5% {
  transform: rotate(945deg)
}

to {
  transform: rotate(1080deg)
}

}

@-webkit-keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@-webkit-keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

.paper-spinner-0 .circle-clipper.paper-spinner {
  display: inline-block;
        position: relative;
        width: 50%;
        height: 100%;
        overflow: hidden;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after {
  left: 45%;
        width: 10%;
        border-top-style: solid;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after,.paper-spinner-0 .circle-clipper.paper-spinner::after {
  content: '';
        box-sizing: border-box;
        position: absolute;
        top: 0;
        border-width: 3px;
        border-radius: 50%;
}

.paper-spinner-0 .circle-clipper.paper-spinner::after {
  bottom: 0;
        width: 200%;
        border-style: solid;
        border-bottom-color: transparent !important;
}

.paper-spinner-0 .circle-clipper.left.paper-spinner::after {
  left: 0;
        border-right-color: transparent !important;
        -webkit-transform: rotate(129deg);
        transform: rotate(129deg);
}

.paper-spinner-0 .circle-clipper.right.paper-spinner::after {
  left: -100%;
        border-left-color: transparent !important;
        -webkit-transform: rotate(-129deg);
        transform: rotate(-129deg);
}

.paper-spinner-0 .active.paper-spinner .gap-patch.paper-spinner::after,.paper-spinner-0 .active.paper-spinner .circle-clipper.paper-spinner::after {
  -webkit-animation-duration: 1333ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-duration: 1333ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.left.paper-spinner::after {
  -webkit-animation-name: left-spin-paper-spinner-0;
        animation-name: left-spin-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.right.paper-spinner::after {
  -webkit-animation-name: right-spin-paper-spinner-0;
        animation-name: right-spin-paper-spinner-0;
}

@-webkit-keyframes left-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(130deg)
}

50% {
  -webkit-transform: rotate(-5deg)
}

to {
  -webkit-transform: rotate(130deg)
}

}

@keyframes left-spin-paper-spinner-0 {
0% {
  transform: rotate(130deg)
}

50% {
  transform: rotate(-5deg)
}

to {
  transform: rotate(130deg)
}

}

@-webkit-keyframes right-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(-130deg)
}

50% {
  -webkit-transform: rotate(5deg)
}

to {
  -webkit-transform: rotate(-130deg)
}

}

@keyframes right-spin-paper-spinner-0 {
0% {
  transform: rotate(-130deg)
}

50% {
  transform: rotate(5deg)
}

to {
  transform: rotate(-130deg)
}

}

.paper-spinner-0 #spinnerContainer.cooldown.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
        animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
}

@-webkit-keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}</style><!-- Shady DOM styles for paper-spinner-lite --><!-- Shady DOM styles for concept-card --><!-- Shady DOM styles for concept-mention --><style scope="concept-mention">.block.concept-mention {
  display: block;
}

[hidden].concept-mention {
  display: none !important;
}

.invisible.concept-mention {
  visibility: hidden !important;
}

.relative.concept-mention {
  position: relative;
}

.fit.concept-mention {
  position: absolute;
        top: 0;
        right: 0;
        bottom: 0;
        left: 0;
}

body.fullbleed.concept-mention {
  margin: 0;
        height: 100vh;
}

.scroll.concept-mention {
  -webkit-overflow-scrolling: touch;
        overflow: auto;
}

.fixed-bottom.concept-mention,.fixed-left.concept-mention,.fixed-right.concept-mention,.fixed-top.concept-mention {
  position: fixed;
}

.fixed-top.concept-mention {
  top: 0;
        left: 0;
        right: 0;
}

.fixed-right.concept-mention {
  top: 0;
        right: 0;
        bottom: 0;
}

.fixed-bottom.concept-mention {
  right: 0;
        bottom: 0;
        left: 0;
}

.fixed-left.concept-mention {
  top: 0;
        bottom: 0;
        left: 0;
}

#target.concept-mention:hover {
  background-color: #e8f0fe;
}

#target[noicon].concept-mention {
  padding: 1px;
}

#target.concept-mention:hover[noicon] {
  border: 1px solid #e8f0fe;
        padding: 0;
}

#target.concept-mention {
  display: inline-block;
}

.inline-icon.concept-mention {
  cursor: pointer;
        height: 12px;
        width: 12px;
        padding-left: 4px;
        color: #5e6368;
}

concept-card.concept-mention {
  z-index: 1;
        position: absolute;
}</style><!-- Shady DOM styles for fterm-concept-card --><!-- Shady DOM styles for fterm-concept-mention --><!-- Shady DOM styles for paper-fab --><!-- Shady DOM styles for paper-icon-button --><!-- Shady DOM styles for paper-icon-button-light --><!-- Shady DOM styles for classification-tree --><style scope="classification-tree">.layout.horizontal.classification-tree,.layout.vertical.classification-tree {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.classification-tree {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.classification-tree {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.classification-tree {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.classification-tree {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.classification-tree {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.classification-tree {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.classification-tree {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.classification-tree {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

classification-tree {
  display: block;
        line-height: 20px;
}

.wrap.classification-tree {
  padding: 6px 12px;
}

.wrap.classification-tree:hover {
  background: #fafafa;
}

.description.classification-tree {
  padding-left: 4px;
}

iron-icon.classification-tree {
  color: #eaeaea;
}

.code[first].classification-tree {
  font-weight: 500;
}

.code[additional].classification-tree {
  font-style: italic;
}</style><!-- Shady DOM styles for classification-viewer --><style scope="classification-viewer">.table.classification-viewer {
  border: 1px solid #eaeaea;
        display: block;
}

.more.classification-viewer {
  padding: 6px 12px;
        cursor: pointer;
        font-style: italic;
        color: #aaa;
}

.more.classification-viewer:hover {
  background: #fafafa;
}

.chip.classification-viewer {
  display: inline-block;
        padding: 4px 6px;
        border-radius: 2px;
}

.chip[additional].classification-viewer {
  font-style: italic;
}</style><!-- Shady DOM styles for image-carousel --><!-- Shady DOM styles for image-viewer --><!-- Shady DOM styles for patent-result --><style scope="patent-result">#wrapper.patent-result {
  padding: 20px;
        max-width: 1050px;
        outline: 0;
}

.scroll-target.patent-result:before {
  display: block;
        content: '';
        visibility: hidden;
}

h1.patent-result {
  font-weight: 500;
        font-size: 20px;
        margin: 0 0 20px 0;
}

h3.patent-result {
  font-size: 15px;
        font-weight: 500;
        margin: 28px 0 18px 0;
}

dl.patent-result {
  line-height: 1.5;
        font-size: 0;
}

dt.patent-result,dd.patent-result {
  display: inline;
        font-size: 13px;
        margin: 0;
}

dt.patent-result {
  font-weight: 500;
        color: #000;
}

dt.patent-result::after {
  content: ': ';
}

dd.patent-result {
  color: #aaa;
}

dd.patent-result ~ dd.patent-result::before {
  content: ', ';
}

dt.patent-result + dd.patent-result::before {
  content: '';
}

dd.patent-result ~ dt.patent-result::before {
  display: block;
        content: '';
        margin-top: 8px;
}

dd.patent-result core-icon.patent-result {
  width: 14px;
        height: 14px;
        vertical-align: top;
        color: inherit;
}

.table.patent-result {
  display: table;
        border-collapse: collapse;
        border-spacing: 0;
        border: 1px solid #eaeaea;
        width: 100%;
        box-sizing: border-box;
}

.tr.patent-result {
  display: table-row;
        border-bottom: 1px solid #eaeaea;
}

.th.patent-result,.td.patent-result {
  display: table-cell;
        padding: 10px 12px;
}

.thead.patent-result {
  display: table-header-group;
}

.tbody.patent-result {
  display: table-row-group;
}

.th.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.td.patent-result {
  vertical-align: top;
}

.td.patent-result > p.patent-result {
  margin-top: 0;
}

.nowrap.patent-result {
  white-space: nowrap;
}

.knowledge-card.patent-result {
  border: 1px solid #e5e5e5;
        border-radius: 2px;
}

.knowledge-card.patent-result > header.patent-result {
  -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
        background: #4285f4;
        color: #fff;
        padding: 20px 12px;
}

.knowledge-card.patent-result > header.patent-result state-modifier.patent-result,.knowledge-card.patent-result > header.patent-result a.patent-result {
  color: inherit;
        margin: 0 12px 0 0;
        display: inline-block;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result,.knowledge-card.patent-result > header.patent-result .tagline.patent-result {
  margin: 0;
        font-weight: normal;
        padding-top: 4px;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result {
  font-size: 20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result {
  background: #3367d6;
        padding: 10px 12px;
        margin: 20px -12px -20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result core-icon.patent-result {
  margin-right: 12px;
        width: 24px;
        height: 24px;
}

.knowledge-card.patent-result dl.patent-result {
  padding: 16px 12px;
}

.knowledge-card.patent-result hr.patent-result {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 0;
}

.main-link.patent-result {
  margin: 14px;
        font-weight: 500;
}

.footer.patent-result h3.patent-result state-modifier.patent-result,.footer.patent-result h3.patent-result a.patent-result {
  float: right;
        font-weight: 400;
        font-size: 13px;
        line-height: 24px;
}

.footer.patent-result dl.patent-result {
  margin-left: 30px;
}

.footer.patent-result > ul.patent-result > li.patent-result {
  margin-bottom: 8px;
}

h3.patent-result .righthead.patent-result {
  color: #aaa;
        font-weight: 400;
        font-size: 13px;
        cursor: help;
}

.tooltip-hint.patent-result {
  border-bottom: 1px dotted #ccc;
}

[marginRight].patent-result {
  margin-right: 60px;
}

.flex-width.patent-result {
  min-width: 0;
        word-break: break-word;
}

.responsive-table.patent-result {
  width: 100%;
        overflow-x: auto;
        overflow-y: hidden;
}

.layout.horizontal.patent-result,.layout.vertical.patent-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.flex.patent-result,.flex-1.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-2.patent-result {
  -ms-flex: 2;
        -webkit-flex: 2;
        flex: 2;
}

.flex-3.patent-result {
  -ms-flex: 3;
        -webkit-flex: 3;
        flex: 3;
}

.flex-4.patent-result {
  -ms-flex: 4;
        -webkit-flex: 4;
        flex: 4;
}

.flex-5.patent-result {
  -ms-flex: 5;
        -webkit-flex: 5;
        flex: 5;
}

.flex-6.patent-result {
  -ms-flex: 6;
        -webkit-flex: 6;
        flex: 6;
}

.flex-7.patent-result {
  -ms-flex: 7;
        -webkit-flex: 7;
        flex: 7;
}

.flex-8.patent-result {
  -ms-flex: 8;
        -webkit-flex: 8;
        flex: 8;
}

.flex-9.patent-result {
  -ms-flex: 9;
        -webkit-flex: 9;
        flex: 9;
}

.flex-10.patent-result {
  -ms-flex: 10;
        -webkit-flex: 10;
        flex: 10;
}

.flex-11.patent-result {
  -ms-flex: 11;
        -webkit-flex: 11;
        flex: 11;
}

.flex-12.patent-result {
  -ms-flex: 12;
        -webkit-flex: 12;
        flex: 12;
}

@media print {
#text.patent-result {
  flex-direction: column-reverse !important;
}

}

patent-result-ref-list.patent-result {
  width: 100%;
}

patent-result-ref-list.patent-result + patent-result-ref-list.patent-result {
  margin-left: 10px;
}

[narrow].patent-result {
  flex-direction: column-reverse !important;
}

.famheader.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.collapse.patent-result {
  color: #616161;
        font-size: 13px;
        cursor: pointer;
}

#imageDrag.patent-result {
  position: fixed;
        cursor: col-resize;
}

#imageDrag.patent-result div.patent-result {
  width: 4px;
        height: 100%;
        margin: 0 4px;
        background: #eee;
}

#imageDrag.patent-result:hover {
  background: #eee;
}

#imageDrag.patent-result:hover div.patent-result {
  background: #ccc;
}

.imageWrapper.patent-result {
  position: fixed;
        top: 60px;
        background: white;
        margin-left: 12px;
}

#notices.patent-result {
  padding: 20px;
}

#figures.patent-result {
  background: #efefef;
}

.headerButton.patent-result {
  color: #3c80f6;
        cursor: pointer;
        display: inline-block;
        padding: 0 14px;
        line-height: 27px;
}

.headerButton.patent-result iron-icon.patent-result {
  width: 16px;
        height: 16px;
}

.tr.conceptDomain.patent-result {
  display: table-row;
}

.responsive-grid.patent-result {
  display: grid;
        gap: 8px;
        grid-template-columns: none;
}</style><!-- Shady DOM styles for family-viewer --><!-- Shady DOM styles for app-row --><!-- Shady DOM styles for application-timeline --><style scope="application-timeline">.layout.horizontal.application-timeline,.layout.vertical.application-timeline {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.application-timeline {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.application-timeline {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.application-timeline {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.application-timeline {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.application-timeline {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.application-timeline {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.application-timeline {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.application-timeline {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.wrap.application-timeline {
  padding: 16px 12px;
}

.event.application-timeline {
  padding: 3px 0;
}

[date].application-timeline {
  color: #5f6368;
        font-size: 13px;
        padding: 3px 0;
        width: 70px;
        line-height: 16px;
}

[critical].application-timeline [date].application-timeline {
  color: #202124;
        font-weight: 500;
        line-height: 18px;
}

.line.application-timeline {
  margin: 9px 6px;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
}

.dot.application-timeline {
  margin: 3px 0;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
        display: inline-block;
}

[critical].application-timeline .line.application-timeline {
  background: #4285f4;
}

[current].application-timeline .line.application-timeline {
  background: #81c995;
}

[current][critical].application-timeline .line.application-timeline {
  background: #81c995;
}

.title.application-timeline {
  font-size: 13px;
        padding: 3px 0;
        line-height: 16px;
}

.title-text.application-timeline {
  color: #5f6368;
}

.description-item.application-timeline {
  font-size: 12px;
        padding: 6px 0;
        max-width: 300px;
}

#legal.application-timeline {
  height: 14px;
        width: 14px;
        padding: 0 3px 1px 3px;
        vertical-align: text-bottom;
}

#icon.application-timeline {
  height: 12px;
        width: 12px;
        padding: 0 3px 3px 3px;
        vertical-align: text-bottom;
}

.unknown.application-timeline {
  font-style: italic;
}

.not_active.application-timeline {
  text-decoration: line-through;
}

.active.application-timeline {
  font-weight: 500;
}

#cc[this].application-timeline {
  color: #202124 !important;
        text-decoration: underline;
}

#cc[this].not_active.application-timeline {
  text-decoration: line-through underline;
}

hr.application-timeline {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 10px 0 16px 0;
}

.header.application-timeline {
  font-size: 13px;
        line-height: 20px;
        font-weight: 500;
        color: #202124;
        padding-bottom: 8px;
}

.block.application-timeline {
  padding: 0 6px 0 0;
}

.year.application-timeline {
  color: #5f6368;
        font-size: 13px;
        font-weight: 500;
        padding: 3px 1px;
        width: 70px;
}

.expand.application-timeline {
  cursor: pointer;
        padding: 6px 0 3px 0;
}</style><!-- Shady DOM styles for patent-text --><style scope="patent-text">.layout.horizontal.patent-text,.layout.vertical.patent-text {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-text {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-text {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-text {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-text {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-text {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-text {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-text {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-text {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-text {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-text {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-text {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-text {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-text {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-text {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-text {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-text {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-text {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-text {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-text {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-text {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-text {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-text {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-text {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-text {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-text {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

patent-text {
  display: block;
}

#text.patent-text {
  line-height: 20px;
        min-width: 0;
}

#margin.patent-text {
  width: 16px;
}

#createHighlight.patent-text {
  position: relative;
        width: 16px;
        height: 16px;
        cursor: pointer;
}

.notranslate.patent-text > .google-src-text.patent-text {
  display: none;
}

.notranslate.patent-text:hover,mark.patent-text {
  background-color: #fbfcae;
}

.description-paragraph.patent-text {
  margin-block-start: 1em;
        margin-block-end: 1em;
}

.claim-text.patent-text {
  margin: 14px 0 0 20px;
}

.claim-dependent.patent-text {
  margin-left: 40px;
        color: #888;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim-text.patent-text {
  height: 0;
        width: 0;
        visibility: hidden;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim.patent-text:after {
  content: ""
}

.patent-full-image.patent-text {
  max-width: 100%;
        height: auto;
}

.small-patent-image.patent-text {
  display: inline;
}

ul.patent-text {
  padding: 0 0 0 50px;
}

li.patent-text {
  list-style-type: none;
        position: relative;
}

ol.claims.patent-text li.patent-text {
  list-style-type: decimal;
        font-weight: bold;
}

ol.claims.patent-text li.patent-text > *.patent-text {
  font-weight: normal;
}

li.patent-text > para-num.patent-text {
  position: absolute;
        left: -45px;
        color: #888;
}

mark.patent-text {
  background: #fff59d;
}

mark.searchText.patent-text {
  background: #80deea;
}

.searchTextHeader.patent-text {
  font-weight: 500;
}

pre.patent-text {
  white-space: pre-wrap;
}

heading.patent-text {
  display: block;
        font-weight: 500;
        font-size: 13px;
}

#comment.patent-text {
  width: 16px;
        height: 16px;
}

[has-search][no-results].patent-text {
  display: none;
}

.highlight.patent-text {
  background-color: #fef7e0;
}</style><!-- Shady DOM styles for para-num --><!-- Shady DOM styles for result-container --><style scope="result-container">paper-spinner.result-container {
  position: absolute;
        
        top: calc(50%  + 56px - 16px);
        left: calc(50% + 175px - 16px);
}</style><!-- Shady DOM styles for scholar-result --><!-- Shady DOM styles for search-result --><style scope="search-result">.layout.horizontal.search-result,.layout.vertical.search-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

search-result {
  display: block;
        font-size: 13px;
}

#mainContainer.search-result {
  min-height: calc(100vh - 127px);
        color: #333;
}

#compactQuery.search-result {
  padding: 18px 20px 10px 20px;
        cursor: pointer;
}

#compactQuery.search-result > span.search-result {
  padding: 0 14px 0 0;
}

#compactQuery.search-result iron-icon.search-result {
  padding-right: 6px;
        height: 16px;
        width: 16px;
}</style><!-- Shady DOM styles for webdoc-result --><!-- Shady DOM styles for iron-pages --><!-- Shady DOM styles for paper-tab --><!-- Shady DOM styles for paper-tabs --><!-- Shady DOM styles for debug-info --><!-- Shady DOM styles for search-paging --><!-- Shady DOM styles for search-result-item --><!-- Shady DOM styles for search-result-image --><!-- Shady DOM styles for search-result-entities --><!-- Shady DOM styles for search-result-measures --><!-- Shady DOM styles for search-results --><!-- Shady DOM styles for summary-box --><!-- Shady DOM styles for timeline-page --><!-- Shady DOM styles for iron-localstorage --><!-- Shady DOM styles for search-app --><style scope="search-app">search-app {
  display: block;
        height: 100%;
}

#toast.search-app {
  min-height: 64px;
        min-width: 742px;
}</style><style>body {transition: opacity ease-in 0.2s; } 
body[unresolved] {opacity: 0; display: block; overflow: hidden; position: relative; } 
</style>
    <title>BR112016000238B1 - 
  method for the control of harmful bacterial organisms in useful plants and kit of parts
 
      - Google Patents</title>

    <meta name="viewport" content="width=device-width, initial-scale=1">
    <meta charset="UTF-8">
    <meta name="referrer" content="origin-when-crossorigin">
    <link rel="canonical" href="https://patents.google.com/patent/BR112016000238B1/en">
    <meta name="description" content="
   
    METHODS FOR THE CONTROL OF HARMFUL BACTERIAL ORGANISMS IN USEFUL PLANTS AND PARTS KIT The present invention relates to the use of a combination comprising at least one host defense inducer and at least one biological control agent in a synergistically effective amount for the containment of harmful bacterial organisms in useful plants. The biological control agent is selected from specific microorganisms and / or a mutant from these strains that has all the identification characteristics of the respective strain, and / or a metabolite produced by the respective strain. In a preferred aspect of the invention, the host defense inducer is isothianyl or a combination of isothianyl and acibenzolar-S-methyl. The present invention is also related to a method for the control of harmful bacterial organisms in useful plants by treatment with a combination comprising at least one host defense inducer and at least one biological control agent in a synergistically effective amount. An additional aspect of the present invention is directed to a method for the control of harmful bacterial organisms in useful plants by submission to the plants to be protected against attack by harmful bacterial organisms to (...).
   
 
   ">
    <meta name="DC.type" content="patent">
    <meta name="DC.title" content="
  method for the control of harmful bacterial organisms in useful plants and kit of parts
 
     ">
    <meta name="DC.date" content="2014-07-10" scheme="dateSubmitted">
    <meta name="DC.description" content="
   
    METHODS FOR THE CONTROL OF HARMFUL BACTERIAL ORGANISMS IN USEFUL PLANTS AND PARTS KIT The present invention relates to the use of a combination comprising at least one host defense inducer and at least one biological control agent in a synergistically effective amount for the containment of harmful bacterial organisms in useful plants. The biological control agent is selected from specific microorganisms and / or a mutant from these strains that has all the identification characteristics of the respective strain, and / or a metabolite produced by the respective strain. In a preferred aspect of the invention, the host defense inducer is isothianyl or a combination of isothianyl and acibenzolar-S-methyl. The present invention is also related to a method for the control of harmful bacterial organisms in useful plants by treatment with a combination comprising at least one host defense inducer and at least one biological control agent in a synergistically effective amount. An additional aspect of the present invention is directed to a method for the control of harmful bacterial organisms in useful plants by submission to the plants to be protected against attack by harmful bacterial organisms to (...).
   
 
   ">
    <meta name="citation_patent_application_number" content="BR:112016000238-5A">
    <meta name="citation_pdf_url" content="https://patentimages.storage.googleapis.com/f9/85/38/ff8356f8156ec6/BR112016000238B1.pdf">
    <meta name="citation_patent_publication_number" content="BR:112016000238:B1">
    <meta name="DC.date" content="2021-03-09">
    <meta name="DC.contributor" content="Karl-Wilhelm Muenks" scheme="inventor">
    <meta name="DC.contributor" content="Rolf Christian Becker" scheme="inventor">
    <meta name="DC.contributor" content="friedrich KERZ-MOEHLENDICK" scheme="inventor">
    <meta name="DC.contributor" content="Bernd Springer" scheme="inventor">
    <meta name="DC.contributor" content="Lino Miguel Dias" scheme="inventor">
    <meta name="DC.contributor" content="Coralie Nicole Van Breukelen-Groeneveld" scheme="inventor">
    <meta name="DC.contributor" content="Gilbert Labourdette" scheme="inventor">
    <meta name="DC.contributor" content="Denise MANKER" scheme="inventor">
    <meta name="DC.contributor" content="Bayer Cropscience Aktiengesellschaft" scheme="assignee">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,400italic,500,500italic,700">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Product+Sans">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Google+Sans:wght@400;500;700">

    <style>
      body { transition: none; }
    </style>

    <script src="https://apis.google.com/_/scs/abc-static/_/js/k=gapi.lb.en.IKZeRvoAYNY.O/m=client/rt=j/sv=1/d=1/ed=1/am=AAAQ/rs=AHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw/cb=gapi.loaded_0?le=scs" async=""></script><script>
      window.version = 'patent-search.search_20240531_RC00';

      function sendFeedback() {
        userfeedback.api.startFeedback({
          'productId': '713680',
          'bucket': 'patent-search-web',
          'productVersion': window.version,
        });
      }

      window.experiments = {};
      window.experiments.patentCountries = "ae,ag,al,am,ao,ap,ar,at,au,aw,az,ba,bb,bd,be,bf,bg,bh,bj,bn,bo,br,bw,bx,by,bz,ca,cf,cg,ch,ci,cl,cm,cn,co,cr,cs,cu,cy,cz,dd,de,dj,dk,dm,do,dz,ea,ec,ee,eg,em,ep,es,fi,fr,ga,gb,gc,gd,ge,gh,gm,gn,gq,gr,gt,gw,hk,hn,hr,hu,ib,id,ie,il,in,ir,is,it,jo,jp,ke,kg,kh,km,kn,kp,kr,kw,kz,la,lc,li,lk,lr,ls,lt,lu,lv,ly,ma,mc,md,me,mg,mk,ml,mn,mo,mr,mt,mw,mx,my,mz,na,ne,ng,ni,nl,no,nz,oa,om,pa,pe,pg,ph,pl,pt,py,qa,ro,rs,ru,rw,sa,sc,sd,se,sg,si,sk,sl,sm,sn,st,su,sv,sy,sz,td,tg,th,tj,tm,tn,tr,tt,tw,tz,ua,ug,us,uy,uz,vc,ve,vn,wo,yu,za,zm,zw";
      
      
      window.experiments.keywordWizard = true;
      
      
      
      window.experiments.definitions = true;

      window.Polymer = {
        dom: 'shady',
        lazyRegister: true,
      };
    </script>

    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/webcomponentsjs/webcomponents-lite.min.js"></script>
    <style>[hidden]:not([style-scope]):not(.style-scope) {
  display: none !important;
}

</style><style></style><style></style><style></style><style></style><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,300,300italic,400italic,500,500italic,700,700italic"><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto+Mono:400,700"><style></style><style></style><style>
  html, body {
    min-width: 100%;
    width: 100%;
    min-height: 100%;
    height: 100%;
  }

  body {
    background-color: #fff;
    font-family: 'Roboto', sans-serif;
    color: #333;
    margin: 0;
    padding: 0;
    /*
     * Turn off https://github.com/WICG/ScrollAnchoring/blob/master/explainer.md
     * https://memegen.googleplex.com/5230756293246976
     */
    overflow-anchor: none;
  }

  body h1, body h2, body h3 {
    -webkit-font-smoothing: antialiased;
    -moz-osx-font-smoothing: grayscale;
  }

  body a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  body a:visited {
    color: #3c80f6;
  }

  body a[open-result]:visited {
    color: #7e57c2;
  }

  /* For Firefox */
  a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  a:visited {
    color: #3c80f6;
  }

  a[open-result]:visited {
    color: #7e57c2;
  }

  ::selection , body ::selection {
    background-color: #c6dafc;
    color: #333;
  }
</style><link rel="import" href="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.html">
  <style>[hidden] { display: none !important; }</style><script type="text/javascript" charset="UTF-8" src="https://apis.google.com/js/client.js" gapi_processed="true"></script></head>
  <body>
    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.js"></script><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span>
    <search-app>
    
    <remote-fetch class="style-scope search-app"></remote-fetch>
    <search-state class="style-scope search-app"></search-state>
    <browser-ui class="style-scope search-app"></browser-ui>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    
      <search-result id="result" class="style-scope search-app">
    
    
    <search-ui mode="result" class="style-scope search-result x-scope search-ui-0">
    
    
    
    <div id="content" class="style-scope search-ui" wide="">
      <search-header show-search="" class="style-scope search-ui">
    
    
    <div class="style-scope search-header" wide="">
      <header class="style-scope search-header">
        <div class="layout horizontal headerpad style-scope search-header">
          <div class="layout horizontal leftheader style-scope search-header">
            <h1 class="style-scope search-header">
              <state-modifier inherit="" act="{&quot;type&quot;: &quot;HOME&quot;}" class="style-scope search-header"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                <div class="lockup style-scope search-header">
                  <span class="lockup-logo style-scope search-header"></span>
                  <span class="lockup-text style-scope search-header">
                    <span class="lockup-brand style-scope search-header">&nbsp;Patents</span>
                  </span>
                </div>
              </a></state-modifier>
            </h1>
          </div>
          
            <search-box class="style-scope search-header">
    
    <div class="layout horizontal style-scope search-box" style="position: relative;">
      <div class="inputbox flex layout horizontal style-scope search-box">
        <div class="suggest-bg flex style-scope search-box">
          <input name="q" id="searchInput" data-proto="SEARCH_INPUT" autocomplete="off" class="style-scope search-box">
        </div>
        <div id="corpora" class="style-scope search-box">
          <iron-icon icon="icons:lightbulb-outline" id="patentIcon" class="style-scope search-box x-scope iron-icon-0" active=""><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M9 21c0 .55.45 1 1 1h4c.55 0 1-.45 1-1v-1H9v1zm3-19C8.14 2 5 5.14 5 9c0 2.38 1.19 4.47 3 5.74V17c0 .55.45 1 1 1h6c.55 0 1-.45 1-1v-2.26c1.81-1.27 3-3.36 3-5.74 0-3.86-3.14-7-7-7zm2.85 11.1l-.85.6V16h-4v-2.3l-.85-.6C7.8 12.16 7 10.63 7 9c0-2.76 2.24-5 5-5s5 2.24 5 5c0 1.63-.8 3.16-2.15 4.1z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#patentIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include patents
    </div>
  </overlay-tooltip>
          <iron-icon icon="social:school" id="nplIcon" class="style-scope search-box x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M5 13.18v4L12 21l7-3.82v-4L12 17l-7-3.82zM12 3L1 9l11 6 9-4.91V17h2V9L12 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#nplIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include non-patent literature
    </div>
  </overlay-tooltip>
          <keyword-wizard id="wizardIcon" class="style-scope search-box">


<div id="wizardContainer" class="style-scope keyword-wizard">
  <iron-icon icon="image:tune" id="wizardIcon" class="style-scope keyword-wizard x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M3 17v2h6v-2H3zM3 5v2h10V5H3zm10 16v-2h8v-2h-8v-2h-2v6h2zM7 9v2H3v2h4v2h2V9H7zm14 4v-2H11v2h10zm-6-4h2V7h4V5h-4V3h-2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
  <paper-material elevation="2" id="wizard" class="style-scope keyword-wizard x-scope paper-material-0" hidden="">
    
    

    
    
    <div class="search-within style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Search within
        <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="within"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="withinHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search within the title, abstract, claims, or full patent document</b>: You can
          restrict your search to a specific field using field names.</p>
        <p class="style-scope keyword-wizard">Use <span class="q style-scope keyword-wizard">TI=</span> to search in the title, <span class="q style-scope keyword-wizard">AB=</span> for the
          abstract, <span class="q style-scope keyword-wizard">CL=</span> for the claims, or <span class="q style-scope keyword-wizard">TAC=</span> for
          all three. For example, <span class="q style-scope keyword-wizard">TI=(safety belt)</span>.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search by Cooperative Patent Classifications (CPCs)</b>: These are commonly used to
          represent ideas in place of keywords, and can also be entered in a search term box. If
          you're searching for<span class="q style-scope keyword-wizard">seat belts</span>, you could also search for
          <span class="q style-scope keyword-wizard">B60R22/00</span> to retrieve documents that mention safety belts or body
          harnesses. <span class="q style-scope keyword-wizard">CPC=B60R22</span> will match documents with exactly this CPC,
          <span class="q style-scope keyword-wizard">CPC=B60R22/low</span> matches documents with this CPC or a child
          classification of this CPC.
        </p>
          <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="filter-chips style-scope keyword-wizard">
        <span class="chip style-scope keyword-wizard" id="title" selected="">Title</span>
        <span class="chip style-scope keyword-wizard" id="abstract" selected="">Abstract</span>
        <span class="chip style-scope keyword-wizard" id="claims" selected="">Claims</span>
        <span class="chip style-scope keyword-wizard" id="fullDoc" selected="">Full Document</span>
      </div>
      
      <div class="cpc-field style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputCPC" class="style-scope keyword-wizard">or CPC</label></span>
        <div class="cpc-inputs style-scope keyword-wizard">
          <input class="keyword-input style-scope keyword-wizard" id="inputCPC" placeholder="Or search with CPC">
          <input type="checkbox" id="childCPC" checked="" class="style-scope keyword-wizard">
          <label class="checkbox-label style-scope keyword-wizard" for="childCPC">
            Include child classifications
          </label>
        </div>
      </div>
    </div>
    
    <div class="find-patents style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Find patents
        <iron-icon class="help-header style-scope keyword-wizard x-scope iron-icon-0" icon="icons:help-outline" id="searchBoolean"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="searchBooleanHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Keywords and boolean syntax (USPTO or EPO format)</b>:
          <span class="q style-scope keyword-wizard">seat belt</span> searches these two words, or their plurals and close
          synonyms. <span class="q style-scope keyword-wizard">"seat belt"</span> searches this exact phrase, in order.
          <span class="q style-scope keyword-wizard">-seat -belt</span> searches for documents not containing either word.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">For searches using boolean logic</b>, the default operator is
          <span class="q style-scope keyword-wizard">AND</span> with left associativity. <i class="style-scope keyword-wizard">Note:</i> this means
          <span class="q style-scope keyword-wizard">safety OR seat belt</span> is searched as <span class="q style-scope keyword-wizard">(safety OR seat)
          AND belt</span>. Each word automatically includes plurals and close synonyms. Adjacent
          words that are implicitly ANDed together, such as <span class="q style-scope keyword-wizard">(safety belt)</span>,
          are treated as a phrase when generating synonyms.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputAnd" class="style-scope keyword-wizard">with ALL of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputAnd" placeholder="with ALL of the words">
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputExact" class="style-scope keyword-wizard">with the EXACT PHRASE</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputExact" placeholder="with the EXACT PHRASE"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputOr" class="style-scope keyword-wizard">with AT LEAST ONE of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputOr" placeholder="with AT LEAST ONE of the words"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputMinus" class="style-scope keyword-wizard">WITHOUT the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputMinus" placeholder="WITHOUT the words"></div>
    </div>
    <div class="search-by style-scope keyword-wizard">
      <div class="wizard-header style-scope keyword-wizard">
          Search by
          <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="chem"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </div>
      
      <div class="help style-scope keyword-wizard" id="chemHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Chemistry searches</b> match terms (trade names, IUPAC names, etc.
          extracted from the entire document, and processed from .MOL files.)
        </p>
        <p class="style-scope keyword-wizard">Substructure (use <span class="q style-scope keyword-wizard">SSS=</span>) and similarity (use
          <span class="q style-scope keyword-wizard">~</span>) searches are limited to one per search at the top-level
          <span class="q style-scope keyword-wizard">AND</span> condition. Exact searches can be used multiple times throughout
          the search query.
        </p>
        <p class="style-scope keyword-wizard">Searching by SMILES or InChi key requires no special syntax. To search by SMARTS, use
          <span class="q style-scope keyword-wizard">SMARTS=</span>.
        </p>
        <p class="style-scope keyword-wizard">To search for multiple molecules, select "Batch" in the "Type" menu. Enter multiple
          molecules separated by whitespace or by comma.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      
      <div class="chemistry-field style-scope keyword-wizard">
          <span class="input-label style-scope keyword-wizard"><label for="inputChem" class="style-scope keyword-wizard">Chemistry</label></span>
          <span class="chem-type-label style-scope keyword-wizard"><label for="chemType" hidden="" class="style-scope keyword-wizard">Type</label></span>
          <select id="chemType" class="style-scope keyword-wizard">
            <option value="identical" class="style-scope keyword-wizard">Identical</option>
            <option value="substructure" class="style-scope keyword-wizard">Substructure</option>
            <option value="smarts" class="style-scope keyword-wizard">SMARTS</option>
            <option value="similarity" class="style-scope keyword-wizard">Similarity</option>
            <option value="batch" class="style-scope keyword-wizard">Batch</option>
          </select>
          <textarea class="keyword-input style-scope keyword-wizard" id="inputChem" placeholder="Trade name, SMILES, InChiKey"></textarea>
      </div>
      <div class="import style-scope keyword-wizard">
        <div class="wizard-header style-scope keyword-wizard">
          Patent numbers
        </div>
        <span class="import-button style-scope keyword-wizard">
          <a href="https://patents.google.com/import" class="style-scope keyword-wizard"><button class="style-scope keyword-wizard">Import</button></a>
        </span>
        <p class="import-text style-scope keyword-wizard">
          Search specific patents by importing a CSV or list of patent publication or application numbers.
        </p>
      </div>
    </div>
    
    <div class="wizard-buttons style-scope keyword-wizard">
      <button type="reset" class="style-scope keyword-wizard">Close</button>
      <button type="button" autofocus="" class="style-scope keyword-wizard">Add</button>
    </div>
  
  </paper-material>
</div>
</keyword-wizard>
          <overlay-tooltip positioning-target="#wizardIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Display advanced search options
    </div>
  </overlay-tooltip>
        </div>
      </div>
      <paper-material id="suggestMenu" class="style-scope search-box x-scope paper-material-0" elevation="1" hidden="">
    
    

    
        <template is="dom-repeat" class="style-scope search-box"></template>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Sorry, we couldn't find this patent number.
        </div>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> 
        </div>
      
  </paper-material>
      <button id="searchButton" class="style-scope search-box"><iron-icon class="style-scope search-box x-scope iron-icon-0" icon="search"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.5 14h-.79l-.28-.27C15.41 12.59 16 11.11 16 9.5 16 5.91 13.09 3 9.5 3S3 5.91 3 9.5 5.91 16 9.5 16c1.61 0 3.09-.59 4.23-1.57l.27.28v.79l5 4.99L20.49 19l-4.99-5zm-6 0C7.01 14 5 11.99 5 9.5S7.01 5 9.5 5 14 7.01 14 9.5 11.99 14 9.5 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></button>
    </div>
  </search-box>
          <template is="dom-if" class="style-scope search-header"></template>
          <div class="flex style-scope search-header"></div>
          
            <div id="header-container" class="style-scope search-header">
              <result-nav class="style-scope search-header">
    
    <div class="style-scope result-nav" hidden="">
      <state-modifier id="current" act="{&quot;type&quot;: &quot;BACK_TO_RESULTS&quot;}" inherit="" class="style-scope result-nav"><a id="link" href="#" class="style-scope state-modifier" inherit=""><span class="style-scope result-nav"></span> of
      <template is="dom-if" class="style-scope result-nav"></template>
      0<template is="dom-if" class="style-scope result-nav"></template></a></state-modifier>
      <state-modifier id="prevResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-left" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.41 7.41L14 6l-6 6 6 6 1.41-1.41L10.83 12z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier><state-modifier id="nextResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-right" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M10 6L8.59 7.41 13.17 12l-4.58 4.59L10 18l6-6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier>
      <overlay-tooltip positioning-target="#prevResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Previous result
    </div>
  </overlay-tooltip>
      <overlay-tooltip positioning-target="#nextResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Next result
    </div>
  </overlay-tooltip>
    </div>
  </result-nav>
            </div>
          <template is="dom-if" class="style-scope search-header"></template>
        </div>
      </header>
    </div>
  </search-header>

      <div class="layout horizontal style-scope search-ui">
        <template is="dom-if" class="style-scope search-ui"></template>

        <div id="main" class="style-scope search-ui">
          <search-term-wizard class="style-scope search-ui"><pat-dialog open="" class="style-scope search-term-wizard">
  <span class="header style-scope search-term-wizard">
    <span class="title style-scope search-term-wizard">Search tools</span>
    <span id="language" class="style-scope search-term-wizard">
      <text-button id="textButton" selected="" class="style-scope search-term-wizard">Text
</text-button>
      <text-button id="classificationButton" class="style-scope search-term-wizard">Classification
</text-button>
      <text-button id="chemistryButton" class="style-scope search-term-wizard">Chemistry
</text-button>
      <text-button id="measureButton" class="style-scope search-term-wizard">Measure
</text-button>
      <text-button id="numbersButton" class="style-scope search-term-wizard">Numbers
</text-button>
    </span>
  </span>
  <span id="panels" class="style-scope search-term-wizard">
    <text-search-term-wizard id="textPanel" class="style-scope search-term-wizard" selected=""><span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Type a concept you want to search for here" class="style-scope text-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Type a concept you want to search for here">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="title" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Title</filter-chip>
  <filter-chip id="abstract" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Abstract</filter-chip>
  <filter-chip id="claims" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="all" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
All</filter-chip>
  <filter-chip id="any" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Any</filter-chip>
  <filter-chip id="exact" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="not" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Not</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope text-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope text-search-term-wizard">Add AND condition</span></mat-button></span></text-search-term-wizard>
    <classification-wizard id="classificationPanel" class="style-scope search-term-wizard"><span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope classification-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Enter a CPC here" uppercase="" class="style-scope classification-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Enter a CPC here">
  
</span>
</outlined-text-field>
</span>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope classification-wizard"></path>
  </svg>
  <filter-chip id="notExact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These CPCs and their children
  </filter-chip>
  <filter-chip selected="" id="exact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These exact CPCs
  </filter-chip>
</span>
<span class="style-scope classification-wizard">
  <mat-button id="button" filled="" class="style-scope classification-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope classification-wizard">Add AND condition</span></mat-button>
</span></classification-wizard>
    <chemistry-search-term-wizard id="chemistryPanel" class="style-scope search-term-wizard"><span class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Trade name, SMILES, InChI Key" class="style-scope chemistry-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Trade name, SMILES, InChI Key">
  
</span>
</outlined-text-field>
  <outlined-textarea id="textArea" placeholder="Enter multiple SMILES or InChI Keys, one per line" rows="4" class="style-scope chemistry-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple SMILES or InChI Keys, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
  <a href="https://support.google.com/faqs/answer/7049475#zippy=%2Csearching-by-chemistry" target="_blank" class="style-scope chemistry-search-term-wizard">
    <svg class="help style-scope chemistry-search-term-wizard" xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49">
      <path d="M11.95 18q.525 0 .888-.363.362-.362.362-.887t-.362-.887q-.363-.363-.888-.363t-.888.363q-.362.362-.362.887t.362.887q.363.363.888.363Zm-.9-3.85h1.85q0-.825.188-1.3.187-.475 1.062-1.3.65-.65 1.025-1.238.375-.587.375-1.412 0-1.4-1.025-2.15T12.1 6q-1.425 0-2.312.75-.888.75-1.238 1.8l1.65.65q.125-.45.563-.975Q11.2 7.7 12.1 7.7q.8 0 1.2.437.4.438.4.963 0 .5-.3.937-.3.438-.75.813-1.1.975-1.35 1.475-.25.5-.25 1.825ZM12 22q-2.075 0-3.9-.788-1.825-.787-3.175-2.137-1.35-1.35-2.137-3.175Q2 14.075 2 12t.788-3.9q.787-1.825 2.137-3.175 1.35-1.35 3.175-2.138Q9.925 2 12 2t3.9.787q1.825.788 3.175 2.138 1.35 1.35 2.137 3.175Q22 9.925 22 12t-.788 3.9q-.787 1.825-2.137 3.175-1.35 1.35-3.175 2.137Q14.075 22 12 22Zm0-2q3.35 0 5.675-2.325Q20 15.35 20 12q0-3.35-2.325-5.675Q15.35 4 12 4 8.65 4 6.325 6.325 4 8.65 4 12q0 3.35 2.325 5.675Q8.65 20 12 20Zm0-8Z" class="style-scope chemistry-search-term-wizard"></path>
    </svg>
  </a>
</span>
<span id="chemQuantifiers" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M5 21.2q-1.4 0-2-1.25-.6-1.25.3-2.325l5.5-6.7V5.15h-.825q-.475 0-.8-.338Q6.85 4.475 6.85 4q0-.475.325-.813.325-.337.8-.337h8.05q.475 0 .8.337.325.338.325.813 0 .475-.325.812-.325.338-.8.338H15.2v5.775l5.5 6.7q.9 1.075.3 2.325-.6 1.25-2 1.25Zm2.15-3.275h9.7l-3.275-3.85h-3.15Zm-2 1h13.7l-5.925-7.2V5.15h-1.85v6.575Zm6.85-6.9Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="exact" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="exactBatch" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact Batch</filter-chip>
  <filter-chip id="similar" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Similar</filter-chip>
  <filter-chip id="substructure" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure</filter-chip>
  <filter-chip id="smarts" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure (SMARTS)</filter-chip>
</span>
<span id="location" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="claims" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims only</filter-chip>
</span>
<span class="style-scope chemistry-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope chemistry-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope chemistry-search-term-wizard">Add AND condition</span></mat-button>
</span>
</chemistry-search-term-wizard>
    <measure-search-term-wizard id="measurePanel" class="style-scope search-term-wizard"><span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M4.1 18.15q-.95 0-1.612-.663-.663-.662-.663-1.612v-7.75q0-.95.663-1.613Q3.15 5.85 4.1 5.85h15.8q.95 0 1.613.662.662.663.662 1.613v7.75q0 .95-.662 1.612-.663.663-1.613.663Zm0-2.275h15.8v-7.75H17V12h-2V8.125h-2V12h-2V8.125H9V12H7V8.125H4.1v7.75ZM7 12h2Zm4 0h2Zm4 0h2Zm-3 0Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="measureExpression" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M3.875 20.15V8.85h4.25v11.3Zm6 0V3.85h4.25v16.3Zm6 0v-7.3h4.25v7.3Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="context" placeholder="activity, wavelength, embossing depth, absorption" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="activity, wavelength, embossing depth, absorption">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope measure-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope measure-search-term-wizard">Add AND condition</span></mat-button>
</span>
</measure-search-term-wizard>
    <numerical-search-term-wizard id="numericalPanel" class="style-scope search-term-wizard"><span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-textarea id="batch" placeholder="Enter multiple Patent Application and Publication Numbers, one per line" rows="4" class="style-scope numerical-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple Patent Application and Publication Numbers, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
</span>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="m10.825 23.45-1.6-1.625L10.9 20.15H8q-.35.9-1.162 1.488-.813.587-1.838.587-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.025.588-1.837Q2.95 16.35 3.85 16V8q-.9-.35-1.487-1.163Q1.775 6.025 1.775 5q0-1.35.938-2.288Q3.65 1.775 5 1.775q1.025 0 1.838.587Q7.65 2.95 8 3.85h2.9L9.225 2.175l1.6-1.625L15.275 5l-4.45 4.45-1.6-1.625L10.9 6.15H8q-.25.65-.725 1.125T6.15 8v8q.65.25 1.125.725T8 17.85h2.9l-1.675-1.675 1.6-1.625 4.45 4.45ZM19 22.225q-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.05.588-1.863.587-.812 1.487-1.137V8q-.9-.325-1.487-1.137-.588-.813-.588-1.863 0-1.35.938-2.288.937-.937 2.287-.937 1.35 0 2.288.937.937.938.937 2.288 0 1.05-.587 1.863Q21.05 7.675 20.15 8v8q.9.35 1.488 1.163.587.812.587 1.837 0 1.35-.937 2.288-.938.937-2.288.937ZM5 19.95q.4 0 .675-.275T5.95 19q0-.4-.275-.675T5 18.05q-.4 0-.675.275T4.05 19q0 .4.275.675T5 19.95Zm14 0q.4 0 .675-.275T19.95 19q0-.4-.275-.675T19 18.05q-.4 0-.675.275T18.05 19q0 .4.275.675t.675.275Zm-14-14q.4 0 .675-.275T5.95 5q0-.4-.275-.675T5 4.05q-.4 0-.675.275T4.05 5q0 .4.275.675T5 5.95Zm14 0q.4 0 .675-.275T19.95 5q0-.4-.275-.675T19 4.05q-.4 0-.675.275T18.05 5q0 .4.275.675T19 5.95ZM5 19Zm14 0ZM5 5Zm14 0Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <filter-chip id="applicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Application Numbers</filter-chip>
  <filter-chip id="publicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Publication Numbers</filter-chip>
  <filter-chip id="either" selected="" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Either</filter-chip>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M12 22.2q-2.1 0-3.962-.8-1.863-.8-3.25-2.175Q3.4 17.85 2.6 15.988 1.8 14.125 1.8 12t.8-3.988q.8-1.862 2.188-3.237Q6.175 3.4 8.038 2.6 9.9 1.8 12 1.8q2.125 0 3.988.8 1.862.8 3.237 2.175Q20.6 6.15 21.4 8.012q.8 1.863.8 3.988t-.8 3.988q-.8 1.862-2.175 3.237Q17.85 20.6 15.988 21.4q-1.863.8-3.988.8Zm-1-2.325v-1.95q-.8 0-1.387-.575-.588-.575-.588-1.4v-.975L4.275 10.2q-.075.45-.137.9-.063.45-.063.9 0 3 1.975 5.25T11 19.875Zm6.85-2.525q.5-.55.888-1.175.387-.625.65-1.313.262-.687.4-1.412.137-.725.137-1.45 0-2.425-1.338-4.438-1.337-2.012-3.612-2.887v.375q0 .825-.587 1.4-.588.575-1.388.575h-2v2q0 .4-.287.687-.288.288-.688.288h-2v2h5.95q.425 0 .713.287.287.288.287.688v2.975h1q.65 0 1.163.387.512.388.712 1.013Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryFilter" placeholder="Restrict search to these countries" class="style-scope numerical-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Restrict search to these countries">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M2.85 18.225V15.95h6.3v2.275Zm0-5.075v-2.3h12.3v2.3Zm0-5.1V5.775h18.3V8.05Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryOrder" placeholder="Prefer results from these countries in this order" class="style-scope numerical-search-term-wizard" value="US, EP, WO, JP, CN"><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Prefer results from these countries in this order">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope numerical-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope numerical-search-term-wizard">Add AND condition</span></mat-button>
</span>
</numerical-search-term-wizard>
  </span>

</pat-dialog>
</search-term-wizard>
          
      <div content="" class="style-scope search-result">
        <div id="mainContainer" class="vertical layout style-scope search-result">
          <template is="dom-if" class="style-scope search-result"></template>
          <result-container class="style-scope search-result">
    

    <paper-spinner class="style-scope result-container x-scope paper-spinner-0" aria-hidden="true" hidden=""><div id="spinnerContainer" class="  style-scope paper-spinner"><div class="spinner-layer layer-1 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-2 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-3 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-4 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div></div></paper-spinner>
    
      <patent-result class="style-scope result-container">
    
    
    <div class="layout horizontal style-scope patent-result">
      <div style="width: 1200px; height: auto; overflow: auto;" class="style-scope patent-result">
        <div id="wrapper" tabindex="0" class="style-scope patent-result">
          <result-tags class="style-scope patent-result"></result-tags>
          <h1 id="title" class="scroll-target style-scope patent-result">
            
  method for the control of harmful bacterial organisms in useful plants and kit of parts
 
     </h1>
          <div class="horizontal layout style-scope patent-result">
            
            <div class="flex-3 style-scope patent-result" style="margin-top:-20px;overflow:hidden;" marginright="">
              <section id="abstract" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Abstract</div>
                  <div class="righthead style-scope patent-result">translated from Portuguese</div>
                </h3>
                <patent-text name="abstract" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><abstract mxw-id="PA445120350" lang="EN" load-source="google" class="style-scope patent-text">
  <p id="p01a" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">MTODOS PARA O CONTROLE DE ORGANISMOS BACTERIANOS NOCIVOS EM PLANTAS TEIS E KIT DE PARTES A presente inveno est relacionada ao uso de uma combinao que compreende pelo menos um indutor da defesa do hospedeiro e pelo menos um agente de controle bi olgico em uma quantidade sinergicamente eficaz para o cont role de organismos bacterianos nocivos em plantas teis. O agente de controle biolgico  selecionado de microorganismos especficos e/ou um mutante dessas cepas que possui todas as caractersticas de identificao da respectiva cepa, e/ou um metablito produzido pela respectiva cepa. Em um aspecto preferido da inveno, o indutor da defesa do hospedeiro  isotianil ou uma combinao de isotianil e acibenzolar-S-metil. A presente inveno tambm est relacionada a um mtodo para o controle de organismos bacterianos nocivos em plantas teis por tratamento com uma combinao que compreende pelo menos um indutor da defesa do hospedeiro e pelo menos um agente de controle biolgico em uma quantidade sinergicamente eficaz. Um aspecto adicional da presente inveno  dirigido a um mto do para o controle de organismos bacterianos nocivos em plantas teis por submisso s plantas a serem protegidas contra ataque por organismos bacterianos nocivos a (...).</span>METHODS FOR THE CONTROL OF HARMFUL BACTERIAL ORGANISMS IN USEFUL PLANTS AND PARTS KIT The present invention relates to the use of a combination comprising at least one host defense inducer and at least one biological control agent in a synergistically effective amount for the containment of harmful bacterial organisms in useful plants. The biological control agent is selected from specific microorganisms and / or a mutant from these strains that has all the identification characteristics of the respective strain, and / or a metabolite produced by the respective strain. In a preferred aspect of the invention, the host defense inducer is isothianyl or a combination of isothianyl and acibenzolar-S-methyl. The present invention is also related to a method for the control of harmful bacterial organisms in useful plants by treatment with a combination comprising at least one host defense inducer and at least one biological control agent in a synergistically effective amount. An additional aspect of the present invention is directed to a method for the control of harmful bacterial organisms in useful plants by submission to the plants to be protected against attack by harmful bacterial organisms to (...).</span>
  </p>
</abstract>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <section id="classifications" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Classifications</div>
                  <div id="machineClassifiedWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">machine-classified</div>
                  <div id="machineClassifiedCPCWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">cpc-machine-classified</div>
                  <div id="machineClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-machine-classified</div>
                  <div class="style-scope patent-result" hidden="">&nbsp;</div>
                  <div id="familyClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-family-classified</div>
                </h3>
                <overlay-tooltip positioning-target="#machineClassifiedWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedCPCWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The CPC classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#familyClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned based on a patent family member containing these classification codes.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <classification-viewer class="style-scope patent-result">
    
    <div class="table style-scope classification-viewer">
      
        <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A01"><a id="link" href="#" class="style-scope state-modifier">A01</a></state-modifier>
                  <span class="description style-scope classification-tree">AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A01N"><a id="link" href="#" class="style-scope state-modifier">A01N</a></state-modifier>
                  <span class="description style-scope classification-tree">PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A01N43/00"><a id="link" href="#" class="style-scope state-modifier">A01N43/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A01N43/48"><a id="link" href="#" class="style-scope state-modifier">A01N43/48</a></state-modifier>
                  <span class="description style-scope classification-tree">Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" additional="true" data-cpc="A01N43/56"><a id="link" href="#" class="style-scope state-modifier">A01N43/56</a></state-modifier>
                  <span class="description style-scope classification-tree">1,2-Diazoles; Hydrogenated 1,2-diazoles</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
      <template is="dom-repeat" class="style-scope classification-viewer"></template>
      
      <div class="style-scope classification-viewer">
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A01"><a id="link" href="#" class="style-scope state-modifier">A01</a></state-modifier>
                  <span class="description style-scope classification-tree">AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A01N"><a id="link" href="#" class="style-scope state-modifier">A01N</a></state-modifier>
                  <span class="description style-scope classification-tree">PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A01N43/00"><a id="link" href="#" class="style-scope state-modifier">A01N43/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A01N43/72"><a id="link" href="#" class="style-scope state-modifier">A01N43/72</a></state-modifier>
                  <span class="description style-scope classification-tree">Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" additional="true" data-cpc="A01N43/80"><a id="link" href="#" class="style-scope state-modifier">A01N43/80</a></state-modifier>
                  <span class="description style-scope classification-tree">Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A01"><a id="link" href="#" class="style-scope state-modifier">A01</a></state-modifier>
                  <span class="description style-scope classification-tree">AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A01N"><a id="link" href="#" class="style-scope state-modifier">A01N</a></state-modifier>
                  <span class="description style-scope classification-tree">PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" additional="true" data-cpc="A01N63/00"><a id="link" href="#" class="style-scope state-modifier">A01N63/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        <template is="dom-repeat" class="style-scope classification-viewer"></template>
        <div class="more style-scope classification-viewer" style="" hidden="">View 2 more classifications</div>
        <div class="more style-scope classification-viewer">Hide more classifications</div>
      </div>
      <template is="dom-if" class="style-scope classification-viewer"></template>
    </div>
  </classification-viewer>
              </section>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              
                <section class="style-scope patent-result">
                  <h3 class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Landscapes</div>
                  </h3>
                  <div class="responsive-grid style-scope patent-result">
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Life Sciences &amp; Earth Sciences"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Life Sciences &amp; Earth Sciences
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Engineering &amp; Computer Science"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Engineering &amp; Computer Science
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    <template is="dom-repeat" class="style-scope patent-result"></template>
                  </div>
                  <s-more-inline class="style-scope patent-result"><hr aria-hidden="true" class="style-scope s-more-inline">

<div class="button style-scope s-more-inline">
  <span slot="expand_text" class="style-scope patent-result">Show more</span>
  <span class="expand more style-scope s-more-inline"></span>
</div>
<div class="button style-scope s-more-inline" hidden="">
  <span slot="collapse_text" class="style-scope patent-result">Show less</span>
  <span class="expand less style-scope s-more-inline"></span>
</div>
</s-more-inline>
                </section>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
            <div class="flex-2 style-scope patent-result">
              <section class="knowledge-card style-scope patent-result">
                <header class="style-scope patent-result">
                  <h2 id="pubnum" class="style-scope patent-result">BR112016000238B1</h2>
                  <p class="tagline style-scope patent-result">Brazil</p>
                  <overlay-tooltip positioning-target="#pubnum" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                    <div style="max-width: 300px;" class="style-scope patent-result">Granted patent filed via PCT</div>
                  
    </div>
  </overlay-tooltip>

                  <div class="knowledge-card-action-bar style-scope patent-result">
                    <a target="_blank" class="style-scope patent-result" href="https://patentimages.storage.googleapis.com/f9/85/38/ff8356f8156ec6/BR112016000238B1.pdf"><iron-icon icon="description" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Download PDF</a>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_FIND_PRIOR_ART&quot;, &quot;keywords&quot;: $keywords, &quot;before&quot;: &quot;$before&quot;}" class="style-scope patent-result" data-keywords="[&quot;plants&quot;,&quot;xanthomonas&quot;,&quot;treatment&quot;,&quot;methyl&quot;,&quot;host defense&quot;]" data-before="20130711"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="find-in-page" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 19.59V8l-6-6H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c.45 0 .85-.15 1.19-.4l-4.43-4.43c-.8.52-1.74.83-2.76.83-2.76 0-5-2.24-5-5s2.24-5 5-5 5 2.24 5 5c0 1.02-.31 1.96-.83 2.75L20 19.59zM9 13c0 1.66 1.34 3 3 3s3-1.34 3-3-1.34-3-3-3-3 1.34-3 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Find Prior Art
                    </a></state-modifier>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_SIMILAR_DOCUMENTS&quot;, &quot;id&quot;: &quot;$id&quot;}" class="style-scope patent-result" data-id="patent/BR112016000238B1"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="editor:functions" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M18 4H6v2l6.5 6L6 18v2h12v-3h-7l5-5-5-5h7z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Similar
                    </a></state-modifier>
                  </div>
                </header>

                <dl class="important-people style-scope patent-result">
                  
                    <dt class="style-scope patent-result">Other languages</dt>
                    <dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/BR112016000238B1/pt"><a id="link" href="#" class="style-scope state-modifier">Portuguese</a></state-modifier></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>
                  
                  <dt class="style-scope patent-result">Inventor</dt>
                  <dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Karl-Wilhelm Muenks"><a id="link" href="#" class="style-scope state-modifier">Karl-Wilhelm Muenks</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Rolf Christian Becker"><a id="link" href="#" class="style-scope state-modifier">Rolf Christian Becker</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="friedrich KERZ-MOEHLENDICK"><a id="link" href="#" class="style-scope state-modifier">friedrich KERZ-MOEHLENDICK</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Bernd Springer"><a id="link" href="#" class="style-scope state-modifier">Bernd Springer</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Lino Miguel Dias"><a id="link" href="#" class="style-scope state-modifier">Lino Miguel Dias</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Coralie Nicole Van Breukelen-Groeneveld"><a id="link" href="#" class="style-scope state-modifier">Coralie Nicole Van Breukelen-Groeneveld</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Gilbert Labourdette"><a id="link" href="#" class="style-scope state-modifier">Gilbert Labourdette</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Denise MANKER"><a id="link" href="#" class="style-scope state-modifier">Denise MANKER</a></state-modifier></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>

                  <template is="dom-if" class="style-scope patent-result"></template>
                </dl>

                <hr class="style-scope patent-result">

                <application-timeline class="style-scope patent-result">
    
    
    <div class="wrap style-scope application-timeline">
      <div class="header style-scope application-timeline">Worldwide applications</div>
      <div class="event style-scope application-timeline">
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">2014</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/PT3019014T/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">PT</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: PT14738507T</div>
                <div class="style-scope application-timeline">Filing date: 2014-07-10</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/NZ715726A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">NZ</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: NZ71572614A</div>
                <div class="style-scope application-timeline">Filing date: 2014-07-10</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/BR112016000238B1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline" this="">BR</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: BR112016000238-5A</div>
                <div class="style-scope application-timeline">Filing date: 2014-07-10</div>
                <div class="style-scope application-timeline">Legal status: IP Right Grant</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">2016</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/ZA201600417B/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">ZA</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: ZA2016/00417A</div>
                <div class="style-scope application-timeline">Filing date: 2016-01-19</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        <template is="dom-repeat" class="style-scope application-timeline"></template>
      </div>
      <hr class="style-scope application-timeline">
      <div class="header style-scope application-timeline">Application BR112016000238-5A events <iron-icon id="legal" icon="icons:help-outline" class="style-scope application-timeline x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        <overlay-tooltip positioning-target="#legal" direction="right" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
          <div style="max-width: 300px;" class="style-scope application-timeline">
            A timeline of key events for this patent application, including priority claims, publications, legal status, reassignments, and litigation.<br class="style-scope application-timeline"><br class="style-scope application-timeline">
            Google has not performed a legal analysis and makes no representation as to the accuracy or completeness of the events listed.
          </div>
        
    </div>
  </overlay-tooltip>
      </div>
      <div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="filed style-scope application-timeline">2014-07-10</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_ASSIGNEE&quot;, &quot;assignee&quot;: &quot;$assignee&quot;}" class="style-scope application-timeline" data-assignee="Bayer Cropscience Aktiengesellschaft"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Application filed by Bayer Cropscience Aktiengesellschaft</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline"><div date="" class="external-priority style-scope application-timeline">2014-07-10</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/WO2015004260A1/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Priority claimed from PCT/EP2014/064873</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="publication style-scope application-timeline">2019-12-31</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/BR112016000238A8/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Publication of BR112016000238A8</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="publication style-scope application-timeline">2021-03-09</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/BR112016000238B1/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Publication of BR112016000238B1</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><template is="dom-repeat" strip-whitespace="" class="style-scope application-timeline"></template>
      <template is="dom-if" class="style-scope application-timeline"></template>
    </div>
  </application-timeline>
                <hr class="style-scope patent-result">

                <dl class="links style-scope patent-result">
                  <dt class="style-scope patent-result">Info</dt>

                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#legalEvents" class="style-scope patent-result">Legal events</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#similarDocuments" class="style-scope patent-result">Similar documents</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#relatedApplications" class="style-scope patent-result">Priority and Related Applications</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <dt class="style-scope patent-result">External links</dt>

                  <dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://worldwide.espacenet.com/publicationDetails/biblio?CC=BR&amp;NR=112016000238B1&amp;KC=B1&amp;FT=D">Espacenet</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://globaldossier.uspto.gov/#/result/publication/BR/112016000238/1">Global Dossier</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://patents.stackexchange.com/questions/tagged/BR112016000238B1">Discuss</a></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                </dl>
              </section>
            </div>
          </div>

          <div id="text" class="horizontal layout style-scope patent-result">
            <div class="flex flex-width style-scope patent-result" marginright="">
              <section id="description" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Description</div>
                  <div class="righthead style-scope patent-result">translated from Portuguese</div>
                </h3>
                <patent-text name="description" id="descriptionText" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><description mxw-id="PDES291279302" lang="EN" load-source="google" class="style-scope patent-text">
  <p id="p0001" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[001] A presente inveno est relacionada ao uso de uma combinao que compreende pelo menos um indutor da defesa do hospedeiro e pelo menos um agente de controle biolgico em uma quantidade sinergicamente eficaz para o controle de organismos bacterianos nocivos em plantas teis. O agente de controle biolgico  selecionado de microorganismos especficos e/ou um mutante dessas cepas que possui todas as caractersticas de identificao da respectiva cepa, e/ou um metablito produzido pela respectiva cepa. Em um aspecto preferido da inveno, o indutor da defesa do hospedeiro  isotianil ou uma combinao de isotianil e acibenzolar-S-metil. A presente inveno tambm est relacionada a um mtodo para o controle de organismos bacterianos nocivos em plantas teis por tratamento com uma combinao que compreende pelo menos um indutor da defesa do hospedeiro e pelo menos um agente de controle biolgico em uma quantidade sinergicamente eficaz. Um aspecto adicional da presente inveno  dirigido a um mtodo para o controle de organismos bacterianos nocivos em plantas teis por submisso s plantas a serem protegidas contra ataque por organismos bacterianos nocivos a dois ou mais blocos de tratamento sequenciais.</span>[001] The present invention relates to the use of a combination comprising at least one host defense inducer and at least one biological control agent in an amount synergistically effective for the control of harmful bacterial organisms in useful plants. The biological control agent is selected from specific microorganisms and / or a mutant from these strains that has all the identification characteristics of the respective strain, and / or a metabolite produced by the respective strain. In a preferred aspect of the invention, the host defense inducer is isothianyl or a combination of isothianyl and acibenzolar-S-methyl. The present invention is also related to a method for the control of harmful bacterial organisms in useful plants by treatment with a combination comprising at least one host defense inducer and at least one biological control agent in a synergistically effective amount. A further aspect of the present invention is directed to a method for the control of harmful bacterial organisms in useful plants by submission to the plants to be protected against attack by harmful bacterial organisms to two or more sequential treatment blocks.</span>
  </p>
  <heading id="h0001" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">INTRODUO E TCNICA ANTECEDENTE</span>INTRODUCTION AND BACKGROUND TECHNIQUE</span>
  </heading>
  <p id="p0002" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[002] O Pedido de Patente Internacional WO2010/089055 A2 e o Pedido de Patente Europia correspondente EP 2393363 A2 geralmente revelam o uso de anlogos de cido heteroaromtico que contm enxofre de acordo com uma frmula geral (I) para o controle de organismos bacterianos nocivos em plantas teis. A frmula geral (I) engloba, entre outras coisas, os indutores da defesa do hospedeiro tiadinil (composto I-1) e isotianil (composto I-15) de uma lista de 20 compostos especficos preferidos diferentes. O indutor da defesa do hospedeiro acibenzolar-S-metil e probenazol no esto englobados pela frmula (I). Alm disso, o pedido se refere amplamente a vrias cepas de bactrias e a diversas plantas a serem tratadas. O pedido especificamente se refere apenas a um exemplo concreto, em que o uso do composto I-15 (isotianil) no tratamento de arroz contra Xanthomonas campestris pv. oryzae  descrito. O uso de uma combinao que compreende pelo menos um desses indutores da defesa do hospedeiro e pelo menos um agente de controle biolgico em uma quantidade sinergicamente eficaz para o controle de organismos bacterianos nocivos em plantas teis no  descrito em WO2010/089055 A2. Os inventores da presente inveno constataram surpreendentemente os efeitos benficos sinrgicos dessas combinaes no combate de organismos bacterianos nocivos em plantas.</span>[002] International Patent Application WO2010 / 089055 A2 and the corresponding European Patent Application EP 2393363 A2 generally disclose the use of sulfur-containing heteroaromatic acid analogs according to a general formula (I) for the control of harmful bacterial organisms in useful plants. General formula (I) encompasses, among other things, the host defense inducers thiadinyl (compound I-1) and isothianyl (compound I-15) from a list of 20 different preferred specific compounds. The host defense inducer acibenzolar-S-methyl and probenazole are not included in formula (I). In addition, the order refers largely to various strains of bacteria and various plants to be treated. The application specifically refers only to a concrete example, in which the use of the compound I-15 (isothianil) in the treatment of rice against Xanthomonas campestris pv. oryzae is described. The use of a combination comprising at least one of these host defense inducers and at least one biological control agent in an amount synergistically effective for the control of harmful bacterial organisms in useful plants is not described in WO2010 / 089055 A2. The inventors of the present invention have surprisingly found the beneficial synergistic effects of these combinations in combating harmful bacterial organisms in plants.</span>
  </p>
  <p id="p0003" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[003] O Pedido de Patente no publicado PCT/EP2013/050772 do presente requerente est relacionado ao uso de indutores da defesa do hospedeiro, preferivelmente isotianil, para o controle de organismos bacterianos nocivos selecionados em plantas teis selecionadas e pode ser considerado como uma inveno de seleo em relao ao WO2010/089055 A2. Combinaes que compreendem uma quantidade sinergicamente eficaz de pelo menos um indutor da defesa do hospedeiro e pelo menos um agente de controle biolgico para o controle de organismos bacterianos nocivos em plantas teis no so nele descritas.</span>[003] The unpublished Patent Application PCT / EP2013 / 050772 of the present applicant is related to the use of host defense inducers, preferably isothianil, for the control of selected harmful bacterial organisms in selected useful plants and can be considered as an invention selection in relation to WO2010 / 089055 A2. Combinations comprising a synergistically effective amount of at least one host defense inducer and at least one biological control agent for the control of harmful bacterial organisms in useful plants are not described therein.</span>
  </p>
  <p id="p0004" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[004] O Pedido de Patente Internacional WO 98/21967 A1 e a Patente U.S. N 5.869.042 correspondente, geralmente revelam mtodos de preveno e tratamento de infeces fngicas e bacterianas acima do solo em plantas por aplicao de uma quantidade eficaz de pelo menos um agente de controle biolgico, por exemplo, uma cepa bacteriana produtora de antibitico de Bacillus sp. AQ175 (N de Acesso ATCC 55608), AQ 77 (N de Acesso ATCC 55609) ou AQ178 (N de Acesso ATCC 53522) ou pelo menos um antibitico produzido por essas cepas. Combinaes dessas cepas bacterianas de Bacillus sp. com pelo menos um indutor da defesa do hospedeiro no so nele mencionadas.</span>[004] International Patent Application WO 98/21967 A1 and corresponding US Patent No. 5,869,042, generally disclose methods of preventing and treating above-ground fungal and bacterial infections in plants by applying an effective amount of at least a biological control agent, for example, an antibiotic-producing bacterial strain of Bacillus sp. AQ175 (ATCC Accession No. 55608), AQ 77 (ATCC Accession No. 55609) or AQ178 (ATCC Accession No. 53522) or at least one antibiotic produced by these strains. Combinations of these bacterial strains of Bacillus sp. with at least one host defense inducer are not mentioned in it.</span>
  </p>
  <p id="p0005" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[005] Alm disso, vrios pedidos de patentes no publicados do presente requerente como, por exemplo, EP 12004160.3, EP 12197956.1, EP 12197951.2, EP 12197949.6, EP 12197945.4, EP 12197942.1, EP 12197941.3, EP 12197939.7, EP 12197141.0, EP 12197131.1, EP 12197132.9, EP 12197134.5, EP 12197135.2, EP 12197137.8, EP 12197139.4, EP 12169936.7 se referem s combinaes que compreendem agentes de controle biolgico, particularmente que compreendem cepas bacterianas de Bacillus sp., e s combinaes desses agentes de controle biolgico com fungicidas e/ou inseticidas.</span>[005] In addition, various unpublished patent applications from the present applicant such as, for example, EP 12004160.3, EP 12197956.1, EP 12197951.2, EP 12197949.6, EP 12197945.4, EP 12197942.1, EP 12197941.3, EP 12197939.7, EP 12197141.0, EP 12197131.1, EP 12197131.1, EP 12197131.1, EP 12197131.1, EP 12197131.1, EP 12197132.9, EP 12197134.5, EP 12197135.2, EP 12197137.8, EP 12197139.4, EP 12169936.7 refer to combinations that comprise biological control agents, particularly that comprise bacterial strains of Bacillus sp., And combinations of those biological control agents with fungicides and / or insecticides.</span>
  </p>
  <p id="p0006" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[006] O Exemplo 13 de WO 98/50422 revela um efeito sinrgico de uma mistura que compreende Bacillus subtilis AQ713 (N de Acesso NRRL B-21661) e azoxistrobina.</span>[006] Example 13 of WO 98/50422 reveals a synergistic effect of a mixture comprising Bacillus subtilis AQ713 (NRRL Accession No. B-21661) and azoxystrobin.</span>
  </p>
  <p id="p0007" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[007] No entanto, nenhum desses pedidos de patente se refere s combinaes dessas cepas bacterianas de Bacillus sp. Como agente de controle biolgico com pelo menos um indutor da defesa do hospedeiro.</span>[007] However, none of these patent applications refers to combinations of these bacterial strains of Bacillus sp. As a biological control agent with at least one host defense inducer.</span>
  </p>
  <p id="p0008" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[008] Os efeitos benficos sinrgicos e um novo uso da combinao que compreende pelo menos um indutor da defesa do hospedeiro e pelo menos um agente de controle biolgico foram agora demonstrados pelos inventores da presente inveno pela primeira vez e no foram sugeridos obviamente pela tcnica estabelecida mencionada.</span>[008] The beneficial synergistic effects and a new use of the combination comprising at least one host defense inducer and at least one biological control agent have now been demonstrated by the inventors of the present invention for the first time and have obviously not been suggested by the established technique mentioned.</span>
  </p>
  <p id="p0009" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[009] Bactrias como patgenos em plantas teis so encontradas, entre outras coisas, em climas temperados ou quentes e midos, onde causam bacterioses e um grande nmero de plantas teis com, em alguns casos, perdas econmicas considerveis.</span>[009] Bacteria as pathogens in useful plants are found, among other things, in temperate or hot and humid climates, where they cause bacteriosis and a large number of useful plants with, in some cases, considerable economic losses.</span>
  </p>
  <p id="p0010" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[010] O arroz, por exemplo, pode ser infectado com Acidovorax avenae ou Burkholderia glumae, causando estrias marrons ou podrido de gros bacterianos, respectivamente.</span>[010] Rice, for example, can be infected with Acidovorax avenae or Burkholderia glumae, causing brown streaks or bacterial grain rot, respectively.</span>
  </p>
  <p id="p0011" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[011] A doena de esverdeamento de ctricos (Huanglongbing, HLB, degenerao dos vasos do floema de ctricos (CVPD), doena do broto amarelo, amarelo matizado da folha (nas Filipinas), libukin (em Taiwan) e perecimento de ctricos (na ndia)), causada por Candidatus liberibacter spp.,  provavelmente a doena de ctricos mais deletria e reduz acentuadamente a produo, destri o valor econmico da fruta e pode, por fim, levar  morte de toda a planta. Candidatus liberibacter spp.  um gnero de bactrias gram-negativas na famlia Rhizobiaceae. Membros do gnero so patgenos de plantas, que so transmitidos principalmente por psildeos. A doena  distinguida pelos sintomas comuns de amarelecimento das veias e tecidos adjacentes; seguido por amarelecimento ou mancheamento de toda a folha; seguido por desfolhamento prematuro, perecimento de galhos finos, queda de radculas alimentadoras e razes laterais, e declnio no vigor; e seguido, no fim, pela morte de toda a planta. As rvores afetadas possuem crescimento retardado, abrigam mltiplas flores fora de estao (a maioria das quais cai), e produzem frutas pequenas, de formato irregular, com uma casca espessa, plida, que permanece verde no fundo. O fruto dessas rvores tem um gosto amargo. As rvores infectadas no se recuperam e no h mtodo curativo existente. O controle de HLB se baseia no controle preventivo dos vetores usando inseticidas sistmicos e inseticidas de contato. No entanto, a eficcia e o espectro de atividade desses compostos nem sempre so completamente satisfatrios. rvores recm-infectadas mostram os primeiros sintomas aps um perodo de latncia de 6-12 meses. Alm disso,  essencial erradicar rvores infectadas para evitar captao adicional por psildeos e disseminao da doena. No h cura para Huanglongbing e esforos para controlar a doena tm sido lentos, pois as plantas ctricas infectadas so difceis de manter, regenerar e estudar. Pesquisadores no Agricultural Research Service usaram rvores de limo infectadas por Huanglongbing para infectar plantas de mirta em um esforo para estudar a doena. Plantas de mirta so facilmente infectadas com a doena e respondem bem quando tratadas experimentalmente com antibiticos. Os pesquisadores esto testando o efeito de penicilina G sdica e do biocida 2,2-dibromo-3- nitrilopropionamida como tratamentos potenciais para plantas ctricas infectadas com base nos resultados positivos que foram observados quando aplicados  mirta infectadas. Bactrias de HLB vivem e se multiplicam exclusivamente no floema de rvores ctricas. At aqui, h, no entanto, somente poucos bactericidas para o controle curativo de HLB, por exemplo, o Pedido Internacional WO2011/029536 A2 se refere ao uso de cetoenis cclicos contra Candidatus liberibacter spp.</span>[011] Citrus greening disease (Huanglongbing, HLB, degeneration of citrus phloem vessels (CVPD), yellow, yellow tinted leaf disease (in the Philippines), libukin (in Taiwan) and perishing of citrus (in Taiwan) India)), caused by Candidatus liberibacter spp., Is probably the most harmful citrus disease and markedly reduces production, destroys the economic value of the fruit and can ultimately lead to the death of the entire plant. Candidatus liberibacter spp. is a genus of gram-negative bacteria in the family Rhizobiaceae. Members of the genus are plant pathogens, which are transmitted mainly by psyllids. The disease is distinguished by the common symptoms of yellowing of the veins and adjacent tissues; followed by yellowing or staining of the entire sheet; followed by premature defoliation, perishing of thin branches, fall of feeder roots and lateral roots, and decline in vigor; and followed, in the end, by the death of the entire plant. The affected trees have retarded growth, harbor multiple flowers out of season (most of which fall), and produce small, irregularly shaped fruits with a thick, pale bark that remains green at the bottom. The fruit of these trees has a bitter taste. Infected trees do not recover and there is no existing curative method. The control of HLB is based on the preventive control of vectors using systemic insecticides and contact insecticides. However, the effectiveness and activity spectrum of these compounds are not always completely satisfactory. Newly infected trees show the first symptoms after a latency period of 6-12 months. In addition, it is essential to eradicate infected trees to prevent further uptake by psyllids and spread of the disease. There is no cure for Huanglongbing and efforts to control the disease have been slow, as infected citrus plants are difficult to maintain, regenerate and study. Researchers at the Agricultural Research Service used Huanglongbing-infected lemon trees to infect myrtle plants in an effort to study the disease. Myrtle plants are easily infected with the disease and respond well when treated experimentally with antibiotics. The researchers are testing the effect of sodium penicillin G and the biocide 2,2-dibromo-3-nitrilopropionamide as potential treatments for infected citrus plants based on the positive results that were observed when applied to the infected myrtle. HLB bacteria live and multiply exclusively in the phloem of citrus trees. So far, however, there are only a few bactericides for the curative control of HLB, for example, International Application WO2011 / 029536 A2 refers to the use of cyclic ketoenols against Candidatus liberibacter spp.</span>
  </p>
  <p id="p0012" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[012] O cancro ctrico  uma doena que afeta espcies ctricas que  causada pela bactria Xanthomonas axonopodis pv. citri (= Xanthomonas campestris pv. citri). A infeco causa leses nas folhas, caules e frutas de rvores ctricas, incluindo limo-galego, laranjas e toronja. Embora no seja prejudicial aos humanos, o cancro afeta significantemente a vitalidade de rvores ctricas, fazendo com que as folhas e frutas caiam prematuramente; uma fruta infectada com cancro pode ser comida com segurana, mas tem uma aparncia muito ruim para ser vendida. O impacto  piorado, pois a presena de cancro ctrico em uma rea desencadeia restries de quarentena imediatas, rompendo o movimento de frutas frescas. Acredita-se que o cancro ctrico tenha se originado na rea do Sudeste Asitico- ndia. Agora tambm est presente no Japo, frica do Sul e Central, no Oriente Mdio, Bangladesh, nas Ilhas do Pacfico, alguns pases na Amrica do Sul, e Flrida. Algumas reas do mundo erradicaram o cancro ctrico e outras possuem programas de erradicao em andamento (pomares de ctricos foram destrudos em tentativas de erradicar a doena), mas a doena permanece endmica na maior parte das reas onde apareceu. Por causa de sua disseminao rpida, potencial elevado para danos e impactos sobre vendas de exportao e comrcio domstico, o cancro ctrico  uma ameaa significante para todas as regies que cultivam ctricos.</span>[012] Citrus cancer is a disease that affects citrus species that is caused by the bacteria Xanthomonas axonopodis pv. citri (= Xanthomonas campestris pv. citri). The infection causes damage to the leaves, stems and fruits of citrus trees, including lemon, oranges and grapefruit. Although not harmful to humans, cancer significantly affects the vitality of citrus trees, causing leaves and fruits to fall prematurely; a cancer-infected fruit can be eaten safely, but it looks too bad to sell. The impact is worsened, as the presence of citrus canker in an area triggers immediate quarantine restrictions, disrupting the movement of fresh fruit. Citrus cancer is believed to have originated in the Southeast Asia-India area. It is now also present in Japan, South and Central Africa, the Middle East, Bangladesh, the Pacific Islands, some countries in South America, and Florida. Some areas of the world have eradicated citrus canker and others have ongoing eradication programs (citrus groves have been destroyed in attempts to eradicate the disease), but the disease remains endemic in most areas where it appeared. Because of its rapid spread, high potential for damage and impacts on export sales and domestic trade, citrus canker is a significant threat to all citrus growing regions.</span>
  </p>
  <p id="p0013" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[013] A clorose variegada dos citros (CVC)  uma doena ctrica adicional que afeta plantas ctricas por toda a Amrica do Sul, em particular Brasil. A CVC  causada pela bactria Xylella fastidiosa da famlia de Xanthomonadaceae. CVC  uma doena sistmica que s sobrevive no xilema da planta ou dentro de seu vetor. Foi demonstrado que X. fastidiosa se move da semente para a muda na laranja-doce. A CVC possui um perodo de latncia de 9-12 meses antes que os sintomas ocorram. A disseminao natural de X. fastidiosa ocorre por vrias espcies de cigarrinhas na ordem Hemiptera. A indstria do kiwi  amplamente afetada por infeces por Pseudomonas ssp., por exemplo, a infeco com Pseudomonas syringae pv. actinidae (Psa) foi identificada primeiro na Nova Zelndia e no Japo e Itlia, tambm, onde  extremamente nociva em kiwi dourado. Atualmente, esto sendo realizadas pesquisas intensivas e testes de possveis solues contra o dano por Psa em frutas kiwi.</span>[013] Citrus variegated chlorosis (CVC) is an additional citrus disease that affects citrus plants throughout South America, in particular Brazil. CVC is caused by the bacterium Xylella fastidiosa of the Xanthomonadaceae family. CVC is a systemic disease that only survives in the plant's xylem or within its vector. X. fastidiosa has been shown to move from seed to seedling in sweet orange. CVC has a latency period of 9-12 months before symptoms occur. The natural spread of X. fastidiosa occurs by several species of leafhoppers in the order Hemiptera. The kiwi industry is largely affected by infections with Pseudomonas ssp., For example, infection with Pseudomonas syringae pv. actinidae (Psa) was first identified in New Zealand and Japan and Italy, too, where it is extremely harmful in golden kiwi. Currently, intensive research and testing of possible solutions against damage by Psa in kiwi fruits are being carried out.</span>
  </p>
  <p id="p0014" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[014] A casca bacteriana do tubrculo da batata (casca comum)  um problema crescente em reas centrais de cultivo de batatas que afeta muito a qualidade do tubrculo. Os tubrculos de batata afetados so classificados como de baixa qualidade e obtm preos baixos no mercado e, em caso de infestao alta, a venda das batatas  difcil.  uma percepo geral entre fazendeiros que a doena cresce a cada ano.</span>[014] The bacterial peel of the potato tuber (common peel) is a growing problem in central potato growing areas that greatly affects the quality of the tuber. The affected potato tubers are classified as low quality and have low prices on the market and, in case of high infestation, selling the potatoes is difficult. It is a general perception among farmers that the disease grows each year.</span>
  </p>
  <p id="p0015" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[015] A infeco com espcies de Erwinia, por exemplo, pode causar a morte de plantaes de frutas inteiras como, por exemplo, mas ou pras. Tambm  conhecida a podrido- mole bacteriana em batatas, formao de tumor em plantas causada por infeco com agrobactrias e tambm um grande nmero de doenas necrticas quando cereais como, por exemplo, trigo ou arroz, vegetais ou frutas ctricas, so infectados por espcies de Xanthomonas.</span>[015] Infection with Erwinia species, for example, can cause the death of whole fruit plantations, such as apples or pears. Also known is bacterial soft rot in potatoes, tumor formation in plants caused by infection with agrobacteria and also a large number of necrotic diseases when cereals, such as wheat or rice, vegetables or citrus fruits, are infected by species of Xanthomonas.</span>
  </p>
  <p id="p0016" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[016] A bacteriose causada por espcies de Pseudomonas, em particular, em vegetais, frutas de rvores e tabaco,  considerada como particularmente destrutiva.</span>[016] Bacteriosis caused by Pseudomonas species, in particular, in vegetables, tree fruits and tobacco, is considered to be particularly destructive.</span>
  </p>
  <p id="p0017" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[017] O tratamento-padro contra organismos bacterianos nocivos compreende o uso de pesticidas qumicos sintticos e, em particular, o uso de antibiticos (convencionais), que so normalmente de origem sinttica ou semi-sinttica ou de origem natural, sendo isolados de organismos vivos e purificados ou geneticamente modificados. Exemplos desses antibiticos convencionais compreendem, por exemplo, estreptomicina, blasticidina S ou casugamicina. A aplicao desses antibiticos convencionais , em princpio, a nica forma eficaz para o controle de bactrias em plantas teis. No entanto, essa abordagem s  adotada em casos raros, na medida em que esses antibiticos se baseiam nos mesmos mecanismos de ao que antibiticos usados em humanos e medicina veterinria e h, portanto, fortes reservas contra o uso de antibiticos na proteo de plantas. H preocupaes de que seja promovida a formao de resistncia; alm disso, a maioria dos antibiticos convencionais  cara e frequentemente s pode ser obtida pelo emprego de mtodos biotecnolgicos, entre outrascoisas.</span>[017] The standard treatment against harmful bacterial organisms includes the use of synthetic chemical pesticides and, in particular, the use of (conventional) antibiotics, which are normally of synthetic or semi-synthetic origin or of natural origin, being isolated from organisms live and purified or genetically modified. Examples of such conventional antibiotics include, for example, streptomycin, blasticidin S or casugamycin. The application of these conventional antibiotics is, in principle, the only effective way to control bacteria in useful plants. However, this approach is only adopted in rare cases, as these antibiotics are based on the same mechanisms of action as antibiotics used in humans and veterinary medicine and there are, therefore, strong reservations against the use of antibiotics in plant protection. There are concerns that resistance training will be promoted; moreover, most conventional antibiotics are expensive and can often only be obtained through the use of biotechnological methods, among other things.</span>
  </p>
  <p id="p0018" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[018] Pesticidas sintticos e semi-sintticos como, por exemplo, antibiticos sintticos ou semi-sintticos, so frequentemente inespecficos e, portanto, podem atuar sobre organismos diferentes dos organismos-alvo, incluindo outros organismos benficos de ocorrncia natural. Por causa de sua natureza qumica, eles tambm podem ser txicos e no biodegradveis. Consumidores em todo o mundo esto cada vez mais conscientes do potencial ambiental e problemas de sade associados aos resduos de substncias qumicas, particularmente em produtos alimentares. Isso resultou em uma presso crescente dos consumidores para reduzir o uso ou pelo menos a quantidade de pesticidas qumicos (ou seja, sintticos). Dessa forma, h uma necessidade para gerenciar critrios da cadeia alimentar permitindo, ao mesmo tempo, um controle de pragas eficaz.</span>[018] Synthetic and semi-synthetic pesticides, such as synthetic or semi-synthetic antibiotics, are often nonspecific and therefore can act on organisms other than the target organisms, including other beneficial naturally occurring organisms. Because of their chemical nature, they can also be toxic and non-biodegradable. Consumers around the world are increasingly aware of the environmental potential and health problems associated with chemical residues, particularly in food products. This resulted in increasing consumer pressure to reduce the use or at least the amount of chemical (ie synthetic) pesticides. Thus, there is a need to manage food chain criteria while allowing effective pest control.</span>
  </p>
  <p id="p0019" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[019] Um problema adicional que surge com o uso de antibiticos sintticos  que a aplicao repetida e exclusiva desses antibiticos convencionais frequentemente leva  seleo de microorganismos resistentes. Normalmente, essas cepas tambm apresentam resistncia cruzada contra outros ingredientes ativos que possuem o mesmo modo de ao. Um controle eficaz dos patgenos com os referidos compostos ativos, portanto, no  mais possvel. No entanto, ingredientes ativos que possuem novos mecanismos de ao so de desenvolvimento difcil e caro.</span>[019] An additional problem that arises with the use of synthetic antibiotics is that the repeated and exclusive application of these conventional antibiotics often leads to the selection of resistant microorganisms. Typically, these strains also have cross-resistance against other active ingredients that have the same mode of action. Effective control of pathogens with said active compounds, therefore, is no longer possible. However, active ingredients that have new mechanisms of action are difficult and expensive to develop.</span>
  </p>
  <p id="p0020" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[020] O risco de desenvolvimento de resistncia em populaes de patgenos, bem como preocupaes ambientais e para a sade, despertou interesse na identificao de alternativas aos antibiticos convencionais para o gerenciamento de doenas de plantas. O uso de agentes de controle biolgico (agentes de controle biolgico)  uma alternativa. No entanto, a efetividade da maioria dos agentes de controle biolgico no est no mesmo nvel que para antibiticos convencionais, especialmente em caso de presso de infeco severa. Consequentemente, agentes de controle biolgicos conhecidos, seus mutantes e metablitos produzidos por eles, no so, em particular em taxas de aplicao baixas, inteiramente satisfatrios.</span>[020] The risk of developing resistance in populations of pathogens, as well as environmental and health concerns, has sparked interest in identifying alternatives to conventional antibiotics for the management of plant diseases. The use of biological control agents (biological control agents) is an alternative. However, the effectiveness of most biological control agents is not at the same level as for conventional antibiotics, especially in the event of severe infection pressure. Consequently, known biological control agents, their mutants and metabolites produced by them, are not, in particular at low application rates, entirely satisfactory.</span>
  </p>
  <p id="p0021" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[021] Outra abordagem para o controle de bactrias em plantas visa o uso de oxicloreto de cobre, que  desvantajoso por causa da necessidade de que sejam aplicadas altas doses no tratamento-padro. O oxicloreto de cobre , por exemplo, usado no controle de Pseudomonas syringae, por exemplo, na proteo de tomates. Alm disso, o oxicloreto de cobre  discutido como sendo fitotxico e seu uso  cada vez mais restrito, j que sabidamente se acumula no solo. Alm disso, as formulaes de oxicloreto de cobre normalmente deixam resduos visveis em folhas e frutas, o que no  apreciado e aceito pelos consumidores.</span>[021] Another approach to the control of bacteria in plants is the use of copper oxychloride, which is disadvantageous because of the need for high doses to be applied in the standard treatment. Copper oxychloride is, for example, used in the control of Pseudomonas syringae, for example, in the protection of tomatoes. In addition, copper oxychloride is discussed as being phytotoxic and its use is increasingly restricted, since it is known to accumulate in the soil. In addition, copper oxychloride formulations usually leave visible residues on leaves and fruits, which is not appreciated and accepted by consumers.</span>
  </p>
  <p id="p0022" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[022] H, portanto, uma grande necessidade por mtodos eficazes especficos com efeitos aprimorados para o controle de doenas bacterianas em plantas teis, cujos mtodos, alm disso, s necessitem que pequenas quantidades de substncia sejam aplicadas e, alm disso, no danifiquem as plantas ou, sejam prejudiciais  sade humana ou animal. Nesse contexto,  dado foco especial na atividade bactericida aumentada e nos efeitos sinrgicos dessas novas combinaes, bem como na combinao de uma eficincia rpida, alm de uma eficincia de longa durao, para fornecer flexibilidade aumentada com relao ao tempo de aplicao, bem como na minimizao das doses de produtos qumicos espalhadas no ambiente e reduo dos custos do tratamento.</span>[022] There is, therefore, a great need for specific effective methods with improved effects for the control of bacterial diseases in useful plants, whose methods, moreover, only require small amounts of substance to be applied and, in addition, do not damage the plants or are harmful to human or animal health. In this context, special focus is given to the increased bactericidal activity and the synergistic effects of these new combinations, as well as the combination of rapid efficiency, in addition to long-term efficiency, to provide increased flexibility with respect to application time, as well as in minimizing the doses of chemicals spread in the environment and reducing treatment costs.</span>
  </p>
  <p id="p0023" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[023] Foi verificado agora que uma combinao que compreende pelo menos um indutor da defesa do hospedeiro, por exemplo, preferivelmente isotianil, ou uma combinao de isotianil e acibenzolar-S-metil, e pelo menos um agente de controle biolgico, por exemplo, preferivelmente Bacillus subtilis cepa QST713/AQ713 (N de Acesso NRRL B21661), Bacillus subtilis cepa AQ153 (N de Acesso NRRL 55614), Bacillus sp. cepa AQ175 (N de Acesso ATCC 55608), Bacillus sp. cepa AQ177 (N de Acesso ATCC 55609) e Bacillus sp. cepa AQ178 (N de Acesso ATCC 53522) e Pseudozyma aphidis em uma quantidade sinergicamente eficaz  particularmente adequada para o controle de organismos bacterianos nocivos em plantas teis.</span>[023] It has now been found that a combination comprising at least one host defense inducer, for example, preferably isothianyl, or a combination of isothianyl and acibenzolar-S-methyl, and at least one biological control agent, for example, preferably Bacillus subtilis strain QST713 / AQ713 (Accession No. NRRL B21661), Bacillus subtilis strain AQ153 (Accession No. NRRL 55614), Bacillus sp. strain AQ175 (ATCC Accession No. 55608), Bacillus sp. strain AQ177 (Accession No. ATCC 55609) and Bacillus sp. strain AQ178 (Accession No. ATCC 53522) and Pseudozyma aphidis in a synergistically effective amount is particularly suitable for the control of harmful bacterial organisms in useful plants.</span>
  </p>
  <p id="p0024" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[024] Alm disso, foi verificado que um mtodo de tratamento de plantas que compreende a submisso das plantas a serem protegidas contra ataque por organismos bacterianos nocivos a dois ou mais blocos de tratamento sequenciais, em que pelo menos um bloco de tratamento compreende a submisso das plantas a pelo menos um tratamento com pelo menos um indutor da defesa do hospedeiro e pelo menos um bloco de tratamento compreende a submisso das plantas a pelo menos um tratamento com pelo menos um agente de controle biolgico  particularmente adequado para o controle de organismos bacterianos nocivos em plantas teis. De acordo com uma modalidade preferida, foi verificado que um mtodo de tratamento de plantas que compreende a submisso das plantas a serem protegidas contra ataque por organismos bacterianos nocivos a dois ou mais blocos de tratamento sequenciais, em que pelo menos um bloco de tratamento compreende a submisso das plantas a pelo menos um tratamento com pelo menos um indutor da defesa do hospedeiro e pelo menos um bloco de tratamento compreende a submisso das plantas a pelo menos um tratamento com pelo menos um agente de controle biolgico, desde que o ltimo bloco de tratamento compreenda a submisso das plantas a pelo menos um tratamento com pelo menos um agente de controle biolgico,  particularmente adequado para o controle de organismos bacterianos nocivos em plantas teis.</span>[024] In addition, it has been found that a plant treatment method that comprises submitting the plants to be protected from attack by harmful bacterial organisms to two or more sequential treatment blocks, in which at least one treatment block comprises submission of plants to at least one treatment with at least one host defense inducer and at least one treatment block comprising subjecting the plants to at least one treatment with at least one biological control agent is particularly suitable for the control of bacterial organisms harmful to useful plants. According to a preferred embodiment, it has been found that a method of plant treatment that comprises submitting the plants to be protected from attack by harmful bacterial organisms to two or more sequential treatment blocks, wherein at least one treatment block comprises the subjecting the plants to at least one treatment with at least one host defense inducer and at least one treatment block comprises subjecting the plants to at least one treatment with at least one biological control agent, provided that the last treatment block includes subjecting plants to at least one treatment with at least one biological control agent, it is particularly suitable for the control of harmful bacterial organisms in useful plants.</span>
  </p>
  <heading id="h0002" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">PROBLEMA A SER SOLUCIONADO</span>PROBLEM TO BE SOLVED</span>
  </heading>
  <p id="p0025" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[025] Foi o objetivo da presente inveno, fornecer novas combinaes de composto ativo com efeitos superiores no controle de organismos bacterianos nocivos em plantas teis e fornecer um novo mtodo de tratamento.</span>[025] It was the aim of the present invention, to provide new combinations of active compound with superior effects in the control of harmful bacterial organisms in useful plants and to provide a new treatment method.</span>
  </p>
  <heading id="h0003" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">DESCRIO DA INVENO</span>DESCRIPTION OF THE INVENTION</span>
  </heading>
  <p id="p0026" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[026] O problema subjacente  presente inveno foi solucionado por fornecimento de novas combinaes de composto ativo que compreendem: (A) pelo menos um indutor da defesa do hospedeiro e (B) pelo menos um agente de controle biolgico em uma quantidade sinergicamente eficaz para o uso no controle de organismos bacterianos nocivos em plantas teis. Indutores da defesa do hospedeiro</span>[026] The problem underlying the present invention has been solved by providing new combinations of active compound comprising: (A) at least one host defense inducer and (B) at least one biological control agent in a synergistically effective amount for the use in the control of harmful bacterial organisms in useful plants. Host defense inducers</span>
  </p>
  <p id="p0027" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[027] No contexto da presente inveno, indutores da defesa do hospedeiro se referem aos compostos que so caracterizados por sua capacidade de estimulao dos mecanismos de defesa da prpria planta, de tal modo que a planta seja protegida contra infeco. Os indutores da defesa do hospedeiro so ento usados para induo de genes precoces e fortemente conhecidos como indutores da defesa da planta. Eles sensibilizam a planta para uma induo mais forte e/ou mais rpida de genes de defesa aps ataque por um patgeno. De acordo com a presente inveno, indutores da defesa do hospedeiro compreendem, por exemplo: Acibenzolar-S-metil:</span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/ed/1a/38/38fc276558f142/img0001.png" class="style-scope patent-text"><img id="i0001" wi="144" he="108" img-content="drawing" img-format="jpg" file="img0001.jpg" orientation="unknown" width="576" height="432" alt="Figure img0001" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/ed/1a/38/38fc276558f142/img0001.png"></a></div> Isotianil:<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/9c/94/20/ba2608331b7b03/img0002.png" class="style-scope patent-text"><img id="i0002" wi="181" he="88" img-content="drawing" img-format="jpg" file="img0002.jpg" orientation="unknown" width="724" height="352" alt="Figure img0002" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/9c/94/20/ba2608331b7b03/img0002.png"></a></div> Probenazol:<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/76/ab/de/b31b4aeabbfac1/img0003.png" class="style-scope patent-text"><img id="i0003" wi="152" he="124" img-content="drawing" img-format="jpg" file="img0003.jpg" orientation="unknown" width="608" height="496" alt="Figure img0003" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/76/ab/de/b31b4aeabbfac1/img0003.png"></a></div> Tiadinil:<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/a8/0c/28/82038f9485e6df/img0004.png" class="style-scope patent-text"><img id="i0004" wi="173" he="106" img-content="drawing" img-format="jpg" file="img0004.jpg" orientation="unknown" width="692" height="424" alt="Figure img0004" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/a8/0c/28/82038f9485e6df/img0004.png"></a></div> Laminarina:<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/b5/4c/2e/c957066cf697e7/img0005.png" class="style-scope patent-text"><img id="i0005" wi="227" he="99" img-content="drawing" img-format="jpg" file="img0005.jpg" orientation="unknown" width="908" height="396" alt="Figure img0005" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/b5/4c/2e/c957066cf697e7/img0005.png"></a></div>
		[027] In the context of the present invention, host defense inducers refer to compounds that are characterized by their ability to stimulate the defense mechanisms of the plant itself, in such a way that the plant is protected against infection. Host defense inducers are then used to induce early genes and are strongly known as plant defense inducers. They sensitize the plant to a stronger and / or faster induction of defense genes after attack by a pathogen. According to the present invention, host defense inducers comprise, for example: Acibenzolar-S-methyl: <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/ed/1a/38/38fc276558f142/img0001.png" class="style-scope patent-text"><img id="i0001" wi="144" he="108" img-content="drawing" img-format="jpg" file="img0001.jpg" orientation="unknown" width="576" height="432" alt="Figure img0001" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/ed/1a/38/38fc276558f142/img0001.png"></a></div> Isothianyl: <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/9c/94/20/ba2608331b7b03/img0002.png" class="style-scope patent-text"><img id="i0002" wi="181" he="88" img-content="drawing" img-format="jpg" file="img0002.jpg" orientation="unknown" width="724" height="352" alt="Figure img0002" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/9c/94/20/ba2608331b7b03/img0002.png"></a></div> Probenazole: <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/76/ab/de/b31b4aeabbfac1/img0003.png" class="style-scope patent-text"><img id="i0003" wi="152" he="124" img-content="drawing" img-format="jpg" file="img0003.jpg" orientation="unknown" width="608" height="496" alt="Figure img0003" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/76/ab/de/b31b4aeabbfac1/img0003.png"></a></div> Thiadinil: <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/a8/0c/28/82038f9485e6df/img0004.png" class="style-scope patent-text"><img id="i0004" wi="173" he="106" img-content="drawing" img-format="jpg" file="img0004.jpg" orientation="unknown" width="692" height="424" alt="Figure img0004" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/a8/0c/28/82038f9485e6df/img0004.png"></a></div> Laminarine: <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/b5/4c/2e/c957066cf697e7/img0005.png" class="style-scope patent-text"><img id="i0005" wi="227" he="99" img-content="drawing" img-format="jpg" file="img0005.jpg" orientation="unknown" width="908" height="396" alt="Figure img0005" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/b5/4c/2e/c957066cf697e7/img0005.png"></a></div> 
  <p class="style-scope patent-text"></p>
  <p id="p0028" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[028] De preferncia, pelo menos um indutor da defesa do hospedeiro (A)  selecionado do grupo que consiste em A.1 acibenzolar-S-metil, A.2 isotianil, A.3 probenazol e A.4 tiadinil ou combinaes destes, mais preferivelmente pelo menos um indutor da defesa do hospedeiro (A)  A.2 isotianil. Em uma modalidade preferida adicional, pelo menos um indutor da defesa do hospedeiro (A)  uma combinao de A.2 isotianil e A.1 acibenzolar-S-metil.</span>[028] Preferably, at least one host defense inducer (A) is selected from the group consisting of A.1 acibenzolar-S-methyl, A.2 isothianyl, A.3 probenazole and A.4 thiadinyl or combinations thereof , more preferably at least one host defense inducer (A) is A.2 isothianyl. In an additional preferred embodiment, at least one host defense inducer (A) is a combination of A.2 isothianyl and A.1 acibenzolar-S-methyl.</span>
  </p>
  <p id="p0029" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[029] Os indutores da defesa do hospedeiro (A) da presente inveno podem, se apropriado, estar presentes na forma de misturas de vrias formas isomricas que so possveis, em particular estereoismeros, por exemplo, ismeros pticos. Agentes de controle biolgico</span>[029] The host defense inducers (A) of the present invention may, if appropriate, be present in the form of mixtures of various isomeric forms that are possible, in particular stereoisomers, for example, optical isomers. Biological control agents</span>
  </p>
  <p id="p0030" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[030] Como aqui usado, controle biolgico  definido como controle de um organismo patognico para plantas como, por exemplo, um patgeno e/ou inseto e/ou um acardeo e/ou um nematdeo pelo uso de um segundo organismo. Mecanismos de controle biolgico conhecidos incluem bactrias entricas que controlam podrido da raiz por fungos que competem por espao na superfcie da raiz. Toxinas bacterianas, por exemplo, antibiticos, tm sido usadas para controlar patgenos. A toxina pode ser isolada e aplicada diretamente  planta ou a espcie bacteriana pode ser administrada de modo a produzir a toxina in situ.</span>[030] As used herein, biological control is defined as the control of a pathogenic organism for plants, for example, a pathogen and / or insect and / or a mite and / or a nematode by the use of a second organism. Known biological control mechanisms include enteric bacteria that control root rot by fungi that compete for space on the root surface. Bacterial toxins, for example, antibiotics, have been used to control pathogens. The toxin can be isolated and applied directly to the plant or the bacterial species can be administered in order to produce the toxin in situ.</span>
  </p>
  <p id="p0031" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[031] Em geral pesticida significa a habilidade de uma substncia para aumentar a mortalidade ou inibir a taxa de crescimento de pragas de planta. O termo  aqui usado para descrever a propriedade de uma substncia para exibir atividade contra insetos, caros, nematdeos e/ou fitopatgenos. No sentido da presente inveno, o termo pragas inclui insetos, caros, nematdeos e/ou bactrias fitopatognicas.</span>[031] In general, "pesticide" means the ability of a substance to increase mortality or inhibit the growth rate of plant pests. The term is used here to describe the property of a substance to exhibit activity against insects, mites, nematodes and / or phytopathogens. In the sense of the present invention, the term "pests" includes insects, mites, nematodes and / or phytopathogenic bacteria.</span>
  </p>
  <p id="p0032" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[032] Inseticidas, bem como o termo inseticida, se referem  habilidade de uma substncia para aumentar a mortalidade ou inibir a taxa de crescimento de insetos. Como aqui usado, o termo insetos inclui todos os organismos na classe Insecta. O termo insetos pr- adultos se refere a qualquer forma de um organismo antes do estgio adulto, incluindo, por exemplo, ovos, larvas e ninfas.</span>[032] "Insecticides", as well as the term "insecticide", refer to the ability of a substance to increase mortality or inhibit the rate of growth of insects. As used herein, the term "insects" includes all organisms in the class "Insecta". The term "pre-adult" insects refers to any form of an organism before the adult stage, including, for example, eggs, larvae and nymphs.</span>
  </p>
  <p id="p0033" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[033] Nematicidas e nematicida se refere  habilidade de uma substncia para aumentar a mortalidade ou inibir a taxa de crescimento de nematdeos. Em geral, o termo nematdeo compreende ovos, larvas, formas juvenis e maduras do referido organismo.</span>[033] "Nematicides" and "nematicides" refer to the ability of a substance to increase mortality or inhibit the rate of growth of nematodes. In general, the term nematode includes eggs, larvae, juvenile and mature forms of the organism.</span>
  </p>
  <p id="p0034" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[034] Acaricidas e acaricida se referem  habilidade de uma substncia para aumentar a mortalidade ou inibir a taxa de crescimento de ectoparasitas que pertencem  classe Arachnida, subclasse Acari.</span>[034] "Acaricides" and "acaricides" refer to the ability of a substance to increase mortality or inhibit the growth rate of ectoparasites that belong to the Arachnida class, subclass Acari.</span>
  </p>
  <p id="p0035" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[035] O termo metablito se refere a qualquer composto, substncia ou subproduto de uma fermentao de um microorganismo que possui atividade pesticida.</span>[035] The term "metabolite" refers to any compound, substance or by-product of a fermentation of a microorganism that has pesticidal activity.</span>
  </p>
  <p id="p0036" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[036] O termo mutante se refere a uma variante da cepa parental, bem como aos mtodos para a obteno de um mutante ou uma variante na qual a atividade pesticida  maior do que aquela expressa pela cepa parental. A cepa progenitora  aqui definida como a cepa original antes de mutagnese. Para obter esses mutantes, a cepa parental pode ser tratada com uma substncia qumica como, por exemplo, N-metil-N-nitro-N-nitrosoguanidina, etilmetanossulfona, ou por irradiao usando irradiao gama, raios-X ou irradiao UV, ou por outros meios bem conhecidos por aqueles habilitados na tcnica.</span>[036] The term mutant refers to a variant of the parental strain, as well as to methods for obtaining a mutant or a variant in which the pesticidal activity is greater than that expressed by the parental strain. The "progenitor strain" is defined here as the original strain before mutagenesis. To obtain these mutants, the parent strain can be treated with a chemical such as, for example, N-methyl-N'-nitro-N-nitrosoguanidine, ethylmethanesulfone, or by irradiation using gamma irradiation, X-rays or UV irradiation, or by other means well known to those skilled in the art.</span>
  </p>
  <p id="p0037" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[037] Uma variante  uma cepa que possui todas as caractersticas de identificao dos Nmeros de Acesso NRRL ou ATCC como indicados nesse texto e pode ser identificada como tendo um genoma que hibridiza, sob condies de rigor elevado, para o genoma dos Nmeros de Acesso NRRL ou ATCC.</span>[037] A variant is a strain that has all the identification characteristics of the NRRL or ATCC Access Numbers as indicated in this text and can be identified as having a genome that hybridizes, under conditions of high stringency, to the Numbers genome. Access NRRL or ATCC.</span>
  </p>
  <p id="p0038" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[038] Hibridizao se refere a uma reao na qual um ou mais polinucleotdeos reagem para formar um complexo que  estabilizado por meio de ligao de hidrognio entre as bases dos resduos de nucleotdeo. A ligao de hidrognio pode ocorrer por pareamento de bases de Watson-Crick, ligao de Hoogstein, ou em qualquer outra forma sequncia- especfica. O complexo pode compreender duas fitas que formam uma estrutura dupla, trs ou mais fitas que formam um complexo de multifitas, uma nica fita auto- hibridizante, ou qualquer combinao dessas. As reaes de hibridizao podem ser realizadas sob condies de rigor diferente. Em geral, uma reao de hibridizao de rigor baixo  realizada em torno de 40 C em 10 X SSC ou uma soluo de fora inica/temperatura equivalentes. Uma hibridizao de rigor moderado  tipicamente realizada em torno de 50 C em 6 X SSC, e uma reao de hibridizao de rigor elevado  geralmente realizada em torno de 60 C em 1 X SSC.</span>[038] "Hybridization" refers to a reaction in which one or more polynucleotides react to form a complex that is stabilized by hydrogen bonding between the nucleotide residue bases. Hydrogen bonding can occur by Watson-Crick base pairing, Hoogstein bonding, or in any other sequence-specific form. The complex can comprise two tapes that form a double structure, three or more tapes that form a multi-tape complex, a single self-hybridizing tape, or any combination thereof. Hybridization reactions can be carried out under conditions of different "stringency". In general, a low stringency hybridization reaction is performed at around 40  C in 10 X SSC or an equivalent ionic strength / temperature solution. A moderate stringency hybridization is typically carried out at around 50  C in 6 X SSC, and a high stringency hybridization reaction is generally carried out at around 60  C in 1 X SSC.</span>
  </p>
  <p id="p0039" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[039] Uma variante do Nmero de Acesso NRRL ou ATCC indicado tambm pode ser definida como uma cepa que possui uma sequncia genmica que  maior do que 85%, mais preferivelmente maior do que 90% ou, mais preferivelmente, maior do que 95% de identidade de sequncia para o genoma do Nmero de Acesso NRRL ou ATCC indicado. Um polinucleotdeo ou uma regio do polinucleotdeo (ou uma polipeptdeo ou regio do polipeptdeo) possui certa porcentagem (por exemplo, 80%, 85%, 90% ou 95%) de identidade de sequncia para outra sequncia significa que, quando alinhada, aquela porcentagem de bases (ou aminocidos)  igual na comparao das duas sequncias. O alinhamento e a homologia percentual ou identidade de sequncia podem ser determinados com o uso de softwares conhecidos na tcnica, por exemplo, aqueles descritos em Current Protocols in Molecular Biology (F.M. Ausubel e cols., eds., 1987) Suplemento 30, seo 7.7.18, Tabela 7.7.1.</span>[039] A variant of the indicated NRRL or ATCC Accession Number can also be defined as a strain that has a genomic sequence that is greater than 85%, more preferably greater than 90% or, more preferably, greater than 95% of identity of sequence for the genome of the indicated NRRL or ATCC Accession Number. A polynucleotide or polynucleotide region (or a polypeptide or polypeptide region) has a certain percentage (for example, 80%, 85%, 90% or 95%) of "sequence identity" for another sequence means that, when aligned, that percentage of bases (or amino acids) is the same when comparing the two sequences. The alignment and percentage homology or sequence identity can be determined using software known in the art, for example, those described in Current Protocols in Molecular Biology (FM Ausubel et al., Eds., 1987) Supplement 30, section 7.7.18, Table 7.7.1.</span>
  </p>
  <p id="p0040" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[040] NRRL  a abreviao para a Agricultural Research Service Culture Collection, uma autoridade depositria internacional para o objetivo de depositar cepas de microorganismos sob o Tratado de Budapeste no reconhecimento internacional do depsito de microorganismos para as finalidades de procedimento de patente, que possui o endereo National Center for Agricultural Utilization Research, Agricultural Research service, U.S. Department of Agriculture, Rua North university 1815, Peroira, Illinois 61604 EUA.</span>[040] NRRL is the abbreviation for the Agricultural Research Service Culture Collection, an international depository authority for the purpose of depositing strains of microorganisms under the Budapest Treaty in international recognition of the deposit of microorganisms for the purposes of patent procedure, which it has the address National Center for Agricultural Utilization Research, Agricultural Research service, US Department of Agriculture, 1815 North university Street, Peroira, Illinois 61604 USA.</span>
  </p>
  <p id="p0041" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[041] ATCC  a abreviao para a American Type Culture Collection, uma autoridade depositria internacional para o objetivo de depositar cepas de microorganismos sob o Tratado de Budapeste no reconhecimento internacional do depsito de microorganismos para as finalidades de procedimento de patente, que possui o endereo ATCC Patente Depository, Boulevard University 10801, Manassas, VA 10110 EUA.</span>[041] ATCC is the abbreviation for the "American Type Culture Collection", an international depository authority for the purpose of depositing strains of microorganisms under the Budapest Treaty in the international recognition of the deposit of microorganisms for the purposes of the patent procedure, which it has the address ATCC Patent Depository, Boulevard University 10801, Manassas, VA 10110 USA.</span>
  </p>
  <p id="p0042" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[042] Agentes de controle biolgico incluem, em particular, bactrias, fungos e/ou leveduras, protozorios, vrus, nematdeos entomopatognicos, Inoculantes e substncias botnicas e/ou seus mutantes que possuem todas as caractersticas de identificao da respectiva cepa, e/ou um metablito produzido pela respectiva cepa que exibe atividade contra organismos bacterianos nocivos, insetos, caros, nematdeos e/ou fitopatgenos.</span>[042] Biological control agents include, in particular, bacteria, fungi and / or yeasts, protozoa, viruses, entomopathogenic nematodes, inoculants and botanical substances and / or their mutants that have all the identification characteristics of the respective strain, and / or a metabolite produced by the respective strain that exhibits activity against harmful bacterial organisms, insects, mites, nematodes and / or phytopathogens.</span>
  </p>
  <p id="p0043" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[043] De acordo com a presente inveno, os agentes de controle biolgico (B) so particularmente selecionados do grupo que consiste em 1) bactrias e 2) fungos (que compreendem leveduras). 1) Bactrias</span>[043] According to the present invention, biological control agents (B) are particularly selected from the group consisting of 1) bacteria and 2) fungi (comprising yeast). 1) Bacteria</span>
  </p>
  <p id="p0044" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[044] De acordo com a inveno, agentes de controle biolgico que so resumidos sob o termo bactrias incluem bactrias formadoras de esporos, bactrias de colonizao da raiz, ou bactrias e seus metablitos teis como inseticidas, nematicidas, acaricidas ou fungicidas biolgicos ou corretores do solo que aumentam a sade e crescimento de plantas. Exemplos dessas bactrias a serem usadas ou empregadas de acordo com a inveno so (a numerao  usada por toda a descrio da inveno completa seguinte): B.1.1 Bacillus subtilis, em particular cepaQST713/AQ713 (disponvel como SERENADE MAX por Bayer CropScience LP, US, que possui o N de Acesso NRRL B21661 e descrita na Patente U.S. N 6.060.051); B.1.2 Bacillus subtilis cepa AQ153 (que possui o N de Acesso NRRL 55614 e descrita na Patente U.S. N 5.753.222); B.1.3 Bacillus sp. cepa AQ175 (que possui o N de Acesso ATCC 55608 e descrita na Patente U.S. N 5.869.042); B.1.4 Bacillus sp. cepa AQ177 (que possui o N de Acesso ATCC 55609 e descrita na Patente U.S. N 5.869.042); B.1.5 Bacillus sp. cepa AQ178 (que possui o N de Acesso ATCC 53522 e descrita na Patente U.S. N 5.869.042); B.1.6 Bacillus amyloliquefaciens, cepa D747 (disponvel como Bacstar por Etec Crop Solutions, NZ e tambm disponvel como Double Nickel por Certis, US, que possui o N de Acesso FERM BP-8234, veja o sumrio da Patente U.S. N 7.094.592); B.1.7 Bacillus pumilus, em particular cepa BU F-33 (disponvel como Integral F-33 por Becker Underwood, US, que possui o N de Acesso B-50185); B.1.8 B. subtilis var. amyloliquefaciens cepa FZB24 (disponvel como Taegro por Novozymes, US, que possui o N de Acesso 000-00-9002); B.1.9 B. thuringiensis cepa AQ52 (N de Acesso NRRL B-21619) por AgraQuest, US; B.1.10 Paenibacillus polimyxa, em particular cepa AC-1 (disponvel como Topseed por Green Biotech Company Ltd., veja WO2013010322A1); B.1.11 Pseudomonas proradix (disponvel como Proradix por Sourcon Padena, N de Acesso PRORADIX- DSM 13134 (veja a reivindicao 1 da Patente U.S. N 6.916.650); B.1.12 Bacillus amyloliquefaciens, em particular cepa IN937a; B.1.13 Bacillus azotoformans; B.1.14 Bacillus smithii; B.1.15 Bacillus subtilis, em particular cepa DB 101; B.1.16 Lysobacter antibioticus, em particular cepa 13-1 (veja Biological Control 2008, 45, 288-296); B.1.17 Pantoea agglomerans, em particular cepa E325 (N de Acesso NRRL B-21856).</span>[044] According to the invention, biological control agents that are summarized under the term "bacteria" include spore-forming bacteria, root colonizing bacteria, or bacteria and their metabolites useful as biological insecticides, nematicides, acaricides or fungicides or soil correctors that increase plant health and growth. Examples of such bacteria to be used or employed according to the invention are (numbering is used throughout the description of the following complete invention): B.1.1 Bacillus subtilis, in particular strain QST713 / AQ713 (available as SERENADE MAX by Bayer CropScience LP , US, which has NRRL Accession No. B21661 and described in US Patent No. 6,060,051); B.1.2 Bacillus subtilis strain AQ153 (which has NRRL Accession No. 55614 and described in U.S. Patent No. 5,753,222); B.1.3 Bacillus sp. strain AQ175 (which has ATCC Accession No. 55608 and described in U.S. Patent No. 5,869,042); B.1.4 Bacillus sp. strain AQ177 (which has ATCC Accession No. 55609 and described in U.S. Patent No. 5,869,042); B.1.5 Bacillus sp. strain AQ178 (which has ATCC Accession No. 53522 and described in U.S. Patent No. 5,869,042); B.1.6 Bacillus amyloliquefaciens, strain D747 (available as Bacstar by Etec Crop Solutions, NZ and also available as Double Nickel  by Certis, US, which has FERM Accession No. BP-8234, see summary of US Patent N 7,094,592); B.1.7 Bacillus pumilus, in particular strain BU F-33 (available as Integral F-33 by Becker Underwood, US, which has Accession No. B-50185); B.1.8 B. subtilis var. amyloliquefaciens strain FZB24 (available as Taegro from Novozymes, US, which has Accession No. 000-00-9002); B.1.9 B. thuringiensis strain AQ52 (NRRL Accession No. B-21619) by AgraQuest, US; B.1.10 Paenibacillus polimyxa, in particular AC-1 strain (available as Topseed by Green Biotech Company Ltd., see WO2013010322A1); B.1.11 Pseudomonas proradix (available as Proradix by Sourcon Padena, PRORADIX-DSM Accession No. 13134 (see US Patent Claim No. 6,916,650); B.1.12 Bacillus amyloliquefaciens, in particular strain IN937a; B. 1.13 Bacillus azotoformans; B.1.14 Bacillus smithii; B.1.15 Bacillus subtilis, in particular strain DB 101; B.1.16 Lysobacter antibioticus, in particular strain 13-1 (see Biological Control 2008, 45, 288-296); B.1.17 Pantoea agglomerans, in particular strain E325 (NRRL Accession No. B-21856).</span>
  </p>
  <p id="p0045" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[045] Bactrias preferidas so B.1.1 Bacillus subtilis, em particular cepa QST713/AQ713 (disponvel como SERENADE MAX por Bayer CropScience LP, US, que possui o N de Acesso NRRL B21661 e descrita na Patente U.S. N 6.060.051); B.1.2 Bacillus subtilis cepa AQ153 (que possui o N de Acesso NRRL 55614 e descrita na Patente U.S. N 5.753.222); B.1.3 Bacillus sp. cepa AQ175 (que possui o N de Acesso ATCC 55608 e descrita na Patente U.S. N 5.869.042); B.1.4 Bacillus sp. cepa AQ177 (que possui o N de Acesso ATCC 55609 e descrita na Patente U.S. N 5.869.042); B.1.5 Bacillus sp. cepa AQ178 (que possui o N de Acesso ATCC 53522 e descrita na Patente U.S. N 5.869.042); B.1.6 Bacillus amyloliquefaciens, cepa D747 (disponvel como Bacstar por Etec Crop Solutions, NZ e tambm disponvel como Double Nickel por Certis, US); B.1.7 Bacillus pumilus, em particular cepa BU F-33 (disponvel como Integral F-33 por Becker Underwood, US); B.1.8 B. subtilis var. amyloliquefaciens cepa FZB24 (disponvel como Taegro por Novozymes, US); B.1.9 B. thuringiensis cepa AQ52 (N de Acesso NRRL B-21619) por AgraQuest, US; B.1.10 Paenibacillus polimyxa, em particular cepa AC-1 (disponvel como Topseed por Green Biotech Company Ltd.); B.1.11 Pseudomonas proradix (disponvel como Proradix por Sourcon Padena).</span>[045] Preferred bacteria are B.1.1 Bacillus subtilis, in particular strain QST713 / AQ713 (available as SERENADE MAX by Bayer CropScience LP, US, which has NRRL Accession No. B21661 and described in US Patent No. 6,060,051) ; B.1.2 Bacillus subtilis strain AQ153 (which has NRRL Accession No. 55614 and described in U.S. Patent No. 5,753,222); B.1.3 Bacillus sp. strain AQ175 (which has ATCC Accession No. 55608 and described in U.S. Patent No. 5,869,042); B.1.4 Bacillus sp. strain AQ177 (which has ATCC Accession No. 55609 and described in U.S. Patent No. 5,869,042); B.1.5 Bacillus sp. strain AQ178 (which has ATCC Accession No. 53522 and described in U.S. Patent No. 5,869,042); B.1.6 Bacillus amyloliquefaciens, strain D747 (available as Bacstar by Etec Crop Solutions, NZ and also available as Double Nickel  by Certis, US); B.1.7 Bacillus pumilus, in particular BU F-33 strain (available as Integral F-33 by Becker Underwood, US); B.1.8 B. subtilis var. amyloliquefaciens strain FZB24 (available as Taegro from Novozymes, US); B.1.9 B. thuringiensis strain AQ52 (NRRL Accession No. B-21619) by AgraQuest, US; B.1.10 Paenibacillus polimyxa, in particular AC-1 strain (available as Topseed by Green Biotech Company Ltd.); B.1.11 Pseudomonas proradix (available as Proradix by Sourcon Padena).</span>
  </p>
  <p id="p0046" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[046] Bactrias particularmente preferidas so B.1.1 Bacillus subtilis, em particular cepa QST713/AQ713 (disponvel como SERENADE MAX por Bayer CropScience LP, US, que possui o N de Acesso NRRL B21661 e descrita na Patente U.S. N 6.060.051); B.1.2 Bacillus subtilis cepa AQ153 (que possui o N de Acesso NRRL 55614 e descrita na Patente U.S. N 5.753.222); B.1.3 Bacillus sp. cepa AQ175 (que possui o N de Acesso ATCC 55608 e descrita na Patente U.S. N 5.869.042); B.1.4 Bacillus sp. cepa AQ177 (que possui o N de Acesso ATCC 55609 e descrita na Patente U.S. N 5.869.042); B.1.5 Bacillus sp. cepa AQ178 (que possui o N de Acesso ATCC 53522 e descrita na Patente U.S. N 5.869.042).</span>[046] Particularly preferred bacteria are B.1.1 Bacillus subtilis, in particular strain QST713 / AQ713 (available as SERENADE MAX by Bayer CropScience LP, US, which has NRRL Accession No. B21661 and described in US Patent No. 6,060,051 ); B.1.2 Bacillus subtilis strain AQ153 (which has NRRL Accession No. 55614 and described in U.S. Patent No. 5,753,222); B.1.3 Bacillus sp. strain AQ175 (which has ATCC Accession No. 55608 and described in U.S. Patent No. 5,869,042); B.1.4 Bacillus sp. strain AQ177 (which has ATCC Accession No. 55609 and described in U.S. Patent No. 5,869,042); B.1.5 Bacillus sp. strain AQ178 (having ATCC Accession No. 53522 and described in U.S. Patent No. 5,869,042).</span>
  </p>
  <p id="p0047" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[047] As bactrias mais preferidas so B.1.1 Bacillus subtilis, em particular cepa QST713/AQ713 (disponvel como SERENADE MAX por Bayer CropScience LP, US, que possui o N de Acesso NRRL B21661 e descrita na Patente U.S. N 6.060.051).</span>[047] The most preferred bacteria are B.1.1 Bacillus subtilis, in particular strain QST713 / AQ713 (available as SERENADE MAX by Bayer CropScience LP, US, which has NRRL Accession No. B21661 and described in US Patent No. 6,060. 051).</span>
  </p>
  <p id="p0048" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[048] As cepas bacterianas Bacillus sp. AQ175 (N de Acesso ATCC 55608), Bacillus sp. AQ 177 (N de Acesso ATCC 55609) e Bacillus sp. AQ178 (N de Acesso ATCC 53522) descritas em WO 98/21697 A1 so sabidamente eficazes no tratamento e proteo de plantas de infeces fngicas e bacterianas acima do solo.</span>[048] The bacterial strains Bacillus sp. AQ175 (ATCC Accession No. 55608), Bacillus sp. AQ 177 (Accession No. ATCC 55609) and Bacillus sp. AQ178 (ATCC Accession No. 53522) described in WO 98/21697 A1 are known to be effective in the treatment and protection of plants from above-ground fungal and bacterial infections.</span>
  </p>
  <p id="p0049" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[049] Bacillus subtilis AQ713 (N de Acesso B-21661), tambm denominada Bacillus subtilis QST713, exibe atividade fungicida e bactericida ampla e tambm exibe atividade na larva-alfinete do milho (WO 98/50422 A1). Formulaes disponveis comercialmente dessa cepa esto disponveis sob os nomes comerciais SERENADE MAX, SERENADE Soil, SERENADE ASO, SERENADE CPB e RHAPSODY por Bayer CropScience LP, US (previamente AgraQuest, Inc. EUA). SERENADE ASO  uma formulao lquida da cepa de Bacillus subtilis, enquanto SERENADE Max  uma formulao seca. Ambos os produtos podem ser usados de forma intercambivel contra doenas bacterianas.</span>[049] Bacillus subtilis AQ713 (Accession No. B-21661), also called Bacillus subtilis QST713, exhibits broad fungicidal and bactericidal activity and also exhibits activity in the corn pinworm (WO 98/50422 A1). Commercially available formulations of this strain are available under the trade names SERENADE MAX, SERENADE Soil, SERENADE ASO, SERENADE CPB and RHAPSODY by Bayer CropScience LP, US (previously AgraQuest, Inc. USA). SERENADE ASO is a liquid formulation of the Bacillus subtilis strain, while SERENADE Max is a dry formulation. Both products can be used interchangeably against bacterial diseases.</span>
  </p>
  <p id="p0050" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[050] As respectivas frmulas dos produtos comerciais so exemplificadas da seguinte forma: SERENADE ASO: Suspenso aquosa/ASO = Suspenso aquosa orgnica Ingrediente ativo: Cepa QST713 de Bacillus subtilis* 1,34% Outros ingredientes 98,66% TOTAL 100,00% *Contm um mnimo de 1x109 UFC/g Patentes U.S. Nos 6.060.051; 6.103.228; 6.291.426 e 6.417.163 sobre cepa QST713 de Bacillus subtilis. SERENADE MAX: P molhvel Ingrediente ativo: Cepa QST713 de Bacillus subtilis seca* 14,6% Outros ingredientes 85,4% TOTAL 100,0% *Contm um mnimo de 7,3x109 UFC/g Patentes U.S. Nos 6.060.051, 6.103.228, 6.291.426 e 6.417.163 sobre cepa QST713 de Bacillus subtilis. SERENADE Soil: Suspenso aquosa Ingrediente ativo: Cepa QST713 de Bacillus subtilis seca Outros ingredientes TOTAL Contm um mnimo de 1x109 UFC/gPatentes U.S. Nos 6.060.051, 6.103.228, 6.291.426 e 6.417.163 sobre cepa QST713 de Bacillus subtilis.</span>[050] The respective formulas of commercial products are exemplified as follows: SERENADE ASO: Aqueous suspension / ASO = Organic aqueous suspension Active ingredient: Bacillus subtilis strain QST713 * 1.34% Other ingredients 98.66% TOTAL 100.00 % * Contains a minimum of 1x109 UFC / g US Patents Nos. 6,060,051; 6,103,228; 6,291,426 and 6,417,163 on Bacillus subtilis strain QST713. SERENADE MAX: Wettable powder Active ingredient: Dry Bacillus subtilis strain QST713 * 14.6% Other ingredients 85.4% TOTAL 100.0% * Contains a minimum of 7.3x109 UFC / g US patents Nos. 6,060,051, 6,103. 228, 6,291,426 and 6,417,163 on the QST713 strain of Bacillus subtilis. SERENADE Soil: Aqueous suspension Active ingredient: Dry Bacillus subtilis QST713 strain Other ingredients TOTAL Contains a minimum of 1x109 UFC / g US Patents Nos. 6,060,051, 6,103,228, 6,291,426 and 6,417,163 on the QST713 strain of Bacillus subtilis .</span>
  </p>
  <p id="p0051" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[051] A atividade bactericida de Bacillus subtilis  conhecida contra mancha bacteriana da folha (Xanthemonas), casca (Venturia), fogo bacteriano (Erwinia), Pseudomonas, bactria-murcha (Ralstonia), cancro (incluindo cancro ctrico, causado por Candidatus liberibacter spec.). O modo de ao compreende atividade antifngica ampla, desencadeamento de respostas da planta - ISR (Resistncia Sistmica Induzida), colonizao da folha e competio de patgenos. A mistura em tanque  possvel com, por exemplo, fungicidas como, por exemplo, azoxistrobina, boscalida e piraclostrobina, clorotalonil, ciprodinil, iprodiona, miclobutanil, bicarbonato de potssio, enxofre; inseticidas como, por exemplo, abamectina, Bacillus thuringiensis, spinosad. A mistura em tanque com Fosetil-Al deve ser evitada, na medida em que pode causar precipitao dos esporos. Consequentemente, em uma modalidade preferida, mistura em tanque, de uma combinao da presente inveno com fosetil-Al,  excluda.</span>[051] The bactericidal activity of Bacillus subtilis is known against bacterial leaf spot (Xanthemonas), bark (Venturia), bacterial fire (Erwinia), Pseudomonas, wilted bacteria (Ralstonia), cancer (including citrus canker, caused by Candidatus liberibacter spec.). The mode of action comprises broad antifungal activity, triggering plant responses - ISR (Induced Systemic Resistance), leaf colonization and competition from pathogens. Tank mixing is possible with, for example, fungicides such as, for example, azoxystrobin, boscalide and pyraclostrobin, chlorothalonil, cyprodinil, iprodione, myclobutanil, potassium bicarbonate, sulfur; insecticides such as, for example, abamectin, Bacillus thuringiensis, spinosad. Tank mixing with Fosetil-Al should be avoided, as it can cause spore precipitation. Consequently, in a preferred embodiment, tank mixing, of a combination of the present invention with fosetyl-Al, is excluded.</span>
  </p>
  <p id="p0052" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[052] Bacillus subtilis AQ153 (N de Acesso ATCC 55614) como descrito em WO 98/21964 A1  eficaz na inibio do crescimento de bactrias e fungos patognicos para plantas.</span>[052] Bacillus subtilis AQ153 (ATCC Accession No. 55614) as described in WO 98/21964 A1 is effective in inhibiting the growth of pathogenic bacteria and fungi for plants.</span>
  </p>
  <p id="p0053" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[053] De acordo com WO 98/21965 A1, a cepa produtora de antibitico de Bacillus thuringiensis AQ52 (N de Acesso NRRL B-21619) exibe atividade fungicida e bactericida ampla. 2) Fungos e/ou leveduras</span>[053] According to WO 98/21965 A1, the antibiotic producing strain of Bacillus thuringiensis AQ52 (NRRL Accession No. B-21619) exhibits broad fungicidal and bactericidal activity. 2) Fungi and / or yeasts</span>
  </p>
  <p id="p0054" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[054] De acordo com a inveno, agentes de controle biolgico que so resumidos sob o termo fungos e/ouleveduras so, como exemplos, os seguintes organismos e e/ou seus mutantes que possuem todas as caractersticas de identificao da respectiva cepa, e/ou metablitos produzidos pela respectiva cepa, que exibem atividade contra insetos, caros, nematdeos e/ou fitopatgenos (a numerao  usada na descrio completa): B.2.1 Pseudozyma aphidis (veja WO2011151819A2); B.2.2 Aureobasidium pullulans, em particular blastosporos da cepa DSM14940; B.2.3 blastosporos de Aureobasidium pullulans da cepa DSM 14941; ou misturas destes; B.2.4 Saccharomyces cerevisiae, em particular cepa CNCM N I-3936; B.2.5 Saccharomyces cerevisiae, em particular cepa CNCM N I3937; B.2.6 Saccharomyces cerevisiae, em particular cepa CNCM N I-3938; B.2.7 Saccharomyces cerevisiae, em particular cepa CNCM N I-3939; B.2.8 Scleroderma citrinum.</span>[054] According to the invention, biological control agents that are summarized under the term "fungi" and / or "yeasts" are, as examples, the following organisms and and / or their mutants that have all the identification characteristics of the respective strain, and / or metabolites produced by the respective strain, which exhibit activity against insects, mites, nematodes and / or phytopathogens (numbering is used in the complete description): B.2.1 Pseudozyma aphidis (see WO2011151819A2); B.2.2 Aureobasidium pullulans, in particular blastospores of the DSM14940 strain; B.2.3 Aureobasidium pullulans blastospores of strain DSM 14941; or mixtures thereof; B.2.4 Saccharomyces cerevisiae, in particular CNCM strain No. I-3936; B.2.5 Saccharomyces cerevisiae, in particular CNCM strain No. I3937; B.2.6 Saccharomyces cerevisiae, in particular CNCM strain No. I-3938; B.2.7 Saccharomyces cerevisiae, in particular CNCM strain No. I-3939; B.2.8 Scleroderma citrinum.</span>
  </p>
  <p id="p0055" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[055] Fungos preferidos so B.2.1 Pseudozyma aphidis.</span>[055] Preferred fungi are B.2.1 Pseudozyma aphidis.</span>
  </p>
  <p id="p0056" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[056] Dessa forma, de acordo com a presente inveno, so preferidas combinaes, nas quais o agente de controle biolgico (B)  selecionado do grupo que consiste em: 1) bactrias que consistem em B.1.1 Bacillus subtilis, em particular cepa QST713/AQ713 (disponvel como SERENADE MAX por Bayer CropScience LP, US, que possui o N de Acesso NRRL B21661 e descrita na Patente U.S. N 6.060.051); B.1.2 Bacillus subtilis cepa AQ153 (que possui o N de Acesso NRRL 55614 e descrita na Patente U.S. N 5.753.222); B.1.3 Bacillus sp. cepa AQ175 (que possui o N de Acesso ATCC 55608 e descrita na Patente U.S. N 5.869.042); B.1.4 Bacillus sp. cepa AQ177 (que possui o N de Acesso ATCC 55609 e descrita na Patente U.S. N 5.869.042); B.1.5 Bacillus sp. cepa AQ178 (que possui o N de Acesso ATCC 53522 e descrita na Patente U.S. N 5.869.042); B.1.6 Bacillus amyloliquefaciens, cepa D747 (disponvel como Bacstar por Etec Crop Solutions, NZ e tambm disponvel como Double Nickel por Certis, US); B.1.7 Bacillus pumilus, em particular cepa BU F-33 (disponvel como Integral F-33 por Becker Underwood, US); B.1.8 B. subtilis var. amyloliquefaciens cepa FZB24 (disponvel como Taegro por Novozymes, US); B.1.9 B. thuringiensis cepa AQ52 (N de Acesso NRRL B-21619) por AgraQuest, US; B.1.10 Paenibacillus polimyxa, em particular cepa AC-1 (disponvel como Topseed por Green Biotech Company Ltd.); B.1.11 Pseudomonas proradix (disponvel como Proradix por Sourcon Padena); e 2) fungos que consistem em B.2.1 Pseudozyma aphidis.</span>[056] Thus, according to the present invention, combinations are preferred, in which the biological control agent (B) is selected from the group consisting of: 1) bacteria consisting of B.1.1 Bacillus subtilis, in particular strain QST713 / AQ713 (available as SERENADE MAX by Bayer CropScience LP, US, which has NRRL Accession No. B21661 and described in US Patent No. 6,060,051); B.1.2 Bacillus subtilis strain AQ153 (which has NRRL Accession No. 55614 and described in U.S. Patent No. 5,753,222); B.1.3 Bacillus sp. strain AQ175 (which has ATCC Accession No. 55608 and described in U.S. Patent No. 5,869,042); B.1.4 Bacillus sp. strain AQ177 (which has ATCC Accession No. 55609 and described in U.S. Patent No. 5,869,042); B.1.5 Bacillus sp. strain AQ178 (which has ATCC Accession No. 53522 and described in U.S. Patent No. 5,869,042); B.1.6 Bacillus amyloliquefaciens, strain D747 (available as Bacstar by Etec Crop Solutions, NZ and also available as Double Nickel  by Certis, US); B.1.7 Bacillus pumilus, in particular BU F-33 strain (available as Integral F-33 by Becker Underwood, US); B.1.8 B. subtilis var. amyloliquefaciens strain FZB24 (available as Taegro from Novozymes, US); B.1.9 B. thuringiensis strain AQ52 (NRRL Accession No. B-21619) by AgraQuest, US; B.1.10 Paenibacillus polimyxa, in particular AC-1 strain (available as Topseed by Green Biotech Company Ltd.); B.1.11 Pseudomonas proradix (available as Proradix by Sourcon Padena); and 2) fungi consisting of B.2.1 Pseudozyma aphidis.</span>
  </p>
  <p id="p0057" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[057] Ainda mais preferidas so combinaes nas quais o agente de controle biolgico (B)  selecionado do grupo que consiste em: 1) bactrias que consistem em B.1.1 Bacillus subtilis, em particular cepa QST713/AQ713 (disponvel como SERENADE MAX por Bayer CropScience LP, US, que possui o N de Acesso NRRL B21661 e descrita na Patente U.S. N 6.060.051); B.1.2 Bacillus subtilis cepa AQ153 (que possui o N de Acesso NRRL 55614 e descrita na Patente U.S. N 5.753.222); B.1.3 Bacillus sp. cepa AQ175 (que possui o N de Acesso ATCC 55608 e descrita na Patente U.S. N 5.869.042); B.1.4 Bacillus sp. cepa AQ177 (que possui o N de Acesso ATCC 55609 e descrita na Patente U.S. N 5.869.042); B.1.5 Bacillus sp. cepa AQ178 (que possui o N de Acesso ATCC 53522 e descrita na Patente U.S. N 5.869.042); e2) fungos que consistem em B.2.1 Pseudozyma aphidis.</span>[057] Even more preferred are combinations in which the biological control agent (B) is selected from the group consisting of: 1) bacteria consisting of B.1.1 Bacillus subtilis, in particular strain QST713 / AQ713 (available as SERENADE MAX for Bayer CropScience LP, US, which has NRRL Accession No. B21661 and described in US Patent No. 6,060,051); B.1.2 Bacillus subtilis strain AQ153 (which has NRRL Accession No. 55614 and described in U.S. Patent No. 5,753,222); B.1.3 Bacillus sp. strain AQ175 (which has ATCC Accession No. 55608 and described in U.S. Patent No. 5,869,042); B.1.4 Bacillus sp. strain AQ177 (which has ATCC Accession No. 55609 and described in U.S. Patent No. 5,869,042); B.1.5 Bacillus sp. strain AQ178 (which has ATCC Accession No. 53522 and described in U.S. Patent No. 5,869,042); and 2) fungi consisting of B.2.1 Pseudozyma aphidis.</span>
  </p>
  <p id="p0058" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[058] As mais preferidas so combinaes nas quais o agente de controle biolgico (B)  selecionado do grupo que consiste em: 1) bactrias que consistem em B.1.1 Bacillus subtilis, em particular cepa QST713/AQ713 (disponvel como SERENADE MAX por Bayer CropScience LP, US, que possui o N de Acesso NRRL B21661 e descrita na Patente U.S. N 6.060.051); e 2) fungos que consistem em B.2.1 Pseudozyma aphidis.</span>[058] The most preferred are combinations in which the biological control agent (B) is selected from the group consisting of: 1) bacteria consisting of B.1.1 Bacillus subtilis, in particular strain QST713 / AQ713 (available as SERENADE MAX for Bayer CropScience LP, US, which has NRRL Accession No. B21661 and described in US Patent No. 6,060,051); and 2) fungi consisting of B.2.1 Pseudozyma aphidis.</span>
  </p>
  <p id="p0059" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[059] Agentes de controle biolgico adicionais incluem, em particular, protozorios, vrus, nematdeos entomopatognicos e substncias botnicas e/ou seus mutantes. 3) Protozorios</span>[059] Additional biological control agents include, in particular, protozoa, viruses, entomopathogenic nematodes and botanical substances and / or their mutants. 3) Protozoa</span>
  </p>
  <p id="p0060" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[060] De acordo com a inveno, agentes de controle biolgico que esto resumidos sob o termo protozorios so os seguintes exemplos (a numerao  usada na descrio completa): B.3.1 Nosema locustae (produtos conhecidos como NoloBait), B.3.2 Thelohania solenopsis e B.3.3 Vairimorpha spp. 4) Vrus</span>[060] According to the invention, biological control agents that are summarized under the term protozoa are the following examples (numbering is used in the complete description): B.3.1 Nosema locustae (products known as NoloBait), B. 3.2 Thelohania solenopsis and B.3.3 Vairimorpha spp. 4) Viruses</span>
  </p>
  <p id="p0061" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[061] De acordo com a inveno, agentes de controle biolgico que esto resumidos sob o termo vrus so os seguintes exemplos. Eles incluem mutantes deles que possuem todas as caractersticas de identificao da respectiva cepa, e/ou metablitos produzidos pela respectiva cepa que exibem atividade contra insetos, caros, nematdeos e/ou fitopatgenos (a numerao  usada na descrio completa):B.4.1 Adoxophyes orana (tortrix das frutas do vero) vrus da granulose (GV), (produto conhecido como BIOFA - Capex), B.4.2 Agrotis segetum (traa do nabo) vrus da poliedrose nuclear (NPV), B.4.3 Anticarsia gemmatalis (traa Woolly pyrol) mNPV (produtos conhecidos como Polygen), B.4.4 Autographa californica (Alfalfa Looper) mNPV (produtos conhecidos como VPN80 de Agricola El Sol), B.4.5 Biston suppressaria (tea looper) NPV, B.4.6 Bombyx mori (bicho-da-seda) NPV, B.4.7 Cryptophlebia leucotreta (traa da ma-verde falsa) GV (produtos conhecidos como Cryptex), B.4.8 Cydia pomonella (traa da ma-verde) vrus da granulose (GV) (produto conhecido como Madex Plus), B.4.9 Dendrolimus punctatus (traa do Masson pine) CPV, B.4.10 Helicoverpa armigera NPV (produto conhecido como AgBiTech - ViVUS Max), B.4.11 Helicoverpa (previamente Heliothis) zea (lagarta da espiga de milho) NPV (produtos conhecidos como Elcar), B.4.12 Leucoma salicis (traa do cetim) NPV, B.4.13 Lymantria dispar (mariposa-cigana) NPV (produtos conhecidos como Gypcheck), B.4.14 Neodiprion abietis (abeto balsmico vespo) NPV (produtos conhecidos como Abietiv), B.4.15 Neodiprion lecontei (vespo do pinheiro de cabea vermelha) NPV (produtos conhecidos como Lecontvirus), B.4.16 Neodiprion sertifer (vespo do pinheiro) NPV (produtos conhecidos como Neocheck-S), B.4.17 Orgyia pseudotsugata (traa de tufos do abeto de Douglas) NPV (produtos conhecidos como Virtuss), B.4.18 Phthorimaea operculella (bicho-mineiro de tabaco) GV (produtos conhecidos como Matapol), B.4.19 Pieris rapae (small white) GV, B.4.20 Plutella xylostella (traa-das-crucferas) GV (produtos conhecidos como Plutec), B.4.21 Spodoptera albula (mariposa grisalha) mNPV (produtos conhecidos como VPN 82), B.4.22 Spodoptera exempta (lagarta verdadeira) mNPV (produtos conhecidos como Spodec), B.4.23 Spodoptera exigua (lagarta da beterraba sacarina) mNPV (produtos conhecidos como Spexit de Andermatt Biocontrol), B.4.24 Spodoptera frugiperda (lagarta-do-cartucho) mNPV (produtos conhecidos como Baculovirus VPN), B.4.25 Spodoptera littoralis (lagarta do tabaco) NPV (produtos conhecidos como Spodoptrin de NPP Calliope France), e B.4.26 Spodoptera litura (traa curuquer oriental) NPV (produtos conhecidos como Littovir). 5) Nematdeos entomopatognicos</span>[061] According to the invention, biological control agents that are summarized under the term "virus" are the following examples. They include mutants of their own that have all the identification characteristics of the respective strain, and / or metabolites produced by the respective strain that exhibit activity against insects, mites, nematodes and / or phytopathogens (numbering is used in the full description): B.4.1 Adoxophyes orana (tortrix of summer fruits) granulose virus (GV), (product known as BIOFA - Capex), B.4.2 Agrotis segetum (turnip moth) nuclear polyhedrosis virus (NPV), B.4.3 Anticarsia gemmatalis (moth Woolly pyrol) mNPV (products known as Polygen), B.4.4 Autographa californica (Alfalfa Looper) mNPV (products known as VPN80 by Agricola El Sol), B.4.5 Biston suppressaria (tea looper) NPV, B.4.6 Bombyx mori (bug) NPV, B.4.7 Cryptophlebia leucotreta (false green apple moth) GV (products known as Cryptex), B.4.8 Cydia pomonella (green apple moth) granulose virus (GV) (product known as Madex Plus), B.4.9 Dendrolimus punctatus (Masson pine moth) CPV, B .4.10 Helicoverpa armigera NPV (product known as AgBiTech - ViVUS Max), B.4.11 Helicoverpa (previously Heliothis) zea (corn cob caterpillar) NPV (products known as Elcar), B.4.12 Leucoma salicis (satin moth) NPV , B.4.13 Lymantria dispar (gypsy moth) NPV (products known as Gypcheck), B.4.14 Neodiprion abietis (balsamic spruce) NPV (products known as Abietiv), B.4.15 Neodiprion lecontei (red-headed pine hornet) NPV (products known as Lecontvirus), B.4.16 Neodiprion sertifer (pine hornet) NPV (products known as Neocheck-S), B.4.17 Orgyia pseudotsugata (Douglas fir moth moth) NPV (products known as Virtuss), B.4.18 Phthorimaea operculella (tobacco miner) GV (products known as Matapol), B.4.19 Pieris rapae (small white) GV, B.4.20 Plutella xylostella (crucifer moth) GV (products known as Plutec) , B.4.21 Spodoptera albula (gray moth) mNPV (products known as VPN 82), B.4.22 Spodoptera exempta (true caterpillar) mNPV (products known as Spodec), B.4.23 Spodoptera exigua (sugar beet caterpillar) mNPV (products known as Andermatt Biocontrol Spexit), B.4.24 Spodoptera frugiperda (cartridge caterpillar) mNPV (products known as Baculovirus VPN), B.4.25 Spodoptera littoralis (tobacco caterpillar) NPV (products known as Spodoptrin from NPP Calliope France), and B.4.26 Spodoptera litura (oriental curcock moth) NPV (products known as Littovir). 5) Entomopathogenic nematodes</span>
  </p>
  <p id="p0062" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[062] De acordo com a inveno, agentes de controle biolgico que esto resumidos sob o termo nematdeos entomopatognicos so (a numerao  usada na descrio completa): B.5.1 Abbreviata caucasica, B.5.2 Acuaria spp., B.5.3 Agamermis decaudata, B.5.4 Allantonema spp., B.5.5 Amphimermis spp., B.5.6 Beddingia (= Deladenus) siridicola, B.5.7 Bovienema spp., B.5.7a Cameronia spp., B.5.8 Chitwoodiella ovofilamenta, B.5.9 Contortylenchus spp., B.5.10 Culicimermis spp., B.5.11 Diplotriaena spp., B.5.12 Empidomermis spp., B.5.13 Filipjevimermis leipsera, B.5.14 Gastromermis spp., B.5.15 Gongylonema spp., B.5.16 Gynopoecilia pseudovipara, B.5.17 Heterorhabditis spp., em particular Heterorhabditis bacteriophora (produtos conhecidos como B-Green), ou Heterorhabditis baujardi, ou Heterorhabditis heliothidis (produtos conhecidos como Nematon), ou Heterorhabditis indica, Heterorhabditis marelatus, Heterorhabditis megidis, Heterorhabditis zealeica, B.5.18 Hexamermis spp., B.5.19 Hydromermis spp., B.5.20 Isomermis spp., B.5.21 Limnomermis spp., B.5.22 Maupasina weissi, B.5.23 Mermis nigrescens, B.5.24 Mesomermis spp., B.5.25 Neomesomermis spp., B.5.26 Neoparasitylenchus rugulosi, B.5.27 Octomyomermis spp., B.5.28 Parasitaphelenchus spp., B.5.29 Parasitorhabditis spp., B.5.30 Parasitylenchus spp., B.5.31 Perutilimermis culicis, B.5.32 Phasmarhabditis hermaphrodita, B.5.33 Physaloptera spp., B.5.34 Protrellatus spp., B.5.35 Pterygodermatites spp., B.5.36 Romanomermis spp., B.5.37 Seuratum cadarachense, B.5.38 Sphaerulariopsis spp., B.5.39 Spirura guianensis, B.5.40 Steinernema spp. (= Neoaplectana spp.), em particular Steinernema carpocapsae (produtos conhecidos como Biocontrol), ou Steinernema feltiae (= Neoaplectana carpocapsae), (produtos conhecidos como Nemasys), ou Steinernema glaseri (produtos conhecidos como Biotopia), ou Steinernema kraussei (produtos conhecidos como Larvesure), ou Steinernema riobrave (produtos conhecidos como Biovector), ou Steinernema scapterisci (produtos conhecidos como Nematac S), ou Steinernema scarabaei, ou Steinernema siamkayai, B.5.41 Strelkovimermis peterseni, B.5.42 Subulura spp., B.5.43 Sulphuretylenchus elongatus e B.5.44 Tetrameres spp.</span>[062] According to the invention, biological control agents that are summarized under the term entomopathogenic nematodes are (the numbering is used in the full description): B.5.1 Abbreviata caucasica, B.5.2 Acuaria spp., B.5.3 Agamermis decaudata, B.5.4 Allantonema spp., B.5.5 Amphimermis spp., B.5.6 Beddingia (= Deladenus) siridicola, B.5.7 Bovienema spp., B.5.7a Cameronia spp., B.5.8 Chitwoodiella ovofilamenta, B. 5.9 Contortylenchus spp., B.5.10 Culicimermis spp., B.5.11 Diplotriaena spp., B.5.12 Empidomermis spp., B.5.13 Filipjevimermis leipsera, B.5.14 Gastromermis spp., B.5.15 Gongylonema spp., B.5.16 Gynopoecilia pseudovipara, B.5.17 Heterorhabditis spp., in particular Heterorhabditis bacteriophora (products known as B-Green), or Heterorhabditis baujardi, or Heterorhabditis heliothidis (products known as Nematon), or Heterorhabditis indica, Heterorhabditisis, Heterorhabditisis, Heterorhabditisis, .5.18 Hexamermis spp., B.5.19 Hydromermis spp., B.5.20 Isomermis spp., B.5.21 Limnomermis spp., B.5.22 Maupasina weissi, B.5.23 Mermis nigrescens, B.5.24 Mesomermis spp., B.5.25 Neomesomermis spp., B.5.26 Neoparasitylenchus rugulosi, B.5.27 Octomyomer spp., B.5.28 Parasitaphelenchus spp., B.5.29 Parasitorhabditis spp., B.5.30 Parasitylenchus spp., B.5.31 Perutilimermis culicis, B.5.32 Phasmarhabditis hermaphrodita, B.5.33 Physaloptera spp., B.5.34 Protratus B.5.35 Pterygodermatites spp., B.5.36 Romanomermis spp., B.5.37 Seuratum cadarachense, B.5.38 Sphaerulariopsis spp., B.5.39 Spirura guianensis, B.5.40 Steinernema spp. (= Neoaplectana spp.), In particular Steinernema carpocapsae (products known as Biocontrol), or Steinernema feltiae (= Neoaplectana carpocapsae), (products known as Nemasys), or Steinernema glaseri (products known as Biotopia), or Steinernema kraussei (products known as Larvesure), or Steinernema riobrave (products known as Biovector), or Steinernema scapterisci (products known as Nematac S), or Steinernema scarabaei, or Steinernema siamkayai, B.5.41 Strelkovimermis peterseni, B.5.42 Subulura spp., B.5.43 Sulfuretylenchus elongatus and B.5.44 Tetrameres spp.</span>
  </p>
  <p id="p0063" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[063] Dentro do significado da presente inveno, pelo menos um agente de controle biolgico (B) compreende no apenas as culturas puras, isoladas, dos respectivos microorganismos, mas tambm suas suspenses em uma cultura de caldo inteiro ou um sobrenadante contendo metablito ou um metablito purificado obtido da cultura de caldo inteiro da cepa. Cultura de caldo inteiro se refere a uma cultura lquida que contm tanto clulas, quanto meios. Sobrenadante se refere ao caldo lquido que permanece quando as clulas desenvolvidas no caldo so removidas por centrifugao, filtrao, sedimentao ou por outros meios bem conhecidos na tcnica.</span>[063] Within the meaning of the present invention, at least one biological control agent (B) comprises not only the pure, isolated cultures of the respective microorganisms, but also their suspensions in a whole broth culture or a supernatant containing metabolite or a purified metabolite obtained from the whole broth culture of the strain. Whole broth culture refers to a liquid culture that contains both cells and media. "Supernatant" refers to the liquid broth that remains when the cells developed in the broth are removed by centrifugation, filtration, sedimentation or by other means well known in the art.</span>
  </p>
  <p id="p0064" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[064] Os metablitos mencionados acima produzidos pelos microorganismos no patognicos incluem antibiticos, enzimas, siderforos e agentes promotores de crescimento, por exemplo, zwittermicina-A, kanosamina, polioxina, enzimas como, por exemplo, -amilase, quitinases, e pectinases, fitormnios e precursores destes, por exemplo, auxinas, substncias como giberelina, compostos como citoquinina, lipopeptdeos como, por exemplo, iturinas, plipastatinas ou surfactinas, por exemplo, agrastatina A, bacilomicina D, bacilisina, dificidina, macrolactina, fengicina, bacilisina e bacilaeno. Metablitos preferidos dos lipopeptdeos listados acima so produzidos, em particular, por Bacillus pumilus (N de Acesso NRRL B- 30087), Bacillus subtilis AQ713 (N de Acesso NRRL B- 21661), Bacillus subtilis cepa AQ30002 (tambm conhecida como QST30002; N de Acesso NRRL B-50421), ou Bacillus subtilis cepa AQ30004 (tambm conhecida como QST30004; N de Acesso NRRL B-50455).</span>[064] The aforementioned metabolites produced by non-pathogenic microorganisms include antibiotics, enzymes, siderophores and growth-promoting agents, for example, zwittermycin-A, kanosamine, polyoxin, enzymes such as -amylase, chitinases, and pectinases, phytohormones and precursors thereof, for example, auxins, substances such as gibberellin, compounds such as cytokinin, lipopeptides such as iturins, plipastatin or surfactins, for example, agrastatin A, bacillomycin D, bacillisin, difidine, macrolactin, phenicine, bacillisine and bacilli . Preferred metabolites of the lipopeptides listed above are produced, in particular, by Bacillus pumilus (NRRL Accession No. B-30087), Bacillus subtilis AQ713 (NRRL Accession No. B- 21661), Bacillus subtilis strain AQ30002 (also known as QST30002; NRRL Accession No. B-50421), or Bacillus subtilis strain AQ30004 (also known as QST30004; NRRL Accession No. B-50455).</span>
  </p>
  <p id="p0065" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[065] De acordo com a inveno, o agente de controle biolgico pode ser empregado ou usado em qualquer estado fisiolgico como, por exemplo, ativo ou dormente.</span>[065] According to the invention, the biological control agent can be employed or used in any physiological state such as, for example, active or dormant.</span>
  </p>
  <p id="p0066" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[066] As combinaes de acordo com a presente inveno so particularmente adequadas no uso para o controle de organismos bacterianos nocivos. De acordo com a presente inveno, organismos bacterianos nocivos incluem, entre outras coisas, bactrias que causam danos a plantas ou a uma parte de uma planta.</span>[066] The combinations according to the present invention are particularly suitable in use for the control of harmful bacterial organisms. According to the present invention, harmful bacterial organisms include, among other things, bacteria that cause damage to plants or a part of a plant.</span>
  </p>
  <p id="p0067" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[067] Bactrias incluem, entre outras coisas, Actinobacteria e Proteobacteria, e so selecionadas das famlias das Burkholderiaceae, Xanthomonadaceae, Pseudomonadaceae, Enterobacteriaceae, Microbacteriaceae e Rhizobiaceae.</span>[067] Bacteria include, among other things, Actinobacteria and Proteobacteria, and are selected from the families of Burkholderiaceae, Xanthomonadaceae, Pseudomonadaceae, Enterobacteriaceae, Microbacteriaceae and Rhizobiaceae.</span>
  </p>
  <p id="p0068" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[068] De acordo com a presente inveno, os organismos bacterianos nocivos so particularmente selecionados do grupo que consiste em: Acidovorax avenae (= Pseudomonas avenae, Pseudomonas avenae subsp. avenae, Pseudomonas rubrilineans), incluindo, por exemplo, Acidovorax avenae subsp. avenae (=Pseudomonas avenae subsp. avenae), Acidovorax avenae subsp. cattleyae ( =Pseudomonas cattleyae), Acidovorax avenae subsp. citrulli (=Pseudomonas pseudoalcaligenes subsp. citrulli, Pseudomonas avenae subsp. citrulli)); Burkholderia spec, incluindo, por exemplo, Burkholderia andropogonis (= Pseudomonas andropogonis, Pseudomonas woodsii), Burkholderia caryophylli (=Pseudomonas caryophylli), Burkholderia cepacia (=Pseudomonas cepacia), Burkholderia gladioli (=Pseudomonas gladioli), Burkholderia gladioli pv. agaricicola (=Pseudomnas gladioli pv. agaricicola), Burkholderia gladioli pv. alliicola (=Pseusomonas gladioli pv. alliicola), Burkholderia gladioli pv. gladioli (=Pseudomonas gladioli, Pseudomonas gladioli pv. gladioli), Burkholderia glumae (=Pseudomonas glumae), Burkholderia plantarii ( =Pseudomonas plantarii) Burkholderia solanacearum (=Ralstonia solanacearum), and Ralstonia spp.;Liberibacter spp., incluindo Candidatus Liberibacter spec, incluindo, por exemplo, Liberibacter africanus (Laj), Liberibacter americanus (Lam), Liberibacter asiaticus (Las), Liberibacter europaeus (Leu), Liberibacter psyllaurous, Liberibacter solanacearum (Lso); Corynebacterium, incluindo, por exemplo, Corynebacterium fascians, Corynebacterium flaccumfaciens pv. flaccumfaciens, Corynebacterium michiganensis, Corynebacterium michiganense pv. tritici, Corynebacterium michiganense pv. nebraskense, Corynebacterium sepedonicum; Erwinia spec, incluindo, por exemplo, Erwinia amylovora, Erwinia ananas, Erwinia carotovora (=Pectobacterium carotovorum), Erwinia carotovora subsp. atroseptica, Erwinia carotovora subsp. carotovora, Erwinia chrysanthemi, Erwinia chrysanthemi pv. zeae, Erwinia dissolvens, Erwinia herbicola, Erwinia rhapontic, Erwinia stewartiii, Erwinia tracheiphila, Erwinia uredovora; Pseudomonas syringae, incluindo, por exemplo, Pseudomonas syringae pv. actinidiae (Psa), Pseudomonas syringae pv. atrofaciens, Pseudomonas syringae pv. coronafaciens, Pseudomonas syringae pv. glycinea, Pseudomonas syringae pv. lachrymans, Pseudomonas syringae pv. maculicola Pseudomonas syringae pv. papulans, Pseudomonas syringae pv. striafaciens, Pseudomonas syringae pv. syringae, Pseudomonas syringae pv. tomato, Pseudomonas syringae pv. tabaci; Streptomyces ssp., incluindo, por exemplo, Streptomyces acidiscabies, Streptomyces albidoflavus, Streptomyces candidus (=Actinomyces candidus), Streptomyces caviscabies, Streptomyces collinus, Streptomyces europaeiscabiei, Streptomyces intermedius, Streptomyces ipomoeae, Streptomyces luridiscabiei, Streptomyces niveiscabiei, Streptomyces puniciscabiei, Streptomyces retuculiscabiei, Streptomyces scabiei, Streptomyces scabies, Streptomyces setonii, Streptomyces steliiscabiei, Streptomyces turgidiscabies, Streptomyces wedmorensis; Xanthomonas axonopodis, incluindo, por exemplo, Xanthomonas axonopodis pv. alfalfae (=Xanthomonas alfalfae), Xanthomonas axonopodis pv. aurantifolii (=Xanthomonas fuscans subsp. aurantifolii) , Xanthomonas axonopodis pv. allii (=Xanthomonas campestris pv. allii), Xanthomonas axonopodis pv. axonopodis, Xanthomonas axonopodis pv. bauhiniae (= Xanthomonas campestris pv. bauhiniae), Xanthomonas axonopodis pv. begoniae (= Xanthomonas campestris pv.begoniae), Xanthomonas axonopodis pv. betlicola (= Xanthomonas campestris pv. betlicola), Xanthomonas axonopodis pv. biophyti (= Xanthomonas campestris pv. biophyti), Xanthomonas axonopodis pv. cajani (= Xanthomonas campestris pv. cajani), Xanthomonas axonopodis pv.cassavae (=Xanthomonas cassavae, Xanthomonas campestris pv. cassavae), Xanthomonas axonopodis pv. cassiae (= Xanthomonas campestris pv. cassiae), Xanthomonas axonopodis pv. citri (=Xanthomonas citri), Xanthomonas axonopodis pv. citrumelo ( =Xanthomonas alfalfae subsp. citrumelonis), Xanthomonas axonopodis pv. clitoriae (= Xanthomonas campestris pv. clitoriae), Xanthomonas axonopodis pv. coracanae (= Xanthomonas campestris pv. coracanae), Xanthomonas axonopodis pv. cyamopsidis (= Xanthomonas campestris pv. cyamopsidis), Xanthomonas axonopodis pv. desmodii (= Xanthomonas campestris pv. desmodii), Xanthomonas axonopodis pv. desmodiigangetici (= Xanthomonas campestris pv. desmodiigangetici), Xanthomonas axonopodis pv. desmodiilaxiflori (= Xanthomonas campestris pv. desmodiilaxiflori), Xanthomonas axonopodis pv. desmodiirotundifoUi (= Xanthomonas campestris pv. desmodiirotundifoUi), Xanthomonas axonopodis pv. dieffenbachiae (= Xanthomonas campestris pv. dieffenbachiae), Xanthomonas axonopodis pv. erythrinae (= Xanthomonas campestris pv. erythrinae), Xanthomonas axonopodis pv. fascicularis (= Xanthomonas campestris pv. fasciculari), Xanthomonas axonopodis pv. glycines (= Xanthomonas campestris pv. glycines), Xanthomonas axonopodis pv. khayae (= Xanthomonas campestris pv. khayae), Xanthomonas axonopodis pv. lespedezae (= Xanthomonas campestris pv. lespedezae), Xanthomonas axonopodis pv. maculifolugardeniae (= Xanthomonas campestris pv. maculifolugardeniae) , Xanthomonas axonopodis pv. malvacearum (= Xanthomonas citri subsp. malvacearum), Xanthomonas axonopodis pv. manihotis (= Xanthomonas campestris pv. manihotis), Xanthomonas axonopodis pv. martyniicola (= Xanthomonas campestris pv. martyniicola), Xanthomonas axonopodis pv. melhusii (= Xanthomonas campestris pv. melhusii), Xanthomonas axonopodis pv. nakataecorchori (= Xanthomonas campestris pv. nakataecorchori), Xanthomonas axonopodis pv. passiflorae (= Xanthomonas campestris pv. passiflorae), Xanthomonas axonopodis pv. patelii (= Xanthomonas campestris pv. patelii), Xanthomonas axonopodis pv. pedalii (= Xanthomonas campestris pv. pedalii), Xanthomonas axonopodis pv. phaseoli (= Xanthomonas campestris pv. phaseoli, Xanthomonas phaseoli), Xanthomonas axonopodis pv. phaseoli var. fuscans (= Xanthomonas fuscans), Xanthomonas axonopodis pv. phyllanthi (= Xanthomonas campestris pv. phyllanthi), Xanthomonas axonopodis pv. physalidicola (= Xanthomonas campestris pv. physalidicola), Xanthomonas axonopodis pv. poinsettiicola (= Xanthomonas campestris pv. poinsettiicola), Xanthomonas axonopodis pv. punicae (= Xanthomonas campestris pv. punicae), Xanthomonas axonopodis pv. rhynchosiae (= Xanthomonas campestris pv. rhynchosiae), Xanthomonas axonopodis pv. new? f= Xanthomonas campestris pv. ricini), Xanthomonas axonopodis pv. sesbaniae (= Xanthomonas campestris pv. sesbaniae), Xanthomonas axonopodis pv. tamarindi (= Xanthomonas campestris pv. tamarindi), Xanthomonas axonopodis pv. vasculorum (= Xanthomonas campestris pv. vasculorum), Xanthomonas axonopodis pv. vesicatoria (= Xanthomonas campestris pv. vesicatoria, Xanthomonas vesicatoria), Xanthomonas axonopodis pv. vignaeradiatae (= Xanthomonas campestris pv. vignaeradiatae), Xanthomonas axonopodis pv. vignicola (= Xanthomonas campestris pv. vignicola), Xanthomonas axonopodis pv. vitians (= Xanthomonas campestris pv. vitians); Xanthomonas campestris pv. musacearum, Xanthomonas campestris pv. /jri/m (=Xanthomonas arboricola pv. pruni), Xanthomonas fragariae; Xanthomonas translucens (=Xanthomonas campestris pv. hordei) incluindo, por exemplo, Xanthomonas translucens pv. arrhenatheri (=Xanthomonas campestris pv. arrhenatheri), Xanthomonas translucens pv. cerealis (=Xanthomonas campestris pv. cerealis), Xanthomonas translucens pv. graminis (=Xanthomonas campestris pv. graminis), Xanthomonas translucens pv. /j/z/ez (=Xanthomonas campestris pv. phlei), Xanthomonas translucens pv. phleipratensis (=Xanthomonas campestris pv. phleipratensis), Xanthomonas translucens pv. /joae (=Xanthomonas campestris pv. poae), Xanthomonas translucens pv. secalis (=Xanthomonas campestris pv. secalis), Xanthomonas translucens pv. translucens (=Xanthomonas campestris pv. translucens), Xanthomonas translucens pv. undulosa (=Xanthomonas campestris pv. undulosa).</span>[068] According to the present invention, harmful bacterial organisms are particularly selected from the group consisting of: Acidovorax avenae (= Pseudomonas avenae, Pseudomonas avenae subsp. Avenae, Pseudomonas rubrilineans), including, for example, Acidovorax avenae subsp. avenae (= Pseudomonas avenae subsp. avenae), Acidovorax avenae subsp. cattleyae (= Pseudomonas cattleyae), Acidovorax avenae subsp. citrulli (= Pseudomonas pseudoalcaligenes subsp. citrulli, Pseudomonas avenae subsp. citrulli)); Burkholderia spec, including, for example, Burkholderia andropogonis (= Pseudomonas andropogonis, Pseudomonas woodsii), Burkholderia caryophylli (= Pseudomonas caryophylli), Burkholderia cepacia (= Pseudomonas cepacia), Burkholderia gladioli (= Pseudomonas gladioli). agaricicola (= Pseudomnas gladioli pv. agaricicola), Burkholderia gladioli pv. alliicola (= Pseusomonas gladioli pv. alliicola), Burkholderia gladioli pv. gladioli (= Pseudomonas gladioli, Pseudomonas gladioli pv. gladioli), Burkholderia glumae (= Pseudomonas glumae), Burkholderia plantarii (= Pseudomonas plantarii) Burkholderia solanacearum (= Ralstonia solanacearum), and Ralstonia spp .; Liberibacter spp., Including Candidatus Liberibacter spec, including, for example, Liberibacter africanus (Laj), Liberibacter americanus (Lam), Liberibacter asiaticus (Las), Liberibacter europaeus (Leu), Liberibacter psyllaurous, Liberibacter solanacearum (Lso); Corynebacterium, including, for example, Corynebacterium fascians, Corynebacterium flaccumfaciens pv. flaccumfaciens, Corynebacterium michiganensis, Corynebacterium michiganense pv. tritici, Corynebacterium michiganense pv. nebraskense, Corynebacterium sepedonicum; Erwinia spec, including, for example, Erwinia amylovora, Erwinia ananas, Erwinia carotovora (= Pectobacterium carotovorum), Erwinia carotovora subsp. atroseptica, Erwinia carotovora subsp. carotovora, Erwinia chrysanthemi, Erwinia chrysanthemi pv. zeae, Erwinia dissolvens, Erwinia herbicola, Erwinia rhapontic, Erwinia stewartiii, Erwinia tracheiphila, Erwinia uredovora; Pseudomonas syringae, including, for example, Pseudomonas syringae pv. actinidiae (Psa), Pseudomonas syringae pv. atrofaciens, Pseudomonas syringae pv. coronafaciens, Pseudomonas syringae pv. glycinea, Pseudomonas syringae pv. lachrymans, Pseudomonas syringae pv. maculicola Pseudomonas syringae pv. papulans, Pseudomonas syringae pv. striafaciens, Pseudomonas syringae pv. syringae, Pseudomonas syringae pv. tomato, Pseudomonas syringae pv. tabaci; Streptomyces spp., Including for example, Streptomyces acidiscabies, albidoflavus Streptomyces, Streptomyces candidus (= Actinomyces candidus), Streptomyces caviscabies, collinus Streptomyces, Streptomyces europaeiscabiei, intermedius, Streptomyces, Streptomyces Ipomoeae, Streptomyces luridiscabiei, Streptomyces niveiscabiei, Streptomyces puniciscabiei, Streptomyces retuculiscabiei, Streptomyces scabiei, Streptomyces scabies, Streptomyces setonii, Streptomyces steliiscabiei, Streptomyces turgidiscabies, Streptomyces wedmorensis; Xanthomonas axonopodis, including, for example, Xanthomonas axonopodis pv. alfalfae (= Xanthomonas alfalfae), Xanthomonas axonopodis pv. aurantifolii (= Xanthomonas fuscans subsp. aurantifolii), Xanthomonas axonopodis pv. allii (= Xanthomonas campestris pv. allii), Xanthomonas axonopodis pv. axonopodis, Xanthomonas axonopodis pv. bauhiniae (= Xanthomonas campestris pv. bauhiniae), Xanthomonas axonopodis pv. begoniae (= Xanthomonas campestris pv.begoniae), Xanthomonas axonopodis pv. betlicola (= Xanthomonas campestris pv. betlicola), Xanthomonas axonopodis pv. biophyti (= Xanthomonas campestris pv. biophyti), Xanthomonas axonopodis pv. cajani (= Xanthomonas campestris pv. cajani), Xanthomonas axonopodis pv.cassavae (= Xanthomonas cassavae, Xanthomonas campestris pv. cassavae), Xanthomonas axonopodis pv. cassiae (= Xanthomonas campestris pv. cassiae), Xanthomonas axonopodis pv. citri (= Xanthomonas citri), Xanthomonas axonopodis pv. citrumelo (= Xanthomonas alfalfae subsp. citrumelonis), Xanthomonas axonopodis pv. clitoriae (= Xanthomonas campestris pv. clitoriae), Xanthomonas axonopodis pv. coracanae (= Xanthomonas campestris pv. coracanae), Xanthomonas axonopodis pv. cyamopsidis (= Xanthomonas campestris pv. cyamopsidis), Xanthomonas axonopodis pv. desmodii (= Xanthomonas campestris pv. desmodii), Xanthomonas axonopodis pv. desmodiigangetici (= Xanthomonas campestris pv. desmodiigangetici), Xanthomonas axonopodis pv. desmodiilaxiflori (= Xanthomonas campestris pv. desmodiilaxiflori), Xanthomonas axonopodis pv. desmodiirotundifoUi (= Xanthomonas campestris pv. desmodiirotundifoUi), Xanthomonas axonopodis pv. dieffenbachiae (= Xanthomonas campestris pv. dieffenbachiae), Xanthomonas axonopodis pv. erythrinae (= Xanthomonas campestris pv. erythrinae), Xanthomonas axonopodis pv. fascicularis (= Xanthomonas campestris pv. fasciculari), Xanthomonas axonopodis pv. glycines (= Xanthomonas campestris pv. glycines), Xanthomonas axonopodis pv. khayae (= Xanthomonas campestris pv. khayae), Xanthomonas axonopodis pv. lespedezae (= Xanthomonas campestris pv. lespedezae), Xanthomonas axonopodis pv. maculifolugardeniae (= Xanthomonas campestris pv. maculifolugardeniae), Xanthomonas axonopodis pv. malvacearum (= Xanthomonas citri subsp. malvacearum), Xanthomonas axonopodis pv. manihotis (= Xanthomonas campestris pv. manihotis), Xanthomonas axonopodis pv. martyniicola (= Xanthomonas campestris pv. martyniicola), Xanthomonas axonopodis pv. melhusii (= Xanthomonas campestris pv. melhusii), Xanthomonas axonopodis pv. nakataecorchori (= Xanthomonas campestris pv. nakataecorchori), Xanthomonas axonopodis pv. passiflorae (= Xanthomonas campestris pv. passiflorae), Xanthomonas axonopodis pv. patelii (= Xanthomonas campestris pv. patelii), Xanthomonas axonopodis pv. pedalii (= Xanthomonas campestris pv. pedalii), Xanthomonas axonopodis pv. phaseoli (= Xanthomonas campestris pv. phaseoli, Xanthomonas phaseoli), Xanthomonas axonopodis pv. phaseoli var. fuscans (= Xanthomonas fuscans), Xanthomonas axonopodis pv. phyllanthi (= Xanthomonas campestris pv. phyllanthi), Xanthomonas axonopodis pv. physalidicola (= Xanthomonas campestris pv. physalidicola), Xanthomonas axonopodis pv. poinsettiicola (= Xanthomonas campestris pv. poinsettiicola), Xanthomonas axonopodis pv. punicae (= Xanthomonas campestris pv. punicae), Xanthomonas axonopodis pv. rhynchosiae (= Xanthomonas campestris pv. rhynchosiae), Xanthomonas axonopodis pv. new? f = Xanthomonas campestris pv. ricini), Xanthomonas axonopodis pv. sesbaniae (= Xanthomonas campestris pv. sesbaniae), Xanthomonas axonopodis pv. tamarindi (= Xanthomonas campestris pv. tamarindi), Xanthomonas axonopodis pv. vasculorum (= Xanthomonas campestris pv. vasculorum), Xanthomonas axonopodis pv. vesicatoria (= Xanthomonas campestris pv. vesicatoria, Xanthomonas vesicatoria), Xanthomonas axonopodis pv. vignaeradiatae (= Xanthomonas campestris pv. vignaeradiatae), Xanthomonas axonopodis pv. vignicola (= Xanthomonas campestris pv. vignicola), Xanthomonas axonopodis pv. vitians (= Xanthomonas campestris pv. vitians); Xanthomonas campestris pv. musacearum, Xanthomonas campestris pv. / jri / m (= Xanthomonas arboricola pv. pruni), Xanthomonas fragariae; Xanthomonas translucens (= Xanthomonas campestris pv. Hordei) including, for example, Xanthomonas translucens pv. arrhenatheri (= Xanthomonas campestris pv. arrhenatheri), Xanthomonas translucens pv. cerealis (= Xanthomonas campestris pv. cerealis), Xanthomonas translucens pv. graminis (= Xanthomonas campestris pv. graminis), Xanthomonas translucens pv. / j / z / ez (= Xanthomonas campestris pv. phlei), Xanthomonas translucens pv. phleipratensis (= Xanthomonas campestris pv. phleipratensis), Xanthomonas translucens pv. / joae (= Xanthomonas campestris pv. poae), Xanthomonas translucens pv. secalis (= Xanthomonas campestris pv. secalis), Xanthomonas translucens pv. translucens (= Xanthomonas campestris pv. translucens), Xanthomonas translucens pv. undulosa (= Xanthomonas campestris pv. undulosa).</span>
  </p>
  <p id="p0069" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[069] Xanthomonas oryzae, Xanthomonas oryzae pv. oryzae (=Xanthomonas campestris pv. oryzae), Xanthomonas oryzae pv. oryzicola (=Xanthomonas campestris pv. oryzicola).</span>[069] Xanthomonas oryzae, Xanthomonas oryzae pv. oryzae (= Xanthomonas campestris pv. oryzae), Xanthomonas oryzae pv. oryzicola (= Xanthomonas campestris pv. oryzicola).</span>
  </p>
  <p id="p0070" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[070] Xylella fastidiosa da famlia de Xanthomonadaceae.</span>[070] Xylella fastidiosa of the Xanthomonadaceae family.</span>
  </p>
  <p id="p0071" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[071] De preferncia, os organismos bacterianos nocivos so selecionados do grupo que consiste em:</span>[071] Preferably, harmful bacterial organisms are selected from the group consisting of:</span>
  </p>
  <p id="p0072" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[072] Acidovorax avenae subsp. avenae (= Pseudomonas avenae subsp. avenae), Acidovorax avenae subsp. citrulli (= Pseudomonas pseudoalcaligenes subsp. citrulli, Pseudomonas avenae subsp. citrulli), Burkholderia glumae (= Pseudomonas glumae), Burkholderia solanacearum (=Ralstonia solanacearum), Corynebacterium michiganense pv. nebraskense, Erwinia amylovora, Erwinia carotovora (= Pectobacterium carotovorum), Erwinia carotovora subsp. atroseptica, Erwinia carotovora subsp. carotovora, Erwinia chrysanthemi, Erwinia chrysanthemi pv. zeae, Erwinia herbicola, Erwinia stewartiii, Erwinia uredovora, Liberibacter spp., Candidatus liberibacter spec., como definidos acima, Pseudomonas syringae, Pseudomonas syringae pv. actinidiae (Psa), Pseudomonas syringae pv. glycinea, Pseudomonas syringae pv. lachrymans, Pseudomonas syringae pv. papulans, Pseudomonas syringae pv. syringae, Pseudomonas syringae pv. tomato, Pseudomonas syringae pv. tabaci, Ralstonia spp., Streptomyces scabies, Xanthomonas axonopodis pv. citri, Xanthomonas axonopodis pv. glycines (= Xanthomonas campestris pv. glycines), Xanthomonas axonopodis pv. punicae (= Xanthomonas campestris pv. punicae), Xanthomonas axonopodis pv. vesicatoria (= Xanthomonas campestris pv. vesicatoria, Xanthomonas vesicatoria), Xanthomonas campestris, Xanthomonas campestris pv. musacearum, Xanthomonas campestris pv. pruni (= Xanthomonas arboricola pv. pruni), Xanthomonas fragariae, Xanthomonas translucens pv. translucens (= Xanthomonas campestris pv. translucens), Xanthomonas oryzae pv. oryzae (= Xanthomonas campestris pv. oryzae), Xylella fastidiosa.</span>[072] Acidovorax avenae subsp. avenae (= Pseudomonas avenae subsp. avenae), Acidovorax avenae subsp. citrulli (= Pseudomonas pseudoalcaligenes subsp. citrulli, Pseudomonas avenae subsp. citrulli), Burkholderia glumae (= Pseudomonas glumae), Burkholderia solanacearum (= Ralstonia solanacearum), Corynebacterium michiganense pv. nebraskense, Erwinia amylovora, Erwinia carotovora (= Pectobacterium carotovorum), Erwinia carotovora subsp. atroseptica, Erwinia carotovora subsp. carotovora, Erwinia chrysanthemi, Erwinia chrysanthemi pv. zeae, Erwinia herbicola, Erwinia stewartiii, Erwinia uredovora, Liberibacter spp., Candidatus liberibacter spec., as defined above, Pseudomonas syringae, Pseudomonas syringae pv. actinidiae (Psa), Pseudomonas syringae pv. glycinea, Pseudomonas syringae pv. lachrymans, Pseudomonas syringae pv. papulans, Pseudomonas syringae pv. syringae, Pseudomonas syringae pv. tomato, Pseudomonas syringae pv. tabaci, Ralstonia spp., Streptomyces scabies, Xanthomonas axonopodis pv. citri, Xanthomonas axonopodis pv. glycines (= Xanthomonas campestris pv. glycines), Xanthomonas axonopodis pv. punicae (= Xanthomonas campestris pv. punicae), Xanthomonas axonopodis pv. vesicatoria (= Xanthomonas campestris pv. vesicatoria, Xanthomonas vesicatoria), Xanthomonas campestris, Xanthomonas campestris pv. musacearum, Xanthomonas campestris pv. pruni (= Xanthomonas arboricola pv. pruni), Xanthomonas fragariae, Xanthomonas translucens pv. translucens (= Xanthomonas campestris pv. translucens), Xanthomonas oryzae pv. oryzae (= Xanthomonas campestris pv. oryzae), Xylella fastidiosa.</span>
  </p>
  <p id="p0073" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[073] Em um aspecto mais preferido da presente inveno, os organismos bacterianos nocivos so selecionados do grupo que consiste em: Acidovorax avenae (= Pseudomonas avenae, Pseudomonas avenae subsp. avenae, Pseudomonas rubrilineans), como definidas acima, Burkholderia spec., como definido acima, Burkholderia glumae, Corynebacterium, como definida acima, Erwinia spec., como definido acima, Erwinia amylovora, Erwinia carotovora (= Pectobacterium carotovorum), Erwinia carotovora subsp. atroseptica, Erwinia carotovora subsp. carotovora, Erwinia chrysanthemi, Erwinia chrysanthemi pv. zeae, Erwinia herbicola, Erwinia stewartiii, Erwinia uredovora, Liberibacter spp., Candidatus liberibacter spec., como definidas acima, Pseudomonas syringae, como definida acima, Pseudomonas syringae pv. actinidae, Pseudomonas syringae pv. glycinea, Pseudomonas syringae pv. tomato, Pseudomonas syringae pv. lachrymans, Ralstonia spp., Streptomyces spp., Streptomyces scabies, Xanthomonas spp., Xanthomonas axonopodis, como definidas acima, Xanthomonas axonopodis pv. citri, Xanthomonas axonopodis pv. glycines, Xanthomonas campestris, Xanthomonas campestris pv. musacearum, Xanthomonas campestris pv. pruni (= Xanthomonas arboricola pv. pruni), Xanthomonas fragariae, Xanthomonas translucens (= Xanthomonas campestris pv. hordei), Xanthomonas oryzae pv. oryzae (= Xanthomonas campestris pv. oryzae) e Xylella fastidiosa, como definidas acima.</span>[073] In a more preferred aspect of the present invention, harmful bacterial organisms are selected from the group consisting of: Acidovorax avenae (= Pseudomonas avenae, Pseudomonas avenae subsp. Avenae, Pseudomonas rubrilineans), as defined above, Burkholderia spec., As defined above, Burkholderia glumae, Corynebacterium, as defined above, Erwinia spec., as defined above, Erwinia amylovora, Erwinia carotovora (= Pectobacterium carotovorum), Erwinia carotovora subsp. atroseptica, Erwinia carotovora subsp. carotovora, Erwinia chrysanthemi, Erwinia chrysanthemi pv. zeae, Erwinia herbicola, Erwinia stewartiii, Erwinia uredovora, Liberibacter spp., Candidatus liberibacter spec., as defined above, Pseudomonas syringae, as defined above, Pseudomonas syringae pv. actinidae, Pseudomonas syringae pv. glycinea, Pseudomonas syringae pv. tomato, Pseudomonas syringae pv. lachrymans, Ralstonia spp., Streptomyces spp., Streptomyces scabies, Xanthomonas spp., Xanthomonas axonopodis, as defined above, Xanthomonas axonopodis pv. citri, Xanthomonas axonopodis pv. glycines, Xanthomonas campestris, Xanthomonas campestris pv. musacearum, Xanthomonas campestris pv. pruni (= Xanthomonas arboricola pv. pruni), Xanthomonas fragariae, Xanthomonas translucens (= Xanthomonas campestris pv. hordei), Xanthomonas oryzae pv. oryzae (= Xanthomonas campestris pv. oryzae) and Xylella fastidiosa, as defined above.</span>
  </p>
  <p id="p0074" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[074] Ainda mais preferida  uma seleo que consiste em: Acidovorax avenae, Burkholderia spec., Burkholderia glumae, Corynebacterium, Erwinia spec., Liberibacter spp., Candidatus liberibacter spec., Pseudomonas syringae, Pseudomonas syringae pv. actinidae, Pseudomonas syringae pv. glycinea, Pseudomonas syringae pv. tomato, Pseudomonas syringae pv. lachrymans, Ralstonia spp., Streptomyces spp., Xanthomonas spp., Xanthomonas axonopodis, Xanthomonas axonopodis pv. citri, Xanthomonas axonopodis pv. glycines, Xanthomonas campestris, Xanthomonas campestris pv. musacearum, Xanthomonas campestris pv. pruni, Xanthomonas fragariae, Xanthomonas transluscens, Xanthomonas oryzae pv. oryzae (= Xanthomonas campestris pv. oryzae) e Xylella fastidiosa.</span>[074] Even more preferred is a selection consisting of: Acidovorax avenae, Burkholderia spec., Burkholderia glumae, Corynebacterium, Erwinia spec., Liberibacter spp., Candidatus liberibacter spec., Pseudomonas syringae, Pseudomonas syringae pv. actinidae, Pseudomonas syringae pv. glycinea, Pseudomonas syringae pv. tomato, Pseudomonas syringae pv. lachrymans, Ralstonia spp., Streptomyces spp., Xanthomonas spp., Xanthomonas axonopodis, Xanthomonas axonopodis pv. citri, Xanthomonas axonopodis pv. glycines, Xanthomonas campestris, Xanthomonas campestris pv. musacearum, Xanthomonas campestris pv. pruni, Xanthomonas fragariae, Xanthomonas transluscens, Xanthomonas oryzae pv. oryzae (= Xanthomonas campestris pv. oryzae) and Xylella fastidiosa.</span>
  </p>
  <p id="p0075" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[075] Em um aspecto ainda mais preferido da presente inveno, os organismos bacterianos nocivos so selecionados do grupo que consiste em: Acidovorax avenae, Burkholderia spec., Burkholderia glumae, Corynebacterium, Erwinia amylovora, Erwinia carotovora, Erwinia carotovora subsp. atroseptica, Erwinia carotovora subsp. carotovora, Erwinia chrysanthemi, Erwinia chrysanthemi pv. zeae, Erwinia herbicola, Erwinia stewartiii, Erwinia uredovora, Liberibacter spp., Candidatus liberibacter spec., Pseudomonas syringae, Pseudomonas syringae pv. actinidae, Pseudomonas syringae pv. glycinea, Pseudomonas syringae pv. lachrymans, Pseudomonas syringae pv. tomato, Ralstonia spp., Streptomyces scabies, Xanthomonas axonopodis, Xanthomonas axonopodis pv. citri, Xanthomonas axonopodis pv. glycines, Xanthomonas campestris, Xanthomonas campestris pv. musacearum, Xanthomonas campestris pv. pruni, Xanthomonas fragariae, Xanthomonas translucens, Xanthomonas oryzae pv. oryzae (= Xanthomonas campestris pv. oryzae) e Xylella fastidiosa.</span>[075] In an even more preferred aspect of the present invention, harmful bacterial organisms are selected from the group consisting of: Acidovorax avenae, Burkholderia spec., Burkholderia glumae, Corynebacterium, Erwinia amylovora, Erwinia carotovora, Erwinia carotovora subsp. atroseptica, Erwinia carotovora subsp. carotovora, Erwinia chrysanthemi, Erwinia chrysanthemi pv. zeae, Erwinia herbicola, Erwinia stewartiii, Erwinia uredovora, Liberibacter spp., Candidatus liberibacter spec., Pseudomonas syringae, Pseudomonas syringae pv. actinidae, Pseudomonas syringae pv. glycinea, Pseudomonas syringae pv. lachrymans, Pseudomonas syringae pv. tomato, Ralstonia spp., Streptomyces scabies, Xanthomonas axonopodis, Xanthomonas axonopodis pv. citri, Xanthomonas axonopodis pv. glycines, Xanthomonas campestris, Xanthomonas campestris pv. musacearum, Xanthomonas campestris pv. pruni, Xanthomonas fragariae, Xanthomonas translucens, Xanthomonas oryzae pv. oryzae (= Xanthomonas campestris pv. oryzae) and Xylella fastidiosa.</span>
  </p>
  <p id="p0076" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[076] A seleo mais preferida compreende o grupo que consiste em: Burkholderia glumae, Liberibacter spp., Candidatus liberibacter spec., Xanthomonas axonopodis pv. citri, Pseudomonas syringae, Pseudomonas syringae pv. actinidae, Pseudomonas syringae pv. glycinea, Pseudomonas syringae pv. lachrymans, Pseudomonas syringae pv. tomato, Ralstonia spp., Streptomyces scabies, Xanthomonas axonopodis pv. glycines, Xanthomonas campestris pv. pruni, Xanthomonas campestris, Xanthomonas oryzae pv. oryzae (= Xanthomonas campestris pv. oryzae) e Xylella fastidiosa.</span>[076] The most preferred selection comprises the group consisting of: Burkholderia glumae, Liberibacter spp., Candidatus liberibacter spec., Xanthomonas axonopodis pv. citri, Pseudomonas syringae, Pseudomonas syringae pv. actinidae, Pseudomonas syringae pv. glycinea, Pseudomonas syringae pv. lachrymans, Pseudomonas syringae pv. tomato, Ralstonia spp., Streptomyces scabies, Xanthomonas axonopodis pv. glycines, Xanthomonas campestris pv. pruni, Xanthomonas campestris, Xanthomonas oryzae pv. oryzae (= Xanthomonas campestris pv. oryzae) and Xylella fastidiosa.</span>
  </p>
  <p id="p0077" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[077] A combinao de acordo com a presente inveno pode, portanto, ser empregada para a proteo de plantas contra ataque pelos patgenos mencionados acima dentro de certo perodo ps-tratamento. O perodo dentro do qual a proteo  gerada geralmente se estende de 1 a 10 dias, preferivelmente 1 a 7 dias, aps o tratamento das plantas com os compostos ativos. Dependendo da forma de aplicao, a acessibilidade dos compostos ativos  planta pode ser controlada de uma forma dirigida.</span>[077] The combination according to the present invention can, therefore, be used to protect plants against attack by the pathogens mentioned above within a certain post-treatment period. The period within which protection is generated generally extends from 1 to 10 days, preferably 1 to 7 days, after treatment of the plants with the active compounds. Depending on the form of application, the accessibility of the active compounds to the plant can be controlled in a targeted manner.</span>
  </p>
  <p id="p0078" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[078] A boa tolerncia de plantas das combinaes nas concentraes do indutor da defesa do hospedeiro e do agente de controle biolgico necessrias para o controle de doenas de plantas permite um tratamento de partes de plantas areas e subterrneas, de material de propagao vegetativa e do solo.</span>[078] The good plant tolerance of the combinations in the concentrations of the host defense inducer and the biological control agent necessary for the control of plant diseases allows a treatment of aerial and underground plant parts, vegetative propagation material and the ground.</span>
  </p>
  <p id="p0079" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[079] As combinaes de acordo com a presente inveno tambm so adequadas para o aumento do rendimento, exibem baixa toxicidade e so bem toleradas por plantas. As combinaes so particularmente adequadas para reduo do dano global de plantas e partes de plantas, bem como de perdas nas frutas ou vegetais colhidos causadas por bactrias fitopatognicas.</span>[079] The combinations according to the present invention are also suitable for increasing yield, exhibit low toxicity and are well tolerated by plants. The combinations are particularly suitable for reducing the overall damage of plants and plant parts, as well as losses in harvested fruits or vegetables caused by phytopathogenic bacteria.</span>
  </p>
  <p id="p0080" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[080] No contexto da presente inveno, com aplicao s plantas, um efeito vantajoso foi observado.</span>[080] In the context of the present invention, with application to plants, an advantageous effect has been observed.</span>
  </p>
  <p id="p0081" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[081] De acordo com a inveno, todas as plantas podem ser tratadas. No presente contexto,  subentendido que plantas significam todas as partes de plantas e populaes de plantas como, por exemplo, plantas selvagens desejadas e indesejadas ou plantas de cultivo (incluindo plantas de cultivo de ocorrncia natural). Plantas de cultivo podem ser plantas que podem ser obtidas por mtodos tradicionais de reproduo e otimizao ou ainda por mtodos biotecnolgicos e recombinantes, ou combinaes desses mtodos, incluindo as plantas transgnicas e incluindo as variedades de plantas capazes ou no de serem protegidas pelos Direitos dos Criadores Agrcolas. Esses mtodos so, por exemplo, haplides duplos, fuso de protoplasto, mutagnese aleatria ou direcionada e tambm marcadores moleculares ou genticos.</span>[081] According to the invention, all plants can be treated. In the present context, it is understood that plants mean all parts of plants and plant populations, for example, desired and unwanted wild plants or cultivation plants (including naturally occurring cultivation plants). Cultivation plants can be plants that can be obtained by traditional methods of reproduction and optimization or by biotechnological and recombinant methods, or combinations of these methods, including transgenic plants and including varieties of plants that may or may not be protected by the Rights of Breeders Agricultural. These methods are, for example, double haploids, protoplast fusion, random or targeted mutagenesis and also molecular or genetic markers.</span>
  </p>
  <p id="p0082" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[082] Partes de plantas significam todas as partes areas e subterrneas e rgos das plantas, por exemplo, erva, pseudocaule, broto, folha, brctea, bainhas foliares, pecolo, lmina, flor e raiz, cujos exemplos que podem ser mencionados so folhas, agulhas, talos, caules, flores, corpos de frutificao, fruta, penca, cachos e sementes de bananas, e tambm razes, tubrculos, rizomas, ramo, broto, crescimento secundrio. As partes de plantas tambm incluem material de cultivo e material de propagao vegetativa e generativa, por exemplo, estacas, tubrculos, rizomas, mudas tipo filhote e sementes.</span>[082] Plant parts mean all aerial and underground parts and plant organs, for example, herb, pseudostem, bud, leaf, bract, leaf sheaths, petiole, blade, flower and root, examples of which can be mentioned are leaves , needles, stems, stems, flowers, fruiting bodies, fruit, cloves, bunches and banana seeds, as well as roots, tubers, rhizomes, branch, bud, secondary growth. Plant parts also include growing material and vegetative and generative propagation material, for example, cuttings, tubers, rhizomes, young seedlings and seeds.</span>
  </p>
  <p id="p0083" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[083] Como j foi mencionado acima, todas as plantas podem ser tratadas de acordo com a inveno. Em uma modalidade preferida, so tratadas espcies de plantas e variedades de plantas, e suas partes, que so encontradas no ambiente selvagem ou que so obtidas por mtodos convencionais de reproduo biolgica, por exemplo, hibridizao, culturas de meristema, micropropagao, embriognese somtica, organognese direta ou fuso de protoplasto. Em uma modalidade preferida adicional, so tratadas plantas transgnicas e variedades de plantas que foram obtidas por mtodos recombinantes, se apropriado em combinao com mtodos tradicionais (organismos geneticamente modificados) como, por exemplo, transformao por meio de Agrobacterium ou bombardeamento de partculas de clulas embriognicas, e micropropagao. Plantas incluem todas as partes de plantas, como mencionado acima.</span>[083] As already mentioned above, all plants can be treated according to the invention. In a preferred embodiment, plant species and plant varieties, and parts thereof, that are found in the wild or that are obtained by conventional methods of biological reproduction are treated, for example, hybridization, meristem cultures, micropropagation, somatic embryogenesis, direct organogenesis or protoplast fusion. In an additional preferred embodiment, transgenic plants and varieties of plants that have been obtained by recombinant methods are treated, if appropriate in combination with traditional methods (genetically modified organisms) such as transformation by means of Agrobacterium or bombardment of embryogenic cell particles. , and micropropagation. Plants include all parts of plants, as mentioned above.</span>
  </p>
  <p id="p0084" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[084]  especialmente preferido tratar, de acordo com a inveno, plantas daquelas variedades de plantas que esto, em cada caso, disponveis comercialmente ou em uso. Subentende-se que variedades de plantas significam plantas com propriedades novas (traos) que foram obtidas por reproduo convencional, por mutagnese ou ainda por tcnicas de DNA recombinante. Elas podem ser variedades, geraes, bitipos e gentipos.</span>[084] It is especially preferred to treat, according to the invention, plants of those varieties of plants that are, in each case, commercially available or in use. It is understood that plant varieties mean plants with new properties (traits) that were obtained by conventional reproduction, mutagenesis or by recombinant DNA techniques. They can be varieties, generations, biotypes and genotypes.</span>
  </p>
  <p id="p0085" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[085] O mtodo de tratamento de acordo com a inveno pode ser usado no tratamento de organismos geneticamente modificados (GMOs), por exemplo, plantas ou sementes. Plantas geneticamente modificadas (ou plantas transgnicas) so plantas nas quais um gene heterlogo foi estavelmente integrado no genoma. A expresso gene heterlogo basicamente significa um gene que  fornecido ou montado fora da planta e, quando introduzido, no genoma nuclear, cloroplstico ou mitocondrial, d  planta transformada propriedades agronmicas ou outras novas ou aprimoradas por expresso de uma protena ou polipeptdeo de interesse ou por infra-regulao ou silenciamento de outro gene (ou genes) que esto presentes na planta (usando, por exemplo, tecnologia anti-senso, tecnologia de co-supresso ou tecnologia de interferncia de RNA [RNAi]). Um gene heterlogo que est localizado no genoma tambm  denominado um transgene. Um transgene que  definido por sua localizao particular no genoma da planta  denominado um evento de transformao ou transgnico.</span>[085] The treatment method according to the invention can be used in the treatment of genetically modified organisms (GMOs), for example, plants or seeds. Genetically modified plants (or transgenic plants) are plants in which a heterologous gene has been stably integrated into the genome. The expression heterologous gene basically means a gene that is supplied or assembled outside the plant and, when introduced, into the nuclear, chloroplastic or mitochondrial genome, gives the transformed plant agronomic or other properties new or enhanced by expression of a protein or polypeptide from interest or by infra-regulation or silencing of another gene (or genes) that are present in the plant (using, for example, antisense technology, co-suppression technology or RNA interference technology [RNAi]). A heterologous gene that is located in the genome is also called a transgene. A transgene that is defined by its particular location in the plant's genome is called a transformation or transgenic event.</span>
  </p>
  <p id="p0086" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[086] Plantas e variedades de plantas que devem preferivelmente ser tratadas de acordo com a inveno incluem todas as plantas que possuem material gentico que transmite traos teis particularmente vantajosos a essas plantas (sejam eles obtidos por reproduo e/ou por meios biotecnolgicos).</span>[086] Plants and varieties of plants that should preferably be treated according to the invention include all plants that have genetic material that imparts useful traits particularly advantageous to those plants (whether obtained by reproduction and / or by biotechnological means).</span>
  </p>
  <p id="p0087" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[087] Plantas que podem ser tratadas de acordo com a inveno so plantas hbridas que j expressam as caractersticas de heterose, ou vigor hbrido, que resultam, geralmente, em rendimento maior, vigor, sade e resistncia contra fatores de estresse bitico e abitico. Essas plantas so tipicamente feitas por cruzamento de uma linhagem progenitora endogmica com esterilidade masculina (o progenitor-fmea) com outra linhagem progenitora endogmica com esterilidade masculina (o progenitor-macho). A semente hbrida  tipicamente colhida das plantas com esterilidade masculina e vendida para cultivadores. Plantas com esterilidade masculina podem algumas vezes (por exemplo, no milho) ser produzidas por despendoamento (ou seja, a remoo mecnica dos rgos reprodutivos masculinos ou flores-macho), mas, mais tipicamente, a esterilidade masculina  o resultado de determinantes genticos no genoma da planta. Naquele caso, e especialmente quando a semente  o produto desejado a ser colhido das plantas hbridas,  tipicamente til assegurar que a fertilidade masculina em plantas hbridas, que contm os determinantes genticos responsveis pela esterilidade masculina, seja totalmente restaurada. Isso pode ser obtido assegurando-se que os progenitores masculinos possuam genes restauradores da fertilidade apropriados que so capazes de restaurar a fertilidade masculina em plantas hbridas que contm os determinantes genticos responsveis pela esterilidade masculina. Os determinantes genticos para a esterilidade masculina podem estar localizados no citoplasma. Exemplos de esterilidade masculina citoplasmtica (CMS) foram, por exemplo, descritos para espcies de Brassica. No entanto, os determinantes genticos para esterilidade masculina tambm podem estar localizados no genoma nuclear. Plantas com esterilidade masculina tambm podem ser obtidas por mtodos de biotecnologia de plantas como, por exemplo, engenharia gentica. Um meio particularmente til para obteno de plantas com esterilidade masculina  descrito em WO 89/10396, no qual, por exemplo, uma ribonuclease como, por exemplo, uma barnase,  seletivamente expressa nas clulas tapetais nos estames. A fertilidade pode ento ser restaurada por expresso nas clulas tapetais de um inibidor de ribonuclease como, por exemplo, barstar.</span>[087] Plants that can be treated according to the invention are hybrid plants that already express the characteristics of heterosis, or hybrid vigor, which generally result in higher yield, vigor, health and resistance against biotic and abiotic stress factors. These plants are typically made by crossing an inbred parent line with male sterility (the female parent) with another inbred parent line with male sterility (the male parent). Hybrid seed is typically harvested from plants with male sterility and sold to growers. Plants with male sterility can sometimes (for example, in maize) be produced by stripping (that is, the mechanical removal of male reproductive organs or male flowers), but more typically, male sterility is the result of genetic determinants in the plant genome. In that case, and especially when the seed is the desired product to be harvested from hybrid plants, it is typically useful to ensure that male fertility in hybrid plants, which contain the genetic determinants responsible for male sterility, is fully restored. This can be achieved by ensuring that male parents have appropriate fertility restoring genes that are capable of restoring male fertility in hybrid plants that contain the genetic determinants responsible for male sterility. The genetic determinants for male sterility may be located in the cytoplasm. Examples of cytoplasmic male sterility (CMS) have, for example, been described for Brassica species. However, the genetic determinants for male sterility may also be located in the nuclear genome. Plants with male sterility can also be obtained by plant biotechnology methods, such as genetic engineering. A particularly useful means of obtaining plants with male sterility is described in WO 89/10396, in which, for example, a ribonuclease such as, for example, a barnase, is selectively expressed in the tapetal cells in the stamens. Fertility can then be restored by expression in the tapetal cells of a ribonuclease inhibitor such as, for example, barstar.</span>
  </p>
  <p id="p0088" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[088] Plantas ou variedades de plantas (obtidos por mtodos de biotecnologia de plantas como, por exemplo, engenharia gentica) que tambm podem ser tratadas de acordo com a inveno so plantas transgnicas resistentes a insetos, ou seja, plantas tornadas resistentes ao ataque por certos insetos-alvo. Essas plantas podem ser obtidas por transformao gentica, ou por seleo de plantas que contm uma mutao que transmite essa resistncia a insetos.</span>[088] Plants or plant varieties (obtained by plant biotechnology methods, such as genetic engineering) that can also be treated according to the invention are insect resistant transgenic plants, that is, plants made resistant to attack by certain target insects. These plants can be obtained by genetic transformation, or by selecting plants that contain a mutation that transmits this resistance to insects.</span>
  </p>
  <p id="p0089" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[089] Plantas que podem ser tratadas de acordo com a inveno e que podem ser mencionadas so as seguintes: algodo, linhaa, videira, vegetais e frutas (por exemplo, kiwi, abacaxi), por exemplo, Rosaceae sp. (por exemplo, pomideas como, por exemplo, mas e pras, mas tambm frutas de caroo como, por exemplo, damascos, cerejas, amndoas e pssegos, e frutas macias como, por exemplo, morangos), ou rom do gnero de Punica, Ribesioidae sp., Jugleaceae sp., Betulaceae sp., Anacardiaceae sp., Fagaceae sp., Moraceae sp., Oleaceae sp., Actinidaceae sp., Lauraceae sp., Musaceae sp. (por exemplo, plantas de banana e plantaes de bananas, alm de pltanos), Rubiaceae sp. (por exemplo, caf), Theaceae sp., Sterculiceae sp., Rutaceae sp. (por exemplo, citros, limes, laranjas e toronja); Solanaceae sp. (por exemplo, tomates), Liliaceae sp., Asteraceae sp. (por exemplo, alface), Umbelliferae sp., Cruciferae sp., Chenopodiaceae sp., Cucurbitaceae sp. (por exemplo, pepinos, meles, cucrbitas, abboras), Alliaceae sp. (por exemplo, alhos- porrs, cebolas), Papilionaceae sp. (por exemplo, ervilhas); plantas de cultivos importantes como, por exemplo, Gramineae sp. (por exemplo, milho, mas, turfa, cereais como, por exemplo, trigo, centeio, arroz, cevada, aveia, sorgo, paino e triticale), Asteraceae sp. (por exemplo, girassol), Brassicaceae sp. (por exemplo, repolho como, por exemplo, repolho branco e repolho vermelho, brcolis, couve-flor, couve-de-bruxelas, repolho branco chins, couve-rbano, rabanetes, e tambm colza, mostarda, raiz-forte e agrio), Fabacae sp. (por exemplo, feijes, amendoins), Papilionaceae sp. (por exemplo, sojas), Solanaceae sp. (por exemplo, batatas), Chenopodiaceae sp.(por exemplo, beterraba sacarina, beterraba forrageira, acelga, beterraba); plantas teis e plantas ornamentais em jardins e florestas; e, em cada caso, tipos modificados geneticamente dessas plantas.</span>[089] Plants that can be treated according to the invention and that can be mentioned are the following: cotton, flaxseed, grapevine, vegetables and fruits (for example, kiwi, pineapple), for example, Rosaceae sp. (for example, pomoids such as apples and pears, but also stone fruits such as apricots, cherries, almonds and peaches, and soft fruits such as strawberries), or pomegranate of the Punica genus, Ribesioidae sp., Jugleaceae sp., Betulaceae sp., Anacardiaceae sp., Fagaceae sp., Moraceae sp., Oleaceae sp., Actinidaceae sp., Lauraceae sp., Musaceae sp. (for example, banana plants and banana plantations, in addition to plantains), Rubiaceae sp. (for example, coffee), Theaceae sp., Sterculiceae sp., Rutaceae sp. (for example, citrus, lemons, oranges and grapefruit); Solanaceae sp. (for example, tomatoes), Liliaceae sp., Asteraceae sp. (for example, lettuce), Umbelliferae sp., Cruciferae sp., Chenopodiaceae sp., Cucurbitaceae sp. (for example, cucumbers, melons, cucurbits, pumpkins), Alliaceae sp. (for example, leeks, onions), Papilionaceae sp. (for example, peas); important crop plants such as, for example, Gramineae sp. (for example, maize, maize, peat, cereals such as, for example, wheat, rye, rice, barley, oats, sorghum, millet and triticale), Asteraceae sp. (for example, sunflower), Brassicaceae sp. (for example, cabbage such as white cabbage and red cabbage, broccoli, cauliflower, Brussels sprouts, Chinese white cabbage, kohlrabi, radishes, and also rapeseed, mustard, horseradish and watercress) , Fabacae sp. (for example, beans, peanuts), Papilionaceae sp. (for example, soybeans), Solanaceae sp. (for example, potatoes), Chenopodiaceae sp. (eg sugar beet, fodder beet, chard, beet); useful plants and ornamental plants in gardens and forests; and, in each case, genetically modified types of these plants.</span>
  </p>
  <p id="p0090" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[090] De preferncia, as combinaes da presente inveno so usadas para o tratamento em plantas selecionadas do grupo que consiste em: vegetais e frutas (por exemplo, kiwi, melo, abacaxi), por exemplo, Rosaceae sp. (por exemplo, pomideas como, por exemplo, mas e pras, mas tambm frutas de caroo como, por exemplo, damascos, cerejas, amndoas e pssegos, e frutas macias como, por exemplo, morangos), ou rom do gnero de Punica, Musaceae sp. (por exemplo, plantas de banana e plantaes de bananas, alm de pltanos), Rutaceae sp. (por exemplo, citros, limes, laranjas e toronja); vegetais como, por exemplo, Solanaceae sp. (por exemplo, tomates), Cucurbitaceae sp. (por exemplo, pepinos, meles, cucrbitas, abboras), plantas de cultivos importantes como, por exemplo, Gramineae sp. (por exemplo, milho, mas, turfa, cereais como, por exemplo, trigo, centeio, arroz, cevada, aveia, sorgo, paino e triticale), Brassicaceae sp. (por exemplo, repolho como, por exemplo, repolho branco e repolho vermelho, brcolis, couve-flor, couve-de-bruxelas, repolho branco chins, couve-rbano, rabanetes, e tambm colza, mostarda, raiz-forte e agrio), Papilionaceae sp. (por exemplo, sojas), Solanaceae sp. (por exemplo, batatas); e, em cada caso, tipos modificados geneticamente dessas plantas.</span>[090] Preferably, the combinations of the present invention are used for the treatment of plants selected from the group consisting of: vegetables and fruits (for example, kiwi, melon, pineapple), for example, Rosaceae sp. (for example, pomoids such as apples and pears, but also stone fruits such as apricots, cherries, almonds and peaches, and soft fruits such as strawberries), or pomegranate of the Punica genus, Musaceae sp. (for example, banana plants and banana plantations, in addition to plantains), Rutaceae sp. (for example, citrus, lemons, oranges and grapefruit); vegetables such as Solanaceae sp. (for example, tomatoes), Cucurbitaceae sp. (for example, cucumbers, melons, cucurbits, pumpkins), plants from important crops such as, for example, Gramineae sp. (for example, maize, maize, peat, cereals such as wheat, rye, rice, barley, oats, sorghum, millet and triticale), Brassicaceae sp. (for example, cabbage such as white cabbage and red cabbage, broccoli, cauliflower, Brussels sprouts, Chinese white cabbage, kohlrabi, radishes, and also rapeseed, mustard, horseradish and watercress) , Papilionaceae sp. (for example, soybeans), Solanaceae sp. (for example, potatoes); and, in each case, genetically modified types of these plants.</span>
  </p>
  <p id="p0091" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[091] Ainda mais preferido  o tratamento de plantas selecionadas do grupo que consiste em: frutas, vegetais, batatas, cereais, milho, arroz e sojas.</span>[091] Even more preferred is the treatment of plants selected from the group consisting of: fruits, vegetables, potatoes, cereals, corn, rice and soybeans.</span>
  </p>
  <p id="p0092" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[092] A partir disso, uma seleo preferida adicional est relacionada ao grupo que consiste em: kiwi, melo, abacaxi, pomideas como, por exemplo, mas, pras e rom, frutas de caroo como, por exemplo, pssegos, frutas macias como, por exemplo, morangos, plantas de banana e plantaes de bananas, alm de pltanos, citros, limes, laranjas e toronja; tomates, pepinos, meles, cucrbitas, milho, cereais como, por exemplo, trigo, arroz, repolho, couve-flor, sojas, batatas; e, em cada caso, tipos modificados geneticamente dessas plantas.</span>[092] From this, an additional preferred selection is related to the group consisting of: kiwi, melon, pineapple, pome such as apples, pears and pomegranates, stone fruits such as peaches, soft fruits such as , for example, strawberries, banana plants and banana plantations, in addition to plantains, citrus, lemons, oranges and grapefruit; tomatoes, cucumbers, melons, cucurbits, corn, cereals such as wheat, rice, cabbage, cauliflower, soybeans, potatoes; and, in each case, genetically modified types of these plants.</span>
  </p>
  <p id="p0093" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[093] A seleo mais preferida de plantas teis a serem tratadas de acordo com a presente inveno est relacionada a: mas, bananas, citros, kiwi, meles, pssegos, pras, abacaxi, pomidea, rom, repolho, couve-flor, pepinos, cucrbitas, tomates, batatas, trigo, arroz e sojas.</span>[093] The most preferred selection of useful plants to be treated according to the present invention is related to: apples, bananas, citrus, kiwi, melons, peaches, pears, pineapple, pome, pomegranate, cabbage, cauliflower, cucumbers , cucurbits, tomatoes, potatoes, wheat, rice and soybeans.</span>
  </p>
  <p id="p0094" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[094] E ainda a: citros, kiwi, pssegos, pepinos, tomates, batatas, trigo, arroz e sojas.</span>[094] And also: citrus, kiwi, peaches, cucumbers, tomatoes, potatoes, wheat, rice and soybeans.</span>
  </p>
  <p id="p0095" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[095] Um aspecto adicional preferido da presente inveno est relacionado ao uso das combinaes que compreendem pelo menos um indutor da defesa do hospedeiro e pelo menos um agente de controle biolgico para o controle de pelo menos um de: Acidovorax avenae, Burkholderia glumae e/ou Xanthomonas campestris pv. oryzae em arroz; Candidatus liberibacter spec., e/ou Xanthomonas axonopodis pv. citri em ctricos; Corynebacterium no milho; Pseudomonas syringae pv. actinidae em kiwi; Xanthomonas campestris em pssegos, bananas e/ou pltanos; Xanthomonas axonopodis em rom;Pseudomonas syringae pv. glycinea e/ou Xanthomonas axonopodis em sojas; Burkholderia spec., e/ou Xanthomonas transluscens em cereais (preferivelmente em trigo); Pseudomonas syringae, Pseudomonas syringae pv. tomato e/ou Xanthomonas campestris em tomates; Pseudomonas syringae e/ou Pseudomonas syringae pv. lachrymans em pepinos; Erwinia carotovora, Erwinia carotovora subsp. atroseptica e/ou Streptomyces scabies em batatas; Erwinia carotovora em bananas e/ou pltanos; e Xylella fastidiosa em ctricos.</span>[095] A further preferred aspect of the present invention relates to the use of combinations comprising at least one host defense inducer and at least one biological control agent for the control of at least one of: Acidovorax avenae, Burkholderia glumae and / or Xanthomonas campestris pv. oryzae in rice; Candidatus liberibacter spec., And / or Xanthomonas axonopodis pv. citri in citrus; Corynebacterium in corn; Pseudomonas syringae pv. actinidae in kiwi; Xanthomonas campestris on peaches, bananas and / or plane trees; Xanthomonas axonopodis on pomegranate; Pseudomonas syringae pv. glycinea and / or Xanthomonas axonopodis in soybeans; Burkholderia spec., And / or Xanthomonas transluscens in cereals (preferably in wheat); Pseudomonas syringae, Pseudomonas syringae pv. tomato and / or Xanthomonas campestris in tomatoes; Pseudomonas syringae and / or Pseudomonas syringae pv. lachrymans on cucumbers; Erwinia carotovora, Erwinia carotovora subsp. atroseptica and / or Streptomyces scabies in potatoes; Erwinia carotovora in bananas and / or plane trees; and Xylella fastidiosa in citrus.</span>
  </p>
  <p id="p0096" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[096]  mais prefervel utilizar as combinaes que compreendem pelo menos um indutor da defesa do hospedeiro e pelo menos um agente de controle biolgico para o controle de pelo menos um de: Acidovorax avenae, Burkholderia spec. (preferivelmente Burkholderia glumae) e/ou Xanthomonas campestris pv. oryzae em arroz; Candidatus liberibacter spec., e/ou Xanthomonas axonopodis (preferivelmente Xanthomonas axonopodis pv. citri) e/ou Xylella fastidiosa em ctricos; Pseudomonas syringae (preferivelmente Pseudomonas syringae pv. actinidae) em Kiwi; Xanthomonas campestris e/ou Xanthomonas campestris pv. pruni em pssegos; Pseudomonas syringae (preferivelmente Pseudomonas syringae pv. glycinea) e/ou Xanthomonas axonopodis (preferivelmente Xanthomonas axonopodis pv. glycines (= Xanthomonas campestris pv. glycines) em sojas; Burkholderia spec., e/ou Xanthomonas transluscens em cereais; Pseudomonas syringae (preferivelmente Pseudomonas syringae pv. tomato) e/ou Xanthomonas campestris em tomates; Pseudomonas syringae e/ou Pseudomonas syringae pv. lachrymans em pepinos; alm de Erwinia atroseptica, Erwinia carotovora e/ou Streptomyces scabies em batatas.</span>[096] It is more preferable to use combinations that comprise at least one host defense inducer and at least one biological control agent for the control of at least one of: Acidovorax avenae, Burkholderia spec. (preferably Burkholderia glumae) and / or Xanthomonas campestris pv. oryzae in rice; Candidatus liberibacter spec., And / or Xanthomonas axonopodis (preferably Xanthomonas axonopodis pv. Citri) and / or Xylella fastidiosa in citrus; Pseudomonas syringae (preferably Pseudomonas syringae pv. Actinidae) in Kiwi; Xanthomonas campestris and / or Xanthomonas campestris pv. pruni on peaches; Pseudomonas syringae (preferably Pseudomonas syringae pv. Glycinea) and / or Xanthomonas axonopodis (preferably Xanthomonas axonopodis pv. Glycines (= Xanthomonas campestris pv. Glycines) in soybeans; Burkholderia spec., And / or Xanthomonas; syringae pv. tomato) and / or Xanthomonas campestris in tomatoes; Pseudomonas syringae and / or Pseudomonas syringae pach. lachrymans in cucumbers; in addition to Erwinia atroseptica, Erwinia carotovora and / or Streptomyces scabies in potatoes.</span>
  </p>
  <p id="p0097" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[097] Principalmente, prefere-se utilizar as combinaes que compreendem pelo menos um indutor da defesa do hospedeiro e pelo menos um agente de controle biolgico para o controle de Burkholderia glumae e/ou Xanthomonas campestris pv. oryzae em arroz, Liberibacter spec., e/ou Xanthomonas axonopodis pv. citri e/ou Xylella fastidiosa em ctricos, Pseudomonas syringae pv. actinidiae (Psa) em kiwi, Pseudomonas syringae pv. glycinea e/ou Xanthomonas axonopodis pv. glycines em sojas, Pseudomonas syringae e/ou Pseudomonas syringae pv. tomato em tomate e Xanthomonas campestris e/ou Xanthomonas campestris pv. pruni em pssegos, Pseudomonas syringae Pseudomonas syringae pv. lachrymans em pepinos e/ou Streptomyces scabies em batatas. Combinaes/Formulaes</span>[097] Mainly, it is preferred to use combinations that comprise at least one host defense inducer and at least one biological control agent for the control of Burkholderia glumae and / or Xanthomonas campestris pv. oryzae in rice, Liberibacter spec., and / or Xanthomonas axonopodis pv. citri and / or Xylella fastidiosa in citrus, Pseudomonas syringae pv. actinidiae (Psa) in kiwi, Pseudomonas syringae pv. glycinea and / or Xanthomonas axonopodis pv. glycines in soybeans, Pseudomonas syringae and / or Pseudomonas syringae pv. tomato in tomato and Xanthomonas campestris and / or Xanthomonas campestris pv. pruni in peaches, Pseudomonas syringae Pseudomonas syringae pv. lachrymans in cucumbers and / or Streptomyces scabies in potatoes. Combinations / Formulations</span>
  </p>
  <p id="p0098" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[098] As combinaes da presente inveno, que compreendem pelo menos um indutor da defesa do hospedeiro (A) e pelo menos um agente de controle biolgico (B), podem ainda compreender pelo menos um composto (C) selecionado do grupo que consiste em agentes antimicrobianos como, por exemplo, bactericidas, antibiticos (convencionais) adicionais, fungicidas, acaricidas, nematicidas, inseticidas, herbicidas, micronutrientes e compostos que contm micronutrientes, protetores, compostos de lipoquito- oligossacardeo (LCO) e produtos para aprimoramento do solo ou produtos para reduo de estresse de plantas, a fim de ampliar o espectro de ao ou evitar o desenvolvimento de resistncia, por exemplo. Dentro do significado da presente inveno, o grupo de compostos adicionais (C) compreende compostos, que no pertencem ao grupo de agentes de controle biolgico (B) como aqui definidos, e tambm no pertencem ao grupo de indutor da defesa do hospedeiro (A) como aqui definido.</span>[098] The combinations of the present invention, which comprise at least one host defense inducer (A) and at least one biological control agent (B), may further comprise at least one compound (C) selected from the group consisting of antimicrobial agents such as, for example, bactericides, additional (conventional) antibiotics, fungicides, acaricides, nematicides, insecticides, herbicides, micronutrients and compounds containing micronutrients, protectors, lipoquito-oligosaccharide (LCO) compounds and soil improvement products or products to reduce plant stress, in order to broaden the spectrum of action or prevent the development of resistance, for example. Within the meaning of the present invention, the group of additional compounds (C) comprises compounds, which do not belong to the group of biological control agents (B) as defined herein, and also do not belong to the host defense inducer group (A) as defined herein.</span>
  </p>
  <p id="p0099" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[099] Consequentemente, dentro do significado da presente inveno, compostos (C), que so selecionados do grupo de antibiticos conhecidos ou convencionais, compreendem C1.1 casugamicina, C1.2 estreptomicina, C1.3 oxitetraciclina, validamicina, gentamicina, aureofungina, blasticidina-S, cicloheximida, griseofulvina, moroxidina, natamicina, polioxinas, polioxorim e combinaes destes. Antibiticos convencionais preferidos so C1.1 casugamicina, C1.2 estreptomicina, e C1.3 oxitetraciclina ou combinaes destes.</span>[099] Consequently, within the meaning of the present invention, compounds (C), which are selected from the group of known or conventional antibiotics, comprise C1.1 casugamycin, C1.2 streptomycin, C1.3 oxytetracycline, validamycin, gentamycin, aureofungin, blasticidin-S, cycloheximide, griseofulvin, moroxidine, natamycin, polyoxins, polyoxorin and combinations thereof. Preferred conventional antibiotics are C1.1 casugamycin, C1.2 streptomycin, and C1.3 oxytetracycline or combinations thereof.</span>
  </p>
  <p id="p0100" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[100] Dentro do significado da presente inveno compostos (C), que so selecionados do grupo de fungicidas conhecidos ou convencionais, compreendem: (a) Inibidores da biossntese de ergosterol, por exemplo, aldimorfe, azaconazol, bitertanol, bromuconazol, ciproconazol, diclobutrazol, difenoconazol, diniconazol, diniconazol-M, dodemorfe, acetato de dodemorfe, epoxiconazol, etaconazol, fenarimol, fenbuconazol, fenhexamid, fenpropidina, fenpropimorfe, fluquinconazol, flurprimidol, flusilazol, flutriafol, furconazol, furconazol-cis, hexaconazol, imazalil, sulfato de imazalil, imibenconazol, ipconazol, metconazol, miclobutanil, naftifina, nuarimol, oxpoconazol, paclobutrazol, pefurazoato, penconazol, piperalina, procloraz, propiconazol, protioconazol, piributicarbe, pirifenox, quinconazol, simeconazol, espiroxamina, tebuconazol, terbinafina, tetraconazol, triadimefon, triadimenol, tridemorfe, triflumizol, triforine, triticonazol,uniconazol, uniconazol-p, viniconazol, voriconazol, 1-(4- clorofenil)-2-(1H-1,2,4-triazol-1-il)cicloheptanol, metil 1-(2,2-dimetil-2,3-dihidro-1H-inden-1-il)-1H-imidazol-5- carboxilato, N-{5-(difluormetil)-2-metil-4- [3- (trimetilsilil)propxi]fenil}-N-etil-N-metilimidoformamida, N-etil-N-metil-N-{2-metil-5-(trifluormetil)-4- [3- (trimetilsilil)propxi]fenil}imidoformamida e O- [1-(4- metoxifenoxi)-3,3-dimetilbutan-2-il]1H-imidazol-1- carbotioato. (b) Inibidores da cadeia respiratria no complexo I ou II, por exemplo, bixafen, boscalid, carboxina, diflumetorim, fenfuram, fluopiram, flutolanil, fluxapiroxad, furametpir, furmeciclox, isopirazam (mistura de racemato syn-epimrico 1RS,4SR,9RS e racemato anti- epimrico 1RS,4SR,9SR), isopirazam (racemato anti-epimrico 1RS,4SR,9SR), isopirazam (enantimero anti-epimrico 1R,4S,9S), isopirazam (enantimero anti-epimrico 1S,4R,9R), isopirazam (racemato syn-epimrico 1RS,4SR,9RS), isopirazam (enantimero syn-epimrico 1R,4S,9R), isopirazam (enantimero syn-epimrico 1S,4R,9S), mepronil, oxicarboxina, C.2.2 penflufen, pentiopirad, sedaxane, tifluzamida, 1-metil-N- [2-(1,1,2,2-tetrafluoretoxi)fenil]- 3-(trifluormetil)-1H-pirazol-4-carboxamida, 3- (difluormetil)-1-metil-N- [2-(1,1,2,2- tetrafluoretoxi)fenil]-1H-pirazol-4-carboxamida, 3- (difluormetil)-N- [4-flor-2-(1,1,2,3,3,3- hexafluorpropoxi)fenil]-1-metil-1H-pirazol-4-carboxamida, N- [1-(2,4-diclorofenil)-1-metoxipropan-2-il]-3- (difluormetil)-1-metil-1H-pirazol-4-carboxamida, 5,8- diflor-N- [2-(2-flor-4-{ [4-(trifluormetil)piridin-2-il]xi}fenil)etil]quinazolin-4-amina, N- [9- (diclorometileno)-1,2,3,4-tetrahidro-1,4-metanonaftalen-5- il]-3-(difluormetil)-1-metil-1H-pirazol-4-carboxamida, N- [(1S,4R)-9-(diclorometileno)-1,2,3,4-tetrahidro-1,4- metanonaftalen-5-il]-3-(difluormetil)-1-metil-1H-pirazol-4- carboxamida e N- [(1R,4S)-9-(diclorometileno)-1,2,3,4- tetrahidro-1,4-metanonaftalen-5-il]-3-(difluormetil)-1- metil-1H-pirazol-4-carboxamida. (c) Inibidores da cadeia respiratria no complexo III, por exemplo, ametoctradina, amisulbrom, C.2.4 azoxistrobina, ciazofamida, cumetoxistrobina, cumoxistrobina, dimoxistrobina, enestroburina, famoxadona, fenamidona, fenoxistrobina, fluoxastrobina, cresoxim-metil, metominostrobina, orisastrobina, picoxistrobina, piraclostrobina, pirametostrobina, piraoxistrobina, piribencarbe, triclopiricarbe, C.2.3 trifloxistrobina, (2E)-2-(2-{ [6-(3-cloro-2-metilfenoxi)-5-fluorpirimidin-4- il]xi}fenil)-2-(metoxiimino)-N-metiletanamida, (2E)-2- (metoxiimino)-N-metil-2-(2-{ [({(1E)-1- [3- (trifluormetil)fenil]etilideno}amino)xi]metil}fenil) etanamida, (2E)-2-(metoxiimino)-N-metil-2-{2- [(E)-({1- [3- (trifluormetil)fenil]etxi}imino)metil]fenil}etanamida, (2E)-2-{2- [({ [(1E)-1-(3-{ [(E)-1-flor-2- feniletenil]xi}fenil)etilideno]amino}xi)metil]fenil}-2- (metoxiimino)-N-metiletanamida, (2E)-2-{2- [({ [(2E,3E)-4- (2,6-diclorofenil)but-3-en-2- ilideno]amino}xi)metil]fenil}-2-(metoxiimino)-N- metiletanamida, 2-cloro-N-(1,1,3-trimetil-2,3-dihidro-1H- inden-4-il)piridina-3-carboxamida, 5-metxi-2-metil-4-(2- { [({(IE)-1- [3-(trifluormetil)fenil]etilideno}amino)xi]metil}fenil)-2,4-dihidro-3H-1,2,4- triazol-3-ona, metil (2E)-2-{2- [({ciclopropil [(4- metoxifenil)imino]metil}sulfanil)metil]fenil}-3-metoxiprop- 2-enoato, N-(3-etil-3,5,5-trimetilciclohexil)-3- (formilamino)-2-hidroxibenzamida, 2-{2- [(2,5-dimetilfenoxi) metil]fenil}-2-metxi-N-metilacetamida e (2R)-2-{2- [(2,5- dimetilfenoxi)metil]fenil}-2-metxi-N-metilacetamida. (d) Inibidores da mitose e diviso celular, por exemplo, benomil, carbendazima, clorfenazol, dietofencarbe, etaboxam, fluopicolida, fuberidazol, pencicuron, tiabendazol, tiofanato-metil, tiofanato, zoxamida, 5-cloro- 7-(4-metilpiperidin-1-il)-6-(2,4,6- trifluorfenil) [1,2,4]triazol [1,5-a]pirimidina e 3-cloro-5- (6-cloropiridin-3-il)-6-metil-4-(2,4,6-trifluorfenil) piridazina. (e) Compostos capazes de ter uma ao multilocais, por exemplo, mistura de Bordeaux, captafol, captan, clorotalonil, hidrxido de cobre, naftenato de cobre, xido de cobre, oxicloreto de cobre, sulfato de cobre (2+), diclofluanida, ditianon, dodina, base livre de dodina, ferbam, fluorfolpet, folpet, guazatina, acetato de guazatina, iminoctadina, albesilato de iminoctadina, triacetato de iminoctadina, mancobre, mancozebe, maneb, metiram, metiram zinco, oxina-cobre, propamidina, propinebe, enxofre e preparaes de enxofre, incluindo polissulfeto de clcio, tiram, tolilfluanida, zineb e ziram. (f) Compostos capazes de induzir a defesa do hospedeiro, por exemplo, acibenzolar-S-metil, isotianil, probenazol e tiadinil.(g) Inibidores da biossntese de aminocido e/ou protena, por exemplo, andoprim, blasticidina-S, ciprodinil, casugamicina, hidrato de cloridrato de casugamicina, mepanipirim, pirimetanil e 3-(5-flor- 3,3,4,4-tetrametil-3,4-dihidroisoquinolin-1-il)quinolina. (h) Inibidores da produo de ATP, por exemplo, acetato de fentina, cloreto de fentina, hidrxido de fentina e siltiofam. (i) Inibidores da sntese da parede celular, por exemplo, bentiavalicarbe, dimetomorfe, flumorfe, iprovalicarbe, mandipropamid, polioxinas, polioxorim, validamicina A e valifenalato. (j) Inibidores da sntese de lipdeo e membrana, por exemplo, bifenil, cloroneb, dicloran, edifenfos, etridiazol, iodocarbe, iprobenfos, isoprotiolano, propamocarbe, cloridrato de propamocarbe, protiocarbe, pirazofos, quintozeno, tecnazeno e tolclofos-metil. (k) Inibidores da biossntese de melanina, por exemplo, carpropamid, diclocimet, fenoxanil, ftalida, piroquilon, triciclazol e 2,2,2-trifluoretil{3-metil-1- [(4- metilbenzoil)amino]butan-2-il}carbamato. (l) Inibidores da sntese de cido nuclico, por exemplo, benalaxil, benalaxil-M (quiralaxil), bupirimato, clozilacon, dimetirimol, etirimol, furalaxil, himexazol, metalaxil, metalaxil-M (mefenoxam), ofurace, oxadixil e cido oxolnico. (m) Inibidores da transduo de sinal, por exemplo, clozolinato, fenpiclonil, fludioxonil, iprodiona, procimidona, quinoxifeno e vinclozolina. (n) Compostos capazes de atuar como um desacoplador, por exemplo, binapacril, dinocap, ferinzona, fluazinam e meptildinocape. (o) Compostos adicionais, por exemplo, bentiazol, betoxazina, capsimicina, carvona, quinometionato, piriofenona (clazafenona), cufraneb, ciflufenamida, cimoxanil, ciprossulfamida, dazomet, debacarbe, diclorofeno, diclomezina, difenzoquat, metilsulfato de difenzoquat, difenilamina, ecomato, fenpirazamina, flumetover, fluorimida, flusulfamida, flutianil, C.2.1 fosetil-alumnio (fosetil-Al), fosetil-clcio, fosetil- sdio, hexaclorobenzeno, irumamicina, metasulfocarbe, isotiocianato de metila, metrafenona, mildiomicina, natamicina, dimetilditiocarbamato de nquel, nitrotal- isopropil, octilinona, oxamocarbe, oxifentiina, pentaclorofenol e sais, fenotrina, cido fosforoso e seus sais, propamocarbe-fosetilato, propanosina-sdio, proquinazid, pirimorfe, (2E)-3-(4-terc-butilfenil)-3-(2- cloropiridin-4-il)-1-(morfolin-4-il)prop-2-en-1-ona, (2Z)- 3-(4-terc-butilfenil)-3-(2-cloropiridin-4-il)-1-(morfolin- 4-il)prop-2-en-1-ona, pirrolnitrina, tebufloquin, tecloftalam, tolnifanida, triazxido, triclamida, zarilamida, (3S,6S,7R,8R)-8-benzil-3- [({3- [(isobutiriloxi)metxi]-4-metoxipiridin-2-il}carbonil) amino]-6-metil-4,9-dioxo-1,5-dioxonan-7-il 2- metilpropanoato, 1-(4-{4- [(5R)-5-(2,6-difluorfenil)-4,5- dihidro-1,2-oxazol-3-il]-1,3-tiazol-2-il}piperidin-1-il)-2- [5-metil-3-(trifluormetil)-1H-pirazol-1-il]etanona, 1-(4- {4- [(5S)-5-(2,6-difluorfenil)-4,5-dihidro-1,2-oxazol-3-il]- 1,3-tiazol-2-il}piperidin-1-il)-2- [5-metil-3- (trifluormetil)-1H-pirazol-1-il]etanona, 1-(4-{4- [5-(2,6-difluorfenil)-4,5-dihidro-1,2-oxazol-3-il]-1,3-tiazol-2- il}piperidin-1-il)-2- [5-metil-3-(trifluormetil)-1H-pirazol- 1-il]etanona, 1-(4-metoxifenoxi)-3,3-dimetilbutan-2-il 1H- imidazol-1-carboxilato, 2,3,5,6-tetracloro-4- (metilsulfonil)piridina, 2,3-dibutil-6-clorotieno [2,3- d]pirimidin-4(3H)-ona, 2- [5-metil-3-(trifluormetil)-1H- pirazol-1-il]-1-(4-{4- [(5R)-5-fenil-4,5-dihidro-1,2-oxazol- 3-il]-1,3-tiazol-2-il}piperidin-1-il)etanona, 2- [5-metil-3- (trifluormetil)-1H-pirazol-1-il]-1-(4-{4- [(5S)-5-fenil-4,5- dihidro-1,2-oxazol-3-il]-1,3-tiazol-2-il]piperidin-1- il)etanona, 2- [5-metil-3-(trifluormetil)-1H-pirazol-1-il]- 1-{4- [4-(5-fenil-4,5-dihidro-1,2-oxazol-3-il)-1,3-tiazol-2- il]piperidin-1-il}etanona, 2-butxi-6-iodo-3-propil-4H- cromen-4-ona, 2-cloro-5- [2-cloro-1-(2,6-diflor-4- metoxifenil)-4-metil-1H-imidazol-5-il]piridina, 2- fenilfenol e sais, 3-(4,4,5-triflor-3,3-dimetil-3,4- dihidroisoquinolin-1-il)quinolina, 3,4,5-tricloropiridina- 2,6-dicarbonitrila, 3- [5-(4-clorofenil)-2,3-dimetil-1,2- oxazolidin-3-il]piridina, 3-cloro-5-(4-clorofenil)-4-(2,6- difluorfenil)-6-metilpiridazina, 4-(4-clorofenil)-5-(2,6- difluorfenil)-3,6-dimetilpiridazina, 5-amino-1,3,4- tiadiazol-2-tiol, 5-cloro-N-fenil-N-(prop-2-in-1- il)tiofeno-2-sulfonohidrazida, 5-flor-2- [(4- fluorbenzil)xi]pirimidin-4-amina, 5-flor-2- [(4- metilbenzil)xi]pirimidin-4-amina, 5-metil-6- octil [1,2,4]triazol [1,5-a]pirimidin-7-amina, etil (2Z)-3- amino-2-ciano-3-fenilprop-2-enoato, N-(4-{ [3-(4- clorobenzil)-1,2,4-tiadiazol-5-il]xi}-2,5-dimet-N-(4- clorobenzil)-3- [3-metxi-4-(prop-2-in-1- ilxi)fenil]propanamida, N- [(4-clorofenil)(ciano)metil]-3- [3-metxi-4-(prop-2-in-1-ilxi)fenil]propanamida, N- [(5- bromo-3-cloropiridin-2-il)metil]-2,4-dicloropiridina-3- carboxamida, N- [1-(5-bromo-3-cloropiridin-2-il)etil]-2,4- dicloropiridina-3-carboxamida, N- [1-(5-bromo-3- cloropiridin-2-il)etil]-2-flor-4-iodopiridina-3- carboxamida, N-{(E)- [(ciclopropilmetoxi)imino] [6- (difluormetoxi)-2,3-difluorfenil]metil}-2-fenilacetamida, N-{(Z)- [(ciclopropilmetoxi)imino] [6-(difluormetoxi)-2,3- difluorfenil]metil}-2-fenilacetamida, N-{4- [(3-terc-butil- 4-ciano-1,2-tiazol-5-il)xi]-2-cloro-5-metilfenil}-N-etil- N-metilimidoformamida, N-metil-2-(1-{ [5-metil-3- (trifluormetil)-1H-pirazol-1-il]acetil}piperidin-4-il)-N- (1,2,3,4-tetrahidronaftalen-1-il)-1,3-tiazol-4-carboxamida, N-metil-2-(1-{ [5-metil-3-(trifluormetil)-1H-pirazol-1- il]acetil}piperidin-4-il)-N- [(1R)-1,2,3,4- tetrahidronaftalen-1-il]-1,3-tiazol-4-carboxamida, N-metil- 2-(1-{ [5-metil-3-(trifluormetil)-1H-pirazol-1- il]acetil}piperidin-4-il)-N- [(1S)-1,2,3,4- tetrahidronaftalen-1-il]-1,3-tiazol-4-carboxamida, pentil {6- [({ [(1-metil-1H-tetrazol-5- il)(fenil)metilideno]amino}xi)metil]piridin-2- il}carbamato, cido fenazina-1-carboxlico, quinolin-8-ol, quinolin-8-ol sulfato (2:1) e terc-butil {6- [({ [(1-metil- 1H-tetrazol-5-il)(fenil)metileno]amino}xi)metil]piridin-2- il}carbamato. (p) Compostos adicionais, por exemplo, 1-metil-3- (trifluormetil)-N- [2-(trifluormetil)bifenil-2-il]-1H- pirazol-4-carboxamida, N-(4-clorobifenil-2-il)-3- (difluormetil)-1-metil-1H-pirazol-4-carboxamida, N-(2,4- diclorobifenil-2-il)-3-(difluormetil)-1-metil-1H-pirazol-4-carboxamida, 3-(difluormetil)-1-metil-N- [4- (trifluormetil)bifenil-2-il]-1H-pirazol-4-carboxamida, N- (2,5-difluorbifenil-2-il)-1-metil-3-(trifluormetil)-1H- pirazol-4-carboxamida, 3-(difluormetil)-1-metil-N- [4- (prop-1-in-1-il)bifenil-2-il]-1H-pirazol-4-carboxamida, 5- flor-1,3-dimetil-N- [4-(prop-1-in-1-il)bifenil-2-il]-1H- pirazol-4-carboxamida, 2-cloro-N- [4-(prop-1-in-1- il)bifenil-2-il]piridina-3-carboxamida, 3-(difluormetil)-N- [4-(3,3-dimetilbut-1-in-1-il)bifenil-2-il]-1-metil-1H- pirazol-4-carboxamida, N- [4-(3,3-dimetilbut-1-in-1- il)bifenil-2-il]-5-flor-1,3-dimetil-1H-pirazol-4- carboxamida, 3-(difluormetil)-N-(4-etinilbifenil-2-il)-1- metil-1H-pirazol-4-carboxamida, N-(4-etinilbifenil-2-il)- 5-flor-1,3-dimetil-1H-pirazol-4-carboxamida, 2-cloro-N- (4-etinilbifenil-2-il)piridina-3-carboxamida, 2-cloro-N- [4-(3,3-dimetilbut-1-in-1-il)bifenil-2-il]piridina-3- carboxamida, 4-(difluormetil)-2-metil-N- [4- (trifluormetil)bifenil-2-il]-1,3-tiazol-5-carboxamida, 5- flor-N- [4-(3-hidrxi-3-metilbut-1-in-1-il)bifenil-2-il]- 1,3-dimetil-1H-pirazol-4-carboxamida, 2-cloro-N- [4-(3- hidrxi-3-metilbut-1-in-1-il)bifenil-2-il]piridina-3- carboxamida, 3-(difluormetil)-N- [4-(3-metxi-3-metilbut-1- in-1-il)bifenil-2-il]-1-metil-1H-pirazol-4-carboxamida, 5- flor-N- [4-(3-metxi-3-metilbut-1-in-1-il)bifenil-2-il]- 1,3-dimetil-1H-pirazol-4-carboxamida, 2-cloro-N- [4-(3- metxi-3-metilbut-1-in-1-il)bifenil-2-il]piridina-3- carboxamida, (5-bromo-2-metxi-4-metilpiridin-3-il)(2,3,4- trimetoxi-6-metilfenil)metanona, N- [2-(4-{ [3-(4- clorofenil)prop-2-in-1-il]xi}-3-metoxifenil)etil]-N2- (metilsulfonil)valinamida, cido 4-oxo-4- [(2- feniletil)amino]butanico e but-3-in-1-il {6- [({ [(Z)-(1- metil-1H-tetrazol-5-il)(fenil)metileno]amino}xi)metil] piridin-2-il}carbamato, e combinaes destes.</span>[100] Within the meaning of the present invention compounds (C), which are selected from the group of known or conventional fungicides, comprise: (a) Ergosterol biosynthesis inhibitors, for example, aldimorph, azaconazole, bitertanol, bromuconazole, cyproconazole, diclobutrazol , diphenoconazole, diniconazole, diniconazole-M, dodemorph, dodemorph acetate, epoxiconazole, etaconazole, fenarimol, fenbuconazole, fenhexamid, fenpropidine, fenpropimorph, fluquinconazole, flurprimidol, flusilazolazole, furazolazole, flacilol, fluoralazole, flacilol, fluoroalazole , imibenconazole, ipconazole, metconazole, miclobutanil, naphthifine, nuarimol, oxpoconazole, paclobutrazol, pefurazoate, penconazole, piperalin, prochloraz, propiconazole, protioconazole, pyributicarb, pyrifoxin, quinconazole, tyrolazole, tyrolazole, tyrolazole, tyrone , triflumizole, triforine, triticonazole, uniconazole, uniconazole-p, viniconazole, voriconazole, 1- (4- cl orophenyl) -2- (1H-1,2,4-triazol-1-yl) cycloheptanol, methyl 1- (2,2-dimethyl-2,3-dihydro-1H-inden-1-yl) -1H-imidazole -5- carboxylate, N '- {5- (difluormethyl) -2-methyl-4- [3- (trimethylsilyl) propoxy] phenyl} -N-ethyl-N-methylimidoformamide, N-ethyl-N-methyl-N' - {2-methyl-5- (trifluoromethyl) -4- [3- (trimethylsilyl) propoxy] phenyl} imidoformamide and O- [1- (4-methoxyphenoxy) -3,3-dimethylbutan-2-yl] 1H-imidazole -1- carbothioate. (b) Respiratory chain inhibitors in complex I or II, for example, bixafen, boscalid, carboxine, diflumetorim, fenfuram, fluopyram, flutolanil, fluxpyroxad, furametpir, furmeciclox, isopyrazam (mixture of syn-epimeric racemate 1RS, 4SR, 9RS and anti-epimeric racemate 1RS, 4SR, 9SR), isopirazam (anti-epimeric racemate 1RS, 4SR, 9SR), isopirazam (anti-epimeric enantiomer 1R, 4S, 9S), isopirazam (anti-epimeric enantiomer 1S, 4R, 9R), isopyrazam (syn-epimeric racemate 1RS, 4SR, 9RS), isopirazam (syn-epimeric enantiomer 1R, 4S, 9R), isopirazam (syn-epimeric enantiomer 1S, 4R, 9S), mepronil, oxycarboxine, C.2.2 penflufen, pentio silkxane, tifluzamide, 1-methyl-N- [2- (1,1,2,2-tetrafluorethoxy) phenyl] - 3- (trifluormethyl) -1H-pyrazol-4-carboxamide, 3- (difluormethyl) -1-methyl -N- [2- (1,1,2,2-tetrafluoroethoxy) phenyl] -1H-pyrazol-4-carboxamide, 3- (difluoromethyl) -N- [4-fluoro-2- (1,1,2, 3,3,3-hexafluorpropoxy) phenyl] -1-methyl-1H-pyrazol-4-carboxamide, N- [1- (2,4-dichlorophenyl) -1-methoxypropan-2-yl] -3- (dif luormethyl) -1-methyl-1H-pyrazol-4-carboxamide, 5,8-difluoro-N- [2- (2-fluoro-4- {[4- (trifluoromethyl) pyridin-2-yl] oxy} phenyl) ethyl] quinazolin-4-amine, N- [9- (dichloromethylene) -1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl] -3- (difluormethyl) -1-methyl-1H- pyrazol-4-carboxamide, N- [(1S, 4R) -9- (dichloromethylene) -1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl] -3- (difluormethyl) -1- methyl-1H-pyrazol-4-carboxamide and N- [(1R, 4S) -9- (dichloromethylene) -1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl] -3- (difluoromethyl ) -1- methyl-1H-pyrazol-4-carboxamide. (c) Respiratory chain inhibitors in complex III, for example, ametoctradine, amisulbrom, C.2.4 azoxystrobin, cyazofamide, cumetoxistrobin, cumoxystrobin, dimoxystrobin, enestroburin, famoxadone, phenamidone, phenoxystrobin, fluoxastrobin, methoxystrobin, methoxytrostrin, methoxystrostrin, methoxystrobin, methoxystrobin, methoxystrobin, methoxystrobin, methoxystrobin, methoxystrobin, methoxystrostrin , pyraclostrobin, pyramethostrobin, piraoxystrobin, pyribencarb, triclopyricarb, C.2.3 trifloxystrobin, (2E) -2- (2- {[6- (3-chloro-2-methylphenoxy) -5-fluorpirimidin-4-yl] oxy} phenyl ) -2- (methoxyimino) -N-methylethylamide, (2E) -2- (methoxyimino) -N-methyl-2- (2- {[({(1E) -1- [3- (trifluoromethyl) phenyl] ethylidene } amino) oxy] methyl} phenyl) ethanamide, (2E) -2- (methoxyimino) -N-methyl-2- {2- [(E) - ({1- [3- (trifluormethyl) phenyl] ethoxy} imino ) methyl] phenyl} ethanamide, (2E) -2- {2- [({[(1E) -1- (3- {[(E) -1-fluor-2-phenylethyl] oxy} phenyl) ethylidene] amino } oxy) methyl] phenyl} -2- (methoxyimino) -N-methylethylamide, (2E) -2- {2- [({[(2E, 3E) -4- (2,6-dichlorophenyl) but-3- en-2-ylidene] amino} oxy) methyl] phenyl} -2- (methoxyimino) -N- methyl namide, 2-chloro-N- (1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl) pyridine-3-carboxamide, 5-methoxy-2-methyl-4- (2- {[({(IE) -1- [3- (trifluormethyl) phenyl] ethylidene} amino) oxy] methyl} phenyl) -2,4-dihydro-3H-1,2,4-triazole-3-one, methyl (2E) -2- {2- [({cyclopropyl [(4-methoxyphenyl) imino] methyl} sulfanyl) methyl] phenyl} -3-methoxyprop-2-enoate, N- (3-ethyl-3,5,5 -trimethylcyclohexyl) -3- (formylamino) -2-hydroxybenzamide, 2- {2- [(2,5-dimethylphenoxy) methyl] phenyl} -2-methoxy-N-methylacetamide and (2R) -2- {2- [ (2,5-dimethylphenoxy) methyl] phenyl} -2-methoxy-N-methylacetamide. (d) Mitosis and cell division inhibitors, for example, benomyl, carbendazim, chlorphenazole, dietofencarb, etaboxam, fluopicolide, fuberidazole, pencicuron, thiabendazole, thiophanate-methyl, thiophanate, zoxamide, 5-chloro-7- (4-methyl-piperidine) 1-yl) -6- (2,4,6-trifluorfenyl) [1,2,4] triazole [1,5-a] pyrimidine and 3-chloro-5- (6-chloropyridin-3-yl) -6 -methyl-4- (2,4,6-trifluorfenyl) pyridazine. (e) Compounds capable of having a multi-local action, for example, Bordeaux mixture, captafol, captan, chlorothalonil, copper hydroxide, copper naphthenate, copper oxide, copper oxychloride, copper sulphate (2+), diclofluanide, dithianon, dodine, dodine free base, ferbam, fluorfolpet, folpet, guazatin, guazatin acetate, iminoctadine, iminoctadine albesylate, iminoctadine triacetate, mancobre, mancozebe, maneb, metiram, zinc, oxidine, propine, propine, propine, propine, copper sulfur and sulfur preparations, including calcium polysulfide, tir, tolylfluanide, zineb and ziram. (f) Compounds capable of inducing host defense, for example, acibenzolar-S-methyl, isothianyl, probenazole and thiadinyl. (g) Amino acid and / or protein biosynthesis inhibitors, for example, andoprim, blasticidin-S, cyprodinil, casugamycin, casugamycin hydrochloride hydrate, mepanipyrim, pyrimethanil and 3- (5-fluorine-3,3,4,4,4 -tetramethyl-3,4-dihydroisoquinolin-1-yl) quinoline. (h) ATP production inhibitors, for example, fentin acetate, fentin chloride, fentin hydroxide and siltiofam. (i) Inhibitors of cell wall synthesis, for example, bentiavalicarb, dimetomorph, flumorfe, iprovalicarb, mandipropamid, polyoxins, polyoxorim, validamycin A and valifenalate. (j) Inhibitors of lipid and membrane synthesis, for example, biphenyl, chloroneb, dichloran, edifenfos, etridiazole, iodocarb, iprobenfos, isoprothiolane, propamocarb, propamocarb hydrochloride, protiocarb, pyrazofos, quintozene, technazene and tolazofen, technazene and tolazofen. (k) Melanin biosynthesis inhibitors, for example, carpropamid, diclocimet, phenoxanil, phthalide, piroquilon, tricyclazole and 2,2,2-trifluorethyl {3-methyl-1- [(4-methylbenzoyl) amino] butan-2- il} carbamate. (l) Nucleic acid synthesis inhibitors, for example, benalaxyl, benalaxyl-M (chiralaxyl), bupirimate, clozilacon, dimethyrimol, ethirimol, furalaxil, himexazole, metalaxyl, metalaxyl-M (mefenoxam), ofurace, oxadic acid. (m) Signal transduction inhibitors, for example, clozolinate, fenpiclonil, fludioxonil, iprodione, procymidone, quinoxyphene and vinclozoline. (n) Compounds capable of acting as a decoupler, for example, binapacril, dinocap, ferinzone, fluazinam and meptildinocape. (o) Additional compounds, for example, bentiazole, betoxazina, capsimicina, carvona, quinomethionate, pyriofenone (clazafenone), cufraneb, ciflufenamide, cimoxanil, ciprosulfamida, dazomet, debacarb, dichlorofen, diclomezine, dificlatine, difenzatine, difenzoat fenpyrazamine, flumetover, fluorimide, flusulfamide, flutianyl, C.2.1 fosetil-aluminum (fosetil-Al), fosetil-calcium, fosetil-sodium, hexachlorobenzene, irumamicina, metasulfocarb, methyl isothiocyanate, metrafenone, mildiomycin, natamycin, dimethylti di, dimethylti di dimethi nitrotal- isopropyl, octylin, oxamocarb, oxyphenol, pentachlorophenol and salts, phenothrin, phosphorous acid and its salts, propamocarb-phosethylate, propanosine-sodium, proquinazid, pyrimorph, (2E) -3- (4-tert-butylphenyl) -3- (2-chloropyridin-4-yl) -1- (morpholin-4-yl) prop-2-en-1-one, (2Z) - 3- (4-tert-butylphenyl) -3- (2-chloropyridin- 4-yl) -1- (morpholin-4-yl) prop-2-en-1-one, pyrrolnitrine, tebufloquin, keyboardoftalam, tolnifanide, triazoxide, tri chlamide, zarylamide, (3S, 6S, 7R, 8R) -8-benzyl-3- [({3- [(isobutyryloxy) methoxy] -4-methoxypyridin-2-yl} carbonyl) amino] -6-methyl-4 , 9-dioxo-1,5-dioxonan-7-yl 2-methylpropanoate, 1- (4- {4- [(5R) -5- (2,6-difluorfenyl) -4,5-dihydro-1,2 -oxazol-3-yl] -1,3-thiazol-2-yl} piperidin-1-yl) -2- [5-methyl-3- (trifluormethyl) -1H-pyrazol-1-yl] ethanone, 1- (4- {4- [(5S) -5- (2,6-difluorfenyl) -4,5-dihydro-1,2-oxazol-3-yl] - 1,3-thiazol-2-yl} piperidin- 1-yl) -2- [5-methyl-3- (trifluormethyl) -1H-pyrazol-1-yl] ethanone, 1- (4- {4- [5- (2,6-difluorphenyl) -4.5 -dihydro-1,2-oxazol-3-yl] -1,3-thiazol-2-yl} piperidin-1-yl) -2- [5-methyl-3- (trifluormethyl) -1H-pyrazole- 1- yl] ethanone, 1- (4-methoxyphenoxy) -3,3-dimethylbutan-2-yl 1H-imidazol-1-carboxylate, 2,3,5,6-tetrachlor-4- (methylsulfonyl) pyridine, 2,3- dibutyl-6-chlorothieno [2,3- d] pyrimidin-4 (3H) -one, 2- [5-methyl-3- (trifluormethyl) -1H-pyrazol-1-yl] -1- (4- {4 - [(5R) -5-phenyl-4,5-dihydro-1,2-oxazol-3-yl] -1,3-thiazol-2-yl} piperidin-1-yl) ethanone, 2- [5- methyl-3- (trifluormethyl) -1H-pyrazol-1-yl] -1- (4- {4- [(5 S) -5-phenyl-4,5-dihydro-1,2-oxazol-3-yl] -1,3-thiazol-2-yl] piperidin-1-yl) ethanone, 2- [5-methyl-3 - (trifluormethyl) -1H-pyrazol-1-yl] - 1- {4- [4- (5-phenyl-4,5-dihydro-1,2-oxazol-3-yl) -1,3-thiazole- 2-yl] piperidin-1-yl} ethanone, 2-butoxy-6-iodo-3-propyl-4H-chromen-4-one, 2-chloro-5- [2-chloro-1- (2,6- diflor-4-methoxyphenyl) -4-methyl-1H-imidazol-5-yl] pyridine, 2-phenylphenol and salts, 3- (4,4,5-trifluor-3,3-dimethyl-3,4-dihydroisoquinolin- 1-yl) quinoline, 3,4,5-trichloropyridine-2,6-dicarbonitrile, 3- [5- (4-chlorophenyl) -2,3-dimethyl-1,2-oxazolidin-3-yl] pyridine, 3 -chloro-5- (4-chlorophenyl) -4- (2,6-difluorphenyl) -6-methylpyridazine, 4- (4-chlorophenyl) -5- (2,6-difluorphenyl) -3,6-dimethylpyridazine, 5 -amino-1,3,4- thiadiazole-2-thiol, 5-chloro-N'-phenyl-N '- (prop-2-in-1-yl) thiophene-2-sulfonohydrazide, 5-fluorine-2- [(4-fluorbenzyl) oxy] pyrimidin-4-amine, 5-fluoro-2- [(4-methylbenzyl) oxy] pyrimidin-4-amine, 5-methyl-6-octyl [1,2,4] triazole [ 1,5-a] pyrimidin-7-amine, ethyl (2Z) -3-amino-2-cyano-3-phenylprop-2-enoate, N '- (4- {[3- (4- clo robenzil) -1,2,4-thiadiazol-5-yl] oxy} -2,5-dimet-N- (4-chlorobenzyl) -3- [3-methoxy-4- (prop-2-in-1- yloxy) phenyl] propanamide, N- [(4-chlorophenyl) (cyano) methyl] -3- [3-methoxy-4- (prop-2-in-1-yloxy) phenyl] propanamide, N- [(5- bromo-3-chloropyridin-2-yl) methyl] -2,4-dichloropyridine-3-carboxamide, N- [1- (5-bromo-3-chloropyridin-2-yl) ethyl] -2,4-dichloropyridine- 3-carboxamide, N- [1- (5-bromo-3-chloropyridin-2-yl) ethyl] -2-fluoro-4-iodopyridine-3-carboxamide, N - {(E) - [(cyclopropylmethoxy) imino] [6- (difluormethoxy) -2,3-difluorfenyl] methyl} -2-phenylacetamide, N - {(Z) - [(cyclopropylmethoxy) imino] [6- (difluormethoxy) -2,3- difluorfenyl] methyl} -2 -phenylacetamide, N '- {4- [(3-tert-butyl- 4-cyano-1,2-thiazol-5-yl) oxide] -2-chloro-5-methylphenyl} -N-ethyl- N-methylimidoformamide , N-methyl-2- (1- {[5-methyl-3- (trifluoromethyl) -1H-pyrazol-1-yl] acetyl} piperidin-4-yl) -N- (1,2,3,4- tetrahydronaphthalen-1-yl) -1,3-thiazol-4-carboxamide, N-methyl-2- (1- {[5-methyl-3- (trifluormethyl) -1H-pyrazol-1-yl] acetyl} piperidin- 4-yl) -N- [(1R) -1,2,3,4- tetrahydronaftale n-1-yl] -1,3-thiazol-4-carboxamide, N-methyl- 2- (1- {[5-methyl-3- (trifluormethyl) -1H-pyrazol-1-yl] acetyl} piperidin- 4-yl) -N- [(1S) -1,2,3,4- tetrahydronaphthalen-1-yl] -1,3-thiazol-4-carboxamide, pentyl {6- [({[(1-methyl- 1H-tetrazol-5-yl) (phenyl) methylidene] amino} oxy) methyl] pyridin-2-yl} carbamate, phenazine-1-carboxylic acid, quinolin-8-ol, quinolin-8-ol sulfate (2: 1 ) and tert-butyl {6- [({[(1-methyl-1H-tetrazol-5-yl) (phenyl) methylene] amino} oxy) methyl] pyridin-2-yl} carbamate. (p) Additional compounds, for example, 1-methyl-3- (trifluormethyl) -N- [2 '- (trifluormethyl) biphenyl-2-yl] -1H-pyrazol-4-carboxamide, N- (4'-chlorobiphenyl -2-yl) -3- (difluormethyl) -1-methyl-1H-pyrazol-4-carboxamide, N- (2 ', 4'- dichlorobiphenyl-2-yl) -3- (difluormethyl) -1-methyl- 1H-pyrazol-4-carboxamide, 3- (difluormethyl) -1-methyl-N- [4'- (trifluormethyl) biphenyl-2-yl] -1H-pyrazol-4-carboxamide, N- (2 ', 5' -difluorbiphenyl-2-yl) -1-methyl-3- (trifluormethyl) -1H-pyrazol-4-carboxamide, 3- (difluormethyl) -1-methyl-N- [4'- (prop-1-in-1 -yl) biphenyl-2-yl] -1H-pyrazol-4-carboxamide, 5-fluor-1,3-dimethyl-N- [4 '- (prop-1-in-1-yl) biphenyl-2-yl ] -1H-pyrazol-4-carboxamide, 2-chloro-N- [4 '- (prop-1-in-1-yl) biphenyl-2-yl] pyridine-3-carboxamide, 3- (difluormethyl) -N - [4 '- (3,3-dimethylbut-1-in-1-yl) biphenyl-2-yl] -1-methyl-1H-pyrazol-4-carboxamide, N- [4' - (3,3- dimethylbut-1-in-1-yl) biphenyl-2-yl] -5-fluor-1,3-dimethyl-1H-pyrazol-4-carboxamide, 3- (difluormethyl) -N- (4'-ethynylbiphenyl-2 -yl) -1- methyl-1H-pyrazol-4-carboxamide, N- (4'-ethynylbiphenyl-2-yl ) - 5-fluor-1,3-dimethyl-1H-pyrazol-4-carboxamide, 2-chloro-N- (4'-ethynylbiphenyl-2-yl) pyridine-3-carboxamide, 2-chloro-N- [4 '- (3,3-dimethylbut-1-in-1-yl) biphenyl-2-yl] pyridine-3-carboxamide, 4- (difluormethyl) -2-methyl-N- [4'- (trifluormethyl) biphenyl- 2-yl] -1,3-thiazol-5-carboxamide, 5-fluorine-N- [4 '- (3-hydroxy-3-methylbut-1-in-1-yl) biphenyl-2-yl] - 1 , 3-dimethyl-1H-pyrazol-4-carboxamide, 2-chloro-N- [4 '- (3-hydroxy-3-methylbut-1-in-1-yl) biphenyl-2-yl] pyridine-3- carboxamide, 3- (difluormethyl) -N- [4 '- (3-methoxy-3-methylbut-1- in-1-yl) biphenyl-2-yl] -1-methyl-1H-pyrazol-4-carboxamide, 5- fluorine-N- [4 '- (3-methoxy-3-methylbut-1-in-1-yl) biphenyl-2-yl] - 1,3-dimethyl-1H-pyrazol-4-carboxamide, 2- chloro-N- [4 '- (3-methoxy-3-methylbut-1-in-1-yl) biphenyl-2-yl] pyridine-3-carboxamide, (5-bromo-2-methoxy-4-methylpyridin- 3-yl) (2,3,4-trimethoxy-6-methylphenyl) methanone, N- [2- (4- {[3- (4-chlorophenyl) prop-2-in-1-yl] oxy} -3 -methoxyphenyl) ethyl] -N2- (methylsulfonyl) valinamide, 4-oxo-4- [(2-phenylethyl) amino] butanoic acid and but-3-in-1-yl {6- [({[ (Z) - (1-methyl-1H-tetrazol-5-yl) (phenyl) methylene] amino} oxy) methyl] pyridin-2-yl} carbamate, and combinations thereof.</span>
  </p>
  <p id="p0101" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[101] Fungicidas convencionais preferidos so selecionados do grupo que consiste em C.2.1 fosetil-Al, C.2.2 penflufen, estrobilurinas, particularmente C.2.3 trifloxistrobina e C.2.4 azoxistrobina.</span>[101] Preferred conventional fungicides are selected from the group consisting of C.2.1 fosetyl-Al, C.2.2 penflufen, strobilurins, particularly C.2.3 trifloxystrobin and C.2.4 azoxystrobin.</span>
  </p>
  <p id="p0102" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[102] Fungicidas convencionais mais preferidos so selecionados do grupo que consiste em C.2.1 fosetil-Al e C.2.3 trifloxistrobina.</span>[102] Most preferred conventional fungicides are selected from the group consisting of C.2.1 fosetyl-Al and C.2.3 trifloxystrobin.</span>
  </p>
  <p id="p0103" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[103] Dentro do significado da presente inveno compostos (C), que so selecionados do grupo de acaricidas, nematicidas e inseticidas conhecidos ou convencionais, compreendem: (a) Inibidores de acetilcolinasterase (AChE), por exemplo, carbamatos, por exemplo, alanicarbe, aldicarbe, bendiocarbe, benfuracarbe, butocarboxim, butoxicarboxim, carbaril, carbofurano, carbossulfano, etiofencarbe, fenobucarbe, formetanato, Furatiocarbe, isoprocarbe, metiocarbe, metomil, metolcarbe, oxamil, pirimicarbe, propoxur, tiodicarbe, tiofanox, triazamato, trimetacarbe, XMC e xililcarbe; ou organofosfatos, por exemplo, acefato, azametifos, azinfos-etil, azinfos-metil, cadusafos, cloretoxifos, clorfenvinfos, clormefos, clorpirifos, clorpirifos-metil, cumafos, cianofos, demeton-S-metil, diazinon, diclorvos/DDVP, dicrotofos, dimetoato, dimetilvinfos, dissulfoton, EPN, ethion, etoprofos, fanfur, fenamifos, fenitrotion, fention, fostiazato, heptenofos, imiciafos, isofenfos, isopropil O-(metoxiaminotio-fosforil) salicilato, isoxation, malation, mecarbam, metamidofos, metidation, mevinfos, monocrotofos, naled, ometoato, oxidemeton-metil, paration, paration-metil, fentoato, forato, fosalona, fosmet, fosfamidon, foxim, pirimifos- metil, profenofos, propetanfos, protiofos, piraclofos, piridafention, quinalfos, sulfotep, tebupirimfos, temefos, terbufos, tetraclorvinfos, tiometon, triazofos, triclorfon, e vamidotion. (b) Antagonistas do canal de cloreto controlados por GABA, por exemplo, organocloros de ciclodieno, por exemplo, clordano e endossulfano; ou fenilpirazis (fiproles), por exemplo, etiprole e fipronil. (c) Moduladores do canal de sdio/bloqueadores do canal de sdio voltagem-dependente, por exemplo, piretrides, por exemplo, acrinatrina, aletrina, d-cis- trans aletrina, d-trans Aletrina, C.3.5 betaciflutrina, bifentrina, bioaletrina, bioaletrina S-ciclopentenil ismero, bioresmetrina, cicloprotrina, ciflutrina, beta- ciflutrina, cialotrina, lambda-Cialotrina, gama-cialotrina, cipermetrina, alfa-cipermetrina, beta-cipermetrina, teta- cipermetrina, zeta-cipermetrina, cifenotrina [ismeros (1R)-trans], C.3.6 deltametrina, empentrina [ismeros (EZ)- (1R)), esfenvalerato, etofenprox, fenpropatrina, fenvalerato, flucitrinato, flumetrina, tau-fluvalinato, halfenprox, Imiprotrina, cadetrina, permetrina, fenotrina [ismero (1R)-trans), Praletrina, piretrina (piretrum), resmetrina, silafluofen, teflutrina, tetrametrina, tetrametrina [ismeros (1R)], tralometrina e transflutrina; ou DDT; ou Metoxicloro. (d) Agonistas do receptor nicotnico de acetilcolina (nAChR), por exemplo, neonicotinides (CNIs), por exemplo, C.3.1 acetamiprida, C.3.2 clotianidina, dinotefurano, C.3.3 imidacloprida, nitenpiram, C.3.4 tiacloprida e tiametoxam; ou nicotina. (e) Ativadores alostricos do receptor nicotnico de acetilcolina (nAChR), por exemplo, espinosinas, por exemplo, spinetoram e spinosad. (f) Ativadores do canal de cloreto, por exemplo, avermectinas/milbemicinas, por exemplo, abamectina, benzoato de emamectina, lepimectina e milbemectina. (g) Mimticos do hormnio juvenil, por exemplo, anlogos do hormnio juvenil, por exemplo, hidropreno, quinopreno e metopreno; ou fenoxicarbe; ou piriproxifeno. (h) Inibidores no especficos (multilocais) diversos, por exemplo, haletos de alquila, por exemplo, brometo de metila e outros haletos de alquila; ou cloropicrina; ou fluoreto de sulfurila; ou Borax; ou emtico de trtaro. (i) Bloqueadores seletivos da alimentao de hompteros, por exemplo, pimetrozina; ou flonicamid. (j) Inibidores do crescimento de caros, por exemplo, clofentezina, hexitiazox e diflovidazina; ou etoxazol. (k) Rompedores microbianos da membrana do intestino mdio de insetos, por exemplo, Bacillus thuringiensis subespcie israelensis, Bacillus sphaericus, Bacillus thuringiensis subespcie aizawai, Bacillus thuringiensis subespcie kurstaki, Bacillus thuringiensis subespcie tenebrionis, e protenas de cultivo BT: Cry1Ab, Cry1Ac, Cry1Fa, Cry2Ab, mCry3A, Cry3Ab, Cry3Bb, Cry34/35Ab1. (l) Inibidores da ATP sintase mitocondrial, por exemplo, diafentiuron; ou acaricidas de organotina, por exemplo, azociclotina, cihexatina e xido de fembutatina; ou propargita; ou tetradifon. (m) Desacopladores da fosforilao oxidativa por meio da ruptura do gradiente do prton, por exemplo, clorfenapir, DNOC e sulfluramida. (n) Bloqueadores do canal do receptor nicotnico de acetilcolina (nAChR), por exemplo, bensultap, cloridrato de cartap, tiociclam e tiossultap-sdio. (o) Inibidores da biossntese de quitina, tipo 0, por exemplo, bistrifluron, clorfluazuron, diflubenzuron, flucicloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, teflubenzuron e triflumuron. (p) Inibidores da biossntese de quitina, tipo 1, por exemplo, buprofezina. (q) Rompedores de mudas, por exemplo, ciromazina. (r) Agonistas do receptor de ecdisona, por exemplo, cromafenozida, halofenozida, metoxifenozida e tebufenozida. (s) Agonistas do receptor de octopamina, por exemplo, amitraz. (t) Inibidores do transporte de eltrons mitocondrial do Complexo III, por exemplo, hidrametilnon; ou acequinocil; ou fluacripirim. (u) Inibidores do transporte de eltrons mitocondrial do Complexo I, por exemplo, acaricidas METI, por exemplo, fenazaquina, fenpiroximato, pirimidifeno, piridabeno, tebufenpirad e tolfenpirad; ou rotenona (Derris). (v) Bloqueadores do canal de sdio voltagem- dependentes, por exemplo, indoxacarbe; ou metaflumizona. (w) Inibidores da acetil CoA carboxilase, por exemplo, derivados do cido tetrnico e tetrmico, por exemplo, cetoenis como, por exemplo, particularmente C.3.7 espirotetramat, C.3.8 espiromesifeno, e C.3.9 espirodiclofeno. (x) Inibidores do transporte de eltrons mitocondrial do Complexo IV, por exemplo, fosfinas, por exemplo, fosfeto de alumnio, fosfeto de clcio, fosfina e fosfeto de zinco; ou cianeto. (y) Inibidores do transporte de eltrons mitocondrial do Complexo II, por exemplo, cienopirafeno. (z) Moduladores do receptor de rianodina, por exemplo, diamidas, por exemplo, clorantraniliprol e flubendiamida.</span>[103] Within the meaning of the present invention compounds (C), which are selected from the group of known or conventional acaricides, nematicides and insecticides, comprise: (a) Acetylcholinasterase (AChE) inhibitors, for example, carbamates, for example, alanicarb , aldicarb, bendiocarb, benfuracarb, butocarboxy, butoxycarboxy, carbaryl, carbofuran, carbosulfan, ethiofencarb, phenobucarb, formethanate, Furatiocarb, isoprocarb, metiocarb, methyl, metolcarb, oxamil, pyrimicarb, pyrimicarb, trimicarb, trioxide, propoxur, propoxur, propoxur ; or organophosphates, for example, acephate, azametiphos, azinphos-ethyl, azinphos-methyl, cadusaphos, chlorethoxyphos, chlorfenvinfos, chlorephs, chlorpyrifos, chlorpyrifos-methyl, cumafos, cyanophos, demeton-S-methyl, diazinon, dichloros, dichloros, dichloros, dichloros dimetoate, dimethylvinfos, disulfoton, EPN, ethion, etoprofos, fanfur, fenamiphos, fenitrotion, fention, fostiazate, heptenophos, imiciafos, isofenfos, isopropil O- (methoxyminothiophosphoryl, methoxy, methoxy, methoxy, methoxy, methoxy, maid, metha, monocrotofos, naled, ometoate, oxidemeton-methyl, paration, paration-methyl, fentoate, phorate, fosalone, fosmet, phosphamidon, foxim, pirimiphos-methyl, profenofos, propetanfos, protiofos, piraclofos, piridafention, quinalfos, tosfos, sulfate, t terbufos, tetrachlorvinfos, tiometon, triazofos, triclorfon, and vamidotion. (b) Chloride channel antagonists controlled by GABA, for example, cyclodiene organochlorines, for example, chlordane and endosulfan; or phenylpyrazoles (fiproles), for example, etiprole and fipronil. (c) Sodium channel modulators / voltage-dependent sodium channel blockers, for example, pyrethroids, for example, acrinatrin, alletrin, d-cis-trans alethrin, d-trans Alethrin, C.3.5 betaciflutrin, bifenthrin, bioallethrin , bioalethrin S-cyclopentenyl isomer, bioresmethrin, cycloprotrin, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, gamma-cyhalothrin, cypermethrin, alpha-cypermethrin, beta-cypermethrin, tetra-kypermethrin (zeta-kyrene) ) -trans], C.3.6 deltamethrin, empentrine [isomers (EZ) - (1R)), sphenvalerate, etofenprox, fenpropatrin, fenvalerate, flucitrinate, flumethrin, tau-fluvalinate, halfenprox, Imiprotrin, cadetrine, permethrin (permethrin, permethrin, permethrin, permethrin, permethrin, permethrin, permethrin, permethrin, permethrin, permethrin, permethrin) 1R) -trans), Pralethrin, pyrethrin (pyrethrin), resmethrin, silafluofen, teflutrin, tetramethrin, tetramethrin [isomers (1R)], tralometrine and transflutrin; or DDT; or Methoxychlor. (d) Nicotinic acetylcholine receptor (nAChR) agonists, for example, neonicotinoids (CNIs), for example, C.3.1 acetamipride, C.3.2 clothianidin, dinotefuran, C.3.3 imidacloprid, nitenpiram, C.3.4 thiaclopride and thiamethoxam; or nicotine. (e) Allosteric activators of the nicotinic acetylcholine receptor (nAChR), for example, spinosyns, for example, spinetoram and spinosad. (f) Chloride channel activators, for example, avermectins / milbemycins, for example, abamectin, emamectin benzoate, lepimectin and milbemectin. (g) Juvenile hormone mimetics, for example, juvenile hormone analogs, for example, hydroprene, quinoprene and methoprene; or phenoxycarb; or pyriproxifene. (h) miscellaneous non-specific (multi-site) inhibitors, for example, alkyl halides, for example, methyl bromide and other alkyl halides; or chloropicrin; or sulfuryl fluoride; or Borax; or tartar emetic. (i) Selective homopteran food blockers, for example, pymetrozine; or flonicamid. (j) Mite growth inhibitors, for example, clofentezine, hexithiazox and diflovidazine; or ethoxazole. (k) Microbial disruptors of the insect midgut membrane, for example, Bacillus thuringiensis subspecies israelensis, Bacillus sphaericus, Bacillus thuringiensis subspecies aizawai, Bacillus thuringiensis subspecies kurstaki, Bacillus thuringiensis subspecies, CryE1, Cryptography, and , Cry2Ab, mCry3A, Cry3Ab, Cry3Bb, Cry34 / 35Ab1. (l) Inhibitors of mitochondrial ATP synthase, for example, diafentiuron; or organotin acaricides, for example, azocyclotine, cyhexatin and fembutatin oxide; or propargita; or tetradifon. (m) Decoupling oxidative phosphorylation by breaking the proton gradient, for example, chlorfenapyr, DNOC and sulfluramide. (n) Nicotinic acetylcholine receptor (nAChR) channel blockers, for example, bensultap, cartap hydrochloride, thiocyclam and thiossultap-sodium. (o) Chitin biosynthesis inhibitors, type 0, for example, bistrifluron, chlorfluazuron, diflubenzuron, flucicloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, teflubenzuron and triflumuron. (p) Chitin biosynthesis inhibitors, type 1, for example, buprofezin. (q) Seed breakers, for example, cyromazine. (r) Ecdysone receptor agonists, for example, chromafenozide, halofenozide, methoxyfenozide and tebufenozide. (s) Octopamine receptor agonists, for example, amitraz. (t) Complex III mitochondrial electron transport inhibitors, for example, hydramethylnon; or acequinocil; or fluacripyrim. (u) Complex I mitochondrial electron transport inhibitors, for example, METI acaricides, for example, phenazaquin, fenpyroximate, pyrimidifene, pyridabene, tebufenpirad and tolfenpirad; or rotenone (Derris). (v) Voltage-dependent sodium channel blockers, for example, indoxacarb; or metaflumizone. (w) Acetyl CoA carboxylase inhibitors, for example, derivatives of tetronic and tetramic acid, for example, ketoenols such as, for example, particularly C.3.7 spirotetramat, C.3.8 spiromesifene, and C.3.9 spirodiclofen. (x) Complex IV mitochondrial electron transport inhibitors, for example, phosphines, for example, aluminum phosphide, calcium phosphide, phosphine and zinc phosphide; or cyanide. (y) Inhibitors of complex II mitochondrial electron transport, for example, cyienopyraphene. (z) Modifiers of the ryanodine receptor, for example, diamides, for example, chloranthraniliprol and flubendiamide.</span>
  </p>
  <p id="p0104" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[104] Ingredientes ativos adicionais com modo de ao desconhecido ou incerto, por exemplo, amidoflumet, azadiractina, benclotiaz, benzoximato, bifenazato, bromopropilato, quinometionato, criolita, ciantraniliprol (Cyazypyr), ciflumetofeno, dicofol, diflovidazina, fluensulfona, flufenerim, flufiprol, fluopyram, fufenozida, imidaclotiz, iprodiona, meperflutrina, piridalil, pirifluquinazona, tetrametilflutrina e iodometano; alm disso, produtos baseados em Bacillus firmus (incluindo, sem limitao, cepa CNCM I-1582 como, por exemplo, VOTiVO, BioNem) ou um dos seguintes compostos ativos conhecidos: 3- bromo-N-{2-bromo-4-cloro-6- [(1-ciclopropiletil)carbamoil] fenil}-1-(3-cloropiridin-2-il)-1H-pirazol-5-carboxamida (conhecida de WO2005/077934), 4-{ [(6-bromopiridin-3- il)metil](2-fluoretil)amino}furan-2-(5H)-ona (conhecida de WO2007/115644), 4-{ [(6-fluorpiridin-3-il)metil](2,2- difluoretil)amino}furan-2-(5H)-ona (conhecida de WO2007/115644), 4-{ [(2-cloro-1,3-tiazol-5-il)metil](2-fluoretil)amino}furan-2-(5H)-ona (conhecida de WO2007/115644), 4-{ [(6-clorpiridin-3-il)metil](2- fluoretil)amino}furan-2-(5H)-ona (conhecida de WO2007/115644), C.3.10 flupiradifurona, 4-{ [(6-clor-5- fluorpiridin-3-il)metil](metil)amino}furan-2-(5H)-ona (conhecida de WO2007/115643), 4-{ [(5,6-dicloropiridin-3- il)metil](2-fluoretil)amino}furan-2-(5H)-ona (conhecida de WO2007/115646), 4-{ [(6-cloro-5-fluorpiridin-3- il)metil](ciclopropil)amino}furan-2-(5H)-ona (conhecida de WO2007/115643), 4-{ [(6-cloropiridin-3- il)metil](ciclopropil)amino}furan-2-(5H)-ona (conhecida de EP-A-0 539 588), 4-{ [(6-clorpiridin-3- il)metil](metil)amino}furan-2-(5H)-ona (conhecida de EP-A-0 539 588), { [1-(6-cloropiridin-3-il)etil](metil)xido-4- sulfanilideno}cianamida (conhecida de WO2007/149134) e seus diasteremeros { [(1R)-1-(6-cloropiridin-3-il)etil](metil) xido-4-sulfanilideno}cianamida (A) e { [(1S)-1-(6- cloropiridin-3-il)etil](metil)xido-4-sulfanilideno} cianamida (B) (tambm conhecida de WO2007/149134), bem como sulfoxaflor e seus diasteremeros [(R)-metil(xido) {(1R)- 1- [6-(trifluormetil)piridin-3-il]etil}-4-sulfanilideno] cianamida (A1) e [(S)-metil(xido) {(1S)-1- [6- (trifluormetil)piridin-3-il]etil}-4-sulfanilideno] cianamida (A2), citados como grupo de diasteremeros A (conhecidos de WO2010/074747, WO2010/074751), [(R)- metil(xido) {(1S)-1- [6-(trifluormetil)piridin-3-il]etil}- 4-sulfanilideno]cianamida (B1) e [(S)-metil(xido) {(1R)- 1- [6-(trifluormetil)piridin-3-il]etil}-4-sulfanilideno] cianamida (B2), citados como grupo de diasteremeros B (tambm conhecidos de WO2010/074747, WO2010/074751), e 11- (4-cloro-2,6-dimetilfenil)-12-hidrxi-1,4-dioxa-9- azadispiro [4.2.4.2]tetradec-11-en-10-ona (conhecida de WO2006/089633), 3-(4-flor-2,4-dimetilbifenil-3-il)-4- hidrxi-8-oxa-1-azaspiro [4.5]dec-3-en-2-ona (conhecida de WO2008/067911), 1-{2-flor-4-metil-5- [(2,2,2- trifluoretil)sulfmil]fenil}-3-(trifluormetil)-1H-1,2,4- triazol-5-amina (conhecida de WO2006/043635), [(3S,4aR,12R,12aS,12bS)-3- [(ciclopropilcarbonil)xi]-6,12- dihidroxi-4,12b-dimetil-11-oxo-9-(piridin-3-il)- 1,3,4,4a,5,6,6a,12,12a,12b-decahidro-2H,11H- benzo [f]pirano [4,3-b]cromen-4-il]metil ciclopropanocarboxilato (conhecido de WO2008/066153), 2- ciano-3-(difluormetoxi)-N,N-dimetilbenzenossulfonamida (conhecida de WO2006/056433), 2-ciano-3-(difluormetoxi)-N- metilbenzenossulfonamida (conhecida de WO2006/100288), 2- ciano-3-(difluormetoxi)-N-etilbenzenossulfonamida (conhecida de WO2005/035486), 4-(difluormetoxi)-N-etil-N- metil-1,2-benzotiazol-3-amina 1,1-dixido (conhecido de WO2007/057407), N- [1-(2,3-dimetilfenil)-2-(3,5- dimetilfenil)etil]-4,5-dihidro-1,3-tiazol-2-amina (conhecida de WO2008/104503), {1- [(2E)-3-(4- clorofenil)prop-2-en-1-il]-5-fluorspiro [indol-3,4- piperidin]-1(2H)-il}(2-cloropiridin-4-il)metanona (conhecida de WO2003/106457), 3-(2,5-dimetilfenil)-4- hidrxi-8-metxi-1,8-diazaspiro [4.5]dec-3-en-2-ona (conhecida de WO2009/049851), 3-(2,5-dimetilfenil)-8- metxi-2-oxo-1,8-diazaspiro [4.5]dec-3-en-4-il etil carbonato (conhecido de WO2009/049851), 4-(but-2-in-1- ilxi)-6-(3,5-dimetilpiperidin-1-il)-5-fluorpirimidina (conhecida de WO2004/099160), (2,2,3,3,4,4,5,5-octafluorpentil)(3,3,3-trifluorpropil)malononitrila (conhecida de WO2005/063094), (2,2,3,3,4,4,5,5- octafluorpentil)(3,3,4,4,4-pentafluorbutil)malononitrila (conhecida de WO2005/063094), 8- [2-(ciclopropilmetoxi)-4- (trifluormetil)fenxi]-3- [6-(trifluormetil)piridazin-3-il]- 3-azabiciclo [3.2.1]octano (conhecido de WO2007/040280), flometoquina, PF1364 (Reg. CAS N 1204776-60-2) (conhecido de JP2010/018586), 5- [5-(3,5-diclorofenil)-5- (trifluormetil)-4,5-dihidro-1,2-oxazol-3-il]-2-(1H-1,2,4- triazol-1-il)benzonitrila (conhecida de WO2007/075459), 5- [5-(2-cloropiridin-4-il)-5-(trifluormetil)-4,5-dihidro-1,2- oxazol-3-il]-2-(1H-1,2,4-triazol-1-il)benzonitrila (conhecida de WO2007/075459), 4- [5-(3,5-diclorofenil)-5- (trifluormetil)-4,5-dihidro-1,2-oxazol-3-il]-2-metil-N-{2- oxo-2- [(2,2,2-trifluoretil)amino]etil}benzamida (conhecida de WO2005/085216), 4-{ [(6-cloropiridin-3-il)metil] (ciclopropil)amino}-1,3-oxazol-2(5H)-ona, 4-{ [(6- cloropiridin-3-il)metil](2,2-difluoretil)amino}-1,3-oxazol- 2(5H)-ona, 4-{ [(6-cloropiridin-3-il)metil](etil)amino}-1,3- oxazol-2(5H)-ona, 4-{ [(6-cloropiridin-3-il)metil](metil) amino}-1,3-oxazol-2(5H)-ona (todas de WO2010/005692), NNI- 0711 (conhecido de WO2002/096882), 1-acetil-N- [4- (1,1,1,3,3,3-hexaflor-2-metoxipropan-2-il)-3- isobutilfenil]-N-isobutiril-3,5-dimetil-1H-pirazol-4- carboxamida (conhecida de WO2002/096882), metil 2- [2-({ [3- bromo-1-(3-cloropiridin-2-il)-1H-pirazol-5- il]carbonil}amino)-5-cloro-3-metilbenzoil]-2- metilhidrazinacarboxilato (conhecido de WO2005/085216), metil 2- [2-({ [3-bromo-1-(3-cloropiridin-2-il)-1H-pirazol-5- il]carbonil}amino)-5-ciano-3-metilbenzoil]-2- etilhidrazinacarboxilato (conhecido de WO2005/085216), metil 2- [2-({ [3-bromo-1-(3-cloropiridin-2-il)-1H-pirazol-5- il]carbonil}amino)-5-ciano-3-metilbenzoil]-2- metilhidrazinacarboxilato (conhecido de WO2005/085216), metil 2- [3,5-dibromo-2-({ [3-bromo-1-(3-cloropiridin-2-il)- 1H-pirazol-5-il]carbonil}amino)benzoil]-1,2- dietilhidrazinacarboxilato (conhecido de WO2005/085216), metil 2- [3,5-dibromo-2-({ [3-bromo-1-(3-cloropiridin-2-il)- 1H-pirazol-5-il]carbonil}amino)benzoil]-2- etilhidrazinacarboxilato (conhecido de WO2005/085216), (5RS,7RS;5RS,7SR)-1-(6-cloro-3-piridilmetil)-1,2,3,5,6,7- hexahidro-7-metil-8-nitro-5-propoxiimidazo [1,2-a]piridina (conhecida de WO2007/101369), 2-{6- [2-(5-fluorpiridin-3- il)-1,3-tiazol-5-il]piridin-2-il}pirimidina (conhecida de WO2010/006713), 2-{6- [2-(piridin-3-il)-1,3-tiazol-5- il]piridin-2-il}pirimidina (conhecida de WO2010/006713), 1- (3-cloropiridin-2-il)-N- [4-ciano-2-metil-6-(metilcarbamoil) fenil]-3-{ [5-(trifluormetil)-1H-tetrazol-1-il]metil}-1H- pirazol-5-carboxamida (conhecida de WO2010/069502), 1-(3- cloropiridin-2-il)-N- [4-ciano-2-metil-6- (metilcarbamoil)fenil]-3-{ [5-(trifluormetil)-2H-tetrazol-2- il]metil}-1H-pirazol-5-carboxamida (conhecida de WO2010/069502), N- [2-(terc-butilcarbamoil)-4-ciano-6- metilfenil]-1-(3-cloropiridin-2-il)-3-{ [5-(trifluormetil)- 1H-tetrazol-1-il]metil}-1H-pirazol-5-carboxamida (conhecida de WO2010/069502), N- [2-(terc-butilcarbamoil)-4-ciano-6- metilfenil]-1-(3-cloropiridin-2-il)-3-{ [5-(trifluormetil)- 2H-tetrazol-2-il]metil}-1H-pirazol-5-carboxamida (conhecida de WO2010/069502), (1E)-N- [(6-cloropiridin-3-il)metil]-N- ciano-N-(2,2-difluoretil)etanimidamida (conhecida deWO2008/009360), N- [2-(5-amino-1,3,4-tiadiazol-2-il)-4- cloro-6-metilfenil]-3-bromo-1-(3-cloropiridin-2-il)-1H- pirazol-5-carboxamida (conhecida de CN102057925) e metil 2- [3,5-dibromo-2-({ [3-bromo-1-(3-cloropiridin-2-il)-1H- pirazol-5-il]carbonil}amino)benzoil]-2-etil-1- metilhidrazinacarboxilato (conhecido de WO2011/049233), e combinaes destes.</span>[104] Additional active ingredients with unknown or uncertain mode of action, for example, amidoflumet, azadiractin, benclothiaz, benzoxide, biphenazate, bromopropylate, quinomethionate, cryolite, cyantraniliprol (Cyazypyr), ciflumetofen, dicofol, fluulfol, flifid, fllovidone fluopyram, fufenozide, imidaclotiz, iprodione, meperflutrina, pyridalil, pyrifluquinazone, tetramethylflutrina and iodomethane; in addition, products based on Bacillus firmus (including, without limitation, CNCM I-1582 strain such as, for example, VOTiVO , BioNem) or one of the following known active compounds: 3-bromo-N- {2-bromo-4- chloro-6- [(1-cyclopropylethyl) carbamoyl] phenyl} -1- (3-chloropyridin-2-yl) -1H-pyrazol-5-carboxamide (known from WO2005 / 077934), 4- {[(6-bromopyridin -3- yl) methyl] (2-fluorethyl) amino} furan-2- (5H) -one (known from WO2007 / 115644), 4- {[(6-fluorpiridin-3-yl) methyl] (2,2 - difluorethyl) amino} furan-2- (5H) -one (known from WO2007 / 115644), 4- {[(2-chloro-1,3-thiazol-5-yl) methyl] (2-fluorethyl) amino} furan-2- (5H) -one (known from WO2007 / 115644), 4- {[(6-chlorpyridin-3-yl) methyl] (2-fluorethyl) amino} furan-2- (5H) -one (known WO2007 / 115644), C.3.10 flupiradifurone, 4- {[(6-chlor-5-fluorpiridin-3-yl) methyl] (methyl) amino} furan-2- (5H) -one (known from WO2007 / 115643 ), 4- {[(5,6-dichloropyridin-3-yl) methyl] (2-fluorethyl) amino} furan-2- (5H) -one (known from WO2007 / 115646), 4- {[(6- chloro-5-fluorpiridin-3-yl) methyl] (ci clopropyl) amino} furan-2- (5H) -one (known from WO2007 / 115643), 4- {[(6-chloropyridin-3-yl) methyl] (cyclopropyl) amino} furan-2- (5H) -one (known from EP-A-0 539 588), 4- {[(6-chlorpyridin-3-yl) methyl] (methyl) amino} furan-2- (5H) -one (known from EP-A-0 539 588), {[1- (6-chloropyridin-3-yl) ethyl] (methyl) oxide-4-sulfanilidene} cyanamide (known from WO2007 / 149134) and its diastereomers {[((1R) -1- (6-chloropiridin -3-yl) ethyl] (methyl) oxide-4-sulfanilidene} cyanamide (A) and {[(1S) -1- (6-chloropyridin-3-yl) ethyl] (methyl) oxide-4-sulfanilidene} cyanamide (B) (also known from WO2007 / 149134), as well as sulfoxaflor and its diastereomers [(R) -methyl (oxide) {(1R) - 1- [6- (trifluoromethyl) pyridin-3-yl] ethyl} -4 -sulfanilidene] cyanamide (A1) and [(S) -methyl (oxide) {(1S) -1- [6- (trifluormethyl) pyridin-3-yl] ethyl} -4-sulfanilidene] cyanamide (A2) diastereomer group A (known from WO2010 / 074747, WO2010 / 074751), [(R) - methyl (oxide) {(1S) -1- [6- (trifluoromethyl) pyridin-3-yl] ethyl} - 4-sulfanilidene ] cyanamide (B1) and [(S) -methyl (oxide) {(1R) - 1- [6- (trifluormethyl) pyridin-3-yl] ethyl} -4-sulfanylidene] cyanamide (B2), cited as a group of B diastereomers (also known from WO2010 / 074747, WO2010 / 074751), and 11- (4-chloro-2,6-dimethylphenyl) -12-hydroxy-1,4-dioxa-9-azadispiro [4.2.4.2] tetradec-11- en-10-one (known from WO2006 / 089633), 3- (4'-fluoro-2,4-dimethylbiphenyl-3-yl) -4-hydroxy-8-oxa-1-azaspiro [4.5] dec-3- en-2-one (known from WO2008 / 067911), 1- {2-fluor-4-methyl-5- [(2,2,2-trifluorethyl) sulfmil] phenyl} -3- (trifluormethyl) -1H-1 , 2,4-triazole-5-amine (known from WO2006 / 043635), [(3S, 4aR, 12R, 12aS, 12bS) -3- [(cyclopropylcarbonyl) oxy] -6,12- dihydroxy-4,12b- dimethyl-11-oxo-9- (pyridin-3-yl) - 1,3,4,4a, 5,6,6a, 12,12a, 12b-decahydro-2H, 11H-benzo [f] pyran [4, 3-b] chromen-4-yl] methyl cyclopropanecarboxylate (known from WO2008 / 066153), 2-cyano-3- (difluormethoxy) -N, N-dimethylbenzenesulfonamide (known from WO2006 / 056433), 2-cyano-3- ( difluormethoxy) -N- methylbenzenesulfonamide (known from WO2006 / 100288), 2- cyano-3- (difluormethoxy) -N-ethylbenzenesulfonamide (known from WO2005 / 035486), 4- (difluormethoxy) -N-ethyl-N-methyl-1,2-benzothiazole-3-amine 1,1-dioxide (known from WO2007 / 057407), N- [1- (2,3-dimethylphenyl) -2- (3,5-dimethylphenyl) ethyl] -4,5-dihydro-1,3-thiazol-2-amine (known from WO2008 / 104503), {1'- [(2E) -3- (4-chlorophenyl) prop-2-en-1-yl] -5-fluorspiro [indole-3,4'- piperidin] -1 (2H) -il } (2-chloropyridin-4-yl) methanone (known from WO2003 / 106457), 3- (2,5-dimethylphenyl) -4-hydroxy-8-methoxy-1,8-diazaspiro [4.5] dec-3-en -2-one (known from WO2009 / 049851), 3- (2,5-dimethylphenyl) -8-methoxy-2-oxo-1,8-diazaspiro [4.5] dec-3-en-4-yl ethyl carbonate ( known from WO2009 / 049851), 4- (but-2-in-1-yloxy) -6- (3,5-dimethylpiperidin-1-yl) -5-fluorpirimidine (known from WO2004 / 099160), (2,2 , 3,3,4,4,5,5- octafluorpentil) (3,3,3-trifluorpropyl) malononitrile (known from WO2005 / 063094), (2,2,3,3,4,4,5,5- octafluorpentil) (3,3,4,4,4-pentafluorbutil) malononitrile (known from WO2005 / 063094), 8- [2- (cyclopropylmethoxy) -4- ( trifluormethyl) phenoxy] -3- [6- (trifluormethyl) pyridazin-3-yl] - 3-azabicyclo [3.2.1] octane (known from WO2007 / 040280), flometoquin, PF1364 (Reg. CAS No. 1204776-60-2) (known from JP2010 / 018586), 5- [5- (3,5-dichlorophenyl) -5- (trifluormethyl) -4,5-dihydro-1,2-oxazol-3- yl] -2- (1H-1,2,4-triazol-1-yl) benzonitrile (known from WO2007 / 075459), 5- [5- (2-chloropyridin-4-yl) -5- (trifluormethyl) - 4,5-dihydro-1,2-oxazol-3-yl] -2- (1H-1,2,4-triazol-1-yl) benzonitrile (known from WO2007 / 075459), 4- [5- (3 , 5-dichlorophenyl) -5- (trifluormethyl) -4,5-dihydro-1,2-oxazol-3-yl] -2-methyl-N- {2-oxo-2- [(2,2,2- trifluorethyl) amino] ethyl} benzamide (known from WO2005 / 085216), 4- {[(6-chloropyridin-3-yl) methyl] (cyclopropyl) amino} -1,3-oxazol-2 (5H) -one, 4 - {[(6-chloropyridin-3-yl) methyl] (2,2-difluorethyl) amino} -1,3-oxazol-2 (5H) -one, 4- {[(6-chloropyridin-3-yl) methyl] (ethyl) amino} -1,3-oxazol-2 (5H) -one, 4- {[(6-chloropyridin-3-yl) methyl] (methyl) amino} -1,3-oxazol-2 ( 5H) -one (all from WO2010 / 005692), NNI-0711 (known from WO2002 / 096882), 1-acetyl-N- [4- (1,1,1,3,3,3-hexafluor-2-methoxypropan -2-yl) -3-isobutylphenyl] -N-isobutyryl-3,5-dimethyl-1H-pyrazol-4-carboxamide (known WO2002 / 096882), methyl 2- [2 - ({[3-bromo-1- (3-chloropyridin-2-yl) -1H-pyrazol-5-yl] carbonyl} amino) -5-chloro-3- methylbenzoyl] -2-methylhydrazinecarboxylate (known from WO2005 / 085216), methyl 2- [2 - ({[3-bromo-1- (3-chloropyridin-2-yl) -1H-pyrazol-5-yl] carbonyl} amino ) -5-cyano-3-methylbenzoyl] -2-ethylhydrazinecarboxylate (known from WO2005 / 085216), methyl 2- [2 - ({[3-bromo-1- (3-chloropyridin-2-yl) -1H-pyrazol -5- yl] carbonyl} amino) -5-cyano-3-methylbenzoyl] -2- methylhydrazinecarboxylate (known from WO2005 / 085216), methyl 2- [3,5-dibromo-2 - ({[3-bromo-1 - (3-chloropyridin-2-yl) - 1H-pyrazol-5-yl] carbonyl} amino) benzoyl] -1,2-diethylhydrazinecarboxylate (known from WO2005 / 085216), methyl 2- [3,5-dibromo-2 - ({[3-bromo-1- (3-chloropyridin-2-yl) - 1H-pyrazol-5-yl] carbonyl} amino) benzoyl] -2-ethylhydrazinecarboxylate (known from WO2005 / 085216), (5RS, 7RS ; 5RS, 7SR) -1- (6-chloro-3-pyridylmethyl) -1,2,3,5,6,7-hexahydro-7-methyl-8-nitro-5-propoxyimidazo [1,2-a] pyridine (known from WO2007 / 101369), 2- {6- [2- (5-fluorpir idin-3-yl) -1,3-thiazol-5-yl] pyridin-2-yl} pyrimidine (known from WO2010 / 006713), 2- {6- [2- (pyridin-3-yl) -1, 3-thiazol-5-yl] pyridin-2-yl} pyrimidine (known from WO2010 / 006713), 1- (3-chloropyridin-2-yl) -N- [4-cyano-2-methyl-6- (methylcarbamoyl ) phenyl] -3- {[5- (trifluormethyl) -1H-tetrazol-1-yl] methyl} -1H-pyrazol-5-carboxamide (known from WO2010 / 069502), 1- (3-chloropyridin-2-yl ) -N- [4-cyano-2-methyl-6- (methylcarbamoyl) phenyl] -3- {[5- (trifluormethyl) -2H-tetrazol-2-yl] methyl} -1H-pyrazol-5-carboxamide ( known from WO2010 / 069502), N- [2- (tert-butylcarbamoyl) -4-cyano-6-methylphenyl] -1- (3-chloropyridin-2-yl) -3- {[5- (trifluormethyl) - 1H -tetrazol-1-yl] methyl} -1H-pyrazol-5-carboxamide (known from WO2010 / 069502), N- [2- (tert-butylcarbamoyl) -4-cyano-6-methylphenyl] -1- (3- chloropyridin-2-yl) -3- {[5- (trifluormethyl) - 2H-tetrazol-2-yl] methyl} -1H-pyrazol-5-carboxamide (known from WO2010 / 069502), (1E) -N- [ (6-chloropyridin-3-yl) methyl] -N'- cyano-N- (2,2-difluorethyl) etanimidamide (known from WO2008 / 009360), N- [2- (5- amino-1,3,4-thiadiazol-2-yl) -4-chloro-6-methylphenyl] -3-bromo-1- (3-chloropyridin-2-yl) -1H-pyrazol-5-carboxamide (known from CN102057925) and methyl 2- [3,5-dibromo-2 - ({[3-bromo-1- (3-chloropyridin-2-yl) -1H-pyrazol-5-yl] carbonyl} amino) benzoyl] -2 -ethyl-1-methylhydrazinecarboxylate (known from WO2011 / 049233), and combinations thereof.</span>
  </p>
  <p id="p0105" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[105] Compostos preferidos (C) so selecionados do grupo de inseticidas (convencionais), preferivelmente dos grupos que consistem em neonicotinides (CNIs), como particularmente C.3.1 acetamiprida, C.3.2 clotianidina, C.3.3 imidacloprida e C.3.4 tiacloprida; piretrides, como particularmente C.3.5 betaciflutrina e C.3.6 deltametrina; cetoenis, como particularmente C.3.7 espirotetramat, C.3.8 espiromesifeno e C.3.9 espirodiclofeno; C.3.10 flupiradifurona; e combinaes destes, particularmente combinaes de CNIs e piretrides.</span>[105] Preferred compounds (C) are selected from the group of (conventional) insecticides, preferably from groups consisting of neonicotinoids (CNIs), such as particularly C.3.1 acetamipride, C.3.2 clothianidine, C.3.3 imidacloprid and C.3.4 thiaclopride ; pyrethroids, such as particularly C.3.5 betaciflutrin and C.3.6 deltamethrin; ketoenols, particularly C.3.7 spirotetramat, C.3.8 spiromesifene and C.3.9 spirodiclofen; C.3.10 flupiradifurone; and combinations of these, particularly combinations of CNIs and pyrethroids.</span>
  </p>
  <p id="p0106" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[106] Inseticidas convencionais mais preferidos so selecionados do grupo que consiste em C.3.3 imidacloprida, C.3.4 tiacloprida, C.3.5 betaciflutrina, C.3.6 deltametrina, C.3.10 flupiradifurona, e combinaes destes.</span>[106] Most preferred conventional insecticides are selected from the group consisting of C.3.3 imidacloprid, C.3.4 thiaclopride, C.3.5 betaciflutrin, C.3.6 deltamethrin, C.3.10 flupiradifurone, and combinations thereof.</span>
  </p>
  <p id="p0107" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[107] Dentro do significado da presente inveno compostos (C), que so selecionados do grupo de micronutrientes e compostos que contm micronutrientes, compreendem compostos selecionados do grupo que consiste em ingredientes ativos que contm pelo menos um on de metal selecionado do grupo que consiste em zinco, mangans, molibdnio, ferro e cobre ou o micronutriente boro. Mais preferivelmente, esses micronutrientes e compostos que contm micronutrientes so selecionados do grupo que consiste nos compostos que contm zinco Propinebe, Polioxina Z (sal de zinco), Zineb, Ziram, zinco tiodazol, naftenato de zinco e Mancozebe (que tambm contm mangans), os compostos que contm mangans Maneb, Metiram e Mancobre (que tambm contm cobre), os compostos que contm ferro Ferbam, cobre (Cu) e os composto que contm cobre mistura de Bordeaux, mistura de Burgundy, mistura de Cheshunt, oxicloreto de cobre, sulfato de cobre, sulfato de cobre bsico (por exemplo, sulfato de cobre tribsico), xido de cobre, octanoato de cobre, hidrxido de cobre, oxina-cobre, amnio acetato de cobre, naftenato de cobre, cobre quelado (por exemplo, como quelatos de aminocido), mancobre, acipetacs-cobre, acetato de cobre, carbonato de cobre bsico, oleato de cobre, silicato de cobre, cromato de cobre-zinco, cufraneb, cuprobam, saisentong e tiodiazol- cobre, e combinaes destes.</span>[107] Within the meaning of the present invention compounds (C), which are selected from the group of micronutrients and compounds that contain micronutrients, comprise compounds selected from the group consisting of active ingredients that contain at least one metal ion selected from the group consisting of in zinc, manganese, molybdenum, iron and copper or the micronutrient boron. More preferably, these micronutrients and micronutrient-containing compounds are selected from the group consisting of the compounds containing zinc Propineb, Polyoxin Z (zinc salt), Zineb, Ziram, zinc thiodazole, zinc naphthenate and Mancozebe (which also contains manganese), the compounds containing manganese Maneb, Metiram and Mancobre (which also contains copper), the compounds containing Ferbam iron, copper (Cu) and the compounds containing copper Bordeaux mixture, Burgundy mixture, Cheshunt mixture, copper oxychloride, copper sulphate, basic copper sulphate (eg, tribasic copper sulphate), copper oxide, copper octanoate, copper hydroxide, copper oxine, copper ammonium acetate, copper naphthenate, chelated copper (eg as amino acid chelates), mancobre, acipetacs-copper, copper acetate, basic copper carbonate, copper oleate, copper silicate, copper-zinc chromate, cufraneb, cuprobam, saisentong and thiodiazole-copper, and combinations thereof.</span>
  </p>
  <p id="p0108" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[108] De preferncia, os micronutrientes e compostos que contm micronutrientes so selecionados do grupo que consiste em C.4.1 cobre (Cu), C.4.2 hidrxido de cobre, C.4.3 sulfato de cobre, C.4.4 oxicloreto de cobre, C.4.5 Propinebe e C.4.6 Mancozebe. Mais preferivelmente, os micronutrientes e compostos que contm micronutrientes so selecionados do grupo que consiste em C.4.2 hidrxido de cobre, C.4.3 sulfato de cobre, C.4.5 Propinebe e C.4.6 Mancozebe. Os mais preferidos so C.4.5 Propinebe e C.4.6 Mancozebe.</span>[108] Preferably, micronutrients and compounds containing micronutrients are selected from the group consisting of C.4.1 copper (Cu), C.4.2 copper hydroxide, C.4.3 copper sulfate, C.4.4 copper oxychloride, C .4.5 Propineb and C.4.6 Mancozebe. More preferably, micronutrients and compounds containing micronutrients are selected from the group consisting of C.4.2 copper hydroxide, C.4.3 copper sulfate, C.4.5 Propineb and C.4.6 Mancozebe. The most preferred are C.4.5 Propineb and C.4.6 Mancozebe.</span>
  </p>
  <p id="p0109" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[109] Dentro do significado da presente inveno, compostos (C), que so selecionados do grupo de compostos de lipoquito-oligossacardeo (LCO), compreendem compostos que possuem a estrutura geral de LCO, ou seja, uma coluna oligomrica de resduos de N-acetil-D-glucosamina P-1,4- ligados com uma cadeia de acil graxo N-ligada na extremidade no redutora, como descrito na Patente U.S. N 5.549.718; Patente U.S. N 5.646.018; Patente U.S. N 5.175.149; e Patente U.S. N 5.321.011. Essa estrutura bsica pode conter modificaes ou substituies encontradas em LCOs de ocorrncia natural, tais como aquelas descritas em Spaink, Critical Reviews in Plant Sciences 54: 257-288, 2000; DHaeze e Holsters, Glycobiology 12: 79R-105R, 2002. LCOs de ocorrncia natural so definidos como compostos que podem ser encontrados na natureza. Essa estrutura bsica tambm pode conter modificaes ou substituies que no foram encontradas at agora em LCOs de ocorrncia natural. Exemplos desses anlogos para os quais a ligao amida conjugada  mimetizada por uma ligao benzamida ou que contm uma funo do tipo benzilamina so os compostos de frmula (I) seguintes que so descritos em WO2005/063784 e WO2008/071672, cujo teor  aqui incorporado por referncia. Os compostos de LCOs podem ser isolados diretamente de uma cultura de cepas bacterianas de Rhizobiaceae particular, sintetizados quimicamente, ou obtidos quimio- enzimaticamente. Por meio do ltimo mtodo, o esqueleto de oligossacardeos pode ser formado por cultivo de cepas bacterianas recombinantes, por exemplo, Escherichia coli, em um fermentador, e a cadeia de lipdeo pode ento ser anexada quimicamente. LCOs usados em modalidades da inveno podem ser recuperados de cepas bacterianas de Rhizobiaceae naturais que produzem LCOs, por exemplo, cepas de Azorhizobium, Bradyrhizobium (incluindo B. japonicum), Mesorhizobium, Rhizobium (incluindo R. leguminosarum), Sinorhizobium (incluindo S. meliloti), ou de cepas bacterianas modificadas geneticamente para produzir LCOs. Esses mtodos so conhecidos na tcnica e foram descritos, por exemplo, nas Patentes U.S. Nos 5.549.718 e 5.646.018, que so aqui incorporados por referncia. Hungria e Stacey (Soil Biol. Biochem. 29: 819-830, 1997) listam estruturas de LCO especficas que so produzidos por espcies rizobianas diferentes. LCOs podem ser utilizados em vrias formas de pureza e podem ser usados isoladamente ou com rizbias. Mtodos para fornecer apenas LCOs incluem a remoo simples das clulas rizobianas de uma mistura de LCOs e rizbias, ou continuando para isolar e purificar as molculas de LCO por meio de separao de fases de LCO- solvente, seguida por cromatografia por HPLC, como descrita por Lerouge, e cols. (US 5.549.718). A purificao pode ser aumentada por HPLC repetida, e as molculas de LCO purificada podem ser liofilizadas para armazenamento em longo prazo. Esse mtodo  aceitvel para a produo de LCOs a partir de todos os gneros e espcies das Rhizobiaceae. Produtos comerciais que contm LCOs esto disponveis, por exemplo, OPTIMIZE (EMD Crop Bioscience). Compostos de LCO, que podem ser idnticos ou no aos LCOs de ocorrncia natural, tambm podem ser obtidos por sntese qumica e/ou por meio de engenharia gentica. A sntese de molculas de oligossacardeos precursoras para a construo de LCO por organismos modificados geneticamente  revelada em Samain e cols., Carbohydrate Research 302: 35-42, 1997. A preparao de numerosos compostos de LCOs nos quais o esqueleto de oligossacardeos  obtido por cultivo de cepas bacterianas recombinantes, por exemplo, clulas de Escherichia coli recombinantes que abrigam gene heterlogo de rizbias, e nas quais a cadeia de lipdeo  anexada quimicamente em WO2005/063784 e WO2008/07167, cujo teor  aqui incorporado por referncia. Exemplos de compostos de lipoquito-oligossacardeo incluem, sem limitao, compostos de LCO especificamente revelados em WO2010/125065.</span>[109] Within the meaning of the present invention, compounds (C), which are selected from the group of lipoquito-oligosaccharide (LCO) compounds, comprise compounds that have the general structure of LCO, that is, an oligomeric column of N residues -acetyl-D-glucosamine P-1,4- linked with an N-linked fatty acyl chain at the non-reducing end, as described in US Patent No. 5,549,718; U.S. Patent No. 5,646,018; U.S. Patent No. 5,175,149; and U.S. Patent No. 5,321,011. This basic structure may contain modifications or substitutions found in naturally occurring LCOs, such as those described in Spaink, Critical Reviews in Plant Sciences 54: 257-288, 2000; DHaeze and Holsters, Glycobiology 12: 79R-105R, 2002. Naturally occurring LCOs are defined as compounds that can be found in nature. This basic structure may also contain modifications or replacements that have not been found so far in naturally occurring LCOs. Examples of such analogs for which the conjugated amide bond is mimicked by a benzamide bond or which contain a benzylamine-like function are the following compounds of formula (I) which are described in WO2005 / 063784 and WO2008 / 071672, the content of which is incorporated herein by reference. The compounds of LCOs can be isolated directly from a culture of bacterial strains of particular Rhizobiaceae, chemically synthesized, or obtained chemo-enzymatically. Using the latter method, the oligosaccharide skeleton can be formed by cultivating recombinant bacterial strains, for example, Escherichia coli, in a fermenter, and the lipid chain can then be chemically attached. LCOs used in embodiments of the invention can be recovered from natural bacterial strains of Rhizobiaceae that produce LCOs, for example, strains of Azorhizobium, Bradyrhizobium (including B. japonicum), Mesorhizobium, Rhizobium (including R. leguminosarum), Sinorhizobium (including S. meliloti ), or from genetically modified bacterial strains to produce LCOs. Such methods are known in the art and have been described, for example, in U.S. Patent Nos. 5,549,718 and 5,646,018, which are incorporated herein by reference. Hungary and Stacey (Soil Biol. Biochem. 29: 819-830, 1997) list specific LCO structures that are produced by different rhizobian species. LCOs can be used in various forms of purity and can be used alone or with rhizobia. Methods for providing only LCOs include simple removal of rhizobial cells from a mixture of LCOs and rhizobia, or continuing to isolate and purify LCO molecules by separating LCO-solvent phases, followed by HPLC chromatography, as described by Lerouge, et al. (US 5,549,718). Purification can be increased by repeated HPLC, and the purified LCO molecules can be lyophilized for long-term storage. This method is acceptable for the production of LCOs from all genera and species of Rhizobiaceae. Commercial products that contain LCOs are available, for example, OPTIMIZE (EMD Crop Bioscience). LCO compounds, which may or may not be identical to naturally occurring LCOs, can also be obtained by chemical synthesis and / or by genetic engineering. The synthesis of oligosaccharide molecules precursors for the construction of LCO by genetically modified organisms is disclosed in Samain et al., Carbohydrate Research 302: 35-42, 1997. The preparation of numerous compounds of LCOs in which the oligosaccharide skeleton is obtained by cultivation of recombinant bacterial strains, for example, recombinant Escherichia coli cells that harbor a rhizobial heterologous gene, and to which the lipid chain is chemically attached in WO2005 / 063784 and WO2008 / 07167, the content of which is incorporated herein by reference. Examples of lipoquito-oligosaccharide compounds include, without limitation, LCO compounds specifically disclosed in WO2010 / 125065.</span>
  </p>
  <p id="p0110" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[110] Dentro do significado da presente inveno compostos (C), que so selecionados do grupo de produtos para aprimoramento do solo ou produtos para reduo de estresse de plantas, compreendem, por exemplo, C.5 Myconate. Alm disso, dentro do significado da presente inveno, o composto (C) pode ser selecionado de pelo menos um composto ativo selecionado do grupo que consiste em: cido actico (por exemplo, cido naftaleno actico), cido peractico, cidos orgnicos (por exemplo, cido ctrico, cido ltico), aminocidos (por exemplo, 1- arginina), cidos hmicos, cidos flvicos, cido brico, cido oxolnico, cido 1,2,3-benzotiadiazol-7- tiocarboxlico-S-metil ster, 5-hidrxi-1,4-naftalenodiona, bromo-cloro-dimetil-hidantona, cido tricloroisocianrico, cido saliclico, diclorofeno, canamicina, casugamicina, estreptomicina, sulfato de estreptomicina, oxitetraciclina, gentamicina (por exemplo, hidrato de sulfato de gentamicina), imidacloprida, tebuconazol, tiabendazol, tiram, teracep, octilinona, quinoxifeno, azadiractina, furanoflavona, forclorfenuron, minerais de plantas (por exemplo, clcio, carbonato de clcio, hipoclorito, EDTA de clcio), enzimas (por exemplo, protease, amilase, lipase), microelementos e microelementos quelados (por exemplo, como quelatos de aminocido), vitaminas e extratos de plantas, derivados de salicilato, bioflavonides e cidos orgnicos derivados de vegetais e frutas, polifenis extrados de frutas naturais, leo de laranja-da-terra, extratos ctricos, quitosana, amido, extrato de alga marinha, organossilicone, complexo de silcio ionizado ativado (Zumsil), cera de abelhas, uria, Bacillus subtilis, Bacillus amyloliquefaciens, Pseudomonas fluorescens, Pseudomonas putida, Pantoea agglomerans, Trichoderma koningii, Trichoderma harzianum, cloro e compostos de cloro (por exemplo, gua clorada, dixido de cloro, clorito de sdio, hipoclorito de sdio, cido hipocloroso, cloreto de amnio, cloreto de didecil dimetil amnio, cloreto de benzalcnio), oxignio, perxido de hidrognio (H2O2) e compostos de peroxignio, hidrognio cianamida, sulfato de nquel (III), persulfato de sdio, fosfitos como, por exemplo, fosfito de metal, como particularmente etil fosfito de alumnio, fosfato, fosfato trissdico, cido fosfrico, nitrognio inorgnico, prata e compostos que contm prata (por exemplo, prata coloidal), glutaraldedo, ramnolipdeo (Zonix).</span>[110] Within the meaning of the present invention compounds (C), which are selected from the group of products for soil improvement or plant stress reduction products, comprise, for example, C.5 Myconate. In addition, within the meaning of the present invention, compound (C) can be selected from at least one active compound selected from the group consisting of: Acetic acid (eg naphthalene acetic acid), peracetic acid, organic acids (eg , citric acid, lactic acid), amino acids (for example, 1-arginine), humic acids, fulvic acids, boric acid, oxolinic acid, 1,2,3-benzothiadiazole-7-thiocarboxylic-S-methyl ester, 5- hydroxy-1,4-naphthalenedione, bromo-chloro-dimethylhydantoin, trichloroisocyanuric acid, salicylic acid, dichlorophene, kanamycin, casugamycin, streptomycin, streptomycin sulfate, oxytetracycline, gentamicin (eg gentamicin sulfate hydrate, gentamicin hydrate), tebuconazole, thiabendazole, strip, teracep, octyline, quinoxyphen, azadiractin, furanoflavone, forclorfenuron, plant minerals (e.g. calcium, calcium carbonate, hypochlorite, calcium EDTA), enzymes (e.g. protease, amylase, lipase), mi chelated croelements and microelements (for example, as amino acid chelates), vitamins and plant extracts, salicylate derivatives, bioflavonoids and organic acids derived from vegetables and fruits, polyphenols extracted from natural fruits, ground orange oil, citrus extracts , chitosan, starch, kelp extract, organosilicone, activated ionized silicon complex (Zumsil), beeswax, urea, Bacillus subtilis, Bacillus amyloliquefaciens, Pseudomonas fluorescens, Pseudomonas putida, Pantoea agglomerans, Trichoderma cloning and chlorine compounds (eg, chlorinated water, chlorine dioxide, sodium chlorite, sodium hypochlorite, hypochlorous acid, ammonium chloride, didecyl dimethyl ammonium chloride, benzalkonium chloride), oxygen, hydrogen peroxide (H2O2) and peroxygen compounds, hydrogen cyanamide, nickel (III) sulfate, sodium persulfate, phosphites, such as metal phosphite, as particularly ethyl l aluminum phosphite, phosphate, trisodium phosphate, phosphoric acid, inorganic nitrogen, silver and compounds containing silver (eg colloidal silver), glutaraldehyde, ramnolipid (Zonix).</span>
  </p>
  <p id="p0111" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[111] Por conseguinte,  dada preferncia aos fosfitos como, por exemplo, fosfito de metal, como particularmente etil fosfito de alumnio.</span>[111] Therefore, preference is given to phosphites, such as metal phosphite, such as particularly ethyl aluminum phosphite.</span>
  </p>
  <p id="p0112" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[112] De preferncia, os indutores da defesa do hospedeiro e agentes de controle biolgico esto presentes em uma combinao que compreende pelo menos um composto adicional (C), que  selecionado do grupo que consiste em bactericidas (convencionais), antibiticos (convencionais), fungicidas (convencionais), inseticidas (convencionais), herbicidas (convencionais), cada um no pertencendo ao grupo de agentes de controle biolgico (B), micronutrientes e compostos que contm micronutrientes, e compostos de lipoquito-oligossacardeo (LCO), cada um como definido acima.</span>[112] Preferably, host defense inducers and biological control agents are present in a combination comprising at least one additional compound (C), which is selected from the group consisting of (conventional) bactericides, (conventional) antibiotics , fungicides (conventional), insecticides (conventional), herbicides (conventional), each not belonging to the group of biological control agents (B), micronutrients and compounds containing micronutrients, and lipoquito-oligosaccharide (LCO) compounds, each as defined above.</span>
  </p>
  <p id="p0113" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[113] De preferncia, pelo menos um composto adicional (C)  selecionado do grupo que consiste em fosetil-Al; fosfitos de metal, particularmente etil fosfito de alumnio; penflufen; estrobilurinas, como particularmente trifloxistrobina; neonicotinides (CNIs), como particularmente acetamiprida, clotianidina, imidacloprida e tiacloprida, piretrides, como particularmente betaciflutrina e deltametrina, flupiradifurona, cetoenis, como particularmente espirotetramat, espiromesifeno e espirodiclofeno; compostos que contm cobre e/ou zinco, como particularmente hidrxido de cobre, sulfato de cobre, propinebe e mancozebe; compostos de lipoquito- oligossacardeo (LCO); e antibiticos convencionais selecionados do grupo que consiste em casugamicina, estreptomicina e oxitetraciclina.</span>[113] Preferably, at least one additional compound (C) is selected from the group consisting of fosetyl-Al; metal phosphites, particularly ethyl aluminum phosphite; penflufen; strobilurins, such as particularly trifloxystrobin; neonicotinoids (CNIs), such as particularly acetamipride, clothianidin, imidacloprid and thiaclopride, pyrethroids, such as particularly betaciflutrin and deltamethrin, flupiradifurone, ketoenols, such as particularly spirotetramat, spiromesifene and spirodiclofen; compounds containing copper and / or zinc, such as copper hydroxide, copper sulfate, propineb and mancozebe; lipoquito-oligosaccharide compounds (LCO); and conventional antibiotics selected from the group consisting of casugamycin, streptomycin and oxytetracycline.</span>
  </p>
  <p id="p0114" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[114] Mais preferivelmente, pelo menos um composto adicional (C)  selecionado do grupo que consiste em fosetil-Al, etil fosfito de alumnio; trifloxistrobina; imidacloprida, tiacloprida, betaciflutrina, deltametrina, flupiradifurona, e combinaes destes; antibiticos convencionais selecionados do grupo que consiste em casugamicina, estreptomicina e oxitetraciclina.</span>[114] More preferably, at least one additional compound (C) is selected from the group consisting of fosetyl-Al, ethyl aluminum phosphite; trifloxystrobin; imidacloprid, thiaclopride, betaciflutrin, deltamethrin, flupiradifurone, and combinations thereof; conventional antibiotics selected from the group consisting of casugamycin, streptomycin and oxytetracycline.</span>
  </p>
  <p id="p0115" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[115] Uma modalidade particularmente preferida da presente inveno est relacionada ao uso da combinao, em que:(A) o indutor da defesa do hospedeiro  isotianil, (B) o agente de controle biolgico  selecionado do grupo que consiste em: 1) bactria consistindo em Bacillus subtilis cepa QST713/AQ713 (N de Acesso NRRL B21661), Bacillus subtilis cepa AQ 153 (N de Acesso NRRL 55614), Bacillus sp. cepa AQ 175 (N de Acesso ATCC 55608), Bacillus sp. cepa AQ 177 (N de Acesso ATCC 55609), e Bacillus sp. cepa AQ178 (N de Acesso ATCC 53522); e 2) fungo consistindo em Pseudozyma aphidis, e (C) pelo menos um composto adicional  selecionado do grupo que consiste em: fosetil-Al; etil fosfito de alumnio; trifloxistrobina; imidacloprida, tiacloprida, betaciflutrina, deltametrina, flupiradifurona, e combinaes destes; antibiticos adicionais selecionados do grupo que consiste em casugamicina, estreptomicina e oxitetraciclina.</span>[115] A particularly preferred embodiment of the present invention relates to the use of the combination, in which: (A) the host's defense inducer is isothianyl, (B) the biological control agent is selected from the group consisting of: 1) bacteria consisting of Bacillus subtilis strain QST713 / AQ713 (NRRL Accession No. B21661), Bacillus subtilis strain AQ 153 (NRRL Accession No. 55614), Bacillus sp. strain AQ 175 (ATCC Accession No. 55608), Bacillus sp. strain AQ 177 (ATCC Accession No. 55609), and Bacillus sp. strain AQ178 (ATCC Accession No. 53522); and 2) fungus consisting of Pseudozyma aphidis, and (C) at least one additional compound is selected from the group consisting of: fosetyl-Al; ethyl aluminum phosphite; trifloxystrobin; imidacloprid, thiaclopride, betaciflutrin, deltamethrin, flupiradifurone, and combinations thereof; additional antibiotics selected from the group consisting of casugamycin, streptomycin and oxytetracycline.</span>
  </p>
  <p id="p0116" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[116] Uma modalidade ainda mais preferida da presente inveno est relacionada ao uso de uma combinao, em que: (A) o indutor da defesa do hospedeiro  uma combinao de isotianil e acibenzolar-S-metil, (B) o agente de controle biolgico  selecionado do grupo que consiste em: 1) bactria consistindo em Bacillus subtilis cepa QST713/AQ713 (N de Acesso NRRL B21661), Bacillus subtilis cepa AQ153 (N de Acesso NRRL 55614), Bacillus sp. cepa AQ 175 (N de Acesso ATCC 55608), Bacillus sp. cepa AQ177 (N de Acesso ATCC 55609), e Bacillus sp. Cepa AQ178 (N de Acesso ATCC 53522); e 2) fungo consistindo em Pseudozyma aphidis, e(C) pelo menos um composto adicional  selecionado do grupo que consiste em: fosetil-Al; etil fosfito de alumnio; trifloxistrobina; imidacloprida, tiacloprida, betaciflutrina, deltametrina, flupiradifurona, e combinaes destes; antibiticos adicionais selecionados do grupo que consiste em casugamicina, estreptomicina e oxitetraciclina.</span>[116] An even more preferred embodiment of the present invention relates to the use of a combination, in which: (A) the host defense inducer is a combination of isothianyl and acibenzolar-S-methyl, (B) the control agent biological is selected from the group consisting of: 1) bacteria consisting of Bacillus subtilis strain QST713 / AQ713 (NRRL Accession No. B21661), Bacillus subtilis strain AQ153 (NRRL Accession No. 55614), Bacillus sp. strain AQ 175 (ATCC Accession No. 55608), Bacillus sp. strain AQ177 (ATCC Accession No. 55609), and Bacillus sp. AQ178 strain (ATCC Accession No. 53522); and 2) fungus consisting of Pseudozyma aphidis, and (C) at least one additional compound is selected from the group consisting of: fosetyl-Al; ethyl aluminum phosphite; trifloxystrobin; imidacloprid, thiaclopride, betaciflutrin, deltamethrin, flupiradifurone, and combinations thereof; additional antibiotics selected from the group consisting of casugamycin, streptomycin and oxytetracycline.</span>
  </p>
  <p id="p0117" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[117] De acordo com a presente inveno,  dada preferncia s seguintes combinaes binrias selecionadas do grupo que consiste em:</span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/24/d7/08/1a93c40cf5f8b2/img0006.png" class="style-scope patent-text"><img id="i0006" wi="463" he="466" img-content="drawing" img-format="jpg" file="img0006.jpg" orientation="unknown" width="1852" height="1864" alt="Figure img0006" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/24/d7/08/1a93c40cf5f8b2/img0006.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/d6/51/01/5d4c084c6214da/img0007.png" class="style-scope patent-text"><img id="i0007" wi="479" he="292" img-content="drawing" img-format="jpg" file="img0007.jpg" orientation="unknown" width="1916" height="1168" alt="Figure img0007" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/d6/51/01/5d4c084c6214da/img0007.png"></a></div>
		[117] In accordance with the present invention, preference is given to the following binary combinations selected from the group consisting of: <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/24/d7/08/1a93c40cf5f8b2/img0006.png" class="style-scope patent-text"><img id="i0006" wi="463" he="466" img-content="drawing" img-format="jpg" file="img0006.jpg" orientation="unknown" width="1852" height="1864" alt="Figure img0006" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/24/d7/08/1a93c40cf5f8b2/img0006.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/d6/51/01/5d4c084c6214da/img0007.png" class="style-scope patent-text"><img id="i0007" wi="479" he="292" img-content="drawing" img-format="jpg" file="img0007.jpg" orientation="unknown" width="1916" height="1168" alt="Figure img0007" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/d6/51/01/5d4c084c6214da/img0007.png"></a></div> 
  <p class="style-scope patent-text"></p>
  <p id="p0118" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[118] Dessas, as seguintes combinaes so ainda mais preferidas:</span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/08/84/d0/d36a40a6869934/img0008.png" class="style-scope patent-text"><img id="i0008" wi="484" he="196" img-content="drawing" img-format="jpg" file="img0008.jpg" orientation="unknown" width="1936" height="784" alt="Figure img0008" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/08/84/d0/d36a40a6869934/img0008.png"></a></div>
		[118] Of these, the following combinations are even more preferred: <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/08/84/d0/d36a40a6869934/img0008.png" class="style-scope patent-text"><img id="i0008" wi="484" he="196" img-content="drawing" img-format="jpg" file="img0008.jpg" orientation="unknown" width="1936" height="784" alt="Figure img0008" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/08/84/d0/d36a40a6869934/img0008.png"></a></div> 
  <p class="style-scope patent-text"></p>
  <p id="p0119" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[119] Principalmente,  dada preferncia s seguintes combinaes:</span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/2f/9c/a4/6faf42ac64baf3/img0009.png" class="style-scope patent-text"><img id="i0009" wi="507" he="98" img-content="drawing" img-format="jpg" file="img0009.jpg" orientation="unknown" width="2028" height="392" alt="Figure img0009" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/2f/9c/a4/6faf42ac64baf3/img0009.png"></a></div>
		[119] Mainly, preference is given to the following combinations: <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/2f/9c/a4/6faf42ac64baf3/img0009.png" class="style-scope patent-text"><img id="i0009" wi="507" he="98" img-content="drawing" img-format="jpg" file="img0009.jpg" orientation="unknown" width="2028" height="392" alt="Figure img0009" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/2f/9c/a4/6faf42ac64baf3/img0009.png"></a></div> 
  <p class="style-scope patent-text"></p>
  <p id="p0120" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[120] Dessas, a combinao (A.2) + (B.1.1)  a mais preferida.</span>[120] Of these, the combination (A.2) + (B.1.1) is the most preferred.</span>
  </p>
  <p id="p0121" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[121] Todas as combinaes binrias mencionadas acima podem ser combinadas com pelo menos um bactericida, antibitico, fungicida, acaricida, nematicida, herbicida, inseticida conhecido adicional, micronutrientes e composto que contm micronutriente, protetor, lipoquito- oligossacardeos (LCO), produto para aprimoramento do solo ou produto para reduo de estresse de plantas, por exemplo, Myconate, a fim de ampliar o espectro de ao ou evitar o desenvolvimento de resistncia, por exemplo.</span>[121] All binary combinations mentioned above can be combined with at least one bactericide, antibiotic, fungicide, acaricide, nematicide, herbicide, additional known insecticide, micronutrients and compound containing micronutrient, protector, lipoquito-oligosaccharides (LCO), product for improvement of the soil or product to reduce plant stress, for example, Myconate, in order to broaden the spectrum of action or prevent the development of resistance, for example.</span>
  </p>
  <p id="p0122" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[122] De acordo com a presente inveno,  dada preferncia s seguintes combinaes ternrias selecionadas do grupo que consiste em:</span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/fc/92/e9/65957b824f5c06/img0010.png" class="style-scope patent-text"><img id="i0010" wi="478" he="147" img-content="drawing" img-format="jpg" file="img0010.jpg" orientation="unknown" width="1912" height="588" alt="Figure img0010" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/fc/92/e9/65957b824f5c06/img0010.png"></a></div>
		[122] In accordance with the present invention, preference is given to the following ternary combinations selected from the group consisting of: <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/fc/92/e9/65957b824f5c06/img0010.png" class="style-scope patent-text"><img id="i0010" wi="478" he="147" img-content="drawing" img-format="jpg" file="img0010.jpg" orientation="unknown" width="1912" height="588" alt="Figure img0010" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/fc/92/e9/65957b824f5c06/img0010.png"></a></div> 
  <p class="style-scope patent-text"></p>
  <p id="p0123" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[123] Tambm  dada preferncia s seguintes combinaes quaternrias selecionadas do grupo que consiste em:</span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/75/36/49/6bc69bb1458a40/img0011.png" class="style-scope patent-text"><img id="i0011" wi="494" he="235" img-content="drawing" img-format="jpg" file="img0011.jpg" orientation="unknown" width="1976" height="940" alt="Figure img0011" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/75/36/49/6bc69bb1458a40/img0011.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/10/2f/e8/034147daaec306/img0012.png" class="style-scope patent-text"><img id="i0012" wi="502" he="718" img-content="drawing" img-format="jpg" file="img0012.jpg" orientation="unknown" width="2008" height="2872" alt="Figure img0012" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/10/2f/e8/034147daaec306/img0012.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/07/dd/da/f5ca1dbd464173/img0013.png" class="style-scope patent-text"><img id="i0013" wi="479" he="723" img-content="drawing" img-format="jpg" file="img0013.jpg" orientation="unknown" width="1916" height="2892" alt="Figure img0013" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/07/dd/da/f5ca1dbd464173/img0013.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/c3/50/b5/5e9fc4239436a4/img0014.png" class="style-scope patent-text"><img id="i0014" wi="475" he="369" img-content="drawing" img-format="jpg" file="img0014.jpg" orientation="unknown" width="1900" height="1476" alt="Figure img0014" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/c3/50/b5/5e9fc4239436a4/img0014.png"></a></div>
		[123] Preference is also given to the following quaternary combinations selected from the group consisting of: <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/75/36/49/6bc69bb1458a40/img0011.png" class="style-scope patent-text"><img id="i0011" wi="494" he="235" img-content="drawing" img-format="jpg" file="img0011.jpg" orientation="unknown" width="1976" height="940" alt="Figure img0011" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/75/36/49/6bc69bb1458a40/img0011.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/10/2f/e8/034147daaec306/img0012.png" class="style-scope patent-text"><img id="i0012" wi="502" he="718" img-content="drawing" img-format="jpg" file="img0012.jpg" orientation="unknown" width="2008" height="2872" alt="Figure img0012" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/10/2f/e8/034147daaec306/img0012.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/07/dd/da/f5ca1dbd464173/img0013.png" class="style-scope patent-text"><img id="i0013" wi="479" he="723" img-content="drawing" img-format="jpg" file="img0013.jpg" orientation="unknown" width="1916" height="2892" alt="Figure img0013" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/07/dd/da/f5ca1dbd464173/img0013.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/c3/50/b5/5e9fc4239436a4/img0014.png" class="style-scope patent-text"><img id="i0014" wi="475" he="369" img-content="drawing" img-format="jpg" file="img0014.jpg" orientation="unknown" width="1900" height="1476" alt="Figure img0014" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/c3/50/b5/5e9fc4239436a4/img0014.png"></a></div> 
  <p class="style-scope patent-text"></p>
  <p id="p0124" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[124] De acordo com a presente inveno, tambm  dada preferncia s seguintes combinaes ternrias selecionadas do grupo que consiste em:</span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/05/57/f8/7822eff596df80/img0015.png" class="style-scope patent-text"><img id="i0015" wi="483" he="309" img-content="drawing" img-format="jpg" file="img0015.jpg" orientation="unknown" width="1932" height="1236" alt="Figure img0015" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/05/57/f8/7822eff596df80/img0015.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/99/a4/e8/8d1f999c5c7d86/img0016.png" class="style-scope patent-text"><img id="i0016" wi="493" he="726" img-content="drawing" img-format="jpg" file="img0016.jpg" orientation="unknown" width="1972" height="2904" alt="Figure img0016" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/99/a4/e8/8d1f999c5c7d86/img0016.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/8e/c0/ff/4652fd65614400/img0017.png" class="style-scope patent-text"><img id="i0017" wi="476" he="725" img-content="drawing" img-format="jpg" file="img0017.jpg" orientation="unknown" width="1904" height="2900" alt="Figure img0017" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/8e/c0/ff/4652fd65614400/img0017.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/c6/9d/c6/53b1739c66067f/img0018.png" class="style-scope patent-text"><img id="i0018" wi="506" he="735" img-content="drawing" img-format="jpg" file="img0018.jpg" orientation="unknown" width="2024" height="2940" alt="Figure img0018" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/c6/9d/c6/53b1739c66067f/img0018.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/f7/bc/50/01a283156fdb71/img0019.png" class="style-scope patent-text"><img id="i0019" wi="480" he="721" img-content="drawing" img-format="jpg" file="img0019.jpg" orientation="unknown" width="1920" height="2884" alt="Figure img0019" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/f7/bc/50/01a283156fdb71/img0019.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/81/82/eb/e3d64d5f4e0a5a/img0020.png" class="style-scope patent-text"><img id="i0020" wi="491" he="722" img-content="drawing" img-format="jpg" file="img0020.jpg" orientation="unknown" width="1964" height="2888" alt="Figure img0020" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/81/82/eb/e3d64d5f4e0a5a/img0020.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/95/d9/2c/bc482ec8cce969/img0021.png" class="style-scope patent-text"><img id="i0021" wi="477" he="720" img-content="drawing" img-format="jpg" file="img0021.jpg" orientation="unknown" width="1908" height="2880" alt="Figure img0021" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/95/d9/2c/bc482ec8cce969/img0021.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/8f/8b/00/350da2bb5406bd/img0022.png" class="style-scope patent-text"><img id="i0022" wi="482" he="730" img-content="drawing" img-format="jpg" file="img0022.jpg" orientation="unknown" width="1928" height="2920" alt="Figure img0022" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/8f/8b/00/350da2bb5406bd/img0022.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/06/8b/ca/803a48330eb3ed/img0023.png" class="style-scope patent-text"><img id="i0023" wi="470" he="731" img-content="drawing" img-format="jpg" file="img0023.jpg" orientation="unknown" width="1880" height="2924" alt="Figure img0023" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/06/8b/ca/803a48330eb3ed/img0023.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/27/d7/42/e9239af2fab422/img0024.png" class="style-scope patent-text"><img id="i0024" wi="483" he="738" img-content="drawing" img-format="jpg" file="img0024.jpg" orientation="unknown" width="1932" height="2952" alt="Figure img0024" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/27/d7/42/e9239af2fab422/img0024.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/21/c7/6f/a3765770086499/img0025.png" class="style-scope patent-text"><img id="i0025" wi="474" he="729" img-content="drawing" img-format="jpg" file="img0025.jpg" orientation="unknown" width="1896" height="2916" alt="Figure img0025" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/21/c7/6f/a3765770086499/img0025.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/5e/09/43/1d10116d4629e2/img0026.png" class="style-scope patent-text"><img id="i0026" wi="489" he="723" img-content="drawing" img-format="jpg" file="img0026.jpg" orientation="unknown" width="1956" height="2892" alt="Figure img0026" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/5e/09/43/1d10116d4629e2/img0026.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/1a/9b/90/60da14695a02f9/img0027.png" class="style-scope patent-text"><img id="i0027" wi="472" he="714" img-content="drawing" img-format="jpg" file="img0027.jpg" orientation="unknown" width="1888" height="2856" alt="Figure img0027" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/1a/9b/90/60da14695a02f9/img0027.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/10/a1/6b/924f4d9c6aab81/img0028.png" class="style-scope patent-text"><img id="i0028" wi="474" he="737" img-content="drawing" img-format="jpg" file="img0028.jpg" orientation="unknown" width="1896" height="2948" alt="Figure img0028" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/10/a1/6b/924f4d9c6aab81/img0028.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/de/6c/eb/f89241822f4be9/img0029.png" class="style-scope patent-text"><img id="i0029" wi="478" he="714" img-content="drawing" img-format="jpg" file="img0029.jpg" orientation="unknown" width="1912" height="2856" alt="Figure img0029" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/de/6c/eb/f89241822f4be9/img0029.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7a/05/0d/c2b420591820a4/img0030.png" class="style-scope patent-text"><img id="i0030" wi="477" he="731" img-content="drawing" img-format="jpg" file="img0030.jpg" orientation="unknown" width="1908" height="2924" alt="Figure img0030" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7a/05/0d/c2b420591820a4/img0030.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/01/12/db/6282d1089a1f51/img0031.png" class="style-scope patent-text"><img id="i0031" wi="478" he="716" img-content="drawing" img-format="jpg" file="img0031.jpg" orientation="unknown" width="1912" height="2864" alt="Figure img0031" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/01/12/db/6282d1089a1f51/img0031.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/e7/86/d8/56fcea16c4797e/img0032.png" class="style-scope patent-text"><img id="i0032" wi="475" he="722" img-content="drawing" img-format="jpg" file="img0032.jpg" orientation="unknown" width="1900" height="2888" alt="Figure img0032" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/e7/86/d8/56fcea16c4797e/img0032.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/f9/f0/9a/f2bb49221816cc/img0033.png" class="style-scope patent-text"><img id="i0033" wi="475" he="712" img-content="drawing" img-format="jpg" file="img0033.jpg" orientation="unknown" width="1900" height="2848" alt="Figure img0033" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/f9/f0/9a/f2bb49221816cc/img0033.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/de/0a/72/a1a8483134099c/img0034.png" class="style-scope patent-text"><img id="i0034" wi="477" he="717" img-content="drawing" img-format="jpg" file="img0034.jpg" orientation="unknown" width="1908" height="2868" alt="Figure img0034" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/de/0a/72/a1a8483134099c/img0034.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/97/de/23/23b0034a0c1504/img0035.png" class="style-scope patent-text"><img id="i0035" wi="478" he="720" img-content="drawing" img-format="jpg" file="img0035.jpg" orientation="unknown" width="1912" height="2880" alt="Figure img0035" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/97/de/23/23b0034a0c1504/img0035.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/73/ef/c6/cc1824a0d10959/img0036.png" class="style-scope patent-text"><img id="i0036" wi="488" he="731" img-content="drawing" img-format="jpg" file="img0036.jpg" orientation="unknown" width="1952" height="2924" alt="Figure img0036" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/73/ef/c6/cc1824a0d10959/img0036.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/f8/6a/85/de428ad651fcda/img0037.png" class="style-scope patent-text"><img id="i0037" wi="492" he="736" img-content="drawing" img-format="jpg" file="img0037.jpg" orientation="unknown" width="1968" height="2944" alt="Figure img0037" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/f8/6a/85/de428ad651fcda/img0037.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/4a/ec/4b/4685b841c5d555/img0038.png" class="style-scope patent-text"><img id="i0038" wi="469" he="721" img-content="drawing" img-format="jpg" file="img0038.jpg" orientation="unknown" width="1876" height="2884" alt="Figure img0038" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/4a/ec/4b/4685b841c5d555/img0038.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/0a/24/85/4967f15142e423/img0039.png" class="style-scope patent-text"><img id="i0039" wi="475" he="710" img-content="drawing" img-format="jpg" file="img0039.jpg" orientation="unknown" width="1900" height="2840" alt="Figure img0039" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/0a/24/85/4967f15142e423/img0039.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/01/d1/fe/62266c3029b9d6/img0040.png" class="style-scope patent-text"><img id="i0040" wi="494" he="733" img-content="drawing" img-format="jpg" file="img0040.jpg" orientation="unknown" width="1976" height="2932" alt="Figure img0040" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/01/d1/fe/62266c3029b9d6/img0040.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/cd/83/4efcb4377775fd/img0041.png" class="style-scope patent-text"><img id="i0041" wi="459" he="727" img-content="drawing" img-format="jpg" file="img0041.jpg" orientation="unknown" width="1836" height="2908" alt="Figure img0041" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/cd/83/4efcb4377775fd/img0041.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/ee/37/fa/29f0c1e21aeff1/img0042.png" class="style-scope patent-text"><img id="i0042" wi="458" he="727" img-content="drawing" img-format="jpg" file="img0042.jpg" orientation="unknown" width="1832" height="2908" alt="Figure img0042" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/ee/37/fa/29f0c1e21aeff1/img0042.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/27/1b/10/50061c5087ee33/img0043.png" class="style-scope patent-text"><img id="i0043" wi="491" he="711" img-content="drawing" img-format="jpg" file="img0043.jpg" orientation="unknown" width="1964" height="2844" alt="Figure img0043" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/27/1b/10/50061c5087ee33/img0043.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/b1/91/bc/1e7908fe23e59d/img0044.png" class="style-scope patent-text"><img id="i0044" wi="481" he="722" img-content="drawing" img-format="jpg" file="img0044.jpg" orientation="unknown" width="1924" height="2888" alt="Figure img0044" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/b1/91/bc/1e7908fe23e59d/img0044.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/f9/35/85/548ab1b39d1a19/img0045.png" class="style-scope patent-text"><img id="i0045" wi="466" he="727" img-content="drawing" img-format="jpg" file="img0045.jpg" orientation="unknown" width="1864" height="2908" alt="Figure img0045" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/f9/35/85/548ab1b39d1a19/img0045.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/97/ff/12/6cb47d30b77662/img0046.png" class="style-scope patent-text"><img id="i0046" wi="473" he="724" img-content="drawing" img-format="jpg" file="img0046.jpg" orientation="unknown" width="1892" height="2896" alt="Figure img0046" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/97/ff/12/6cb47d30b77662/img0046.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/85/b4/81/e2dfac1e105e86/img0047.png" class="style-scope patent-text"><img id="i0047" wi="469" he="727" img-content="drawing" img-format="jpg" file="img0047.jpg" orientation="unknown" width="1876" height="2908" alt="Figure img0047" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/85/b4/81/e2dfac1e105e86/img0047.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/56/43/91/f1b9eb2b6c13af/img0048.png" class="style-scope patent-text"><img id="i0048" wi="467" he="735" img-content="drawing" img-format="jpg" file="img0048.jpg" orientation="unknown" width="1868" height="2940" alt="Figure img0048" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/56/43/91/f1b9eb2b6c13af/img0048.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/82/aa/9e/1412887685044d/img0049.png" class="style-scope patent-text"><img id="i0049" wi="469" he="725" img-content="drawing" img-format="jpg" file="img0049.jpg" orientation="unknown" width="1876" height="2900" alt="Figure img0049" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/82/aa/9e/1412887685044d/img0049.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/03/b7/ce/8feefc5f8c2865/img0050.png" class="style-scope patent-text"><img id="i0050" wi="462" he="711" img-content="drawing" img-format="jpg" file="img0050.jpg" orientation="unknown" width="1848" height="2844" alt="Figure img0050" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/03/b7/ce/8feefc5f8c2865/img0050.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/b9/7d/e8/4555afdbcdbbfd/img0051.png" class="style-scope patent-text"><img id="i0051" wi="474" he="723" img-content="drawing" img-format="jpg" file="img0051.jpg" orientation="unknown" width="1896" height="2892" alt="Figure img0051" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/b9/7d/e8/4555afdbcdbbfd/img0051.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/ed/b3/5a/936fda57b3aa04/img0052.png" class="style-scope patent-text"><img id="i0052" wi="473" he="717" img-content="drawing" img-format="jpg" file="img0052.jpg" orientation="unknown" width="1892" height="2868" alt="Figure img0052" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/ed/b3/5a/936fda57b3aa04/img0052.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/ab/94/0a/2ace483b749be6/img0053.png" class="style-scope patent-text"><img id="i0053" wi="475" he="567" img-content="drawing" img-format="jpg" file="img0053.jpg" orientation="unknown" width="1900" height="2268" alt="Figure img0053" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/ab/94/0a/2ace483b749be6/img0053.png"></a></div>
		[124] In accordance with the present invention, preference is also given to the following ternary combinations selected from the group consisting of: <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/05/57/f8/7822eff596df80/img0015.png" class="style-scope patent-text"><img id="i0015" wi="483" he="309" img-content="drawing" img-format="jpg" file="img0015.jpg" orientation="unknown" width="1932" height="1236" alt="Figure img0015" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/05/57/f8/7822eff596df80/img0015.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/99/a4/e8/8d1f999c5c7d86/img0016.png" class="style-scope patent-text"><img id="i0016" wi="493" he="726" img-content="drawing" img-format="jpg" file="img0016.jpg" orientation="unknown" width="1972" height="2904" alt="Figure img0016" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/99/a4/e8/8d1f999c5c7d86/img0016.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/8e/c0/ff/4652fd65614400/img0017.png" class="style-scope patent-text"><img id="i0017" wi="476" he="725" img-content="drawing" img-format="jpg" file="img0017.jpg" orientation="unknown" width="1904" height="2900" alt="Figure img0017" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/8e/c0/ff/4652fd65614400/img0017.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/c6/9d/c6/53b1739c66067f/img0018.png" class="style-scope patent-text"><img id="i0018" wi="506" he="735" img-content="drawing" img-format="jpg" file="img0018.jpg" orientation="unknown" width="2024" height="2940" alt="Figure img0018" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/c6/9d/c6/53b1739c66067f/img0018.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/f7/bc/50/01a283156fdb71/img0019.png" class="style-scope patent-text"><img id="i0019" wi="480" he="721" img-content="drawing" img-format="jpg" file="img0019.jpg" orientation="unknown" width="1920" height="2884" alt="Figure img0019" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/f7/bc/50/01a283156fdb71/img0019.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/81/82/eb/e3d64d5f4e0a5a/img0020.png" class="style-scope patent-text"><img id="i0020" wi="491" he="722" img-content="drawing" img-format="jpg" file="img0020.jpg" orientation="unknown" width="1964" height="2888" alt="Figure img0020" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/81/82/eb/e3d64d5f4e0a5a/img0020.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/95/d9/2c/bc482ec8cce969/img0021.png" class="style-scope patent-text"><img id="i0021" wi="477" he="720" img-content="drawing" img-format="jpg" file="img0021.jpg" orientation="unknown" width="1908" height="2880" alt="Figure img0021" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/95/d9/2c/bc482ec8cce969/img0021.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/8f/8b/00/350da2bb5406bd/img0022.png" class="style-scope patent-text"><img id="i0022" wi="482" he="730" img-content="drawing" img-format="jpg" file="img0022.jpg" orientation="unknown" width="1928" height="2920" alt="Figure img0022" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/8f/8b/00/350da2bb5406bd/img0022.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/06/8b/ca/803a48330eb3ed/img0023.png" class="style-scope patent-text"><img id="i0023" wi="470" he="731" img-content="drawing" img-format="jpg" file="img0023.jpg" orientation="unknown" width="1880" height="2924" alt="Figure img0023" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/06/8b/ca/803a48330eb3ed/img0023.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/27/d7/42/e9239af2fab422/img0024.png" class="style-scope patent-text"><img id="i0024" wi="483" he="738" img-content="drawing" img-format="jpg" file="img0024.jpg" orientation="unknown" width="1932" height="2952" alt="Figure img0024" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/27/d7/42/e9239af2fab422/img0024.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/21/c7/6f/a3765770086499/img0025.png" class="style-scope patent-text"><img id="i0025" wi="474" he="729" img-content="drawing" img-format="jpg" file="img0025.jpg" orientation="unknown" width="1896" height="2916" alt="Figure img0025" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/21/c7/6f/a3765770086499/img0025.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/5e/09/43/1d10116d4629e2/img0026.png" class="style-scope patent-text"><img id="i0026" wi="489" he="723" img-content="drawing" img-format="jpg" file="img0026.jpg" orientation="unknown" width="1956" height="2892" alt="Figure img0026" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/5e/09/43/1d10116d4629e2/img0026.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/1a/9b/90/60da14695a02f9/img0027.png" class="style-scope patent-text"><img id="i0027" wi="472" he="714" img-content="drawing" img-format="jpg" file="img0027.jpg" orientation="unknown" width="1888" height="2856" alt="Figure img0027" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/1a/9b/90/60da14695a02f9/img0027.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/10/a1/6b/924f4d9c6aab81/img0028.png" class="style-scope patent-text"><img id="i0028" wi="474" he="737" img-content="drawing" img-format="jpg" file="img0028.jpg" orientation="unknown" width="1896" height="2948" alt="Figure img0028" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/10/a1/6b/924f4d9c6aab81/img0028.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/de/6c/eb/f89241822f4be9/img0029.png" class="style-scope patent-text"><img id="i0029" wi="478" he="714" img-content="drawing" img-format="jpg" file="img0029.jpg" orientation="unknown" width="1912" height="2856" alt="Figure img0029" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/de/6c/eb/f89241822f4be9/img0029.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7a/05/0d/c2b420591820a4/img0030.png" class="style-scope patent-text"><img id="i0030" wi="477" he="731" img-content="drawing" img-format="jpg" file="img0030.jpg" orientation="unknown" width="1908" height="2924" alt="Figure img0030" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7a/05/0d/c2b420591820a4/img0030.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/01/12/db/6282d1089a1f51/img0031.png" class="style-scope patent-text"><img id="i0031" wi="478" he="716" img-content="drawing" img-format="jpg" file="img0031.jpg" orientation="unknown" width="1912" height="2864" alt="Figure img0031" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/01/12/db/6282d1089a1f51/img0031.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/e7/86/d8/56fcea16c4797e/img0032.png" class="style-scope patent-text"><img id="i0032" wi="475" he="722" img-content="drawing" img-format="jpg" file="img0032.jpg" orientation="unknown" width="1900" height="2888" alt="Figure img0032" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/e7/86/d8/56fcea16c4797e/img0032.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/f9/f0/9a/f2bb49221816cc/img0033.png" class="style-scope patent-text"><img id="i0033" wi="475" he="712" img-content="drawing" img-format="jpg" file="img0033.jpg" orientation="unknown" width="1900" height="2848" alt="Figure img0033" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/f9/f0/9a/f2bb49221816cc/img0033.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/de/0a/72/a1a8483134099c/img0034.png" class="style-scope patent-text"><img id="i0034" wi="477" he="717" img-content="drawing" img-format="jpg" file="img0034.jpg" orientation="unknown" width="1908" height="2868" alt="Figure img0034" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/de/0a/72/a1a8483134099c/img0034.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/97/de/23/23b0034a0c1504/img0035.png" class="style-scope patent-text"><img id="i0035" wi="478" he="720" img-content="drawing" img-format="jpg" file="img0035.jpg" orientation="unknown" width="1912" height="2880" alt="Figure img0035" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/97/de/23/23b0034a0c1504/img0035.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/73/ef/c6/cc1824a0d10959/img0036.png" class="style-scope patent-text"><img id="i0036" wi="488" he="731" img-content="drawing" img-format="jpg" file="img0036.jpg" orientation="unknown" width="1952" height="2924" alt="Figure img0036" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/73/ef/c6/cc1824a0d10959/img0036.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/f8/6a/85/de428ad651fcda/img0037.png" class="style-scope patent-text"><img id="i0037" wi="492" he="736" img-content="drawing" img-format="jpg" file="img0037.jpg" orientation="unknown" width="1968" height="2944" alt="Figure img0037" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/f8/6a/85/de428ad651fcda/img0037.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/4a/ec/4b/4685b841c5d555/img0038.png" class="style-scope patent-text"><img id="i0038" wi="469" he="721" img-content="drawing" img-format="jpg" file="img0038.jpg" orientation="unknown" width="1876" height="2884" alt="Figure img0038" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/4a/ec/4b/4685b841c5d555/img0038.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/0a/24/85/4967f15142e423/img0039.png" class="style-scope patent-text"><img id="i0039" wi="475" he="710" img-content="drawing" img-format="jpg" file="img0039.jpg" orientation="unknown" width="1900" height="2840" alt="Figure img0039" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/0a/24/85/4967f15142e423/img0039.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/01/d1/fe/62266c3029b9d6/img0040.png" class="style-scope patent-text"><img id="i0040" wi="494" he="733" img-content="drawing" img-format="jpg" file="img0040.jpg" orientation="unknown" width="1976" height="2932" alt="Figure img0040" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/01/d1/fe/62266c3029b9d6/img0040.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/cd/83/4efcb4377775fd/img0041.png" class="style-scope patent-text"><img id="i0041" wi="459" he="727" img-content="drawing" img-format="jpg" file="img0041.jpg" orientation="unknown" width="1836" height="2908" alt="Figure img0041" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/cd/83/4efcb4377775fd/img0041.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/ee/37/fa/29f0c1e21aeff1/img0042.png" class="style-scope patent-text"><img id="i0042" wi="458" he="727" img-content="drawing" img-format="jpg" file="img0042.jpg" orientation="unknown" width="1832" height="2908" alt="Figure img0042" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/ee/37/fa/29f0c1e21aeff1/img0042.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/27/1b/10/50061c5087ee33/img0043.png" class="style-scope patent-text"><img id="i0043" wi="491" he="711" img-content="drawing" img-format="jpg" file="img0043.jpg" orientation="unknown" width="1964" height="2844" alt="Figure img0043" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/27/1b/10/50061c5087ee33/img0043.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/b1/91/bc/1e7908fe23e59d/img0044.png" class="style-scope patent-text"><img id="i0044" wi="481" he="722" img-content="drawing" img-format="jpg" file="img0044.jpg" orientation="unknown" width="1924" height="2888" alt="Figure img0044" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/b1/91/bc/1e7908fe23e59d/img0044.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/f9/35/85/548ab1b39d1a19/img0045.png" class="style-scope patent-text"><img id="i0045" wi="466" he="727" img-content="drawing" img-format="jpg" file="img0045.jpg" orientation="unknown" width="1864" height="2908" alt="Figure img0045" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/f9/35/85/548ab1b39d1a19/img0045.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/97/ff/12/6cb47d30b77662/img0046.png" class="style-scope patent-text"><img id="i0046" wi="473" he="724" img-content="drawing" img-format="jpg" file="img0046.jpg" orientation="unknown" width="1892" height="2896" alt="Figure img0046" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/97/ff/12/6cb47d30b77662/img0046.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/85/b4/81/e2dfac1e105e86/img0047.png" class="style-scope patent-text"><img id="i0047" wi="469" he="727" img-content="drawing" img-format="jpg" file="img0047.jpg" orientation="unknown" width="1876" height="2908" alt="Figure img0047" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/85/b4/81/e2dfac1e105e86/img0047.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/56/43/91/f1b9eb2b6c13af/img0048.png" class="style-scope patent-text"><img id="i0048" wi="467" he="735" img-content="drawing" img-format="jpg" file="img0048.jpg" orientation="unknown" width="1868" height="2940" alt="Figure img0048" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/56/43/91/f1b9eb2b6c13af/img0048.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/82/aa/9e/1412887685044d/img0049.png" class="style-scope patent-text"><img id="i0049" wi="469" he="725" img-content="drawing" img-format="jpg" file="img0049.jpg" orientation="unknown" width="1876" height="2900" alt="Figure img0049" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/82/aa/9e/1412887685044d/img0049.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/03/b7/ce/8feefc5f8c2865/img0050.png" class="style-scope patent-text"><img id="i0050" wi="462" he="711" img-content="drawing" img-format="jpg" file="img0050.jpg" orientation="unknown" width="1848" height="2844" alt="Figure img0050" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/03/b7/ce/8feefc5f8c2865/img0050.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/b9/7d/e8/4555afdbcdbbfd/img0051.png" class="style-scope patent-text"><img id="i0051" wi="474" he="723" img-content="drawing" img-format="jpg" file="img0051.jpg" orientation="unknown" width="1896" height="2892" alt="Figure img0051" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/b9/7d/e8/4555afdbcdbbfd/img0051.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/ed/b3/5a/936fda57b3aa04/img0052.png" class="style-scope patent-text"><img id="i0052" wi="473" he="717" img-content="drawing" img-format="jpg" file="img0052.jpg" orientation="unknown" width="1892" height="2868" alt="Figure img0052" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/ed/b3/5a/936fda57b3aa04/img0052.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/ab/94/0a/2ace483b749be6/img0053.png" class="style-scope patent-text"><img id="i0053" wi="475" he="567" img-content="drawing" img-format="jpg" file="img0053.jpg" orientation="unknown" width="1900" height="2268" alt="Figure img0053" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/ab/94/0a/2ace483b749be6/img0053.png"></a></div> 
  <p class="style-scope patent-text"></p>
  <p id="p0125" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[125] Dessas, as seguintes combinaes so ainda mais preferidas:</span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/c9/db/20/3d1ef9bbd694fa/img0054.png" class="style-scope patent-text"><img id="i0054" wi="452" he="107" img-content="drawing" img-format="jpg" file="img0054.jpg" orientation="unknown" width="1808" height="428" alt="Figure img0054" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/c9/db/20/3d1ef9bbd694fa/img0054.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/04/be/f5/033627ee5d9db4/img0055.png" class="style-scope patent-text"><img id="i0055" wi="480" he="733" img-content="drawing" img-format="jpg" file="img0055.jpg" orientation="unknown" width="1920" height="2932" alt="Figure img0055" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/04/be/f5/033627ee5d9db4/img0055.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/2a/ff/37/a596c86e199287/img0056.png" class="style-scope patent-text"><img id="i0056" wi="483" he="743" img-content="drawing" img-format="jpg" file="img0056.jpg" orientation="unknown" width="1932" height="2972" alt="Figure img0056" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/2a/ff/37/a596c86e199287/img0056.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/31/21/42/7859c31b82f091/img0057.png" class="style-scope patent-text"><img id="i0057" wi="469" he="701" img-content="drawing" img-format="jpg" file="img0057.jpg" orientation="unknown" width="1876" height="2804" alt="Figure img0057" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/31/21/42/7859c31b82f091/img0057.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/71/f9/d4/16dbd198bbf5a8/img0058.png" class="style-scope patent-text"><img id="i0058" wi="478" he="717" img-content="drawing" img-format="jpg" file="img0058.jpg" orientation="unknown" width="1912" height="2868" alt="Figure img0058" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/71/f9/d4/16dbd198bbf5a8/img0058.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/2f/d0/28/316d6bb8e441ea/img0059.png" class="style-scope patent-text"><img id="i0059" wi="490" he="738" img-content="drawing" img-format="jpg" file="img0059.jpg" orientation="unknown" width="1960" height="2952" alt="Figure img0059" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/2f/d0/28/316d6bb8e441ea/img0059.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/10/a7/26/69fa58b0b63a57/img0060.png" class="style-scope patent-text"><img id="i0060" wi="478" he="580" img-content="drawing" img-format="jpg" file="img0060.jpg" orientation="unknown" width="1912" height="2320" alt="Figure img0060" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/10/a7/26/69fa58b0b63a57/img0060.png"></a></div>
		[125] Of these, the following combinations are even more preferred: <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/c9/db/20/3d1ef9bbd694fa/img0054.png" class="style-scope patent-text"><img id="i0054" wi="452" he="107" img-content="drawing" img-format="jpg" file="img0054.jpg" orientation="unknown" width="1808" height="428" alt="Figure img0054" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/c9/db/20/3d1ef9bbd694fa/img0054.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/04/be/f5/033627ee5d9db4/img0055.png" class="style-scope patent-text"><img id="i0055" wi="480" he="733" img-content="drawing" img-format="jpg" file="img0055.jpg" orientation="unknown" width="1920" height="2932" alt="Figure img0055" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/04/be/f5/033627ee5d9db4/img0055.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/2a/ff/37/a596c86e199287/img0056.png" class="style-scope patent-text"><img id="i0056" wi="483" he="743" img-content="drawing" img-format="jpg" file="img0056.jpg" orientation="unknown" width="1932" height="2972" alt="Figure img0056" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/2a/ff/37/a596c86e199287/img0056.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/31/21/42/7859c31b82f091/img0057.png" class="style-scope patent-text"><img id="i0057" wi="469" he="701" img-content="drawing" img-format="jpg" file="img0057.jpg" orientation="unknown" width="1876" height="2804" alt="Figure img0057" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/31/21/42/7859c31b82f091/img0057.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/71/f9/d4/16dbd198bbf5a8/img0058.png" class="style-scope patent-text"><img id="i0058" wi="478" he="717" img-content="drawing" img-format="jpg" file="img0058.jpg" orientation="unknown" width="1912" height="2868" alt="Figure img0058" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/71/f9/d4/16dbd198bbf5a8/img0058.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/2f/d0/28/316d6bb8e441ea/img0059.png" class="style-scope patent-text"><img id="i0059" wi="490" he="738" img-content="drawing" img-format="jpg" file="img0059.jpg" orientation="unknown" width="1960" height="2952" alt="Figure img0059" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/2f/d0/28/316d6bb8e441ea/img0059.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/10/a7/26/69fa58b0b63a57/img0060.png" class="style-scope patent-text"><img id="i0060" wi="478" he="580" img-content="drawing" img-format="jpg" file="img0060.jpg" orientation="unknown" width="1912" height="2320" alt="Figure img0060" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/10/a7/26/69fa58b0b63a57/img0060.png"></a></div> 
  <p class="style-scope patent-text"></p>
  <p id="p0126" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[126]  dada preferncia ainda mais s seguintes combinaes:</span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/74/ce/4e/f0f31c56cd0898/img0061.png" class="style-scope patent-text"><img id="i0061" wi="458" he="86" img-content="drawing" img-format="jpg" file="img0061.jpg" orientation="unknown" width="1832" height="344" alt="Figure img0061" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/74/ce/4e/f0f31c56cd0898/img0061.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/82/10/17/0f3c334ce18075/img0062.png" class="style-scope patent-text"><img id="i0062" wi="493" he="731" img-content="drawing" img-format="jpg" file="img0062.jpg" orientation="unknown" width="1972" height="2924" alt="Figure img0062" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/82/10/17/0f3c334ce18075/img0062.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/61/b1/2c/8b625b665675db/img0063.png" class="style-scope patent-text"><img id="i0063" wi="467" he="652" img-content="drawing" img-format="jpg" file="img0063.jpg" orientation="unknown" width="1868" height="2608" alt="Figure img0063" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/61/b1/2c/8b625b665675db/img0063.png"></a></div>
		[126] Even more preference is given to the following combinations: <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/74/ce/4e/f0f31c56cd0898/img0061.png" class="style-scope patent-text"><img id="i0061" wi="458" he="86" img-content="drawing" img-format="jpg" file="img0061.jpg" orientation="unknown" width="1832" height="344" alt="Figure img0061" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/74/ce/4e/f0f31c56cd0898/img0061.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/82/10/17/0f3c334ce18075/img0062.png" class="style-scope patent-text"><img id="i0062" wi="493" he="731" img-content="drawing" img-format="jpg" file="img0062.jpg" orientation="unknown" width="1972" height="2924" alt="Figure img0062" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/82/10/17/0f3c334ce18075/img0062.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/61/b1/2c/8b625b665675db/img0063.png" class="style-scope patent-text"><img id="i0063" wi="467" he="652" img-content="drawing" img-format="jpg" file="img0063.jpg" orientation="unknown" width="1868" height="2608" alt="Figure img0063" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/61/b1/2c/8b625b665675db/img0063.png"></a></div> 
  <p class="style-scope patent-text"></p>
  <p id="p0127" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[127] Principalmente,  dada preferncia s seguintes combinaes:</span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/03/cf/6f/05349f45ad79c8/img0064.png" class="style-scope patent-text"><img id="i0064" wi="152" he="55" img-content="drawing" img-format="jpg" file="img0064.jpg" orientation="unknown" width="608" height="220" alt="Figure img0064" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/03/cf/6f/05349f45ad79c8/img0064.png"></a></div>
			<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/14/32/84/482a47ff8cd38b/img0065.png" class="style-scope patent-text"><img id="i0065" wi="473" he="137" img-content="drawing" img-format="jpg" file="img0065.jpg" orientation="unknown" width="1892" height="548" alt="Figure img0065" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/14/32/84/482a47ff8cd38b/img0065.png"></a></div>
		[127] Mainly, preference is given to the following combinations: <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/03/cf/6f/05349f45ad79c8/img0064.png" class="style-scope patent-text"><img id="i0064" wi="152" he="55" img-content="drawing" img-format="jpg" file="img0064.jpg" orientation="unknown" width="608" height="220" alt="Figure img0064" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/03/cf/6f/05349f45ad79c8/img0064.png"></a></div> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/14/32/84/482a47ff8cd38b/img0065.png" class="style-scope patent-text"><img id="i0065" wi="473" he="137" img-content="drawing" img-format="jpg" file="img0065.jpg" orientation="unknown" width="1892" height="548" alt="Figure img0065" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/14/32/84/482a47ff8cd38b/img0065.png"></a></div> 
  <p class="style-scope patent-text"></p>
  <p id="p0128" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[128] Todas as combinaes ternrias mencionadas acima podem ser combinadas com pelo menos um bactericida, fungicida, acaricida, nematicida, herbicida, inseticida conhecido adicional, micronutrientes e composto que contm micronutrientes, protetor, lipoquito-oligossacardeos (LCO), produto para aprimoramento do solo ou produto para reduo de estresse de plantas, por exemplo, Myconate, a fim de ampliar o espectro de ao ou evitar o desenvolvimento de resistncia, por exemplo.</span>[128] All the ternary combinations mentioned above can be combined with at least one bactericide, fungicide, acaricide, nematicide, herbicide, additional known insecticide, micronutrients and compound containing micronutrients, protector, lipoquito-oligosaccharides (LCO), product for improving the soil or plant stress reduction product, for example, Myconate, in order to broaden the spectrum of action or prevent the development of resistance, for example.</span>
  </p>
  <p id="p0129" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[129] De preferncia, as combinaes ternrias e quaternrias mencionadas acima podem ainda ser combinadas com pelo menos um composto selecionado do grupo que consiste em (A.1) acibenzolar-S-metil, (A.2) isotianil, (A.3) probenazol, (A.4) tiadinil, (C.2.1) Fosetil-Al, (C.2.4) azoxistrobina, (C.2.3) trifloxistrobina, (C.3.3) imidacloprida, (C.3.4) tiacloprida, (C.3.5) betaciflutrina, (C.3.6) deltametrina, (C.3.10) flupiradifurona, (C.4.1) cobre (Cu), (C.4.2) hidrxido de cobre, (C.4.3) sulfato de cobre, (C.4.4) oxicloreto de cobre, (C.4.5) Propinebe, (C.4.6) Mancozebe, e (C.5) Myconate.</span>[129] Preferably, the ternary and quaternary combinations mentioned above can still be combined with at least one compound selected from the group consisting of (A.1) acibenzolar-S-methyl, (A.2) isothianyl, (A.3 ) probenazole, (A.4) thiadinyl, (C.2.1) Fosetyl-Al, (C.2.4) azoxystrobin, (C.2.3) trifloxystrobin, (C.3.3) imidacloprid, (C.3.4) thiaclopride, (C. 3.5) betaciflutrin, (C.3.6) deltamethrin, (C.3.10) flupyradifurone, (C.4.1) copper (Cu), (C.4.2) copper hydroxide, (C.4.3) copper sulfate, (C.4.4 ) copper oxychloride, (C.4.5) Propineb, (C.4.6) Mancozebe, and (C.5) Myconate.</span>
  </p>
  <p id="p0130" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[130] Todos os parceiros de combinao denominados, alm dos indutores da defesa do hospedeiro da presente inveno, podem, caso seus grupos funcionais o permitam, opcionalmente formar sais com bases ou cidos adequados.</span>[130] All named combination partners, in addition to the host defense inducers of the present invention, may, if their functional groups allow it, optionally form salts with suitable bases or acids.</span>
  </p>
  <p id="p0131" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[131] Alm disso, os indutores da defesa do hospedeiro da presente inveno podem ser combinados com pelo menos um composto ativo selecionado do grupo que consiste em:</span>[131] In addition, the host defense inducers of the present invention can be combined with at least one active compound selected from the group consisting of:</span>
  </p>
  <p id="p0132" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[132] cido actico (por exemplo, cido naftaleno actico), cido peractico, cidos orgnicos (por exemplo, cido ctrico, cido ltico), aminocidos (por exemplo, 1- arginina), cidos hmicos, cidos flvicos, cido brico, cido oxolnico, cido 1,2,3-Benzotiadiazol-7- tiocarboxlico-S-metil ster, 5-hidrxi-1,4-naftalenodiona, bromo-cloro-dimetil-hidantona, cido tricloroisocianrico, cido saliclico, diclorofeno, canamicina, casugamicina, estreptomicina, sulfato de estreptomicina, oxitetraciclina e, gentamicina (por exemplo, hidrato de sulfato de gentamicina), imidacloprida, tebuconazol tiabendazol, tiram, teracep, octilinona, quinoxifeno, azadiractina, furanoflavona, forclorfenuron, minerais de plantas (por exemplo, clcio, carbonato de clcio, hipoclorito, EDTA de clcio), enzimas (por exemplo, protease, amilase, lipase), microelementos e microelementos quelados (por exemplo, como quelatos de aminocido), vitaminas e extratos de plantas, derivados de salicilato, bioflavonides e cidos orgnicos derivados de vegetais e frutas, polifenis extrados de frutas naturais, leo de laranja-da-terra, extratos ctricos, quitosana, amido, extrato de alga marinha, organossilicone, complexo de silcio ionizado ativado (Zumsil), cera de abelhas, uria, Bacillus subtilis, Bacillus amyloliquefaciens, Pseudomonas fluorescens, Pseudomonas putida, Pantoea agglomerans, Trichoderma koningii, Trichoderma harzianum, cloro e compostos de cloro (por exemplo, gua clorada, dixido de cloro, clorito de sdio, hipoclorito de sdio, cido hipocloroso, cloreto de amnio, cloreto de didecil dimetil amnio, cloreto de benzalcnio), oxignio, perxido de hidrognio (H2O2) e compostos de peroxignio, hidrognio cianamida, sulfato de nquel (III), persulfato de sdio, fosfito, fosfato, fosfato trissdico, cido fosfrico, nitrognio inorgnico, prata e compostos que contm prata (por exemplo, prata coloidal), glutaraldedo, ramnolipdeo (Zonix).</span>[132] Acetic acid (eg naphthalene acetic acid), peracetic acid, organic acids (eg citric acid, lactic acid), amino acids (eg 1-arginine), humic acids, fulvic acids, boric acid, acid oxolinic, 1,2,3-benzothiadiazole-7-thiocarboxylic acid-S-methyl ester, 5-hydroxy-1,4-naphthalenedione, bromo-chloro-dimethylhydantoin, trichloroisocyanuric acid, salicylic acid, dichlorophene, kanamycin, casugamycin, streptomycin, streptomycin sulfate, oxytetracycline and, gentamicin (eg gentamicin sulfate hydrate), imidacloprid, tebuconazole tiabendazole, tiram, teracep, octilinone, quinoxyphen, azadiractin, furanoflavone, for example, calcium chloride, carbonate, minerals calcium, hypochlorite, calcium EDTA), enzymes (eg protease, amylase, lipase), chelated microelements and microelements (eg, as amino acid chelates), vitamins and plant extracts, salicylate derivatives, bioflavonoids and organic acids derived from vegetables and fruits, polyphenols extracted from natural fruits, earthy orange oil, citrus extracts, chitosan, starch, kelp extract, organosilicone, activated ionized silicon complex (Zumsil), beeswax , urea, Bacillus subtilis, Bacillus amyloliquefaciens, Pseudomonas fluorescens, Pseudomonas putida, Pantoea agglomerans, Trichoderma koningii, Trichoderma harzianum, chlorine and chlorine compounds (eg chlorinated water, chlorine dioxide, sodium chloride, sodium hypochlorite, hypochlorite, sodium hypochlorite , ammonium chloride, didecyl dimethyl ammonium chloride, benzalkonium chloride), oxygen, hydrogen peroxide (H2O2) and peroxygen compounds, hydrogen cyanamide, nickel (III) sulfate, sodium persulfate, phosphite, phosphate, tri-sodium phosphate, phosphoric acid, inorganic nitrogen, silver and compounds containing silver (for example, colloidal silver), glutaraldehyde, ramnolipid (Zonix).</span>
  </p>
  <p id="p0133" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[133] Por conseguinte,  dada preferncia s combinaes de pelo menos um dos indutores da defesa do hospedeiro da presente inveno com pelo menos um composto adicional selecionado do grupo que consiste em:</span>[133] Therefore, preference is given to combinations of at least one of the host defense inducers of the present invention with at least one additional compound selected from the group consisting of:</span>
  </p>
  <p id="p0134" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[134] Fosetil-Al, estrobilurinas, selecionadas preferivelmente de azoxistrobina e trifloxistrobina e micronutrientes e compostos que contm micronutrientes, como aqui definidos, preferivelmente selecionados de cobre (Cu), hidrxido de cobre, sulfato de cobre, oxicloreto de cobre, Propinebe e Mancozebe.</span>[134] Fosetil-Al, strobilurins, preferably selected from azoxystrobin and trifloxystrobin and micronutrients and compounds containing micronutrients, as defined herein, preferably selected from copper (Cu), copper hydroxide, copper sulfate, copper oxychloride, Propineb and Mancozebe .</span>
  </p>
  <p id="p0135" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[135] Nesse contexto e dentro do significado da presente inveno, o termo combinao ou formulao significa vrias combinaes de pelo menos um indutor da defesa do hospedeiro com pelo menos um agente de controle biolgico e, opcionalmente, pelo menos um composto (C), cada um como aqui definido, e que pode ser fornecida, por exemplo, na forma de misturas prontas, misturas de tanque (que significam pastas em spray preparadas a partir das formulaes dos compostos ativos individuais por combinao e diluio antes da aplicao) ou combinaes dessas (por exemplo, uma mistura pronta binria de dois dos compostos ativos mencionados acima  feita em uma mistura de tanque por utilizao de uma formulao da terceira substncia individual). Formas de aplicao e mtodo de tratamento</span>[135] In this context and within the meaning of the present invention, the term "combination" or "formulation" means various combinations of at least one host defense inducer with at least one biological control agent and, optionally, at least one compound (C), each as defined herein, and which can be supplied, for example, in the form of ready mixes, tank mixes (meaning spray pastes prepared from the formulations of the individual active compounds by combination and dilution before application ) or combinations thereof (for example, a ready-made binary mixture of two of the active compounds mentioned above is made in a tank mixture using a formulation of the third individual substance). Forms of application and treatment method</span>
  </p>
  <p id="p0136" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[136] O tratamento de acordo com a inveno das plantas e partes de plantas com as combinaes de composto ativo ou composies  realizado diretamente ou por ao em suas vizinhanas, habitat ou espao de armazenamento com o uso de mtodos de tratamento comuns, por exemplo, por imerso, pulverizao, atomizao, irrigao, evaporao, polvilhamento, fumigao, propagao, formao de espuma, pintura, espalhamento, rega (encharcamento), irrigao por gotejamento e, no caso de material de propagao, em particular no caso de sementes, ainda como um p para tratamento de semente seca, uma soluo para tratamento de sementes, um p hidrossolvel para tratamento com pasta, por incrustao, por revestimento com um ou mais revestimentos etc.  dada preferncia  aplicao por imerso, pulverizao, atomizao, irrigao, evaporao, polvilhamento, fumigao, propagao, formao de espuma, pintura, espalhamento, rega (encharcamento) e irrigao por gotejamento. Tambm englobado pela presente inveno  o tratamento em caixa de viveiros.</span>[136] Treatment according to the invention of plants and plant parts with combinations of active compound or compositions is carried out directly or by action in their neighborhoods, habitat or storage space using common treatment methods, for example , by immersion, spraying, atomization, irrigation, evaporation, dusting, fumigation, propagation, foaming, painting, spreading, watering (drenching), drip irrigation and, in the case of propagating material, in particular in the case of seeds, as a powder for treating dry seed, a solution for treating seeds, a water-soluble powder for treatment with paste, by incrustation, by coating with one or more coatings, etc. Preference is given to application by immersion, spraying, atomization, irrigation, evaporation, dusting, fumigation, propagation, foaming, painting, spreading, watering (drenching) and drip irrigation. Also encompassed by the present invention is boxed treatment of nurseries.</span>
  </p>
  <p id="p0137" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[137] O tratamento de acordo com a presente inveno pode ser realizado curativamente ou preventivamente.</span>[137] The treatment according to the present invention can be carried out curatively or preventively.</span>
  </p>
  <p id="p0138" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[138] De acordo com a inveno, os compostos ativos individuais tambm podem ser empregados sequencialmente, ou seja, um depois do outro, em um intervalo razovel de poucas horas ou dias, no caso do tratamento de sementes, por exemplo, tambm por aplicao de diversas camadas que contm compostos ativos diferentes. De preferncia,  indiferente em qual ordem os compostos ativos individuais podem ser empregados.</span>[138] According to the invention, the individual active compounds can also be used sequentially, that is, one after the other, within a reasonable interval of a few hours or days, in the case of seed treatment, for example, also by application several layers that contain different active compounds. Preferably, it does not matter in which order the individual active compounds can be employed.</span>
  </p>
  <p id="p0139" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[139] Em uma modalidade especialmente preferida da presente inveno, as combinaes que compreendem os indutores da defesa do hospedeiro e agentes de controle biolgico, ou suas formulaes so usados para aplicao na forma de solues, emulses ou suspenses a serem aplicadas por pulverizao, para o tratamento de material de propagao vegetativa, ou para aplicao no rizoma ou foliar. Dependendo de suas respectivas propriedades fsicas e/ou qumicas, os compostos selecionados das combinaes da presente inveno podem ser convertidos nas formulaes comuns, por exemplo, solues, emulses, suspenses, ps, espumas, pastas, grnulos, sachs, aerossis, microencapsulaes em substncias polimricas, e formulaes ULV para fumigao a quente ou a frio.</span>[139] In an especially preferred embodiment of the present invention, combinations comprising host defense inducers and biological control agents, or their formulations are used for application in the form of solutions, emulsions or suspensions to be applied by spraying, to the treatment of vegetative propagation material, or for application to the rhizome or leaf. Depending on their respective physical and / or chemical properties, the compounds selected from the combinations of the present invention can be converted into common formulations, for example, solutions, emulsions, suspensions, powders, foams, pastes, granules, sachets, aerosols, microencapsulations in substances polymeric, and ULV formulations for hot or cold fumigation.</span>
  </p>
  <p id="p0140" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[140] Essas formulaes so preparadas de uma forma conhecida, por exemplo, por mistura dos indutores da defesa do hospedeiro e/ou agentes de controle biolgico e/ou opcionais compostos adicionais (C) com extensores, ou seja, solventes lquidos, gases liquefeitos pressurizados e/ou carreadores slidos, opcionalmente com o uso de tensoativos, ou seja, emulsificantes e/ou dispersantes e/ou formadores de espuma. Caso gua seja usada como o extensor,  possvel, por exemplo, tambm usar solventes orgnicos como co-solventes. Solventes lquidos que so adequados so: aromticos como, por exemplo, xileno, tolueno ou alquil-naftalenos, hidrocarbonetos aromticos clorados ou hidrocarbonetos alifticos clorados como, por exemplo, clorobenzenos, cloroetilenos ou cloreto de metileno, hidrocarbonetos alifticos, por exemplo, ciclohexano ou parafinas, por exemplo, fraes de leo mineral, lcoois como, por exemplo, butanol ou glicol, e seus teres e steres, cetonas como, por exemplo, acetona, metil etil cetona, metil isobutil cetona ou ciclohexanona, solventes fortemente polares como, por exemplo, dimetilformamida e sulfxido de dimetila, e gua, e tambm leos minerais, animais e vegetais como, por exemplo, azeite-de-dend ou outros leos de sementes de plantas. Subentende-se que extensores ou carreadores gasosos liquefeitos significam aqueles lquidos que so gasosos em temperatura normal e sob presso normal, por exemplo, propelentes de aerossol como, por exemplo, halo-hidrocarbonetos e butano, propano, nitrognio e dixido de carbono.</span>[140] These formulations are prepared in a known manner, for example, by mixing host defense inducers and / or biological control agents and / or optional additional compounds (C) with extenders, ie liquid solvents, liquefied gases pressurized and / or solid carriers, optionally with the use of surfactants, that is, emulsifiers and / or dispersants and / or foaming agents. If water is used as the extender, it is possible, for example, to also use organic solvents as co-solvents. Liquid solvents which are suitable are: aromatics such as, for example, xylene, toluene or alkyl naphthalenes, chlorinated aromatic hydrocarbons or chlorinated aliphatic hydrocarbons such as, for example, chlorobenzenes, chloroethylenes or methylene chloride, aliphatic hydrocarbons, for example, cyclohexane or paraffins , for example, fractions of mineral oil, alcohols such as butanol or glycol, and their ethers and esters, ketones such as acetone, methyl ethyl ketone, methyl isobutyl ketone or cyclohexanone, strongly polar solvents such as, for example , dimethylformamide and dimethyl sulfoxide, and water, as well as mineral, animal and vegetable oils such as palm oil or other plant seed oils. It is understood that extenders or liquefied gaseous carriers mean those liquids that are gaseous at normal temperature and under normal pressure, for example, aerosol propellants such as, for example, halohydrocarbons and butane, propane, nitrogen and carbon dioxide.</span>
  </p>
  <p id="p0141" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[141] Carregadores slidos adequados so: por exemplo, minerais naturais triturados como, por exemplo, caulins, argilas, talco, giz, quartzo, atapulgita, montmorillonita ou terra diatomcea, e minerais sintticos triturados como, por exemplo, slica altamente dispersa, alumina e silicatos. Carreadores slidos adequados para grnulos so: por exemplo, pedras naturais esmagadas ou fracionadas como, por exemplo, calcita, pedra-pomes, mrmore, sepiolita, dolomita, e grnulos sintticos de farinhas inorgnicas e orgnicas, e grnulos de material orgnico como, por exemplo, serragem, cascas de coco, espigas de milho e talos de tabaco. Emulsificantes e/ou formadores de espuma que so adequados so: por exemplo, emulsificantes no inicos, catinicos e aninicos como, por exemplo, steres de cido graxo-polioxietileno, teres de lcool graxo- polioxietileno, por exemplo, alquilaril poliglicol teres, alquilsulfonatos, alquil sulfatos, arilsulfonatos e hidrolisados de protena. Dispersantes adequados so: por exemplo, licores de resduo de lignossulfito e metilcelulose.</span>[141] Suitable solid carriers are: for example, crushed natural minerals such as kaolin, clays, talc, chalk, quartz, atapulgite, montmorillonite or diatomaceous earth, and crushed synthetic minerals, such as highly dispersed silica, alumina and silicates. Solid carriers suitable for granules are: for example, crushed or fractionated natural stones such as, for example, calcite, pumice, marble, sepiolite, dolomite, and synthetic granules of inorganic and organic flours, and granules of organic material such as, for example , sawdust, coconut husks, corn cobs and tobacco stalks. Emulsifiers and / or foams that are suitable are: for example, non-ionic, cationic and anionic emulsifiers such as, for example, fatty acid-polyoxyethylene esters, fatty alcohol-polyoxyethylene ethers, for example, alkylaryl polyglycol ethers, alkylsulfonates, alkyl sulfates, aryl sulfonates and protein hydrolysates. Suitable dispersants are: for example, lignosulfite and methylcellulose residue liquors.</span>
  </p>
  <p id="p0142" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[142] Adesivos como, por exemplo, carboximetilcelulose, polmeros naturais e sintticos na forma de ps, grnulos ou ltex, por exemplo, goma arbica, lcool polivinlico, acetato de polivinila, e fosfolipdeos naturais como, por exemplo, cefalinas e lecitinas, e fosfolipdeos sintticos, podem ser usados nas formulaes. Aditivos adicionais podem ser leos minerais e vegetais.</span>[142] Adhesives such as carboxymethylcellulose, natural and synthetic polymers in the form of powders, granules or latex, for example, gum arabic, polyvinyl alcohol, polyvinyl acetate, and natural phospholipids such as cephalins and lecithins, and synthetic phospholipids, can be used in formulations. Additional additives can be mineral and vegetable oils.</span>
  </p>
  <p id="p0143" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[143]  possvel usar corantes como, por exemplo, pigmentos inorgnicos, por exemplo, xido de ferro, xido de titnio, azul da Prssia, e tinturas orgnicas como, por exemplo, alizarina, tinturas azo e de ftalocianina de metal, e micronutrientes como, por exemplo, sais de ferro, mangans, boro, cobre, cobalto, molibdnio e zinco.</span>[143] It is possible to use dyes such as inorganic pigments, for example, iron oxide, titanium oxide, Prussian blue, and organic dyes such as alizarin, azo and metal phthalocyanine dyes, and micronutrients such as iron, manganese, boron, copper, cobalt, molybdenum and zinc salts.</span>
  </p>
  <p id="p0144" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[144] Em geral, as formulaes contm entre 0,1 e 95% por peso de composto ativo (indutor da defesa do hospedeiro, agente de controle biolgico e/ou composto (C)), preferivelmente entre 0,5 e 90%.</span>[144] In general, formulations contain between 0.1 and 95% by weight of active compound (host defense inducer, biological control agent and / or compound (C)), preferably between 0.5 and 90%.</span>
  </p>
  <p id="p0145" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[145] O controle dos organismos bacterianos nocivos selecionados por tratamento do material de propagao vegetativa de plantas  conhecido h muito tempo e  o objeto de aprimoramentos contnuos. No entanto, o tratamento de material de propagao vegetativa envolve uma srie de problemas que nem sempre podem ser solucionados de uma forma satisfatria. Dessa forma,  desejvel desenvolver mtodos para a proteo do material de propagao vegetativa e da planta em germinao que afastem, ou pelo menos reduzam acentuadamente, a aplicao adicional de produtos para proteo de plantas aps plantao ou aps emergncia das plantas.  ainda desejvel otimizar a quantidade do composto ativo empregada de tal forma que o material de propagao vegetativa e a planta em germinao sejam protegidos o melhor possvel de ataque pelos organismos bacterianos nocivos sem, no entanto, danificar a prpria planta pelo composto ativo empregado. Em particular, mtodos para o tratamento de material de propagao vegetativa tambm devem levar em conta as propriedades intrnsecas de plantas transgnicas a fim de obter uma proteo tima do material de propagao vegetativa e da planta em germinao mantendo, ao mesmo tempo, a taxa de aplicao de produtos para proteo de plantas o mais baixa possvel.</span>[145] The control of harmful bacterial organisms selected by treating plant propagating material has been known for a long time and is the subject of continuous improvement. However, the treatment of vegetatively propagated material involves a series of problems that cannot always be satisfactorily solved. Thus, it is desirable to develop methods for the protection of vegetative propagating material and the germinating plant that remove, or at least markedly reduce, the additional application of plant protection products after planting or after plant emergence. It is also desirable to optimize the amount of active compound used in such a way that the material of vegetative propagation and the germinating plant are protected as well as possible from attack by harmful bacterial organisms without, however, damaging the plant itself by the active compound used. In particular, methods for the treatment of vegetative propagation material must also take into account the intrinsic properties of transgenic plants in order to obtain an optimal protection of the vegetative propagation material and the germinating plant, while maintaining the application rate. of plant protection products as low as possible.</span>
  </p>
  <p id="p0146" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[146] A presente inveno, portanto, se relaciona, em particular, tambm a um mtodo de proteo de material de propagao vegetativa e plantas em germinao de ataque pelos organismos bacterianos nocivos selecionados, por tratamento da semente e do material de propagao vegetativa com um composto ou formulao de acordo com a inveno.</span>[146] The present invention, therefore, relates, in particular, also to a method of protecting vegetative propagating material and plants from attacking germination by selected harmful bacterial organisms, by treating the seed and vegetative propagating material with a compound or formulation according to the invention.</span>
  </p>
  <p id="p0147" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[147] A inveno tambm est relacionada ao uso dos compostos de acordo com a inveno para o tratamento de material de propagao vegetativa para a proteo do material de propagao vegetativa e da planta em germinao dos organismos bacterianos nocivos selecionados.</span>[147] The invention is also related to the use of compounds according to the invention for the treatment of vegetative propagation material for the protection of vegetative propagation material and the germinating plant from selected harmful bacterial organisms.</span>
  </p>
  <p id="p0148" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[148] Uma das vantagens da presente inveno  que, em funo das propriedades sistmicas especiais dos compostos de acordo com a inveno, o tratamento do material de propagao vegetativa com esses compostos protege no apenas o prprio material de propagao vegetativa, mas tambm as plantas que ele origina aps plantao, dos organismos bacterianos nocivos. Dessa forma, o tratamento imediato do cultivo no momento da plantao, ou logo aps, pode ser dispensado.</span>[148] One of the advantages of the present invention is that, due to the special systemic properties of the compounds according to the invention, the treatment of vegetative propagation material with these compounds protects not only the vegetative propagation material itself, but also the plants that it originates after planting, from harmful bacterial organisms. Thus, immediate treatment of the crop at the time of planting, or soon after, can be dispensed with.</span>
  </p>
  <p id="p0149" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[149] Outra vantagem  que os compostos de acordo com a inveno podem ser empregados em particular tambm em material de propagao vegetativa transgnico.</span>[149] Another advantage is that the compounds according to the invention can also be used in particular in transgenic vegetative propagation material.</span>
  </p>
  <p id="p0150" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[150] Os compostos de acordo com a inveno so adequados para a proteo de material de propagao vegetativa de qualquer variedade de planta que seja empregada em agricultura, na estufa, em florestas ou em horticultura. Em particular, isso  material de propagao vegetativa das plantas como aqui definido e preferido.</span>[150] The compounds according to the invention are suitable for the protection of vegetative propagating material from any variety of plant that is used in agriculture, in the greenhouse, in forests or in horticulture. In particular, this is vegetative propagating material from the plants as defined and preferred herein.</span>
  </p>
  <p id="p0151" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[151] Dentro do escopo da presente inveno, os compostos de acordo com a inveno so aplicados ao material de propagao vegetativa isoladamente ou em uma formulao adequada. De preferncia, o material de propagao vegetativa  tratado em um estado no qual  suficientemente estvel, de tal forma que no ocorra danos durante o tratamento. Em geral, o material de propagao vegetativa pode ser tratado em qualquer ponto no tempo entre a colheita e plantao. Normalmente,  usado material de propagao vegetativa que foi separado da planta e liberado de espigas, cascas, talos, revestimentos, plos ou carnes de frutas.</span>[151] Within the scope of the present invention, the compounds according to the invention are applied to the vegetatively propagated material alone or in a suitable formulation. Preferably, the vegetatively propagated material is treated in a state in which it is sufficiently stable, in such a way that no damage occurs during treatment. In general, vegetative propagating material can be treated at any point in time between harvest and planting. Normally, vegetative propagation material is used that has been separated from the plant and released from ears, peels, stalks, coatings, hair or meat from fruits.</span>
  </p>
  <p id="p0152" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[152] Quando se trata o material de propagao vegetativa, deve-se tomar cuidado, em geral, para que a quantidade do composto ou formulao de acordo com a inveno, e/ou de aditivos adicionais, aplicada ao material de propagao vegetativa seja escolhida de tal forma que a germinao do material de propagao vegetativa no seja afetada adversamente, ou que a planta que ele origina no seja danificada. Isso deve ser considerado, em particular, no caso de compostos ativos que, em certas taxas de aplicao, podem ter efeitos fitotxicos.</span>[152] When dealing with vegetative propagation material, care should be taken, in general, that the amount of the compound or formulation according to the invention, and / or additional additives, applied to the vegetative propagation material is chosen in such a way that the germination of vegetative propagation material is not adversely affected, or that the plant it originates from is not damaged. This should be considered, in particular, in the case of active compounds that, at certain rates of application, can have phytotoxic effects.</span>
  </p>
  <p id="p0153" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[153] Os compostos ou formulaes de acordo com a inveno podem ser aplicados diretamente, ou seja, sem conter componentes adicionais e sem terem sido diludos. Em geral, prefere-se aplicar os compostos ou formulaes ao material de propagao vegetativa na forma de uma formulao adequada. Formulaes e mtodos adequados para o tratamento de sementes e de material de propagao vegetativa so conhecidos pelo profissional experiente. Os compostos ou formulaes que podem ser usados de acordo com a inveno podem ser convertidos nas formulaes comuns, por exemplo, solues, emulses, suspenses, ps, espumas e formulaes ULV.</span>[153] The compounds or formulations according to the invention can be applied directly, that is, without containing additional components and without having been diluted. In general, it is preferred to apply the compounds or formulations to the vegetatively propagated material in the form of a suitable formulation. Formulations and methods suitable for the treatment of seeds and vegetative propagation material are known to the experienced professional. The compounds or formulations that can be used according to the invention can be converted into common formulations, for example, solutions, emulsions, suspensions, powders, foams and ULV formulations.</span>
  </p>
  <p id="p0154" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[154] Essas formulaes so preparadas na forma conhecida por mistura dos indutores da defesa do hospedeiro, agentes de controle biolgico e, opcionalmente, compostos (C) com aditivos comuns como, por exemplo, extensores comuns e tambm solventes ou diluentes, corantes, umidificantes, dispersantes, emulsificantes, antiespumantes, conservantes, espessantes secundrios, adesivos, giberelinas, leos minerais e vegetais, e tambm gua.</span>[154] These formulations are prepared in the known form by mixing host defense inducers, biological control agents and, optionally, compounds (C) with common additives, for example, common extenders and also solvents or diluents, dyes, humidifiers , dispersants, emulsifiers, defoamers, preservatives, secondary thickeners, adhesives, gibberellins, mineral and vegetable oils, and also water.</span>
  </p>
  <p id="p0155" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[155] Corantes que podem estar presentes nas formulaes que podem ser usadas de acordo com a inveno so todos os corantes que so comuns para essas finalidades. Nesse contexto, tanto pigmentos, que so moderadamente solveis em gua, quanto corantes, que so solveis em gua, podem ser usados. Exemplos que podem ser mencionados so os corantes conhecidos pelos nomes Rodamina B, Pigmento C.I. Vermelho 112 e Solvente C.I. Vermelho 1.</span>[155] Dyes that may be present in formulations that can be used according to the invention are all dyes that are common for these purposes. In this context, both pigments, which are moderately soluble in water, and dyes, which are soluble in water, can be used. Examples that can be mentioned are the dyes known by the names Rhodamine B, Pigment C.I.Red 112 and Solvent C.I.Red 1.</span>
  </p>
  <p id="p0156" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[156] Umidificantes que podem estar presentes nas formulaes que podem ser usadas de acordo com a inveno so todas as substncias que so comuns para a formulao de compostos ativos agroqumicos e que promovem umidificao. Alquilnaftalenossulfonatos, por exemplo, diisopropil- ou diisobutilnaftalenossulfonatos, podem ser preferivelmente usados.</span>[156] Humidifiers that can be present in formulations that can be used according to the invention are all substances that are common for the formulation of active agrochemical compounds and that promote humidification. Alkylnaphthalenesulfonates, for example, diisopropyl- or diisobutylnaphthalenesulfonates, can preferably be used.</span>
  </p>
  <p id="p0157" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[157] Dispersantes e/ou emulsificantes adequados que podem estar presentes nas formulaes que podem ser usados de acordo com a inveno todos os dispersantes no inicos, aninicos e catinicos que so convencionalmente usados para a formulao de compostos ativos agroqumicos. Os seguintes podem ser usados por preferncia: dispersantes no inicos ou aninicos ou misturas de dispersantes no inicos ou aninicos. Dispersantes no inicos adequados que podem ser mencionados so, em particular, polmeros em bloco de xido de etileno/xido de propileno, alquilfenol poliglicol teres e triestirilfenol poliglicol teres e seus derivados fosfatados ou sulfatados. Dispersantes aninicos adequados so, em particular, lignossulfonatos, sais de cido poliacrlico e condensados de arilsulfonato/formaldedo.</span>[157] Suitable dispersants and / or emulsifiers that can be present in formulations that can be used according to the invention all nonionic, anionic and cationic dispersants that are conventionally used for the formulation of active agrochemical compounds. The following can be used by preference: nonionic or anionic dispersants or mixtures of nonionic or anionic dispersants. Suitable non-ionic dispersants that can be mentioned are, in particular, ethylene oxide / propylene oxide block polymers, alkylphenol polyglycol ethers and tristyrylphenol polyglycol ethers and their phosphate or sulfate derivatives. Suitable anionic dispersants are, in particular, lignosulfonates, polyacrylic acid salts and arylsulfonate / formaldehyde condensates.</span>
  </p>
  <p id="p0158" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[158] Antiespumantes que podem estar presentes nas formulaes que podem ser usadas de acordo com a inveno so todas as substncias inibidoras de espuma que so convencionalmente usadas para a formulao de compostos ativos agroqumicos. Antiespumantes de silicone e estearato de magnsio podem ser usados por preferncia.</span>[158] Defoamers that can be present in formulations that can be used according to the invention are all foam inhibiting substances that are conventionally used for the formulation of active agrochemicals. Silicone defoamers and magnesium stearate can be used by preference.</span>
  </p>
  <p id="p0159" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[159] Conservantes que podem estar presentes nas formulaes que podem ser usadas de acordo com a inveno so todas as substncias que podem ser empregadas para essas finalidades em composies agroqumicas. Exemplos que podem ser mencionados so diclorofeno e hemiformal de lcool benzlico.</span>[159] Preservatives that can be present in formulations that can be used according to the invention are all substances that can be used for these purposes in agrochemical compositions. Examples that can be mentioned are dichlorophene and hemiformal benzyl alcohol.</span>
  </p>
  <p id="p0160" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[160] Espessantes secundrios que podem estar presentes nas formulaes que podem ser usadas de acordo com a inveno so todas as substncias que podem ser empregadas para essas finalidades em composies agroqumicas. Derivados de celulose, derivados de cido acrlico, xantana, argilas modificadas e slica altamente dispersa so preferivelmente adequados.</span>[160] Secondary thickeners that can be present in formulations that can be used according to the invention are all substances that can be used for these purposes in agrochemical compositions. Cellulose derivatives, derivatives of acrylic acid, xanthan, modified clays and highly dispersed silica are preferably suitable.</span>
  </p>
  <p id="p0161" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[161] Adesivos que podem estar presentes nas formulaes que podem ser usadas de acordo com a inveno so todos os aglutinantes comuns que podem ser usados em mordentes. Polivinilpirrolidona, acetato de polivinila, lcool polivinlico e tilose podem ser mencionados por preferncia.</span>[161] Adhesives that may be present in formulations that can be used according to the invention are all common binders that can be used in mordants. Polyvinylpyrrolidone, polyvinyl acetate, polyvinyl alcohol and tylose can be mentioned by preference.</span>
  </p>
  <p id="p0162" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[162] Giberelinas que podem estar presentes nas formulaes que podem ser usadas de acordo com a inveno so preferivelmente Giberelina A1, Giberelina A3 (cido giberlico), Giberelina A4, Giberelina A7. Prefere-se especialmente cido giberlico.</span>[162] Gibberellins which may be present in the formulations which can be used according to the invention are preferably Gibberellin A1, Gibberellin A3 (gibberellic acid), Gibberellin A4, Gibberellin A7. Gibberellic acid is especially preferred.</span>
  </p>
  <p id="p0163" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[163] As giberelinas so conhecidas (veja R. Wegler Chemie der Pflanzenschutz- e Schadlingsbekampfungsmittel [Chemistry of Plant Protection and Pesticide Agents], volume 2, Springer Verlag, Berlin-Heidelberg-Nova York, 1970, pginas 401 - 412).</span>[163] Gibberellins are known (see R. Wegler Chemie der Pflanzenschutz- and Schadlingsbekampfungsmittel], volume 2, Springer Verlag, Berlin-Heidelberg-New York, 1970, pages 401 - 412).</span>
  </p>
  <p id="p0164" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[164] As formulaes que podem ser usadas de acordo com a inveno podem ser empregadas para o tratamento de vrios tipos de semente, diretamente ou aps terem sido diludas previamente com gua. Dessa forma, os concentrados ou as preparaes que podem ser obtidas a partir deles por diluio com gua podem ser empregados para o tratamento da semente. As formulaes que podem ser usadas de acordo com a inveno, ou suas preparaes diludas, tambm podem ser empregadas para tratamento do material de propagao vegetativa de plantas transgnicas. Aqui, efeitos sinrgicos adicionais tambm podem ocorrer em combinao com as substncias formadas por expresso.</span>[164] The formulations that can be used according to the invention can be used for the treatment of various types of seed, directly or after having been previously diluted with water. In this way, the concentrates or preparations that can be obtained from them by diluting with water can be used to treat the seed. The formulations that can be used according to the invention, or their diluted preparations, can also be used to treat the vegetative propagation material of transgenic plants. Here, additional synergistic effects can also occur in combination with substances formed by expression.</span>
  </p>
  <p id="p0165" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[165] A taxa de aplicao das formulaes que podem ser usadas de acordo com a inveno pode ser variada dentro de uma faixa substancial. Ela depende do respectivo teor de composto ativo nas formulaes, e do material de propagao vegetativa. Como regra, as taxas de aplicao de composto ativo esto entre 0,001 e 50 g por quilograma de material de propagao vegetativa, preferivelmente entre 0,01 e 15 g por quilograma de material de propagao vegetativa.</span>[165] The application rate of the formulations that can be used according to the invention can be varied within a substantial range. It depends on the respective content of active compound in the formulations, and on the material of vegetative propagation. As a rule, application rates of active compound are between 0.001 and 50 g per kilogram of vegetative propagation material, preferably between 0.01 and 15 g per kilogram of vegetative propagation material.</span>
  </p>
  <p id="p0166" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[166] As combinaes da presente inveno podem ser empregadas como tal, na forma de suas formulaes ou nas formas de uso preparadas a partir delas, por exemplo, solues, suspenses, ps molhveis, pastas, ps solveis, poeiras e grnulos prontos para uso. Elas so aplicadas na forma comum, por exemplo, por derramamento, pulverizao, atomizao, disperso, polvilhamento, formao de espuma, pintura sobre e semelhantes.  ainda possvel aplicar os compostos ou formulaes da presente inveno pelo mtodo de volume ultrabaixo ou injetar a preparao de composto ativo, ou o prprio composto ativo, no solo. O material de propagao vegetativa das plantas tambm pode ser tratado.</span>[166] The combinations of the present invention can be used as such, in the form of their formulations or in the forms of use prepared from them, for example, solutions, suspensions, wettable powders, pastes, soluble powders, dusts and granules ready for use . They are applied in common form, for example, by pouring, spraying, atomizing, dispersing, dusting, foaming, painting on and the like. It is also possible to apply the compounds or formulations of the present invention by the ultra-low volume method or to inject the active compound preparation, or the active compound itself, into the soil. The vegetative propagation material of the plants can also be treated.</span>
  </p>
  <p id="p0167" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[167] As taxas de aplicao podem ser variadas dentro de uma faixa substancial, dependendo do tipo de aplicao. No tratamento de partes de plantas, as taxas de aplicao de composto ativo esto geralmente entre 0,1 e 10.000 g/ha, preferivelmente entre 10 e 1000 g/ha. No tratamento de material de propagao vegetativa, as taxas de aplicao de composto ativo esto geralmente entre 0,001 e 50 g por quilograma de material de propagao vegetativa, preferivelmente entre 0,01 e 10 g por quilograma de material de propagao vegetativa. No tratamento do solo, as taxas de aplicao de composto ativo esto geralmente entre 0,1 e 10.000 g/ha, preferivelmente entre 1 e 5.000 g/ha.</span>[167] Application rates can vary within a substantial range, depending on the type of application. In the treatment of plant parts, the application rates of active compound are generally between 0.1 and 10,000 g / ha, preferably between 10 and 1000 g / ha. In the treatment of vegetative propagation material, application rates of active compound are generally between 0.001 and 50 g per kilogram of vegetative propagation material, preferably between 0.01 and 10 g per kilogram of vegetative propagation material. In soil treatment, application rates of active compost are generally between 0.1 and 10,000 g / ha, preferably between 1 and 5,000 g / ha.</span>
  </p>
  <p id="p0168" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[168] A presente inveno ainda est relacionada s combinaes de kit de partes que compreendem: (A) pelo menos um indutor da defesa do hospedeiro como aqui definido, (B) pelo menos um agente de controle biolgico como aqui definido, e (C) opcionalmente pelo menos um composto adicional como aqui definido em uma quantidade sinergicamente eficaz para o controle de organismos bacterianos nocivos em plantas teis.</span>[168] The present invention further relates to kit combinations of parts comprising: (A) at least one host defense inducer as defined herein, (B) at least one biological control agent as defined herein, and (C ) optionally at least one additional compound as defined herein in a synergistically effective amount for the control of harmful bacterial organisms in useful plants.</span>
  </p>
  <p id="p0169" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[169] Esse kit de partes compreende os respectivos componentes em um arranjo espacialmente separado. Nele,  possvel que todos os componentes estejam espacialmente separados uns dos outros como ilustrado, por exemplo, por A / B; A / B / C; A / A / B / C (por exemplo, no caso da modalidade preferida compreendendo uma combinao de isotianil e acibenzolar-S-metil como indutores da defesa do hospedeiro (A)).  ainda possvel que pelo menos dois dos componentes estejam presentes em uma mistura e espacialmente separados por menos um outro componente ou mistura, como ilustrado, por exemplo, por A + B / C; A + C / B; B + C / A; A + A / B / C; A / A + B / C; A / B / C + A; A + B / A / C; A / A / B + C; A + A / B + C etc. (as respectivas combinaes se aplicam consequentemente s modalidades que compreendem combinaes de pelo menos dois agentes de controle biolgico B e B ou pelo menos dois compostos adicionais C e C etc.).  possvel misturar pelo menos dois dos componentes ou misturas espacialmente separadas de dois componentes com o terceiro componente espacialmente separado (ou misturas adicionais) antes da aplicao s plantas. Alternativamente, os componentes espacialmente separados como aqui descritos podem ser usados separadamente e serem aplicados sequencialmente em blocos de tratamento sequenciais separados, como aqui definidos a seguir.</span>[169] This kit of parts comprises the respective components in a spatially separate arrangement. In it, it is possible that all components are spatially separated from each other as illustrated, for example, by A / B; A / B / C; A / A '/ B / C (for example, in the case of the preferred embodiment comprising a combination of isothianyl and acibenzolar-S-methyl as inducers for host defense (A)). It is also possible that at least two of the components are present in a mixture and spatially separated by at least one other component or mixture, as illustrated, for example, by A + B / C; A + C / B; B + C / A; A + A '/ B / C; A / A '+ B / C; A / B / C + A '; A + B / A '/ C; A / A '/ B + C; A + A / B + C etc. (the respective combinations therefore apply to modalities comprising combinations of at least two biological control agents B and B 'or at least two additional compounds C and C' etc.). It is possible to mix at least two of the components or spatially separate mixtures of two components with the third spatially separate component (or additional mixtures) before application to plants. Alternatively, the spatially separated components as described herein can be used separately and applied sequentially in separate sequential treatment blocks, as defined hereinafter.</span>
  </p>
  <p id="p0170" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[170] As formulaes de composto ativo da presente inveno compreendem uma quantidade eficaz e no fitotxica dos ingredientes ativos. A expresso quantidade eficaz e no fitotxica significa uma quantidade dos ingredientes e das combinaes ativas de acordo com a inveno que  suficiente para o controle ou destruio de organismos patognicos bacterianos presentes ou que podem aparecer nas plantas, evitando notavelmente o desenvolvimento de cepas resistentes aos ingredientes ativos e, em cada caso, no confere nenhum sintoma aprecivel de fitotoxicidade aos referidos cultivos. Uma quantidade desse tipo pode variar dentro de uma faixa ampla, dependendo do patgeno a ser combatido ou das bactrias a serem controladas, do tipo de cultivo, das condies climticas e dos compostos includos na combinao bactericida de acordo com a inveno. Essa quantidade pode ser determinada por experimentos de campo sistemticos, que esto dentro das capacidades daqueles habilitados na tcnica.</span>[170] The active compound formulations of the present invention comprise an effective, non-phytotoxic amount of the active ingredients. The expression "effective and non-phytotoxic amount" means an amount of the active ingredients and combinations according to the invention that is sufficient for the control or destruction of bacterial pathogenic organisms present or that may appear on plants, notably avoiding the development of resistant strains to the active ingredients and, in each case, does not give any appreciable symptoms of phytotoxicity to those crops. Such an amount can vary within a wide range, depending on the pathogen to be combated or the bacteria to be controlled, the type of cultivation, the climatic conditions and the compounds included in the bactericidal combination according to the invention. This amount can be determined by systematic field experiments, which are within the capabilities of those skilled in the art.</span>
  </p>
  <p id="p0171" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[171] Consequentemente, a presente inveno  ainda dirigida a um mtodo para o controle de organismos bacterianos nocivos em plantas teis que compreende tratamento das plantas com uma combinao que compreende (A) pelo menos um indutor da defesa do hospedeiro como aqui definido e (B) pelo menos um agente de controle biolgico como aqui definido e, opcionalmente, pelo menos um composto (C) como aqui definido.</span>[171] Consequently, the present invention is further directed to a method for the control of harmful bacterial organisms in useful plants which comprises treating the plants with a combination comprising (A) at least one host defense inducer as defined herein and ( B) at least one biological control agent as defined herein and, optionally, at least one compound (C) as defined herein.</span>
  </p>
  <p id="p0172" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[172] Uma modalidade preferida da presente inveno est relacionada a um mtodo para o controle de organismos bacterianos nocivos em plantas teis, cujo mtodo compreende a submisso das plantas a serem protegidas contra ataque por organismos bacterianos nocivos a dois ou mais blocos de tratamento sequenciais, preferivelmente 2, 3 ou 4 blocos de tratamento sequenciais, em que pelo menos um bloco de tratamento compreende a submisso das plantas a pelo menos um tratamento com pelo menos um indutor da defesa do hospedeiro (A) como aqui definido e pelo menos um bloco de tratamento compreende a submisso das plantas a pelo menos um tratamento com pelo menos um agente de controle biolgico (B) como aqui definido. Uma modalidade ainda mais preferida da presente inveno est relacionada a um mtodo para o controle de organismos bacterianos nocivos em plantas teis, cujo mtodo compreende a submisso das plantas a serem protegidas contra ataque por organismos bacterianos nocivos a dois ou mais blocos de tratamento sequenciais, preferivelmente 2, 3 ou 4 blocos de tratamento sequenciais, em que pelo menos um bloco de tratamento compreende a submisso das plantas a pelo menos um tratamento com pelo menos um indutor da defesa do hospedeiro (A) como aqui definido e pelo menos um bloco de tratamento compreende a submisso das plantas a pelo menos um tratamento com pelo menos um agente de controle biolgico (B) como aqui definido, desde que o ltimo bloco de tratamento compreenda a submisso das plantas a pelo menos um tratamento com pelo menos um agente de controle biolgico.</span>[172] A preferred embodiment of the present invention relates to a method for the control of harmful bacterial organisms in useful plants, the method of which involves submitting the plants to be protected against attack by harmful bacterial organisms to two or more sequential treatment blocks, preferably 2, 3 or 4 sequential treatment blocks, wherein at least one treatment block comprises subjecting the plants to at least one treatment with at least one host defense inducer (A) as defined herein and at least one block of treatment. Treatment comprises subjecting the plants to at least one treatment with at least one biological control agent (B) as defined herein. An even more preferred embodiment of the present invention relates to a method for the control of harmful bacterial organisms in useful plants, the method of which involves submitting the plants to be protected from attack by harmful bacterial organisms to two or more sequential treatment blocks, preferably 2, 3 or 4 sequential treatment blocks, wherein at least one treatment block comprises subjecting the plants to at least one treatment with at least one host defense inducer (A) as defined herein and at least one treatment block comprises subjecting the plants to at least one treatment with at least one biological control agent (B) as defined herein, provided that the last treatment block comprises subjecting the plants to at least one treatment with at least one biological control agent .</span>
  </p>
  <p id="p0173" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[173] Dentro do significado da presente inveno, bloco de tratamento se refere a uma etapa de tratamento que compreende uma ou mais aplicaes de pelo menos um indutor da defesa do hospedeiro (A) ou de pelo menos um agente de controle biolgico (B). Os blocos de tratamento diferentes so distinguidos pelo tipo de compostos ativos usados (um bloco de tratamento compreende a aplicao de pelo menos um indutor da defesa do hospedeiro ou de pelo menos um agente de controle biolgico) e por tempo (ou seja, os blocos de tratamento diferentes no se superpem). No entanto, caso haja mais do que dois blocos de tratamento, um bloco de tratamento pode compreender o tratamento combinado com pelo menos um indutor da defesa do hospedeiro e pelo menos um agente de controle biolgico, por exemplo, por aplicao de uma mistura de pelo menos um indutor da defesa do hospedeiro e pelo menos um agente de controle biolgico. De preferncia, caso haja mais do que dois blocos de tratamento, um bloco de tratamento pode compreender o tratamento combinado com pelo menos um indutor da defesa do hospedeiro e pelo menos um agente de controle biolgico, por exemplo, por aplicao de uma mistura de pelo menos um indutor da defesa do hospedeiro e pelo menos um agente de controle biolgico, desde que o ltimo bloco de tratamento compreenda a submisso das plantas a pelo menos um tratamento com pelo menos um agente de controle biolgico (e no indutor da defesa do hospedeiro). Prefere-se, no entanto, que nenhum bloco de tratamento compreenda o tratamento combinado com pelo menos um indutor da defesa do hospedeiro e pelo menos um agente de controle biolgico; em outras palavras, prefere-se que cada bloco de tratamento compreenda a aplicao de pelo menos um indutor da defesa do hospedeiro ou de pelo menos um agente de controle biolgico.</span>[173] Within the meaning of the present invention, "treatment block" refers to a treatment step comprising one or more applications of at least one host defense inducer (A) or at least one biological control agent ( B). The different treatment blocks are distinguished by the type of active compounds used (a treatment block comprises the application of at least one host defense inducer or at least one biological control agent) and by time (that is, the different treatment methods do not overlap). However, if there are more than two treatment blocks, a treatment block can comprise treatment combined with at least one host defense inducer and at least one biological control agent, for example, by applying a mixture of at least at least one host defense inducer and at least one biological control agent. Preferably, if there are more than two treatment blocks, a treatment block can comprise treatment combined with at least one host defense inducer and at least one biological control agent, for example, by applying a mixture of at least at least one host defense inducer and at least one biological control agent, provided that the last treatment block comprises subjecting the plants to at least one treatment with at least one biological control agent (and the host defense inducer) . It is preferred, however, that no treatment block comprises treatment combined with at least one host defense inducer and at least one biological control agent; in other words, it is preferred that each treatment block comprises the application of at least one host defense inducer or at least one biological control agent.</span>
  </p>
  <p id="p0174" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[174] O ltimo bloco de tratamento  aquele bloco de tratamento que  o ltimo bloco de tratamento de indutor da defesa do hospedeiro em uma estao, por exemplo, antes, durante ou aps a colheita (tratamento do cultivo), ou antes da morte da planta (em caso de plantas anuais).</span>[174] The last treatment block is that treatment block that is the last treatment block of host defense inducer in a season, for example, before, during or after harvest (crop treatment), or before of the death of the plant (in case of annual plants).</span>
  </p>
  <p id="p0175" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[175] De preferncia, o mtodo da inveno compreende dois blocos de tratamento. Dessa forma, a inveno preferivelmente est relacionada a um mtodo para o controle de organismos bacterianos nocivos, cujo mtodo compreende a submisso das plantas a serem protegidascontra ataque por bactrias fitopatognicas a dois blocos de tratamento sequenciais, em que o primeiro bloco de tratamento compreende a submisso das plantas a pelo menos um tratamento com pelo menos um indutor da defesa do hospedeiro e o segundo bloco de tratamento subsequente compreende a submisso das plantas a pelo menos um tratamento com pelo menos um agente de controle biolgico. Em um bloco de tratamento que compreende a submisso das plantas a pelo menos um tratamento com pelo menos um indutor da defesa do hospedeiro, nenhum agente de controle biolgico  aplicado. Em um bloco de tratamento que compreende a submisso das plantas a pelo menos um tratamento com pelo menos um agente de controle biolgico, nenhum indutor da defesa do hospedeiro  aplicado. No mtodo da inveno, um bloco de tratamento  realizado somente aps o bloco de tratamento precedente ter sido finalizado, ou seja, o segundo bloco de tratamento  realizado somente aps o primeiro bloco de tratamento ter sido finalizado, o terceiro bloco de tratamento, se existente, s  realizado aps o segundo bloco de tratamento ter sido finalizado etc.</span>[175] Preferably, the method of the invention comprises two treatment blocks. Thus, the invention preferably relates to a method for the control of harmful bacterial organisms, the method of which involves submitting the plants to be protected against attack by phytopathogenic bacteria to two sequential treatment blocks, in which the first treatment block comprises the subjecting the plants to at least one treatment with at least one host defense inducer, and the second subsequent treatment block comprises subjecting the plants to at least one treatment with at least one biological control agent. In a treatment block that comprises subjecting the plants to at least one treatment with at least one host defense inducer, no biological control agent is applied. In a treatment block that comprises subjecting the plants to at least one treatment with at least one biological control agent, no inducer of host defense is applied. In the method of the invention, a treatment block is performed only after the preceding treatment block has been completed, that is, the second treatment block is performed only after the first treatment block has been completed, the third treatment block, if existing, is only carried out after the second treatment block has been completed, etc.</span>
  </p>
  <p id="p0176" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[176] De preferncia, os respectivos blocos de tratamento so realizados durante estgios de crescimento diferentes das plantas. Em outras palavras, o intervalo de tempo entre os blocos de tratamento subsequentes  preferivelmente tal que as plantas esto em estgios de crescimento diferentes quando so submetidas aos respectivos blocos de tratamento, ou seja, o primeiro, o segundo etc. blocos de tratamento so realizados durante estgios de crescimento no superpostos das plantas, o primeiro bloco de tratamento, evidentemente, sendo realizado em estgios de crescimento anteriores ao segundo etc. Em caso da modalidade preferida da inveno na qual o mtodo compreende dois blocos de tratamento, preferivelmente o intervalo de tempo entre o primeiro e o segundo bloco de tratamento  tal que as plantas esto em estgios de crescimento diferentes quando so submetidas ao primeiro e ao segundo blocos de tratamento, respectivamente, ou seja, o primeiro e o segundo blocos de tratamento so preferivelmente realizados durante estgios de crescimento no superpostos das plantas, o primeiro bloco de tratamento, evidentemente, sendo realizado em estgios de crescimento anteriores.</span>[176] Preferably, the respective treatment blocks are carried out during different growth stages of the plants. In other words, the time interval between the subsequent treatment blocks is preferably such that the plants are in different growth stages when they are subjected to the respective treatment blocks, that is, the first, the second and so on. treatment blocks are carried out during non-overlapping growth stages of the plants, the first treatment block, of course, being carried out in growth stages prior to the second etc. In the case of the preferred embodiment of the invention in which the method comprises two treatment blocks, preferably the time interval between the first and the second treatment block is such that the plants are in different growth stages when they are subjected to the first and the second treatment blocks, respectively, that is, the first and second treatment blocks are preferably carried out during non-overlapping growth stages of the plants, the first treatment block, of course, being carried out in previous growth stages.</span>
  </p>
  <p id="p0177" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[177] O termo estgio de crescimento como usado nos termos da presente inveno se refere aos estgios de crescimento de acordo com a escala estendida de BBCH (BBCH Makrostadien; Biologische Bundesanstalt fur Le- und Forstwirtschaft [BBCH Macrostages; German Federal Biological Research Center for Agriculture and Forestry]; veja www.bba.de/veroeff/bbch/bbcheng.pdf).</span>[177] The term growth stage as used in the present invention refers to the growth stages according to the extended scale of BBCH (BBCH Makrostadien; Biologische Bundesanstalt fur Le- und Forstwirtschaft [BBCH Macrostages; German Federal Biological Research Center for Agriculture and Forestry]; see www.bba.de/veroeff/bbch/bbcheng.pdf).</span>
  </p>
  <p id="p0178" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[178] De preferncia, o primeiro bloco de tratamento termina por ltimo quando as plantas alcanaram o estgio de crescimento 81 e o ltimo bloco de tratamento comea mais cedo quando as plantas esto no estgio de crescimento 41, de acordo com a escala estendida de BBCH. Como j ressaltado, um bloco subsequente  sempre e mandatoriamente realizado aps o trmino do bloco precedente; o que significa, por exemplo, que se o primeiro bloco de tratamento terminou quando a planta est no estgio de crescimento 81, o segundo bloco de tratamento  realizadosomente aps o trmino do primeiro bloco, preferivelmente no incio do estgio de crescimento 82. O ponto do tempo mais adequado para o tratamento depende, entre outras coisas, da planta a ser tratada.</span>[178] Preferably, the first treatment block ends last when the plants have reached growth stage 81 and the last treatment block starts earlier when the plants are in growth stage 41, according to the extended scale of BBCH . As already noted, a subsequent block is always mandatorily completed after the end of the preceding block; which means, for example, that if the first treatment block is finished when the plant is in growth stage 81, the second treatment block is performed only after the end of the first block, preferably at the beginning of growth stage 82. The the most suitable time point for treatment depends, among other things, on the plant to be treated.</span>
  </p>
  <p id="p0179" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[179] Em caso da modalidade preferida da inveno na qual o mtodo compreende dois blocos de tratamento, preferivelmente o primeiro bloco de tratamento termina por ltimo quando as plantas alcanaram o estgio de crescimento 81 e o segundo bloco de tratamento comea mais cedo quando as plantas esto no estgio de crescimento 41. Como j ressaltado, o segundo bloco  sempre e mandatoriamente realizado aps o trmino do primeiro bloco; o que significa, por exemplo, que se o primeiro bloco de tratamento terminou quando a planta est no estgio de crescimento 81, o segundo bloco de tratamento  realizado somente aps o trmino do primeiro bloco, preferivelmente no incio do estgio de crescimento 82. O ponto do tempo mais adequado para o tratamento depende, entre outras coisas, da planta a ser tratada.</span>[179] In the case of the preferred embodiment of the invention in which the method comprises two treatment blocks, preferably the first treatment block ends last when the plants have reached growth stage 81 and the second treatment block starts earlier when the plants they are in the growth stage 41. As already pointed out, the second block is always and mandatorily held after the end of the first block; which means, for example, that if the first treatment block is finished when the plant is in growth stage 81, the second treatment block is performed only after the end of the first block, preferably at the beginning of growth stage 82. The the most suitable time point for treatment depends, among other things, on the plant to be treated.</span>
  </p>
  <p id="p0180" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[180] Mais preferivelmente, o primeiro bloco de tratamento termina por ltimo quando as plantas alcanaram o estgio de crescimento 79 e o ltimo bloco de tratamento, que  preferivelmente o segundo bloco de tratamento, comea mais cedo quando as plantas esto no estgio de crescimento 41. Ainda mais preferivelmente, o primeiro bloco de tratamento  realizado quando as plantas esto no estgio de crescimento 01 a 79, preferivelmente 10 a 79, e o ltimo bloco de tratamento, que  preferivelmente o segundo bloco de tratamento,  realizado quando as plantas esto no estgio de crescimento 41 a 92 ou ainda aps a colheita, ou seja, 41 a 99. O ponto do tempo mais adequado para o tratamento depende, entre outras coisas, da planta a ser tratada. Informao mais detalhada  apresentada abaixo com relao a plantas especficas.</span>[180] More preferably, the first treatment block ends last when the plants have reached the growth stage 79 and the last treatment block, which is preferably the second treatment block, starts earlier when the plants are in the growth stage 41. Even more preferably, the first treatment block is carried out when the plants are in growth stage 01 to 79, preferably 10 to 79, and the last treatment block, which is preferably the second treatment block, is carried out when the plants are in the growth stage 41 to 92 or even after harvest, that is, 41 to 99. The most suitable time point for treatment depends, among other things, on the plant to be treated. More detailed information is presented below with respect to specific plants.</span>
  </p>
  <p id="p0181" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[181] A seguir, plantas especficas e o respectivo intervalo de tempo preferido para os dois blocos de tratamento preferidos so compilados a penas como exemplo:</span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/80/b9/e5/0e16618f515f28/img0066.png" class="style-scope patent-text"><img id="i0066" wi="468" he="490" img-content="drawing" img-format="jpg" file="img0066.jpg" orientation="unknown" width="1872" height="1960" alt="Figure img0066" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/80/b9/e5/0e16618f515f28/img0066.png"></a></div> GS 69; preferivelmente[181] Below, specific plants and the respective preferred time interval for the two preferred treatment blocks are compiled to feathers as an example: <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/80/b9/e5/0e16618f515f28/img0066.png" class="style-scope patent-text"><img id="i0066" wi="468" he="490" img-content="drawing" img-format="jpg" file="img0066.jpg" orientation="unknown" width="1872" height="1960" alt="Figure img0066" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/80/b9/e5/0e16618f515f28/img0066.png"></a></div> GS 69; preferably
  <p class="style-scope patent-text"></p>
  <p id="p0182" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[182] Em uma modalidade especfica, todos os blocos de tratamento que compreendem o tratamento com pelo menos um indutor da defesa do hospedeiro terminam por ltimo ao final do perodo vegetativo da respectiva planta. Em outras palavras, nessa modalidade especfica, nenhum indutor da defesa do hospedeiro  usado para tratamento das plantas aps o final do perodo vegetativo. Nessa modalidade especfica, a etapa de tratamento com pelo menos um agente de controle biolgico  realizado aps o perodo vegetativo no perodo de pr-colheita. No bloco de tratamento no qual pelo menos um indutor da defesa do hospedeiro  usado, esse  aplicado pelo menos uma vez, por exemplo, 1, 2, 3, 4, 5, 6, 7 ou 8 vezes, preferivelmente 1, 2, 3, 4 ou 5 vezes. A frequncia de aplicao depende, entre outras coisas, da presso de patgeno e/ou das condies climticas. Por exemplo, condies climticas que promovem ataque e proliferao bacterianos, por exemplo, umidade extrema, podem necessitar de mais aplicaes de pelo menos um indutor da defesa do hospedeiro do que o clima seco e quente. Caso haja mais do que uma aplicao dos indutores da defesa do hospedeiro, o intervalo de tempo entre as aplicaes nicas depende, entre outras coisas, da presso da praga, da planta a ser tratada, das condies climticas, e pode ser determinado por aqueles habilitados na tcnica. Em geral, a frequncia de aplicao, bem como as taxas de aplicao, corresponder quilo que  comum para a respectiva planta e para o respectivo indutor da defesa do hospedeiro sob as condies apresentadas, com exceo que, aps um estgio de crescimento especfico, o tratamento com o indutor da defesa do hospedeiro  substitudo por um tratamento com um agente de controle biolgico. Caso haja mais do que uma aplicao de pelo menos um indutor da defesa do hospedeiro, essas podem ser realizadas durante estgios de crescimento diferentes.</span>[182] In a specific modality, all treatment blocks that comprise treatment with at least one host defense inducer end last at the end of the vegetative period of the respective plant. In other words, in this specific modality, no host defense inducer is used to treat the plants after the end of the growing season. In this specific modality, the treatment step with at least one biological control agent is carried out after the vegetative period in the pre-harvest period. In the treatment block in which at least one host defense inducer is used, it is applied at least once, for example, 1, 2, 3, 4, 5, 6, 7 or 8 times, preferably 1, 2, 3, 4 or 5 times. The frequency of application depends, among other things, on the pathogen pressure and / or climatic conditions. For example, climatic conditions that promote bacterial attack and proliferation, for example, extreme humidity, may require more applications of at least one host defense inducer than dry, hot weather. If there is more than one application of the host's defense inducers, the time interval between single applications depends, among other things, on the pressure of the pest, the plant to be treated, the climatic conditions, and can be determined by those qualified in the technique. In general, the frequency of application, as well as the application rates, will correspond to what is common for the respective plant and for the respective host defense inducer under the conditions presented, except that, after a specific growth stage, the treatment with the host's defense inducer is replaced by treatment with a biological control agent. If there is more than one application of at least one host defense inducer, these can be performed during different growth stages.</span>
  </p>
  <p id="p0183" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[183] No mtodo da inveno, dependendo do tipo de indutor da defesa do hospedeiro usado, as taxas de aplicao nica de pelo menos um indutor da defesa do hospedeiro so de 0,0001 a 7 kg por ha, preferivelmente de 0,005 a 5 kg por ha, mais preferivelmente de 0,05 a 2 kg por ha.</span>[183] In the method of the invention, depending on the type of host defense inducer used, the single application rates of at least one host defense inducer are from 0.0001 to 7 kg per ha, preferably from 0.005 to 5 kg per ha, more preferably from 0.05 to 2 kg per ha.</span>
  </p>
  <p id="p0184" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[184] No bloco de tratamento no qual pelo menos um agente de controle biolgico  usado, esse  aplicado pelo menos uma vez, por exemplo, 1, 2, 3, 4, 5, 6, 7 ou 8 vezes, preferivelmente 1, 2, 3, 4, 5 ou 6 vezes, mais preferivelmente 1, 2, 3 ou 4 vezes, ainda mais preferivelmente 2, 3 ou 4 vezes e, em particular, 2 ou 3 vezes. Como no caso da aplicao de indutores da defesa do hospedeiro, a frequncia de aplicao depende, entre outras coisas, da presso de patgeno e/ou das condies climticas. Por exemplo, condies climticas que promovem ataque e proliferao bacterianos, por exemplo, umidade extrema, podem necessitar de mais aplicaes do agente de controle biolgico do que clima seco e quente. Caso haja mais do que uma aplicao do agente de controle biolgico, o intervalo de tempo entre as aplicaes nicas depende, entre outras coisas, da presso da praga, da planta a ser tratada, das condies climticas etc., e pode ser determinado por aqueles habilitados na tcnica. Em geral, a frequncia de aplicao, bem como as taxas de aplicao, corresponder quilo que  comum para a respectiva planta e para o respectivo agente de controle biolgico sob as condies apresentadas, com exceo que o tratamento com o agente de controle biolgico comea somente aps a planta ter alcanado um estgio de crescimento especfico e aps o tratamento com um indutor da defesa do hospedeiro ter sido completado. Caso haja mais do que uma aplicao do agente de controle biolgico, essas podem ser realizadas durante estgios de crescimento diferentes.</span>[184] In the treatment block in which at least one biological control agent is used, it is applied at least once, for example, 1, 2, 3, 4, 5, 6, 7 or 8 times, preferably 1, 2, 3, 4, 5 or 6 times, more preferably 1, 2, 3 or 4 times, even more preferably 2, 3 or 4 times and, in particular, 2 or 3 times. As in the case of the application of host defense inducers, the frequency of application depends, among other things, on pathogen pressure and / or climatic conditions. For example, climatic conditions that promote bacterial attack and proliferation, for example, extreme humidity, may require more applications of the biological control agent than dry, hot weather. If there is more than one application of the biological control agent, the time interval between single applications depends, among other things, on the pressure of the pest, the plant to be treated, the climatic conditions etc., and can be determined by those skilled in the technique. In general, the frequency of application, as well as the application rates, will correspond to what is common for the respective plant and for the respective biological control agent under the conditions presented, except that the treatment with the biological control agent begins only after the plant has reached a specific growth stage and after treatment with a host defense inducer has been completed. If there is more than one application of the biological control agent, these can be carried out during different growth stages.</span>
  </p>
  <p id="p0185" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[185] Um mtodo preferido adicional de acordo com a presente inveno compreende a submisso das plantas a dois ou mais blocos de tratamento sequenciais como aqui descrito e ainda pelo menos um tratamento com pelo menos um composto (C) como aqui definido. Um mtodo ainda mais preferido de acordo com a presente inveno compreende a submisso das plantas a dois ou mais blocos de tratamento sequenciais como aqui descrito e ainda pelo menos um tratamento com pelo menos um composto (C) como aqui definido, desde que o ltimo bloco de tratamento compreenda a submisso das plantas a pelo menos um tratamento com pelo menos um agente de controle biolgico e, opcionalmente, pelo menos um composto adicional (C). Nessa modalidade os agentes de controle biolgico no so necessariamente aplicados aps o indutor da defesa do hospedeiro, mas podem ser aplicados aps pelo menos um composto adicional (C), tambm. Concretamente, os trs componentes (A), (B) e (C) podem ser aplicados em qualquer ordem e em que cada um em qualquer repetio diferente de tratamentos. Mais preferido, os trs componentes (A), (B) e (C) podem ser aplicados em qualquer ordem e em que cada um em qualquer repetio diferente de tratamentos, desde que o ltimo bloco de tratamento (final) compreenda a submisso das plantas a pelo menos um tratamento com pelo menos um agente de controle biolgico (e nenhum indutor da defesa do hospedeiro e nenhum composto adicional (C)). Isso significa que o mtodo pode compreender pelo menos dois blocos de tratamento repetidos de composto (A), (B) e/ou (C), tambm. Em geral, a frequncia de aplicao, bem como as taxas de aplicao, e repeties de composto (A), (B) e/ou (C), correspondem quilo que  comum para a respectiva planta e para os respectivos compostos (A), (B) e (C) sob as condies apresentadas, com exceo que o tratamento com composto (A), (B) ou (C) comea somente aps a planta ter alcanado um estgio de crescimento especfico e aps a aplicao de qualquer bloco de tratamento prvio ter sido completado. Caso haja mais do que uma aplicao dos compostos (A), (B) e (C), essas podem ser realizadas durante estgios de crescimento diferentes.</span>[185] An additional preferred method according to the present invention comprises subjecting the plants to two or more sequential treatment blocks as described herein and at least one treatment with at least one compound (C) as defined herein. An even more preferred method according to the present invention comprises subjecting the plants to two or more sequential treatment blocks as described herein and at least one treatment with at least one compound (C) as defined herein, provided that the last block of treatment comprises subjecting the plants to at least one treatment with at least one biological control agent and, optionally, at least one additional compound (C). In this modality, biological control agents are not necessarily applied after the host defense inducer, but can be applied after at least one additional compound (C), as well. Concretely, the three components (A), (B) and (C) can be applied in any order and in which each in any different repetition of treatments. Most preferred, the three components (A), (B) and (C) can be applied in any order and in which each in any different repetition of treatments, as long as the last (final) treatment block comprises the submission of the plants at least one treatment with at least one biological control agent (and no host defense inducers and no additional compounds (C)). This means that the method can comprise at least two repeated treatment blocks of compound (A), (B) and / or (C), as well. In general, the frequency of application, as well as the application rates, and repetitions of compound (A), (B) and / or (C), correspond to what is common for the respective plant and for the respective compounds (A) , (B) and (C) under the conditions presented, except that the treatment with compound (A), (B) or (C) begins only after the plant has reached a specific growth stage and after the application of any block prior treatment has been completed. If there is more than one application of compounds (A), (B) and (C), these can be carried out during different growth stages.</span>
  </p>
  <p id="p0186" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[186] Todos os mtodos aqui descritos englobam o tratamento de plantas transgnicas.</span>[186] All of the methods described here encompass the treatment of transgenic plants.</span>
  </p>
  <p id="p0187" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[187] De acordo com a presente inveno, um efeito sinrgico de, por exemplo, indutores da defesa do hospedeiro ou do agente de controle biolgico sempre est presente quando a atividade das combinaes de composto ativo excede o total das atividades dos compostos ativos quando aplicados individualmente. A atividade esperada para certa combinao de dois compostos ativos (combinao binria) pode ser calculada da seguinte forma:</span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/57/bd/26/98ada3d6f8e6ca/img0067.png" class="style-scope patent-text"><img id="i0067" wi="142" he="59" img-content="drawing" img-format="jpg" file="img0067.jpg" orientation="unknown" width="568" height="236" alt="Figure img0067" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/57/bd/26/98ada3d6f8e6ca/img0067.png"></a></div> em que E representa a porcentagem esperada de inibio da doena para a combinao de dois compostos em doses definidas (por exemplo, igual a x e y, respectivamente), x  a porcentagem de inibio observada para a doena pelo composto (A) em uma dose definida (igual a x), y  a porcentagem de inibio observada para a doena pelo composto (B) em uma dose definida (igual a y). Quando a porcentagem de inibio observada para a combinao  maior do que E, h um efeito sinrgico.[187] According to the present invention, a synergistic effect of, for example, inducers of host defense or biological control agent is always present when the activity of the active compound combinations exceeds the total activity of the active compounds when applied individually. The expected activity for a certain combination of two active compounds (binary combination) can be calculated as follows: <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/57/bd/26/98ada3d6f8e6ca/img0067.png" class="style-scope patent-text"><img id="i0067" wi="142" he="59" img-content="drawing" img-format="jpg" file="img0067.jpg" orientation="unknown" width="568" height="236" alt="Figure img0067" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/57/bd/26/98ada3d6f8e6ca/img0067.png"></a></div> where E represents the expected percentage of disease inhibition for the combination of two compounds at defined doses (for example, equal to x and y, respectively), x is the percentage of inhibition observed for the disease by compound (A) at a defined dose ( equal to x), y is the percentage of inhibition observed for the disease by compound (B) at a defined dose (equal to y). When the percentage of inhibition observed for the combination is greater than E, there is a synergistic effect.
  <p class="style-scope patent-text"></p>
  <p id="p0188" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[188] A atividade esperada para certa combinao de trs compostos ativos (combinao ternria) pode ser calculada da seguinte forma:</span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/0f/3d/34/8976ded9e61865/img0068.png" class="style-scope patent-text"><img id="i0068" wi="347" he="75" img-content="drawing" img-format="jpg" file="img0068.jpg" orientation="unknown" width="1388" height="300" alt="Figure img0068" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/0f/3d/34/8976ded9e61865/img0068.png"></a></div> em que: X  a eficcia quando o composto ativo A  aplicado em uma taxa de aplicao de m ppm (ou g/ha), Y  a eficcia quando o composto ativo B  aplicado em uma taxa de aplicao de n ppm (ou g/ha), Z  a eficcia quando o composto ativo C  aplicado em uma taxa de aplicao de r ppm (ou g/ha), E  a eficcia quando os compostos ativos A, B e C so aplicados em taxas de aplicao de m, n e r ppm (ou g/ha), respectivamente.[188] The expected activity for a certain combination of three active compounds (ternary combination) can be calculated as follows: <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/0f/3d/34/8976ded9e61865/img0068.png" class="style-scope patent-text"><img id="i0068" wi="347" he="75" img-content="drawing" img-format="jpg" file="img0068.jpg" orientation="unknown" width="1388" height="300" alt="Figure img0068" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/0f/3d/34/8976ded9e61865/img0068.png"></a></div> where: X is the effectiveness when the active compound A is applied at an application rate of m ppm (or g / ha), Y is the effectiveness when the active compound B is applied at an application rate of n ppm (or g / ha), Z is the effectiveness when the active compound C is applied at an application rate of r ppm (or g / ha), E is the effectiveness when the active compounds A, B and C are applied at application rates of m, ner ppm (or g / ha), respectively.
  <p class="style-scope patent-text"></p>
  <p id="p0189" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[189] O grau de eficcia, expresso em %,  designado. 0% significa uma eficcia que corresponde quela do controle, enquanto uma eficcia de 100% significa que nenhuma doena  observada.</span>[189] The degree of effectiveness, expressed in%, is designated. 0% means an efficacy that corresponds to that of the control, while an efficacy of 100% means that no disease is observed.</span>
  </p>
  <p id="p0190" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[190] Se a atividade real excede o valor calculado, ento a atividade da combinao  superaditiva, ou seja, existe um efeito sinrgico. Nesse caso, a eficcia que foi realmente observada deve ser maior do que o valor para a eficcia esperada (E) calculado pela frmula mencionada acima. Uma forma adicional de demonstrar um efeito sinrgico  o mtodo de Tammes (veja Isoboles, a Graphic Representation of Synergism in Pesticides em Neth. J. Plant Path., 1964, 70, 73-80).</span>[190] If the actual activity exceeds the calculated value, then the activity of the combination is superadditive, that is, there is a synergistic effect. In this case, the effectiveness that was actually observed must be greater than the value for the expected effectiveness (E) calculated by the formula mentioned above. An additional way of demonstrating a synergistic effect is the Tammes method (see "Isoboles, the Graphic Representation of Synergism in Pesticides" in Neth. J. Plant Path., 1964, 70, 73-80).</span>
  </p>
  <p id="p0191" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[191] Uma modalidade preferida da presente inveno est relacionada ao uso de uma combinao em tomates, em que: (A) o indutor da defesa do hospedeiro  isotianil, (B) o agente de controle biolgico  selecionado do grupo que consiste em: 1) bactrias que consistem em Bacillus subtilis cepa QST713/AQ713 (N de Acesso NRRL B21661), Bacillus subtilis cepa AQ153 (N de Acesso NRRL 55614), Bacillus sp. cepa AQ175 (N de Acesso ATCC 55608), Bacillus sp. cepa AQ177 (N de Acesso ATCC 55609), e Bacillus sp. cepa AQ178 (N de Acesso ATCC 53522); e 2) Bactrias que consistem em Pseudomonas syringae pv. tomato, e (C) pelo menos um composto adicional  selecionado do grupo que consiste em penflufen.</span>[191] A preferred embodiment of the present invention relates to the use of a combination in tomatoes, in which: (A) the host's defense inducer is isothianil, (B) the biological control agent is selected from the group consisting of: 1) bacteria consisting of Bacillus subtilis strain QST713 / AQ713 (NRRL Accession No. B21661), Bacillus subtilis strain AQ153 (NRRL Accession No. 55614), Bacillus sp. strain AQ175 (ATCC Accession No. 55608), Bacillus sp. strain AQ177 (ATCC Accession No. 55609), and Bacillus sp. strain AQ178 (ATCC Accession No. 53522); and 2) Bacteria consisting of Pseudomonas syringae pv. tomato, and (C) at least one additional compound is selected from the group consisting of penflufen.</span>
  </p>
  <p id="p0192" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[192] Outra modalidade preferida da presente inveno est relacionada ao uso de uma combinao como tratamento de sementes em batatas, em que: (A) o indutor da defesa do hospedeiro  isotianil, (B) o agente de controle biolgico  selecionado do grupo que consiste em: 1) bactrias que consistem em Bacillus subtilis cepa QST713/AQ713 (N de Acesso NRRL B21661), Bacillus subtilis cepa AQ153 (N de Acesso NRRL 55614), Bacillus sp. cepa AQ175 (N de Acesso ATCC 55608), Bacillus sp. cepa AQ177 (N de Acesso ATCC 55609), e Bacillus sp. cepa AQ178 (N de Acesso ATCC 53522); e 2) Bactrias que consistem em Streptomyces scabies, e (C) pelo menos um composto adicional  selecionado do grupo que consiste em penflufen. Exemplo 1:</span>[192] Another preferred embodiment of the present invention relates to the use of a combination as seed treatment in potatoes, in which: (A) the host's defense inducer is isothianyl, (B) the biological control agent is selected from the group consisting of: 1) bacteria consisting of Bacillus subtilis strain QST713 / AQ713 (NRRL Accession No. B21661), Bacillus subtilis strain AQ153 (NRRL Accession No. 55614), Bacillus sp. strain AQ175 (ATCC Accession No. 55608), Bacillus sp. strain AQ177 (ATCC Accession No. 55609), and Bacillus sp. strain AQ178 (ATCC Accession No. 53522); and 2) Bacteria consisting of Streptomyces scabies, and (C) at least one additional compound is selected from the group consisting of penflufen. Example 1:</span>
  </p>
  <p id="p0193" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[193] A atividade antibacteriana avanada das combinaes de composto ativo de acordo com a inveno  evidente a partir do exemplo abaixo. Enquanto os compostos ativos individuais exibem fraquezas com relao  atividade antibacteriana, as combinaes possuem uma atividade que excede uma simples adio de atividades.</span>[193] The advanced antibacterial activity of the active compound combinations according to the invention is evident from the example below. While the individual active compounds exhibit weaknesses with respect to antibacterial activity, the combinations have an activity that exceeds a simple addition of activities.</span>
  </p>
  <p id="p0194" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[194] Um efeito sinrgico de bactericidas sempre est presente quando a atividade antibacteriana das combinaes de composto ativo excede o total das atividades dos compostos ativos quando aplicados individualmente. A atividade esperada para certa combinao de dois compostos ativos pode ser calculada como indicado acima. O grau de eficcia, expresso em %,  designado. 0% significa uma eficcia que corresponde quela do controle, enquanto uma eficcia de 100% significa que nenhuma doena  observada.</span>[194] A synergistic effect of bactericides is always present when the antibacterial activity of the active compound combinations exceeds the total activities of the active compounds when applied individually. The expected activity for a certain combination of two active compounds can be calculated as indicated above. The degree of effectiveness, expressed in%, is designated. 0% means an efficacy that corresponds to that of the control, while a 100% efficacy means that no disease is observed.</span>
  </p>
  <p id="p0195" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[195] Se a atividade antibacteriana real excede o valor calculado, ento a atividade da combinao  superaditiva, ou seja, existe um efeito sinrgico. Nesse caso, a eficcia que foi realmente observada deve ser maior do que o valor para a eficcia esperada (E) calculado pela frmula mencionada acima. A inveno  ilustrada pelo exemplo seguinte. No entanto, a inveno no est limitada ao exemplo.Exemplo 1: Teste preventivo in vivo em Pseudomonas syringae pv. tomato (tomates) Solvente: gua deionizada Compostos testados: Isotianil (formulao SC200) a 200 / 100 / 50 g de ingrediente ativo/ha Acibenzolar-S-metil (Bion WG50) a 20/ 10/ 5 g/ha Serenade Max (Bacillus subtilis seco QST 713 cepa/ WP / 14,6%) 6/ 3/ 1,2 g/ha</span>[195] If the actual antibacterial activity exceeds the calculated value, then the activity of the combination is superadditive, that is, there is a synergistic effect. In this case, the effectiveness that was actually observed must be greater than the value for the expected effectiveness (E) calculated by the formula mentioned above. The invention is illustrated by the following example. However, the invention is not limited to the example. Example 1: In vivo preventive test on Pseudomonas syringae pv. tomato (tomatoes) Solvent: deionized water Test compounds: Isothianil (formulation SC200) at 200/100/50 g of active ingredient / ha Acibenzolar-S-methyl (Bion WG50) at 20/10/5 g / ha Serenade Max (Bacillus dry subtilis QST 713 strain / WP / 14.6%) 6/3 / 1.2 g / ha</span>
  </p>
  <p id="p0196" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[196] Para testar a atividade preventiva, plantas jovens so pulverizadas com os compostos preparados em trs taxas de aplicao diferentes. Uma semana aps aplicao, as plantas so inoculadas com uma suspenso aquosa de Pseudomonas syringae pv. tomato. As plantas inoculadas so colocadas em uma cmara de estufa a 25 C em uma umidade atmosfrica relativa de 90%.</span>[196] To test preventive activity, young plants are sprayed with compounds prepared at three different rates of application. One week after application, the plants are inoculated with an aqueous suspension of Pseudomonas syringae pv. tomato. The inoculated plants are placed in a greenhouse chamber at 25  C in a relative atmospheric humidity of 90%.</span>
  </p>
  <p id="p0197" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[197] O teste  avaliado 1 semana aps inoculao. 0% significa uma eficcia que corresponde quela do controle no tratado, enquanto uma eficcia de 100% significa que nenhuma doena  observada.</span>[197] The test is evaluated 1 week after inoculation. 0% means an efficacy that corresponds to that of the untreated control, while a 100% efficacy means that no disease is observed.</span>
  </p>
  <p id="p0198" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[198] A tabela abaixo mostra claramente que a atividade observada da combinao de composto ativo de acordo com a inveno  maior do que a atividade calculada, ou seja, um efeito sinrgico est presente. Exemplo 2: Teste preventivo in vivo (Teste de crescimento de semente) em Streptomyces scabies (batata) Solvente: gua Compostos testados: Isotianil (formulao FS200) a 30 / 24 / 12 mL / 100 kg de semente de batata Penflufen (formulao Ernesto FS240) a 10 mL /100 kg de sementes de batata Serenade ASO (Bacillus subtilis QST 713 cepa/ SC / 1,34%) 5 litros/ha (200 mL /rea semeada sob 100 kg de sementes)</span>[198] The table below clearly shows that the observed activity of the active compound combination according to the invention is greater than the calculated activity, that is, a synergistic effect is present. Example 2: In vivo preventive test (seed growth test) on Streptomyces scabies (potato) Solvent: water Test compounds: Isothianil (formulation FS200) at 30/24/12 mL / 100 kg of Penflufen potato seed (formulation Ernesto FS240 ) to 10 mL / 100 kg of Serenade ASO potato seeds (Bacillus subtilis QST 713 strain / SC / 1.34%) 5 liters / ha (200 mL / sown area under 100 kg of seeds)</span>
  </p>
  <p id="p0199" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[199] Para testar a atividade de tratamento de sementes (tubrculo), misturas de Isotianil FS200 e Serenade ASO SC em combinao com um fungicida adicional opcional, so selecionados tubrculos de batata que possuem infestao razovel por Streptomyces scabies. A semente foi tratada por spray nos tubrculos com pulverizador manual de mochila usando um volume total de pasta de 1.500 mL/100 de kg de sementes. O tratamento da semente foi feito com Isotianil FS 200 isoladamente e em mistura no tanque com Penflufen.</span>[199] To test seed treatment activity (tuber), mixtures of Isotianil FS200 and Serenade ASO SC in combination with an optional additional fungicide, potato tubers are selected that have reasonable infestation with Streptomyces scabies. The seed was spray-treated on the tubers with a manual backpack sprayer using a total paste volume of 1,500 mL / 100 kg of seeds. The seed treatment was done with Isotianil FS 200 alone and mixed in the tank with Penflufen.</span>
  </p>
  <p id="p0200" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[200] Serenade ASO SC 1,34% @ 5.000 mL/ha de produto formulado foi pulverizado nos sulcos de arados imediatamente antes da semeadura de sementes. 100 kg de sementes so semeados em uma rea de 400 m2 e produto formulado de Serenade ASO @ 200 mL foi usado nesse teste. A semente tratada com Isotianil e Penflufen opcional como mtodo descrito acima foi usada em combinao com aplicao no solo de Serenade ASO em sulcos de arados antes da semeadura. Esse estudo foi realizado em cmara com condies naturais de campo e observaes para infestao por Streptomyces scabies na batata foram feitas no momento da colheita.</span>[200] Serenade ASO SC 1.34% @ 5,000 mL / ha of formulated product was sprayed into the plow grooves immediately before sowing seeds. 100 kg of seeds are sown in an area of 400 m2 and Serenade ASO formulated product @ 200 mL was used in this test. The seed treated with Isotianil and optional Penflufen as the method described above was used in combination with application to the soil of Serenade ASO in plow furrows before sowing. This study was carried out in a chamber with natural field conditions and observations for infestation by Streptomyces scabies in the potato were made at the time of harvest.</span>
  </p>
  <p id="p0201" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[201] O teste  avaliado na colheita do cultivo de batatas. 0% significa uma eficcia que corresponde quela do controle no tratado, enquanto uma eficcia de 100% significa que nenhuma doena  observada.</span>[201] The test is evaluated in the potato crop harvest. 0% means an effectiveness that corresponds to that of the untreated control, while a 100% efficiency means that no disease is observed.</span>
  </p>
  <p id="p0202" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[202] A tabela abaixo mostra claramente que o produto combinado aumentou a eficcia contra sarna, enquanto, ao mesmo tempo, a Graduao %tempo mostra um efeito positivo, ou seja, a quantidade de tubrculos maiores  aumentada, em que a combinao de Isotianil com Serenade e Penfluven como fungicida adicional , em particular, vantajosa.</span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/6a/f8/88/257e876bccb794/img0069.png" class="style-scope patent-text"><img id="i0069" wi="479" he="122" img-content="drawing" img-format="jpg" file="img0069.jpg" orientation="unknown" width="1916" height="488" alt="Figure img0069" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/6a/f8/88/257e876bccb794/img0069.png"></a></div>
		[202] The table below clearly shows that the combined product has increased efficacy against scabies, while at the same time, Graduation% time shows a positive effect, ie the number of larger tubers is increased, in which the combination Isotianil with Serenade and Penfluven as an additional fungicide is, in particular, advantageous. <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/6a/f8/88/257e876bccb794/img0069.png" class="style-scope patent-text"><img id="i0069" wi="479" he="122" img-content="drawing" img-format="jpg" file="img0069.jpg" orientation="unknown" width="1916" height="488" alt="Figure img0069" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/6a/f8/88/257e876bccb794/img0069.png"></a></div> 
  <p class="style-scope patent-text"></p>
</description>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
            <div class="flex flex-width style-scope patent-result">
              <section id="claims" class="style-scope patent-result">
                <h3 class="style-scope patent-result">
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Claims <span class="style-scope patent-result">(13)</span></div>
                    <div class="collapse style-scope patent-result">
                      Hide Dependent <iron-icon style="height: 15px; width: 15px;" icon="expand-less" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 8l-6 6 1.41 1.41L12 10.83l4.59 4.58L18 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </div>
                  </div>
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result"></div>
                    <div class="righthead style-scope patent-result">translated from Portuguese</div>
                  </div>
                </h3>
                <patent-text name="claims" enable-text-selection="" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><claims mxw-id="PCLM287442302" lang="EN" load-source="google" class="style-scope patent-text">
  <claim id="c0001" num="0001" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1. Mtodo para o controle de organismos bacterianos nocivos em plantas teis, caracterizado pelo fato de que compreende o tratamento das plantas com uma combinao compreendendo: (A) um indutor da defesa do hospedeiro selecionado do grupo que consiste em isotianil e acibenzolar-S-metil e (B) um agente de controle biolgico que  Bacillus subtilis cepa QST713/AQ713 (N de Acesso NRRL B21661) como ingredientes ativos em uma razo de peso sinrgistica de entre 100:0,1 e 100:1000 se o indutor da defesa do hospedeiro for isotianil e entre 20:0,1 e 20:500 se o indutor da defesa do hospedeiro for acibenzolar-S-metil.</span>1. Method for the control of harmful bacterial organisms in useful plants, characterized by the fact that it comprises the treatment of plants with a combination comprising: (A) an inducer of the defense of the host selected from the group consisting of isothianyl and acibenzolar-S- methyl and (B) a biological control agent that is Bacillus subtilis strain QST713 / AQ713 (NRRL Accession No. B21661) as active ingredients in a synergistic weight ratio of between 100: 0.1 and 100: 1000 if the inducer of host defense is isothianyl and between 20: 0.1 and 20: 500 if the host defense inducer is acibenzolar-S-methyl.</span>
    </claim-text>
  </claim>
  <claim id="c0002" num="0002" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">2. Mtodo, de acordo com a reivindicao 1, caracterizado pelo fato de que a razo de peso sinrgistica est entre 100:1,2 e 100:12 se o indutor da defesa do hospedeiro for isotianil e entre 20:1,2 e 20:6 se o indutor da defesa do hospedeiro for acibenzolar-S-metil.</span>2. Method, according to claim 1, characterized by the fact that the synergistic weight ratio is between 100: 1.2 and 100: 12 if the host defense inducer is isothianyl and between 20: 1.2 and 20 : 6 if the host defense inducer is acibenzolar-S-methyl.</span>
    </claim-text>
  </claim>
  <claim id="c0003" num="0003" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">3. Mtodo, de acordo com a reivindicao 1 ou 2, caracterizado pelo fato de que no tratamento das partes das plantas, as taxas de aplicao dos componentes (A) e (B) so entre 0,1 e 10000 g/ha; no tratamento de material de propagao vegetativa, as taxas de aplicao dos componentes (A) e (B) so entre 0,001 e 50 g por quilograma de material de propagao vegetativa; e no tratamento do solo, as taxas de aplicao dos componentes (A) e (B) so entre 0,1 e 10000 g/ha.</span>3. Method, according to claim 1 or 2, characterized by the fact that in the treatment of plant parts, the application rates of components (A) and (B) are between 0.1 and 10,000 g / ha; in the treatment of vegetative propagation material, the application rates of components (A) and (B) are between 0.001 and 50 g per kilogram of vegetative propagation material; and in soil treatment, the application rates of components (A) and (B) are between 0.1 and 10,000 g / ha.</span>
    </claim-text>
  </claim>
  <claim id="c0004" num="0004" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">4. Mtodo, de acordo com qualquer uma das reivindicaes 1 a 3, caracterizado pelo fato de que o indutor da defesa do hospedeiro  isotianil.</span>Method according to any one of claims 1 to 3, characterized by the fact that the host defense inducer is isothianil.</span>
    </claim-text>
  </claim>
  <claim id="c0005" num="0005" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5. Mtodo, de acordo com qualquer uma das reivindicaes 1 a 4, caracterizado pelo fato de que os organismos bacterianos nocivos so selecionados do grupo que consiste em Burkholderiaceae, Xanthomonadaceae, Pseudomonadaceae, Enterobacteriaceae, Microbacteriaceae e Rhizobiacea.</span>Method according to any one of claims 1 to 4, characterized by the fact that harmful bacterial organisms are selected from the group consisting of Burkholderiaceae, Xanthomonadaceae, Pseudomonadaceae, Enterobacteriaceae, Microbacteriaceae and Rhizobiacea.</span>
    </claim-text>
  </claim>
  <claim id="c0006" num="0006" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">6. Mtodo, de acordo com qualquer uma das reivindicaes 1 a 5, caracterizado pelo fato de que os organismos bacterianos nocivos so selecionados do grupo que consiste em Acidovorax avenae, Burkholderia spec., particularmente Burkholderia glumae, Corynebacterium, Erwinia spec., Liberibacter spp., Candidatus liberibacter spec., Pseudomonas spp., particularmente Pseudomonas syringae, Pseudomonas syringae pv. actinidae, Pseudomonas syringae pv. glycinea, Pseudomonas syringae pv. lachrymans, Pseudomonas syringae pv. tomato, Ralstonia spp., Streptomyces spp., Xanthomonas spp., particularmente Xanthomonas axonopodis, Xanthomonas axonopodis pv. citri, Xanthomonas axonopodis pv. glycines, Xanthomonas campestris, Xanthomonas campestris pv. musacearum, Xanthomonas campestris pv. pruni, Xanthomonas campestris pv. oryzae, Xanthomonas fragariae, Xanthomonas transluscens, e Xylella fastidiosa.</span>6. Method according to any one of claims 1 to 5, characterized by the fact that harmful bacterial organisms are selected from the group consisting of Acidovorax avenae, Burkholderia spec., Particularly Burkholderia glumae, Corynebacterium, Erwinia spec., Liberibacter spp ., Candidatus liberibacter spec., Pseudomonas spp., Particularly Pseudomonas syringae, Pseudomonas syringae pv. actinidae, Pseudomonas syringae pv. glycinea, Pseudomonas syringae pv. lachrymans, Pseudomonas syringae pv. tomato, Ralstonia spp., Streptomyces spp., Xanthomonas spp., particularly Xanthomonas axonopodis, Xanthomonas axonopodis pv. citri, Xanthomonas axonopodis pv. glycines, Xanthomonas campestris, Xanthomonas campestris pv. musacearum, Xanthomonas campestris pv. pruni, Xanthomonas campestris pv. oryzae, Xanthomonas fragariae, Xanthomonas transluscens, and Xylella fastidiosa.</span>
    </claim-text>
  </claim>
  <claim id="c0007" num="0007" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">7. Mtodo, de acordo com qualquer uma das reivindicaes 1 a 6, caracterizado pelo fato de que as plantas teis so selecionadas do grupo que consiste em mas, bananas, citros, kiwi, meles, pssegos, pras, abacaxi, pomidea, rom, repolho, couve-flor, pepinos, cucrbitas, tomates, batatas, trigo, arroz e soja.</span>7. Method according to any one of claims 1 to 6, characterized in that the useful plants are selected from the group consisting of apples, bananas, citrus, kiwi, melons, peaches, pears, pineapple, pome, pomegranate, cabbage, cauliflower, cucumbers, cucurbits, tomatoes, potatoes, wheat, rice and soy.</span>
    </claim-text>
  </claim>
  <claim id="c0008" num="0008" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">8. Mtodo, de acordo com qualquer uma das reivindicaes 1 a 7, caracterizado pelo fato de ser para o controle de Acidovorax avenae, Burkholderia glumae e/ou Xanthomonas campestris pv. oryzae em arroz, Candidatus liberibacter spec. e/ou Xanthomonas axonopodis pv. citri e/ou Xylella fastidiosa em ctricos, Pseudomonas syringae pv. actinidae em kiwi, Xanthomonas campestris e/ou Xanthomonas campestris pv. pruni em pssegos, Pseudomonas syringae pv. glycinea e/ou Xanthomonas axonopodis pv. glycines em soja, Burkholderia spec. e/ou Xanthomonas transluscens em cereais, Pseudomonas syringae, Pseudomonas syringae pv. tomato e/ou Xanthomonas campestris em tomates, Pseudomonas syringae e/ou Pseudomonas syringae pv. lachrymans em pepinos, Erwinia atroseptica, Erwinia caratovora e/ou Streptomyces scabies em batatas.</span>8. Method according to any one of claims 1 to 7, characterized by the fact that it is for the control of Acidovorax avenae, Burkholderia glumae and / or Xanthomonas campestris pv. oryzae in rice, Candidatus liberibacter spec. and / or Xanthomonas axonopodis pv. citri and / or Xylella fastidiosa in citrus, Pseudomonas syringae pv. actinidae in kiwi, Xanthomonas campestris and / or Xanthomonas campestris pv. pruni in peaches, Pseudomonas syringae pv. glycinea and / or Xanthomonas axonopodis pv. glycines in soybeans, Burkholderia spec. and / or Xanthomonas transluscens in cereals, Pseudomonas syringae, Pseudomonas syringae pv. tomato and / or Xanthomonas campestris in tomatoes, Pseudomonas syringae and / or Pseudomonas syringae pv. lachrymans in cucumbers, Erwinia atroseptica, Erwinia caratovora and / or Streptomyces scabies in potatoes.</span>
    </claim-text>
  </claim>
  <claim id="c0009" num="0009" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">9. Mtodo, de acordo com qualquer uma das reivindicaes 1 a 8, caracterizado pelo fato de que a planta tratada  tomate.</span>Method according to any one of claims 1 to 8, characterized in that the treated plant is tomato.</span>
    </claim-text>
  </claim>
  <claim id="c0010" num="0010" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10. Mtodo, de acordo com qualquer uma das reivindicaes 1 a 8, caracterizado pelo fato de que a planta tratada  batata.</span>Method according to any one of claims 1 to 8, characterized in that the treated plant is potato.</span>
    </claim-text>
  </claim>
  <claim id="c0011" num="0011" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">11. Mtodo, de acordo com a reivindicao 1, caracterizado por compreender a submisso das plantas a serem protegidas contra ataque por bactrias fitopatognicas a dois ou mais blocos de tratamento sequenciais, em que um bloco de tratamento compreende a submisso das plantas a um tratamento com um indutor da defesa do hospedeiro (A) como definido em qualquer uma das reivindicaes 1 a 10 e outro bloco de tratamento compreende a submisso das plantas a um tratamento com um agente de controle biolgico (B) como definido em qualquer uma das reivindicaes 1 a 10, desde que o ltimo bloco de tratamento compreenda a submisso das plantas a um tratamento com pelo menos um agente de controle biolgico.</span>11. Method, according to claim 1, characterized in that it comprises the submission of the plants to be protected against attack by phytopathogenic bacteria to two or more sequential treatment blocks, in which a treatment block comprises the submission of the plants to a treatment with a host defense inducer (A) as defined in any of claims 1 to 10 and another treatment block comprises subjecting the plants to treatment with a biological control agent (B) as defined in any of claims 1 to 10, provided that the last treatment block comprises the submission of the plants to a treatment with at least one biological control agent.</span>
    </claim-text>
  </claim>
  <claim id="c0012" num="0012" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">12. Mtodo, de acordo com a reivindicao 11, caracterizado pelo fato de que os respectivos blocos de tratamento so realizados durante estgios de crescimento diferentes das plantas.</span>12. Method according to claim 11, characterized by the fact that the respective treatment blocks are carried out during different growth stages of the plants.</span>
    </claim-text>
  </claim>
  <claim id="c0013" num="0013" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">13. Kit de partes para o controle de organismos bacterianos nocivos em plantas teis, caracteri zado por compreender: (A) um indutor da defesa do hospedeiro como definido na reivindicao 1, e (B) um agente de controle biolgico como definido na reivindicao 1, em uma razo de peso sinrgistica de entre 100:0,1 e 100:1000 se o indutor da defesa do hospedeiro for isotianil e entre 20:0,1 e 20:500 se o indutor da defesa do hospedeiro for acibenzolar-S-metil.</span>13. Kit of parts for the control of harmful bacterial organisms in useful plants, characterized by comprising: (A) a host defense inducer as defined in claim 1, and (B) a biological control agent as defined in claim 1 , at a synergistic weight ratio of between 100: 0.1 and 100: 1000 if the host defense inducer is isothianil and between 20: 0.1 and 20: 500 if the host defense inducer is acibenzolar-S- methyl.</span>
    </claim-text>
  </claim>
</claims>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
          </div>

          <div class="footer style-scope patent-result">

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="similarDocuments" class="scroll-target style-scope patent-result">
              Similar Documents
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication</span>
                    <span class="th style-scope patent-result">Publication Date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP6568059B2/en"><a id="link" href="#" class="style-scope state-modifier">JP6568059B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-08-28</span>
                    <span class="td style-scope patent-result">
  Use of combinations containing host defense inducers and biocontrol agents to control bacterial harmful microorganisms in useful plants
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR102243170B1/en"><a id="link" href="#" class="style-scope state-modifier">KR102243170B1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2021-04-22</span>
                    <span class="td style-scope patent-result">Use of host defense inducers for controlling bacterial harmful organisms in useful plants 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/TWI644617B/en"><a id="link" href="#" class="style-scope state-modifier">TWI644617B</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2018-12-21</span>
                    <span class="td style-scope patent-result">Binary fungicidal and bactericidal combinations 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN104302179A/en"><a id="link" href="#" class="style-scope state-modifier">CN104302179A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-01-21</span>
                    <span class="td style-scope patent-result">Use of host defense inducers for controlling bacterial harmful organisms in useful plants 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2015504077A5/en"><a id="link" href="#" class="style-scope state-modifier">JP2015504077A5</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2018-07-19</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/TW201521583A/en"><a id="link" href="#" class="style-scope state-modifier">TW201521583A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-06-16</span>
                    <span class="td style-scope patent-result">Use of dithiine-tetracarboximides for controlling bacterial harmful organisms in useful plants 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/BR122021026787B1/en"><a id="link" href="#" class="style-scope state-modifier">BR122021026787B1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2023-05-16</span>
                    <span class="td style-scope patent-result">
  USE OF BACILLUS SUBTILIS STRAIN QST 713, AND METHOD TO CONTROL FUSARIUM WILT IN PLANTS OF THE MUSACEAE FAMILY
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP6774575B2/en"><a id="link" href="#" class="style-scope state-modifier">JP6774575B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2020-10-28</span>
                    <span class="td style-scope patent-result">
  A phytotoxicity reducing agent containing a bactericidal compound as an active ingredient, and a herbicidal composition containing the phytotoxicity reducing agent and a herbicidal compound.
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/BR112016000238B1/en"><a id="link" href="#" class="style-scope state-modifier">BR112016000238B1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2021-03-09</span>
                    <span class="td style-scope patent-result">
  method for the control of harmful bacterial organisms in useful plants and kit of parts
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2015055554A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2015055554A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-04-23</span>
                    <span class="td style-scope patent-result">Active substance for treating seed and soil 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/BR112018071851B1/en"><a id="link" href="#" class="style-scope state-modifier">BR112018071851B1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2023-05-23</span>
                    <span class="td style-scope patent-result">
  USE OF FLUOPYRAM AND METHOD FOR CONTROLING FUSARIUM WITHELING IN PLANTS OF THE MUSACEAE FAMILY
 
     </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="relatedApplications" class="scroll-target style-scope patent-result">Priority And Related Applications</h3>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="appsClaimingPriority" class="scroll-target style-scope patent-result">
              Applications Claiming Priority (5)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Application</span>
                    <span class="th style-scope patent-result">Filing date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        EP13176096.9<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2013-07-11</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        EP13176096<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2013-07-11</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US201361859467P<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2013-07-29</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US61/859,467<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2013-07-29</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2015004260A1/en"><a id="link" href="#" class="style-scope state-modifier">PCT/EP2014/064873</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2014-07-10</span>
                    <span class="td style-scope patent-result">Use of combinations comprising host defense inducers and biological control agents for controlling bacterial harmful organisms in useful plants 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="legalEvents" class="scroll-target style-scope patent-result">
              Legal Events
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Date</span>
                    <span class="th style-scope patent-result">Code</span>
                    <span class="th style-scope patent-result">Title</span>
                    <span class="th style-scope patent-result">Description</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2018-02-27</span>
                    <span class="td nowrap style-scope patent-result">B06F</span>
                    <span class="td nowrap style-scope patent-result">Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]</span>
                    <span class="td style-scope patent-result">
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2019-05-21</span>
                    <span class="td nowrap style-scope patent-result">B06T</span>
                    <span class="td nowrap style-scope patent-result">Formal requirements before examination [chapter 6.20 patent gazette]</span>
                    <span class="td style-scope patent-result">
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2020-08-25</span>
                    <span class="td nowrap style-scope patent-result">B07A</span>
                    <span class="td nowrap style-scope patent-result">Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]</span>
                    <span class="td style-scope patent-result">
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2020-09-01</span>
                    <span class="td nowrap style-scope patent-result">B15K</span>
                    <span class="td nowrap style-scope patent-result">Others concerning applications: alteration of classification</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: AS CLASSIFICACOES ANTERIORES ERAM: A01N 43/80 , A01N 63/00 , A01N 1/00 , A01N 43/56</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ipc</strong>: A01N 43/80 (2006.01), A01N 63/00 (2020.01), A01N 4</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2021-01-05</span>
                    <span class="td nowrap style-scope patent-result">B09A</span>
                    <span class="td nowrap style-scope patent-result">Decision: intention to grant [chapter 9.1 patent gazette]</span>
                    <span class="td style-scope patent-result">
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2021-03-09</span>
                    <span class="td nowrap style-scope patent-result">B16A</span>
                    <span class="td nowrap style-scope patent-result">Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 10/07/2014,  OBSERVADAS AS CONDICOES LEGAIS.</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <div id="notices" class="vertical layout center style-scope patent-result">
              
                <span class="style-scope patent-result">Data provided by IFI CLAIMS Patent Services</span>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
          </div>
          <div class="bottombar style-scope patent-result">
            <bottom-bar class="style-scope patent-result"><template is="dom-if" class="style-scope bottom-bar"></template>
</bottom-bar>
          </div>
        </div>
      </div>
      <template is="dom-if" class="style-scope patent-result"></template>
    </div>
  </patent-result>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
  </result-container>
        </div>
      </div>
    
        </div>
      </div>
      <search-footer class="style-scope search-ui">
    
    

    <div id="footer" class="vertical layout center style-scope search-footer">
        <span class="links style-scope search-footer">
          <overlay-tooltip positioning-target="#footerAbout" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Learn more about data coverage, search syntax and other features.
    </div>
  </overlay-tooltip>
          <a id="footerAbout" data-proto="ABOUT" href="https://support.google.com/faqs/answer/6390996" target="_blank" class="style-scope search-footer">About</a>
          <overlay-tooltip positioning-target="#footerFeedback" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Send feedback about technical issues or feature requests for Google Patents.
    </div>
  </overlay-tooltip>
          <a id="footerFeedback" data-proto="SEND_FEEDBACK" href="#" onclick="sendFeedback();" class="style-scope search-footer">Send Feedback</a>
          <a data-proto="PUBLIC_DATASETS" href="https://console.cloud.google.com/marketplace/product/google_patents_public_datasets/google-patents-public-data" target="_blank" class="style-scope search-footer">Public Datasets</a>
          <a data-proto="TERMS" href="https://www.google.com/policies/terms/" target="_blank" class="style-scope search-footer">Terms</a>
          <a data-proto="PRIVACY_POLICY" href="https://www.google.com/privacy/privacy-policy.html" target="blank" class="style-scope search-footer">Privacy Policy</a>
          <a data-proto="SEARCH_HELP" href="https://support.google.com/websearch/" target="_blank" class="style-scope search-footer">Help</a>
        </span>
    </div>
  </search-footer>
    </div>

  </search-ui>
  </search-result>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <paper-toast id="toast" duration="3000" class="style-scope search-app x-scope paper-toast-0" aria-hidden="true" style="outline: none; display: none;">
    

    <span id="label" class="style-scope paper-toast"></span>
    
      <div id="noticeContent" class="style-scope search-app"></div>
    
  </paper-toast>
  </search-app>
    <script type="text/javascript" src="//www.gstatic.com/feedback/api.js"></script>
    <script type="text/javascript" src="//www.gstatic.com/feedback/js/help/prod/service/lazy.min.js"></script>
    <script type="text/javascript">
      if (window.help && window.help.service) {
        helpApi = window.help.service.Lazy.create(0, {apiKey: 'AIzaSyDTEI_0tLX4varJ7bwK8aT-eOI5qr3BmyI', locale: 'en-US'});
        window.requestedSurveys = new Set();
        window.requestSurvey = function(triggerId) {
          if (window.requestedSurveys.has(triggerId)) {
            return;
          }
          window.requestedSurveys.add(triggerId);
          helpApi.requestSurvey({
            triggerId: triggerId,
            enableTestingMode: false,
            callback: (requestSurveyCallbackParam) => {
              if (!requestSurveyCallbackParam.surveyData) {
                return;
              }
              helpApi.presentSurvey({
                productData: {
                  productVersion: window.version,
                  customData: {
                    "experiments": "",
                  },
                },
                surveyData: requestSurveyCallbackParam.surveyData,
                colorScheme: 1,
                customZIndex: 10000,
              });
            }
          });
        };

        window.requestSurvey('YXTwAsvoW0kedxbuTdH0RArc9VhT');
      }
    </script>
    <script src="/sw/null_loader.js"></script>
  

<iframe id="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.3773150179" name="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.3773150179" style="width: 1px; height: 1px; position: absolute; top: -100px; display: none;" src="https://scone-pa.clients6.google.com/static/proxy.html?usegapi=1&amp;jsh=m%3B%2F_%2Fscs%2Fabc-static%2F_%2Fjs%2Fk%3Dgapi.lb.en.IKZeRvoAYNY.O%2Fam%3DAAAQ%2Fd%3D1%2Frs%3DAHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw%2Fm%3D__features__#parent=https%3A%2F%2Fpatents.google.com&amp;rpctoken=236453411" tabindex="-1" aria-hidden="true"></iframe><iron-a11y-announcer>
    
    <div class="style-scope iron-a11y-announcer" aria-live="polite"></div>
  </iron-a11y-announcer></body></html>